ࡱ>  HJL ibjbjVV -<<US DD##)))***_,4-*lg33(#4#4#4ZZZ&)_YZ__###4#4%____##4)#4____&(#4v2;7*_Cd0_)Z:\_\]ZZZ_ZZZ____ZZZZZZZZZD M":  MINIMAL REQUIREMENTS FOR A CANCER SCREENING VISIT ASSESSMENTINITIAL VISITANNUAL VISITComprehensive Health History to include: Family history of breast/genital/colon-rectal cancers LMP or date of menopause Contraceptive method if childbearing age Documentation of HRT or ERT if menopausal Date of last Pap/mammogram and results Previous abnormal Pap, diagnostics, treatments Previous breast problems, diagnostics, treatments Assessment for breast/cervical cancer risk factors Required (Health History and Physical Examination Form ) Required (Interval Health History and Physical Examination Form) Physical Examination to include: Documentation of general appearance and mental status Height/Weight/BMI Blood pressure Clinical breast examination (Using MammaCare Technique) Pelvic examination that includes visualization of the vulva, vagina, cervix/vaginal cuff and thorough bimanual including adnexae Rectal exam (age 50 and as indicated for others) Other as neededRequiredRequiredLaboratory: Pap test (as indicated by age guidelines found later in this PHPR section)RequiredRequiredFecal occult blood testing (ages 50 and older) 3 kits given with instructions If positive, refer to M.D.RequiredRequiredHemoglobinIf indicatedIf indicatedSTD testingIf indicated by history/examIf indicated by history/examReferral for annual mammogram (age > 40)RequiredRequiredCounseling: (Documentation in medical record required) - ACH-40 (Improving Health for Women) CSEM given/counseled and patient verbalized understanding Monthly BSE/Annual CBE Pap/Mammogram rescreening recommendations Regular exercise Adequate diet (low fat, high fiber, 5 fruits/vegetables daily) Osteoporosis/prevention and bone density testing Risks/Benefits of HRT if menopausal Contraception if needed Smoking risks/cessation and referral Immunization needs/update STD risk counseling if indicated Ovarian Cancer Screening at age 50 (age 25 if family history) (Locations: UKMC; Hardin, Mason, Floyd, McCracken, and Pulaski County Health Centers) call 1-800-766-8279 for appt.RequiredRequiredDocumentation of Return Clinic AppointmentsRequiredRequiredFollow-up of Abnormal Test ResultsRequired Required KENTUCKYS WOMENS CANCER SCREENING PROGRAM OVERVIEW Public health has a unique opportunity to educate women on the benefits of early detection of breast and cervical cancer with self-breast examination, clinical breast examination, screening mammograms and pelvic examination with Pap test screening. Early detection of breast and cervical cancer with a corresponding decrease in mortality is dependent on periodic rescreening. A woman may be eligible for low cost breast and cervical cancer screening through the Kentucky Womens Cancer Screening Program (KWCSP) if she meets the following requirements: 21 to 64 years of age, household income less than 250% of the current annual federal poverty guideline and has no third party payer source (no Medicare, no Medicaid and no private health insurance). Women who receive cancer-screening services should be counseled on the importance of rescreening at recommended intervals. Services provided through the program include female adult preventive visits, cancer screening, diagnostic evaluation, patient education, and case management. All providers including contracted providers who receive state or federal funds from this program are expected and held accountable to abide by the written protocols. Protocols are based on grant requirements and the recommendations of the Medical Advisory Committees for Breast and Cervical Cancer. SCREENING SERVICES Licensed physicians, nurse practitioners or physician assistants are the preferred providers of cancer-screening services. However, if a preferred provider is unavailable, an R.N. who has completed and received certification from the DPH approved Breast and Cervical Cancer training course may provide cancer-screening services to meet the minimal requirements of the program. If the DPH adult physical assessment course has been completed as well, the nurse may also offer full adult preventive screenings. Breast and Cervical Cancer services may be provided as part of the complete adolescent or adult preventive visit or as an evaluation and management (E/M) office visit if the services provided only satisfy the minimal requirements of the program. A patient shall be counseled and encouraged to receive complete breast and cervical screenings when applicable. However, the patient has the right to refuse any part of her screening. Refusal of either breast or cervical services will not make her ineligible for the KWCSP or Breast and Cervical Cancer Treatment Program (BCCTP). The preceding page is a matrix detailing the required services needed to meet the minimal requirements for a cancer-screening visit. See the matrix on page 1 under the tab Preventive Guidelines-Adult for the full adult preventive visit requirements. REQUIREMENTS FOR ACCEPTING FOLLOW-UP REFERRALS FROM PROVIDERS Healthcare providers should be encouraged to refer uninsured women to the local health department as soon as possible to determine eligibility for the Kentucky Womens Cancer Screening Program (KWCSP). In the event a KWCSP eligible woman presents to the LHD for cancer-screening services, but has had a physical examination within the past 6 months that included CBE, Pelvic and Pap test from another healthcare provider, the following are requirements of the Kentucky Womens Cancer Screening Program. The woman must meet the eligibility requirements of the program and provide consent for services. The patient is responsible for bringing her records at time of visit or having them sent to LHD prior to the visit. This will enable the LHD provider to assess if all the minimum requirements were met. These records must include copies of the actual physical examination (including CBE and pelvic examination) and a copy of the Pap test result as well as any other pertinent laboratory work such as stool for occult blood, hemoglobin, blood sugar, and cholesterol results. (A note from a physician such as normal CBE needs mammogram is not acceptable for medical record documentation). The comprehensive health history form must be completed and reviewed with the patient. The height, weight, BMI and blood pressure should be obtained and recorded. If the physical examination portion of the visit was completed elsewhere (within past 6 months) the nurse or clinician shall document on the physical exam form See incoming records for the physical examination. If the provider has failed to provide documentation of ANY of the minimal requirements on the patient, the LHD is responsible for completing these components prior to referral for screening or diagnostic services. CBE must be performed at LHD if done >30 days prior to visit. It is imperative to know if the breast exam is normal or abnormal prior to determining if a screening or diagnostic mammogram is indicated. It is the responsibility of the LHD to educate providers as to the minimal referral requirements of the program in order to accept patients for screening and possibly follow-up diagnostic services. BREAST CANCER SCREENING & FOLLOW-UP Early diagnosis of breast cancer offers women more treatment options and greatly reduces mortality. Early diagnosis is aided by the triad of monthly breast self-exam, annual clinical breast exam and, if age appropriate, regular mammography screening. BREAST CANCER RISK FACTORS: Female age 40 or older First degree relative (mother, sister, daughter) with history of breast cancer before the age of 50 (pre-menopausal) Personal history of a benign breast condition Early menarche (prior to age 12) Late menopause (after age 52) No pregnancies or first pregnancy after age 30 Obesity and a high fat diet may also contribute to the development of breast cancer BREAST SCREENING HISTORY: Include dates and results of previous mammograms Elicit personal history of breast symptoms including pain, tenderness, nipple discharge, palpable mass or skin changes Document any personal history of breast cancer and previous biopsies or treatments Screen for risk factors (listed above) CLINICAL BREAST EXAMINATION AND MAMMOGRAPHY All females should be taught monthly SBE beginning at age 20. Counseling shall be documented in the medical record at the initial and annual visits. A clinical breast exam is recommended annually on all females beginning at age 20. The required method for performing the clinical breast exam and teaching SBE is the MammaCare Method using the principles of positioning, three levels of palpation, and recommended search patterns. Routine screening mammograms will begin at age 40 and are recommended on an annual basis. In menstruating women, the mammogram should be scheduled about 2 weeks after the LMP. Women age 30 and older with an abnormal clinical breast examination should be referred for a diagnostic mammogram. If the woman is under the age of 30, an ultrasound is usually preferred as a substitution for the mammogram due to the typically dense breast tissue hindering interpretation of the test; however the radiologist may choose to do a diagnostic mammogram in this age group if appropriate. Women with a family history (mother, sister or daughter) of pre-menopausal breast cancer (before the age of 50) and with a NORMAL CBE should begin yearly screening mammograms 10 years earlier than family members breast cancer diagnosis (no younger than age 25). If patient is unable to remember 1st degree family members age, begin screening mammogram at age 35. Women that have been diagnosed with either of 4 lesions; atypical hyperplasia, radial scar, papillomatosis, or lobular cancer in situ by biopsy, will need to begin annual screening mammograms. BREAST CANCER SCREENING & FOLLOW-UP (continued) Women with breast implants should be scheduled for an annual screening mammogram beginning at age 40 unless clinical complaint (i.e., pain in breast). Women that have had chest wall radiation will need to begin annual screening mammograms 10 years after radiation completed (no younger than age 25). Women post mastectomy will need annual diagnostic mammogram of the opposite breast. D. SURGICAL REFERRALS Women with an abnormal CBE must be referred for surgical consultation regardless of diagnostic mammogram or ultrasound results unless CBE is done by radiologist and found to be negative/benign. Thorough documentation by the radiologist shall be required. Any patient with a bloody nipple discharge (unilateral or bilateral) requires a referral to a surgeon for evaluation. Any patient with a spontaneous (without nipple stimulation) and/or unilateral nipple discharge requires a referral to a surgeon for evaluation. Bilateral non-bloody discharge that occurs only with nipple stimulation does not need referral to a surgeon. This type of nipple discharge may be due to fibrocystic changes (usually greenish), hormonal imbalance, pregnancy, lactation and some medications (oral contraceptives, phenothiazides, anti-hypertensives, tranquilizers). If the clinician (MD or ARNP) determines the need for further evaluation of this type of nipple discharge, it typically is to either a gynecologist or endocrinologist. If a patient presents with a breast lump that she has discovered on BSE but both the CBE and mammogram (or ultrasound) are normal, she does not need a referral to a surgeon. E. PATIENT EDUCATION ON BREAST HEALTH Counseling with documentation at the initial and annual visits shall include teaching BSE using the MammaCare method, individual breast cancer risk factors and the importance of annual CBE with regular mammogram screenings if age appropriate. Patients with either an abnormal CBE or mammogram result will have documented counseling done as appropriate. F. FOLLOW-UP Patients with an abnormal mammogram or ultrasound result shall be notified by the health department within 10 working days of receiving the result or within 30 days of the procedure, whichever comes first. Referrals for a surgical consult, requested additional mammography views or request for a breast ultrasound must be made within 3 weeks (21 days) of abnormal CBE or receipt of abnormal mammogram. A final diagnosis must be made within 60 days of the abnormal CBE or abnormal mammogram result (from date screened). Copies of results from consults & diagnostic procedures (including pathology reports) will be received and placed in the medical record within 60 days of the consult or diagnostic procedure. The month and year the next mammogram is due will be documented on the CH3A. TREATMENT Patients that have been screened/diagnosed through KWCSP may be eligible for the treatment fund if diagnosed with pre-cancer/cancer of breast. For more information and forms related to BCCTP, please refer to their website at HYPERLINK "http://chfs.ky.gov/dms/bcctp"http://chfs.ky.gov/dms/bcctp. To be eligible for Medicaid, an applicant or recipient shall be a citizen of the United States as verified through documented evidence presented during initial application as required in 907 KAR 1:011. The LHD shall verify patients identity and citizenship by viewing the patients driver license and birth certificate. For patients who were born in Kentucky and do not have a copy of their birth certificate or for more information about the citizenship documentation requirement, contact the Department for Medicaid Services at 502-564-6204. Other patients will need to contact Vital Statistics in their state of birth in order to obtain an original birth certificate. A passport may also be used for documentation of both identity and citizenship. Complete the Pre-screening Eligibility Form using the Medicaid Web application. Then, complete application and call Medicaid for confirmation number. The original signed application, Pre-screening Eligibility Form and proof of identity and citizenship should be maintained in the patients chart in the administrative section. As stated on the Department for Medicaid Services BCCTP website, some patients may require longer than the standard period of treatment and may be granted a Medicaid eligibility extension. An eligibility extension form (HYPERLINK "http://chfs.ky.gov/NR/rdonlyres/BEB8C3CD-9F59-40D0-9332-7F3C934FB514/0/MAP813D.pdf"MAP - 813D Breast and Cervical Cancer Treatment Program Extension) can be obtained from the department's Web site or by calling toll-free (866) 818-0073. During the initial BCCTP application process, the NCM shall inform the patient to contact the NCM two weeks prior to the end of her Medicaid eligibility period if her treatment plan will extend past that eligibility period. Extension requests must be initiated by the treating physician. The NCM will assist the physician in obtaining an extension form to complete on the patients behalf. When extension request review is completed, recipients will receive a notice of their new eligibility status. The link for information related to the BCCTP is http://chfs.ky.gov/dms/bcctp/. TREATMENT PROGRAM ELIGIBILITY INFORMATION A Pap test, mammogram, ultrasound or MRI does not provide a definitive diagnosis of pre-cancer or cancer. These are considered screening tests. Note: The KWCSP does not reimburse for an MRI. A patient must have a biopsy that confirms either a diagnosis of cancer or pre-cancer of the cervix or breast for her to be eligible for the BCCTP. Cancer or pre-cancer of the vagina, vulva, labia or uterine/endometrial lining do not make a patient eligible for the BCCTP. The BCCTP is for cancer or pre-cancer treatment of the breast or cervix for women diagnosed through the KWCSP. A biopsy result of CIN II Moderate Dysplasia or greater on a biopsy of the cervix is required for a patient to be considered eligible clinically for the BCCTP. Once the biopsy diagnosis is confirmed, the NCM will begin the process of ensuring that an application is completed for the patient to be enrolled with Medicaid (BCCTP). The NCM is responsible for initiating the BCCTP application when a final diagnosis has been received and patient eligibility determined. Support staff at the LHD may assist or perform the application process. Below, are some conditions that are considered pre-cancerous conditions when found on a biopsy. If the patient receives one of these diagnoses or a diagnosis of cancer, she is eligible for the BCCTP. Breast Pre-cancerous Conditions Lobular carcinoma-in-situ Atypical hyperplasia Benign Phylloides tumors Some types of papillomatosis Radial scar sometimes referred to as sclerosing lesions H. BI-RADS CLASSIFICATION OF MAMMOGRAM RESULTS AND MANAGEMENT Category 0: Assessment Incomplete This category indicates the need for additional imaging, which will be recommended by the radiologist or old films required for comparison. Category 1: Negative Recommendation should be made for routine follow-up according to the screening guidelines. Notify the patient when it is time for re-screening. (Refer to surgeon if CBE is abnormal) Category 2: Benign Finding Recommendation should be made for routine follow-up according to the screening guidelines. Notify the patient when it is time for re-screening. (Refer to surgeon if CBE is abnormal) Category 3: Probably Benign Follow-up should be provided according to the radiologists recommendation. Usually the radiologist will recommend a repeat mammogram in six months. Counsel the patient on the results of the mammogram and provide a re-screening appointment. (Refer to surgeon if CBE is abnormal) Category 4: Suspicious Abnormality A biopsy should be considered. Refer to a surgeon for further evaluation. Counsel the patient on the results of the mammogram and assure that arrangements are made for the surgical consultation. Category 5: Highly Suggestive of Malignancy There is probability of cancer. Refer to a surgeon for further evaluation. Counsel the patient on the results of the mammogram and assure that the arrangements are made for the surgical consultation. Category 6: Known Biopsy-Proven Malignancy-Appropriate Action Should Be Taken This category is reserved for lesions identified on the imaging study with biopsy proof of malignancy prior to definitive therapy. ALGORITHM FOR BREAST CANCER SCREENING FOLLOW-UP ANNUAL CLINICAL BREAST EXAMINATION    MOBILE MAMMOGRAPHY SCREENING GUIDELINES A requirement of the Kentucky Womens Cancer Screening Program (KWCSP), as previously noted in the PHPR, is to provide all income eligible women at least minimal services that include a health history, physical examination (including CBE, Pap and bimanual pelvic examination) and anticipatory guidance/counseling. With the expansion of the number and availability of mobile mammography units and the programs goal of increasing the numbers of income eligible women screened, it is necessary to address community mammography screenings arranged for or conducted by the LHD. It is strongly recommended that women have the minimum requirements including a clinical breast examination, Pap test, and pelvic examination prior to obtaining a mobile mammogram screening. However, it is understood that there are circumstances making this impractical. Examples of such circumstances may be the inability to get patients scheduled in the LHD clinics prior to the date the mobile unit is available, inadequate facilities or the lack of personnel available on the given screening day to perform examinations. The following are the minimal requirements necessary to comply with the KWCSP guidelines to receive reimbursement for community mobile mammography screenings that are restricted to women ages 40 and older who are income eligible and who lack insurance. PATIENT HISTORY Completion of ACH-16 that includes age, breast symptoms, family or personal history of breast cancer, previous breast biopsy and date of last mammogram. Completion of consent for services (CH-5). EXAMINATION Clinical breast examination using the MammaCare technique. Client with an abnormal CBE would not have screening mammogram on mobile mammography unit but must be referred for diagnostic mammogram and surgeon referral. COUNSELING/APPOINTMENT Minimal documentation in the medical record must include the patient has been counseled on the importance of monthly BSE, yearly CBE with mammogram and annual Pap test with pelvic. The patient may either be given an appointment to return to the clinic for completion of the minimal examination or given a number to call and make an appointment. The appointment for completion of the minimal requirements must be made within 60 working days of the date of the mobile mammogram screening. Once the patient keeps the appointment, routine protocols are to be followed. If the patient fails to keep the appointment for completion of the examination, appropriate follow-up must be provided. If the patient refuses an appointment or otherwise does not have the minimal requirements, the LHD must make an intensive effort to assure that she receives the services, meeting those requirements. Those efforts must be detailed in the patients chart. Evidence of those efforts is necessary in order for KWCSP to continue reimbursement for screening mammograms in the community setting. CERVICAL CANCER SCREENING & FOLLOW-UP Routine periodic screening encourages early identification of precancerous conditions of the cervix and early stage diagnosis of cervical cancer. Most cervical cancer can be PREVENTED with detection and early treatment of precancerous lesions. A. Cervical Cancer Risk Factors History of HPV and/or Dysplasia Multiple (3 or more) sexual partners in lifetime A sex partner with multiple sex partners A sex partner who has had a partner with HPV/dysplasia/cervical cancer Cigarette smoking (any amount) Beginning sexual intercourse at a young age (age 18 or less) History of 2 or more sexually transmitted infections Intrauterine exposure to diethylstilbestrol (DES) Infrequent screening (>5 years since last Pap) Immunosuppressed (HIV/AIDS, diabetes, transplant recipient, chronic steroid use, auto-immune disorders) B. CERVICAL SCREENING HISTORY 1. Elicit date and result of last Pap test 2. Determine if a previous history of an abnormal Pap and/or HPV 3. Determine if history of a previous colposcopy & biopsy and/or treatment 4. Screen for risk factors (listed above) 5. Screen for history of abnormal bleeding patterns Pelvic Examination The purpose of this section of the PHPR is to outline components of a pelvic exam, when to start screening, and how often to continue screening. The pelvic examination serves multiple purposes, including the assessment of the vulva, vagina, cervix, uterus and adnexa. The pelvic examination includes: inspection of the external genitalia, urethra and introitus; examination of the vagina and cervix; and bimanual examination of the uterus, cervix, adnexa and ovaries. If indicated, rectovaginal examination is performed as a part of the examination. Some health care providers incorporate the rectovaginal examination as part of the routine examination. Annual pelvic examination is a routine part of the preventive care for all women 21 years of age and older even if they do not need a Pap smear. A bimanual pelvic examination is generally not necessary at the initial reproductive health visit. A general physical examination, including an external genital examination, may be done because it allows assessment of secondary sexual development, reassurance and education. A teaching external-only genital examination can provide an opportunity to familiarize adolescents with normal anatomy, assess adequacy of hygiene and allow the health care provider an opportunity to visualize the perineum for any anomalies. Pelvic examination need only be performed in adolescents when it is likely to yield important information regarding conditions such as amenorrhea, abnormal bleeding, vaginitis, presence of a possible foreign body, pelvic pain, pelvic mass or a sexually transmitted disease (STD). If the patient has had sexual intercourse, screening for STDs is important. Refer to STD Guidelines in PHPR. Refer any abnormal finding on the pelvic examination to a mid level or higher clinician or a contracted gynecologist for further evaluation. Adapted from ACOG Committee Opinion, Number 431, May 2009. C. Cervical Cancer Screening Guidelines Pap tests beginning at 21 years of age (may be done earlier at clinicians discretion based on abnormal clinical findings). Perform Pap test before Genprobe specimens, wet mounts, or pelvic examination. If the patient is a minor with a potentially life-threatening test result (includes Adenocarcinoma-In-Situ, HSIL or ASC-H result) and cannot be contacted, the parent or guardian may be contacted (KRS 214.185(6)). Minors shall be made aware of this policy at the screening visit. Reschedule Pap test if patient is on her menses with heavy bleeding. May use small amount K-Y jelly on the outer surface of the speculum for patient comfort. The entire portio of the cervix must be visualized to obtain an adequate specimen. The sample from the portio should be taken first followed by the endocervical sample. Place collected material immediately in the liquid fixative container if doing a liquid-based Pap such as ThinPrep. If using the conventional method, the collected material should be applied uniformly to the slide without clumping and rapidly fixed to avoid air-drying which results in artifact and unsatisfactory specimens. For DES exposed patients, a smear from the upper two thirds of the vagina should be obtained in addition to the cervix on an annual basis. In those patients who are post hysterectomy: With a cervical stump continue cervical Pap tests as recommended. Without a cervical stump: Cessation of Screening: Women who have had a hysterectomy with removal of the cervix for benign reasons (benign gyn disease such as fibroids) and with no history of abnormal or cancerous cell growth may discontinue routine cytology testing (Pap tests). Women with a total hysterectomy still need to have annual vulvar/vaginal exam, CBE, and mammogram visits. Exceptions of cessation: Women with the following conditions should be screened annually regardless of their age: immunosuppression (i.e., renal transplant, etc.), HIV infection, DES exposure in utero or unknown Pap test screening history. Patients with a history of cervical cancer or treatment for CIN 2 or CIN 3 need annual screening for the next 20 years. 8. Always complete the laboratory form in its entirety including LMP, contraceptive method, HRT/ERT and previous abnormal Pap tests or diagnostic/treatment procedures. D. The Bethesda 2001 System The Bethesda System for reporting cervical and/or vaginal cytology is the recognized system for reporting results. The LHD is required to contract with a laboratory that uses this system of reporting. The state computerized reporting options for Pap test findings, and the protocols for management of abnormal findings are based on the Bethesda 2001 System. Specimen Adequacy Satisfactory Unsatisfactory CERVICAL CANCER SCREENING & FOLLOW-UP (continued) General Categorization Negative for Intraepithelial Lesion or Malignancy (NIL) Epithelial Cell Abnormality Negative for intraepithelial lesion or malignancy Negative for Intraepithelial Lesion or Malignancy with: Presence of Organisms Trichomoniasis Candida Shift in vaginal flora suggestive of bacterial vaginosis Bacterial morphology consistent with Actinomyces Cellular changes consistent with Herpes simplex virus Reactive cellular changes Inflammation Radiation effects IUD effects Metaplasia (normal) Atrophy Epithelial Cell Abnormalities present Squamous Cell Abnormality Atypical Squamous Cells of Undetermined Significance (ASC-US) Atypical Squamous Cells cannot exclude a High-Grade Lesion (ASC-H) Low Grade Squamous Intraepithelial Lesion (CIN I, Mild Dysplasia, HPV) (LSIL) High Grade Squamous Intraepithelial Lesion (CIN II, CIN III, Moderate Dysplasia, Severe Dysplasia, Carcinoma-In-Situ/CIS) (HSIL) Squamous Cell Carcinoma Glandular Cell Abnormality (AGC) Atypical endocervical, glandular or endometrial cells Adenocarcinoma-In-Situ or Adenocarcinoma PATIENT EDUCATION ON CERVICAL HEALTH Counseling on cervical cancer risk factors and risk reduction (including smoking cessation) during screening visits is required. If Pap test results reveal HPV or dysplasia, the patient is to be counseled on HPV and smoking (as a co-factor in developing cervical cancer). Also counsel on the increased exposure risks with multiple partners. These patients must have documented counseling as appropriate. FOLLOW-UP Patients with abnormal Pap test shall be notified within 10 working days from the date the Pap test is received at the clinic. Referral appointments must be made within 3 weeks (21 days) of the clinic receiving the abnormal Pap test result. Any delay in meeting this timeframe must be documented in the patients medical record, including any 1st available appointment A final diagnosis must be made within 60 days of the Pap test screening. The final diagnosis is based on colposcopy and biopsy results. Results of referrals including colposcopy, biopsy path reports, cryotherapy, LEEP procedure and pathology reports, CKC procedure and pathology reports and Laser treatment documentation must be received within 60 days of the procedure. The month and year the next Pap test is due is to be documented on the progress note. ABNORMAL PAP TEST REFERRAL AND MANAGEMENT Local health departments will provide (either onsite or by offsite provider) for diagnostic evaluation of the following Pap results: High Grade Squamous Intraepithelial Neoplasia (CIN II, CIN III, CIS). Atypical Glandular (Includes atypical endocervical and atypical endometrial) Cells of Undetermined Significance (AGC) Squamous Cell Carcinoma or Carcinoma-In-Situ Adenocarcinoma-In-Situ or Invasive Adenocarcinoma Low Grade Intraepithelial Neoplasia (CIN I, Condyloma) (LSIL) ASC-H (Atypical Squamous Cells: Cannot Exclude High-Grade SIL) Atypical Squamous Cells of Undetermined Significance (ASC-US) All colposcopy providers are expected to have at least an 85% correlation between the Pap and biopsy result. The contracted provider should review the cytology, colposcopy and histology results when no lesion or only biopsy-confirmed CIN 1 is identified after coloposcopy in women with HSIL Pap test results. If the review yields a revised interpretation, management should follow American Society for Colposcopy and Cervical Pathology (ASCCP) guidelines for the revised interpretation; if a cytological interpretation of HSIL is upheld or if review is not possible, a diagnostic excisional procedure (e.g., LEEP) is preferred in non-pregnant patients. Benign glandular cells in a post hysterectomy female is normal and does not require further evaluation unless the cells are atypical glandular. If a negative (for intraepithelial lesion or malignancy) Pap test is received without endocervical cells or lacking a transformation zone (TZ), repeat the Pap within 6 months if: a) the patient has a prior Pap result of ASC-US or greater without 3 negative follow-up Pap test results (at least one of which contained an EC/TZ component) b) a previous Pap with unexplained glandular abnormality c) a positive high-risk/oncongenic human papillomavirus (HPV) test within 12 months d) clinician inability to clearly visualize the cervix or sample the endocervical canal e) immunosuppression f) insufficient previous screening (not participating in at least routine screening). Otherwise, repeat at next annual pelvic examination. Refer patient if abnormal cervix or polyps visualized. A result of endometrial cells in a woman past age 40 requires a consult with the contracted provider if she is having abnormal bleeding or is post menopausal and not using hormone replacement therapy; otherwise repeat Pap test at next regular visit. TREATMENT Patients that have been screened/diagnosed through KWCSP may be eligible for the treatment fund if diagnosed with pre-cancer/cancer of cervix (includes endocervical). For more information and forms related to BCCTP, please refer to their website at HYPERLINK "http://chfs.ky.gov/dms/bcctp"http://chfs.ky.gov/dms/bcctp. To be eligible for Medicaid, an applicant or recipient shall be a citizen of the United States as verified through documented evidence presented during initial application as required in 907 KAR 1:011. The LHD shall verify patients identity and citizenship by viewing the patients driver license and birth certificate. For patients who were born in Kentucky and do not have a copy of their birth certificate or for more information about the citizenship documentation requirement, contact the Department for Medicaid Services at 502-564-6204. Other patients will need to contact Vital Statistics in their state of birth in order to obtain an original birth certificate. A passport may also be used for documentation of both identity and citizenship. Complete the Pre-screening Eligibility Form using the Medicaid Web application. Then, complete application and call Medicaid for confirmation number. The original signed application, Pre-screening Eligibility Form and proof of identity and citizenship should be maintained in the patients chart in the administrative section. As stated on the Department for Medicaid Services BCCTP website, some patients may require longer than the standard period of treatment and may be granted a Medicaid eligibility extension. An eligibility extension form (HYPERLINK "http://chfs.ky.gov/NR/rdonlyres/BEB8C3CD-9F59-40D0-9332-7F3C934FB514/0/MAP813D.pdf"MAP - 813D Breast and Cervical Cancer Treatment Program Extension) can be obtained from the department's Web site or by calling toll-free (866) 818-0073. During the initial BCCTP application process, the NCM shall inform the patient to contact the NCM two weeks prior to the end of her Medicaid eligibility period if her treatment plan will extend past that eligibility period. Extension requests must be initiated by the treating physician. The NCM will assist the physician in obtaining an extension form to complete on the patients behalf. When extension request review is completed, recipients will receive a notice of their new eligibility status. The link for information related to the BCCTP is http://chfs.ky.gov/dms/bcctp/. TREATMENT PROGRAM ELIGIBILITY INFORMATION A Pap test, mammogram, ultrasound or MRI does not provide a definitive diagnosis of pre-cancer or cancer. These are considered screening tests. Note: The KWCSP does not reimburse for an MRI. A patient must have a biopsy that confirms either a diagnosis of cancer or pre-cancer of the cervix or breast for her to be eligible for the BCCTP. Cancer or pre-cancer of the vagina, vulva, labia or uterine/endometrial lining do not make a patient eligible for the BCCTP. The BCCTP is for cancer or pre-cancer treatment of the breast or cervix for women diagnosed through the KWCSP. A biopsy result of CIN II Moderate Dysplasia or greater on a biopsy of the cervix is required for a patient to be considered eligible clinically for the BCCTP. Once the biopsy diagnosis is confirmed, the NCM will begin the process of ensuring that an application is completed for the patient to be enrolled with Medicaid (BCCTP). The NCM is responsible for initiating the BCCTP application when a final diagnosis has been received and patient eligibility determined. Support staff at the LHD may assist or perform the application process. Below, are some conditions that are considered pre-cancerous conditions when found on a biopsy. If the patient receives one of these diagnoses or a diagnosis of cancer, she is eligible for the BCCTP. Cervical Pre-cancerous Conditions High grade squamous epithelial lesions (CIN II Moderate Dysplasia, CIN lll Severe Dysplasia/ Carcinoma in Situ) Adenocarcinoma-in-Situ LOOP ELECTRICAL EXCISION PROCEDURE (LEEP), Diagnostic vs Treatment A local surgical procedure known as a LEEP or a HYPERLINK "http://en.wikipedia.org/wiki/Cervical_conization" \o "Cervical conization"cone biopsy can be considered either a diagnostic or treatment procedure. A patients colposcopy biopsy may be benign, show mild dysplasia or a biopsy may not be performed. However, a physician may determine that it is necessary to perform a LEEP to obtain a more comprehensive or accurate specimen. When a patients colposcopy biopsy is benign, mild or a biopsy was not performed, a LEEP would be considered a diagnostic procedure and would be covered under the KWCSP. When a LEEP procedure is performed on a patient who had a colposcopy diagnosis of CIN ll Moderate Dysplasia or greater, the LEEP would be considered treatment and should be covered under the BCCTP. The NCM should ensure that the patient begins the application process for the BCCTP after receiving the colposcopy diagnosis. Age Delineated Cervical Cancer Screening Schedule EMBED Word.Document.12 GUIDELINES FOR COLLECTING A CERVICAL SPECIMEN FOR PAP TESTING Physicians, Nurse Practitioners, Physician Assistants, and Registered Nurses who have received formal training and certification through the Department for Public Health Breast and Cervical Cancer Screening Program may perform Pap tests and pelvic examinations. A. Ideal conditions for collecting a Pap test specimen Patient is NOT on her menses Cervix is NOT contaminated with lubricants, creams, infection, or semen May use small amount of K-Y jelly on the outer surface of the speculum for patient comfort. The patient has NOT douched within the past 48 hours Cervix does NOT have abrasions from contraceptives, douching, or sex Pap test should be taken before Genprobe or wet mount specimens Pap test done prior to the pelvic examination B. Instruction to the Patient Do NOT douche, have sex, or put anything into the vagina for at least 48 hours prior to the Pap test. Make the appointment for the Pap test 12 weeks after the menstrual period. Pap tests recommended beginning at 21 years of age (may be done earlier at clinicians discretion based on abnormal clinical findings) C. Laboratory equipment needed (usually provided by the contracted lab) Glass slides with frosted ends Ayre spatula for the ectocervical component (plastic or wooden) Endocervical brush (or cotton swab if pregnant) Cervical broom Fixative (either spray or liquid; hairspray not to be used) Mailers or transport materials, collection and report forms D. Instruction to the Provider Obtain Pap specimen BEFORE wet mounts, Genprobe, etc. Every Pap test report shall have the date received recorded on the hard copy and the nurse initial that she/he has reviewed prior to entering the results in the PSRS system or placing the report into the patients medical record. A tracking system is required to account for all tests. Lab forms must be complete including LMP, previous abnormal Paps and other as required by the lab. This assists the lab in the interpretation of the test. Alternative positioning of the patient, other than lithotomy, may be necessary for disabled individuals. If you have difficulty locating the cervix you may need to use a larger speculum, digitally locate the cervix, or have a second provider attempt. Gentleness and respect for the patient should always be the unspoken rule. Any visible lesion of the cervix should be referred to the contracted gynecologist. If the guidelines require follow-up Pap test, DO NOT repeat prior to the recommended time to allow time for the cells to regenerate. MANAGEMENT OF ABNORMAL PAP TEST RESULTS (Numbers correspond to PSRS submission) #1 SATISFACTORY / NEGATIVE FOR INTRAEPITHELIAL LESION For women 21 to 29 years old repeat every 2 years depending on patients cervical diagnostic history. Three consecutive negative Pap tests are not required prior to beginning screening every 2 years for this age range. For women 30 to 64 years old, repeat annually until 3 consecutive negatives then may repeat every 3 years depending on patients cervical diagnostic history. Repeat in women without a cervix as indicated (see under Cervical Cancer Screening guidelines) SATISFACTORY/ NEGATIVE FOR INTRAEPITHELIAL LESION WITH PRESENCE OF ORGANISMS OR REACTIVE CELLULAR CHANGES: Clinician consult to decide if treatment is indicated Repeat Pap test at next scheduled screening #2 ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE (ASC-US) Per ASCCP guidelines, the standard of care is that the woman can be referred for repeat Pap in 6 and 12 months or referral for immediate colposcopy. Contact the contracted provider to discuss the plan of care for follow-up. Document the providers order on the CH3-A. ACS-US or greater result on either 6 or 12 month repeat Pap requires colposcopic evaluation. If both tests are negative, return to routine screening. Please note that another standard of care, per ASCCP, is high-risk HPV DNA testing. The HPV DNA testing CPT code, 87621, is a reimbursable procedure if used in the following cases for women 30 and over: 1a) Follow-up of an ASC-US result from the screening exam; 1b) Surveillance at one year following an LSIL Pap test and no CIN 2, 3 on colposcopy-directed biopsy. If testing for High Risk HPV DNA in patients age 30 and over is done: If negative, repeat Pap test yearly until 3 documented annual normal Pap tests then every 3 years (See screening algorithm) If positive, then refer for colposcopy. In patients 21 to 29 years old, HPV DNA testing can be used only for triage of an ASCUS Pap patient to determine if colposcopy is needed. The KWCSP does not reimburse for HPV DNA testing in this age group. If positive, then refer for colposcopy. If negative, repeat Pap test in 12 months. Patients with ASCUS Pap results in this age group (21-29 years old) can also be managed by repeat cytology (Pap test) at 6 months and 12 months without HPV DNA testing. For patients under 21 who were screened prior to the 2009 ACOG screening guideline changes, no follow-up required and patient should return for annual Pap screening until age 21. #3 ATYPICAL SQUAMOUS CELLS CANNOT RULE OUT HIGH GRADE (ASC-H) Refer for colposcopy evaluation and biopsy when indicated. For patients under 21 who were screened prior to the 2009 ACOG screening guideline changes, refer patient to your contracted provider for ASC-H Pap results. #4 LOW GRADE INTRAEPITHELIAL NEOPLASIA (CIN I, Mild dysplasia, HPV) (LSIL) Refer for colposcopy evaluation For patients under 21 who were screened prior to the 2009 ACOG screening guideline changes, no follow-up required and patient should return for annual Pap screening until age 21. #5 HIGH GRADE INTRAEPITHELIAL NEOPLASIA (CIN II, CIN III, Moderate-Severe dysplasia, or carcinoma-in-situ) (HSIL) Refer for colposcopy evaluation or LEEP. The contracted provider shall perform a review of the cytology, colposcopy, and histology results when no lesion or only biopsy-confirmed CIN 1 is identified after colposcopy in women with HSIL Pap test reports. If the review yields a revised interpretation, management should follow guidelines for the revised interpretation; if a cytological interpretation of HSIL is upheld or if review is not possible, a diagnostic excisional procedure (e.g., LEEP) is preferred in nonpregnant patients. For patients under 21 who were screened prior to 2009 ACOG screening guideline changes, refer patient to your contracted provider for HSIL Pap results. #6 SQUAMOUS CELL CARCINOMA Refer to a qualified provider #7 ADENOCARCINOMA OR ADENOCARCINOMA-IN-SITU Refer to a qualified provider #8 UNSATISFACTORY Repeat Pap between 816 weeks (24 months) #9 ATYPICAL GLANDULAR CELLS OF UNDETERMINED SIGNIFICANCE (AGC) Atypical Endometrial Cells: Refer for colposcopy with ECC. Endometrial biopsy is also indicated. Consider HPV DNA testing for a Pap result of Atypical Glandular Cells; however KWCSP does not reimburse for HPV DNA testing for Atypical Glandular Cells on a Pap result. All Subcategories (except atypical endometrial cells): Refer to contracted providers for colposcopy with ECC, HPV testing and endometrial sampling if age 35 and older or at risk for endometrial neoplasia (includes abnormal vaginal bleeding or conditions suggesting chronic anovulation). HPV DNA testing will be reimbursed for all subcategories of AGC except Atypical Endometrial Cells if age 35 and older or at risk for endometrial neoplasia. The 2006 Consensus Guidelines for cervical follow-up are on the American Society for Colposcopy and Cervical Pathology website at HYPERLINK "http://www.asccp.org/"http://www.asccp.org/. FOLLOW-UP PAP TESTS AFTER COLPOSCOPY EVALUATION OR TREATMENT A. Post Colposcopy Plan: observation for neg, ascus, or LSIL BIOPSY Following a patient with Pap tests only (that has had confirmation of LSIL with cervical biopsy) has become an acceptable standard of care. To avoid unnecessary procedures (and their possible adverse effects) clinicians following standardized guidelines are now choosing not to treat these patients with Cryotherapy, Laser, or LEEP. Observational management is acceptable unless the lesion extends into the endocervical canal, the Pap test remains ASC-US or progresses to a higher-grade lesion or the lesion does not spontaneously resolve after 1824 months. For women being followed with observation for LSIL (confirmed with the diagnostic colposcopy and biopsy) a Pap test shall be repeated at 6 - 12 months. If repeat Pap is ASCUS or greater, refer for colposcopy. Or, HPV DNA testing may be peformed at 12 months. If HPV DNA testing is negative, return to routine screening. If HPV testing is positive refer for colposcopy. KWCSP does not reimburse for HPV DNA testing for a LSIL Pap result except for at one year surveillance. Observation only is not the standard of care for women with biopsy confirmed high-grade lesions. Follow-up colposcopy will not be paid for by the KWCSP outside of the PHPR protocols. However, if the colposcopist prefers to follow the patient with additional colposcopy examinations and/or perform their own Pap tests it will be considered for reimbursement by the KWCSP on an individual basis. There may be an occasion when a physician may choose to perform a LEEP on a patient with a negative colposcopy biopsy or when no biopsy was performed during the colposcopy. Reimbursement for a LEEP in these circumstances may be approved on a case-by-case basis. Information necessary for consideration of reimbursement shall be obtained from the provider by the NCM prior to contacting the Clinical Coordinator for consideration of payment for these services. The health department will be responsible for obtaining copies of the Pap tests performed outside of the clinic. B. POST COLPOSCOPY PLAN: FOLLOWING TREATMENT If the patient has had Cryotherapy, Laser, LEEP, or a Cold Knife Conization (CKC) or hysterectomy (with removal of cervix and uterus) for treatment of CIN 2 or CIN 3 or cervical cancer, a Pap test will be repeated at the health department every 6 months for 1 year after treatment Pap should be repeated annually for 20 years after treatment. (If abnormal result, refer to Management of Abnormal Pap Test Results) If the provider and patient make a decision to have the Pap tests performed at the physicians office this will be considered for reimbursement by the KWCSP on an individual basis. The health department will be responsible for obtaining Pap results from the provider. DIAGNOSTIC SERVICES The Kentucky Womens Cancer Screening Program covers most but not all diagnostic services on income eligible women for the screening test results listed below. Sometimes, a screening or diagnostic test result will have multiple diagnoses or results. When reading a test result, the NCM must always use the more severe diagnosis for planning diagnostic referrals or determining eligibility for the BCCTP. As a federally funded program, KWCSP is forbidden to use program funds to pay for diagnostic services on women with Medicaid, Medicare, or private insurance. Mammogram Results (Screening or Diagnostic) The corresponding number reflects the universal BI-RADS reporting system 0 - Assessment Incomplete 3 - Probably Benign 4 - Suspicious Abnormality 5 - Highly Suggestive of Malignancy 6- Known Biopsy-Proven Malignancy Ultrasound Results 0-Needs additional imaging evaluation 3-Probably Benign Finding 4- Suspicious Abnormality 5-Highly Suggestive of Malignancy 6- Known Biopsy-Proven Malignancy Abnormal Clinical Breast Examination Includes discrete masses or abnormal nipple discharge but excludes normal nodularity and/or fibrocystic changes Pap Test Results The corresponding number reflects reporting used in PSRS #2 ASC-US x2 consecutive #3: ASC-H #4: Low Grade Squamous Intraepithelial Lesion-LSIL #5: High Grade Squamous Intraepithelial Lesion HSIL #6: Squamous Cell Carcinoma #7: Adenocarcinoma or Adenocarcinoma-In-Situ #9: AGC (Atypical Glandular Cells of Undetermined Significance) The following page is a list of the screening and diagnostic procedures covered by the KWCSP. They are listed by CPT code in numerical order. These procedures must be provided for all women enrolled in the program who meet eligibility requirements either on-site (if applicable) or with a contracted provider. To make best use of limited resources, it is necessary that all cancer screening and preventive visits as well as Pap tests following diagnostics/treatments be performed at the local health department. The following list does not include reimbursement rates and is not intended to replace the Kentucky Womens Cancer Screening Program Approved CPT Codes and Reimbursement Rates for Breast and Cervical Cancer Screening Follow-up. REQUIRED DIAGNOSTIC PROCEDURES AS INDICATED BY THE ABNORMAL TEST RESULT (May be provided either on site or off site as appropriate) Kentucky Women's Cancer Screening ProjectApproved CPT Codes Breast and Cervical Cancer Screening and Follow-upCost Center-CPT CodeService DescriptionMinor Obj00400 (anesthesiology, breast follow up (base rate per unit cost)813-20500940 *(anesthesiology, cervical follow up (base rate per unit cost)813-20510021fine needle aspiration without image813-30410022fine needle aspiration with image813-30419000cyst aspiration (puncture)813-30419001cyst aspiration, additional813-30419030 *injection procedure only for ductogram or galactogram813-30419100breast biopsy, needle core no imaging guidance813-30419101breast biopsy, incisional, open813-30419102percutaneous, needle core, using imaging guidance813-30419103percutaneous, automated vacuum assisted813-30419120 excision of breast tissue813-30419125 excision of tissue identified preoperatively813-30419126 excision of tissue identified preoperatively, additional813-30419290preoperative placement of needle wire813-30419291preoperative placement of needle wire, additional813-30419295image guided placement813-30457452colposcopy of cervix, upper/adjacent vagina700-30557454colposcopy with biopsy of cervix & endocervical curettage700-30557455colposcopy with biopsy of the cervix700-30557456colposcopy with endocervical curettage700-30557460 colposcopy with loop electrode excision of cervix700-30557461 colposcopy with loop electrode conization of cervix813-30557500 biopsy or excision of lesion, with or without fulguration813-30557505 endocervical curettage813-30557510 *cauterization of cervix813-30557511 *Cryocautery700-30557513 *laser ablation813-30557520 conization of cervix813-30557522 loop electrode excision813-30558100 endometrial biopsy (only when linked with AGUS result)700-30558110 *eendometrial biopsy performed in conjunction with colposcopy700-305S0613 *Clinical Breast Exam700-11077052 *CAD for use with screening mammogram (use in conjunction with 77057 or G0202)813-304/30877053 *Ductogram813-30477054 *ductogram, multiple ducts813-30477055diagnostic mammogram, unilateral813-304/30877056diagnostic mammogram, bilateral813-304/30877057screening mammogram813-308G0202 ddigital mammography813-308G0204 ddiagnostic digital mammography, bilateral813-304/308G0206 ddiagnostic digital mammography, unilateral813-304/30877031 stereotactic localization for breast biopsy813-30477032 preoperative placement of needle wire, interpretation813-30476098radiologic examination, breast surgical specimen813-30476645ultrasound (breast echography)813-309 76937 *ultrasonic guidance for cyst aspiration 813-30476942ultrasonic guidance for needle biopsy (use in conjunction with 19000 or 19001)813-30487621 apapillomavirus, human, amplified probe technique (Hybrid Capture II from Digene-HPV Test)718-30588104 *bcytopathology, fluids, washings or brushings (breast)718-30488141pap smear, requiring interpretation by physician (abnormals only)718-30588142pap smear, thin layer preparation, manual screening 718-30588143 *pap smear, thin layer preparation, manual screening and rescreening 718-30588164pap smear, technical component718-25088172evaluation of fine needle aspiration813-30488173interpretation and report of fine needle aspiration813-30488174 *pap smear, thin layer preparation, automated 718-30588175 pap smear, thin layer preparation, automated & manual718-30588305surgical pathology, gross and microscopic examination813-304/30588307surgical pathology, associated with LEEP or breast excision requiring evaluation of margins813-30588331 *pathology consultation during surgery, first tissue block, with frozen section(s), single specimen813-30588332 *pathology consultation during surgery, each additional tissue block with frozen section(s)813-30599201 cinitial-brief evaluation/management700-20199202 cinitial-expanded evaluation/management700-20199203 cinitial-detailed evaluation/management700-20199204 *cinitial-comprehensive evaluation/management700-20199205 *ccomplex-evaluation/management700-20199211 csubsequent-brief evaluation/management700-20199212 csubsequent-limited evaluation/management700-20199213 csubsequent-expanded evaluation/management700-20199214 *csubsequent-detailed evaluation/management700-20199215 *csubsequent-comprehensive evaluation/management700-20199385 *cinitial preventative medicine evaluation 21 - 39 yrs700-20199386 cinitial preventative medicine evaluation 40 - 64 yrs700-20199387 *cinitial preventative medicine evaluation 65 and older700-20199395 *cperiodic preventative medicine evaluation 21 - 39 yrs700-20199396 cperiodic preventative medicine evaluation 40 - 64 yrs700-20199397 *cperiodic preventative medicine evaluation 65 and older700-201W9201 initial-brief evaluation/management700W9202 initial-expanded evaluation/management700W9203 initial-detailed evaluation/management700W9204 *initial-comprehensive evaluation/management700W9205 *complex-evaluation/management700W9211 subsequent-brief evaluation/management700W9212 subsequent-limited evaluation/management700W9213 subsequent-expanded evaluation/management700W9214 *subsequent-detailed evaluation/management700W9215 *subsequent-comprehensive evaluation/management700W9385 *initial preventative medicine evaluation 21 - 39 yrs700W9386 initial preventative medicine evaluation 40 64 yrs700W9387 *initial preventative medicine evaluation 65 and older700W9395 *periodic preventative medicine evaluation 21 - 39 yrs700W9396 periodic preventative medicine evaluation 40 - 64 yrs700W9397 *periodic preventative medicine evaluation 65 and older700W0166 *charge for use of hospital room (outpatient)813-31199241office consultation (minimal level) outside provider813-201/20299242office consultation (low level) outside provider813-201/20299243office consultation (low-moderate level) outside prov.813-201/20299244office consultation (moderate level) outside provider813-201/202( Maximum 4 units up to 1 hour* Covered by State Funds only a The HPV DNA testing CPT code, 87621, is a reimbursable procedure if used in the following cases for women 30 years and older: 1a) Follow-up of an ASC-US result from the screening exam; 1b) Surveillance at one year following an LSIL Pap test and no CIN 2, 3 on colposcopy-directed biopsy; and 2) In the initial workup of women 35 years and older or at risk for endometrial neoplasia with ATYPLICAL GLANDULAR CELLS OF UNDETERMINED SIGNIFICANCE (AGC) (except atypical endometrial cells), a colposcopy, HPV DNA Test and Endometrial Sampling shall be performed. b Effective October 1, 2001, this pathology code is not to be used on routine breast cysts (clear fluid/disappears on ultrasound). Only to be used for cases with bloody/abnormal fluid or cysts that does not disappear on ultrasound.c When this evaluation/management or preventative service is performed in-house by a Registered Nurse, code W920- should be billed instead of 9920- for a new patient and code W921- instead of 9921- for established patients.d Digital mammography is approved at the conventional film rate per CDC 10/6/05.e Use code 58110 in conjunction with 57452, 57454-57456, and 57460-57461. List code separately in addition to code for primary procedure. CASE MANAGEMENT Tracking and Follow-up Requirements The Local Health Department (LHD) is accountable for tracking patients with abnormal screening test results regardless of the patients age, income or insurance status, to ensure that all women receive the necessary re-screening or diagnostic follow-up services to reach a timely final diagnosis and begin treatment. This includes those patients where the screening occurred in another program such as family planning, pediatrics, or prenatal. Each clinic site is responsible for assigning this tracking responsibility to a Registered Nurse, Advanced Registered Nurse Practitioner or Licensed Practical Nurse. The nurse that assumes this responsibility is referred to as the Nurse Case Manager (NCM). Prior to assuming the role and responsibilities of NCM with the KWCSP, the nurse must complete the following educational modules on TRAIN; How to Best Utilize the States Breast and Cervical Cancer Screening and Treatment Programs (Course # 1009091), Cancer Screening and Follow-Up Using the Public Health Practice Reference (Course # 1013695), Kentucky Public Health Nurse Case Management: Helping Women with Abnormal Breast and Cervical Cancer Screening Results (Course # 1013696) and Documentation: Kentucky Public Health Nurse Case Management for Abnormal Breast and Cervical Cancer Screening Follow-up (Course # 1020005). These modules are optional for the backup NCM who assumes this role during an absence of the assigned NCM as described below. The following modules are highly recommended; Who are the Never and Rarely Screened? Kentucky Women Share Insights about the Impact of their Care and How You Can Make the Difference (Part 1 Course # 1010683, Part 2 Course # 1010684). When there is a staff change for the NCM position, the Nursing or Clinical Supervisor must notify the Clinical Coordinator of the KWCSP at 502-564-3236, as soon as possible. Face-to-face training will be provided to each new NCM by the Clinical Case Management Coordinators assigned to each county. There must also be another RN, LPN or ARNP trained by the Clinical Coordinator or Case Management Coordinator assigned to your county and knowledgeable about cancer screening follow-up available to assume the Nurse Case Managers (NCM) role and responsibilities in the event the NCM is absent for more than seven calendar days. A timely diagnosis is crucial to creating positive outcomes in cancer screening. Tracking and follow-up can be time consuming and therefore it is recommended that professional and support staff work as a team toward this effort. The NCM is required to provide patient contact, counseling, tracking, and follow-up while the support staff may assist the case manager by scheduling appointments, obtaining records, and electronic entry of data. The NCM shall review all patient appointment arrangements and medical records to provide detailed documentation in the Progress Notes of the patients medical chart. Administrative time is imperative for NCMs to meet program requirements. The NCM should assure that all aspects of the case management process are appropriately documented in the patients service record. The NCM must have an organized manual or electronic tracking system in place to assure that patients receive appropriate and timely intervention. It is also strongly recommended that the ACH-58 Case Management Form side (in this section) be used to assist staff with this required tracking and follow-up. (See Administrative Reference for instructions on Data Collection side of form.) It is the responsibility of the KWCSP Nurse Case Manager (NCM) to contact the patient, surgeon or oncologist to ensure the patient has begun treatment for a cancer or pre-cancerous condition. The patient must have had a service that either removed part or all of her cancer or received chemotherapy or radiation to reduce her cancer for her treatment to be considered started. The NCM does not continue to provide case management for treatment once a patient is on the treatment program (BCCTP). The patients care will be managed by her Kentucky Medicaid health care providers. The NCM does not need to request treatment records. However, the NCM must document on the CH-3 nursing notes, the type of treatment that began the patients care and the date that it was performed. The NCM shall document the source of this information (doctors name and specialty, patient, etc.). For further testing and management after the initial abnormal result, patients who qualify for KWCSP should be case managed by the local health department according to program guidelines. However, when a patient has a medical home, the patient may be referred back to the primary care physician for follow-up management, after the patient is informed of the abnormal test and need for follow-up. Health departments should have good communication with local medical home providers so that each providers role and expectations are clear. A flowchart outlining the case management guidelines can be found at the end of this case management section. A. Informing the Patient of Abnormal Results Patients with an abnormal Pap test or mammogram result must be notified within 10 working days from receipt of the abnormal test result or within 30 days from the test date (which ever comes first) following this plan of action: Whenever possible, the NCM shall contact the patient by telephone and have her come to the clinic for face-to-face counseling for abnormal test results. It is expected that the clinic has emergency numbers for all no home contact patients. Guidance for no home contact patients and minors is found in KRS 214.185. When the patient comes in to the Health Department for counseling, test results and recommendations for follow-up are reviewed with the patient, options discussedand a letter explaining the result in writing is given to the patient. Arrangements for follow-up are then made (see Section B). The visit shall be documented in the patient chart. If the NCM is unable to make verbal contact with the patient by phone then an attempt to contact the patient by letter on the same day as the unsuccessful phone call is necessary. The letter shall inform the patient about the abnormal test result with instructions to contact the NCM at the health department. If the patient does not respond within 10 working days after the letter is mailed, the nurse shall then send a certified letter to the patient informing her of her abnormal test results with instructions to contact the health department. If the patient does not contact the health department within 10 working days after the certified letter is mailed, a home visit should be attempted on those patients with test results that are potentially life threatening (includes a HSIL or ASC-H result on a Pap test or a Suspicious Abnormality or Highly Suggestive of Malignancy mammogram result). Once the above has been completed with no response then it is appropriate to document the patient as lost to follow-up. B. Follow-up for Abnormal Test Results All patients with abnormal lab tests need follow-up. Patients who meet eligibility criteria for KWCSP must be referred according to program guidelines to contracted specialists for further testing/evaluation. Other patients mayhave a medical home (regular source of medical care) outside of the local health department (LHD). The patients medical home/PCP can be determined at registration. Medical homes may include private physicians, Passport providers, Primary Care Centers, FQHCs, and Community Health Centers. These providers generally arrange and provide follow-up care for their patients. Each local health department should maintain open communication with primary care providers in their area to be sure there is agreement on roles and expectations for follow-up of patients with abnormal results. B1. Follow-up Arrangements for KWSCP-eligible Patients The NCM will schedule an appointment for the patient with a KWCSP contracted provider for the appropriate follow-up testing or evaluation. A referral letter and reports of the abnormal test results are sent to the contracted provider who will be seeing the patient. The NCM tracks to see that the patient showed for the appointment and documents the visit in the patients chart. The NCM collects reports from the contracted provider and makes arrangements for further diagnostic testing as ordered. If the patient does not keep an appointment for a scheduled consult appointment, diagnostic procedure, treatment, or follow-up/repeat Pap, a certified letter will be sent to the patient within 10 working days of the missed appointment. No further follow up tracking is needed for these patients. All attempts of patient contact shall be documented in the progress notes (CH3A). B2. Follow-up Arrangements for Patients with a Medical Home The NCM will schedule an appointment for the patient with their PCP for the appropriate follow-up testing or evaluation. A referral letter and reports of the abnormal test results are sent to the Primary Care provider who will be seeing the patient. NOTE: It is imperative that the PCP is informed of any of their patients abnormal test results. This will allow the PCP to assure that the patient receives the appropriate follow-up care. The NCM tracks to see that the patient showed for the appointment and documents the visit in the patients chart. Once the patient has kept her follow-up appointment with her PCP, the responsibility for further follow-up is transferred from the LHD to the PCP. The PCP assumes the follow-up care for their patient. If the patient does not keep the scheduled appointment with her PCP for follow-up on her abnormal test result, a certified letter will be sent to the patient within 10 working days of the missed appointment. A copy of the certified letter is to be sent to the PCP. If the patient does not contact the health department within 10 working days after the certified letter is mailed, the NCM shall contact the PCP. The NCM must verify that the PCP is aware of the findings and accepts responsibility for patient follow-up. All attempts of contact with the patient and PCP shall be documented in the patients progress notes (CH3A). B3. Follow-Up Arrangements for Patients with a Medical Home Under Passport The NCM will schedule an appointment for the patient with their PCP for the appropriate follow-up testing or evaluation. A referral letter and reports of the abnormal test result(s) are to be sent to the PCP who will be seeing the patient. NOTE: It is imperative that the PCP is informed of any of their patients abnormal test results. This will allow the PCP to assure that the patient receives the appropriate follow-up care. In addition, a letter shall be mailed or faxed to the Passport Case Management Department at 502-585-7997 regarding their beneficiaries with an abnormal test result to inform Passport of the abnormal test results and the need for further follow-up, tracking and monitoring. The NCM tracks to see that the patient showed for the appointment and documents the visit in the patients chart. Once the patient has kept her follow-up appointment with her PCP then the responsibility for further follow-up is transferred from the LHD to the PCP. The PCP assumes the follow-up care for their patient. If the patient does not keep the scheduled appointment with her PCP for follow-up on her abnormal test result(s), a certified letter will be sent to the patient within 10 working days of the missed appointment. A copy of the certified letter is to be sent to the PCP. If the patient does not contact the health department within 10 working days after the certified letter is mailed, the NCM shall contact the PCP. The NCM must verify that the PCP is aware of the findings and accepts responsibility for patient follow-up. If the patient is a minor with a potentially life-threatening test result (includes a HSIL or ASC-H result on a Pap test or a Suspicious Abnormality or Highly Suggestive of Malignancy mammogram or ultrasound result) and cannot be contacted, the parent or guardian must be contacted. Minors shall be made aware of this policy at the screening visit. All attempts of contact with the patient and PCP shall be documented in the patients progress notes (CH3A). C. Other Situations: Patients who are not KWCSP eligible and do not have a medical home: Local Health Departments may screen some patients who are not eligible for KWCSP and do not have a medical home. Efforts should be made to find the patient a medical home. If that is not possible, then the LHD may manage these patients following KWCSP protocols and providers. Efforts should be made to find other resources for financial assistance in these circumstances as they would not be covered by the KWCSP. Work-up Refused: occurs when a patient has been notified and counseled (by phone or in person) regarding an abnormal result and either fails to keep a referral appointment for diagnostics/treatment or verbalizes her desire not to seek follow-up. The date of final contact should be noted in the service record (CH3A) and on ACH-58 Data Collection Form side (women 4064 years old). Lost to Follow-up: occurs when unable to inform and counsel the patient, either by phone or in person, regarding an abnormal test result. The date of the final contact attempt should be noted in the service record (CH3A) and on ACH-58 Data Collection Form side (women 4064 years old).  SHAPE \* MERGEFORMAT    PAP TEST LOG (ACH-259) Individual tickler systems are required to be used by each Nurse Case Manager (NCM) to ensure timely follow-up for any abnormal cervical cancer screenings. The tickler system provides reminders for tasks to be completed by the NCM to ensure complete follow-up for each patient. However, tickler systems do not provide an overall view or listing of patients screened at the local health department. The Pap Test Log is needed to provide a quick reference of all patients who received a Pap test and to determine if they have received complete follow-up. The Pap Test Log is a mandatory form that is used by the state Case Management Coordinators as a quality review tool during their site visits/chart reviews at the local health department. The Pap Test Log must also be used by the local health department NCM for a monthly quality review tool to ensure all patients receiving cervical cancer screening have received complete follow-up. The nurse will review each page until that page is marked as having all patient follow-up completed. All patients listed should be marked as receiving complete follow-up, work-up refused or lost to follow-up to be considered complete. After the Pap has been completed and processed for mailing, a lab label should be placed on the Pap log. The date of the Pap test must be written in the column provided on the Pap log. When the Pap results are received, every Pap report must be reviewed, initialed and dated by a nurse as stated in the Public Health Practice Reference. The appropriate result code must be determined by the nurse reviewing the Pap report and written in the results column. The NCM will also complete the rest of the information required on the Pap Test Log. The date for the next Pap Due Date should not be entered onto the form until all diagnostic services are completed and the next screening is ordered by the physician. The results should be entered into the PSRS by the appropriate staff. MAMMOGRAM AND ABNORMAL CBE LOG (ACH-100) The Mammogram and Abnormal CBE Log is a mandatory form that is used by the state Case Management Coordinators as a quality review tool during their site visits/chart reviews at the local health department. The Mammogram and Abnormal CBE Log must also be used by the local health department NCM for a monthly quality review tool to ensure all patients receiving breast cancer screening have received complete follow-up. The nurse will review each page until that page is marked as having all patient follow-up completed. All patients listed should be marked as receiving complete follow-up, work-up refused or lost to follow-up to be considered complete. A lab label should be placed on the mammogram log after the patient is scheduled for the exam and/or when the patient receives a clinical breast examination. When the mammogram result is received, it must be reviewed, initialed by a nurse and appropriate BI-RADSTM code recorded in the results column. The NCM will also complete the rest of the information on the Mammogram and Abnormal CBE Log when it becomes available. The date for the next Mammogram Due Date should not be entered onto the form until all diagnostic services are completed and the next screening is ordered by the physician. Enter into PSRS and supplemented as appropriate. PAP TEST LOG ACH-259 MONTH/YEAR___________________________ PATIENT IDENTIFICATION (MAY USE LABEL)KWCSP (y/n)  DATE OF PAP PAP Result (1-9)  NEXT PAP DUE (MM/YY)  SELECT ONE WORK-UP COMPLETE WORK-UP REFUSED LOST TO FOLLOW-UP       MAMMOGRAM & CBE LOG ACH-100 MONTH/YEAR___________________________ PATIENT IDENTIFICATION (MAY USE LABEL)KWCSP (Y/N) CBE RESULT (normal/abnormal) & date  MAMM RESULT (0-6) AND DATE NEXT MAMM DUE (MM/YY) SELECT ONE WORK-UP COMPLETE WORK-UP REFUSED LOST TO FOLLOW-UP       INSTRUCTIONS FOR USE OF THE BREAST CANCER SCREENING REPORT (ACH-16) The ACH-16 is used to request and document results of mammograms from the radiology provider. The mammogram narrative report should be kept with the completed ACH-16 and filed together in the medical record. The ACH-16 should be filled out on all women being referred for a mammogram regardless of income, age, or payer status. TO BE COMPLETED BY LHD Enter the name of the LHD requesting the mammogram or diagnostic breast ultrasound. Attach a lab label in the place provided. Complete items 15 with information from the current history. Enter the results of the clinical breast examination in item 6. Enter the type of mammogram requested, the visit date, and the signature and identification number of the clinical breast examination provider in item 7i. Enter the name, address, and telephone number of the contracted surgeon who will be evaluating abnormal test results (or patients PMD). TO BE SIGNED BY THE PATIENT Have the patient sign the referral section. Retain the copy of the form in a tickler file at the LHD to track receipt of the mammogram results. The form should be sent to the radiology facility. If desired by the patient, have a release of information (ROI) signed so a copy of the mammogram result can be sent to the patients family physician. TO BE COMPLETED BY MAMMOGRAPHY PROVIDER Check the one type of mammogram performed in item 8. If a screening mammogram is requested in item 7, a screening mammogram should be performed. If the LHD requests a diagnostic mammogram in item 7, an initial diagnostic mammogram should be performed. When a screening mammogram has been requested and performed and the radiologist has determined the need for additional views, a second ACH-16 should be initiated and Follow-up Diagnostic checked in item 8. The applicable BI-RAD category is checked by the radiologist in item 9. Include a description of any negative findings, the date of the mammogram, and the signature of the radiologist. Enter the name and address of the agency storing the mammography films. The mammography provider keeps a copy of the form. A copy of the completed ACH-16 is returned to the LHD. A LHD nurse shall note results and the patient shall be notified. A copy of the form shall be filed in the medical record with the narrative report attached to it  CONTRACTS for KWCSP SERVICES PROVIDERS Below, is recommended wording for requirements to be used in FY 2011-2012 contracts between your Local Health Department and local providers (lab, hospital, gynecologist, breast surgeon, etc.). This includes Mammography Requirements and Pap/Pathology Requirements. These contracts will be created by appropriate staff at your LHD. The NCM should provide assistance in ensuring that all required services are covered through contracts with local providers in the community. KWCSP Mammography Requirements Mammography in accordance with the requirements listed below: 1. The health department or screening sub-contractor* will screen patients for eligibility, including income criteria. The health department or screening sub-contractor will authorize which patients are to receive screening mammograms under this program. 2. Facilities performing mammograms shall be accredited by the American College of Radiology Accreditation Program and certified by the federal Food and Drug Administration (FDA). 3. A list of radiologists providing interpretation will be provided to the health department or screening sub-contractor and attached to the contract. Updating this list (additions or deletions) will be the responsibility of the Contractor. 4. Each radiologist responsible for interpretation of results will have current continuing education in the field of mammography. 5. Interpretation of mammogram and ultrasound results will be recorded on the ACH-16 form, which must be completed, signed and submitted by the health department or screening sub-contractor. Results must be recorded as a single category on the ACH-16 form based on the following categories. (Results of subsequent tests, e.g. additional views, ultrasound, etc. shall be reported separately from the mammogram results.) 0 Assessment Incomplete - need additional imaging. 1 Negative. 2 Benign Finding. 3 Probably Benign - short interval follow-up indicated. 4 Suspicious Abnormality - biopsy should be considered. 5 Highly Suggestive of Malignancy - appropriate action should be taken. 6 Known Biopsy Proven MalignancyAppropriate Action Should Be Taken 6. Payment for a screening or a diagnostic mammogram will be made only if specifically ordered by the health department or screening sub-contractor on the completed and signed ACH-16 form. The Bi-Rads on the ACH-16 form must match the narrative report before payment will be issued. 7. The report of the mammogram reading must indicate the name and address of the facility where the x-rays are stored so that the woman and the local health department/screening sub-contractor know where the mammogram films are should they be needed at another location for consultation/referral studies. 8. There will be no billing of the patient by any member of the Contractor. For these purposes, Contractor includes cooperating hospital, radiologist, or technician. 9. The Contractor agrees to provide information required for the health department or screening sub-contractor to meet state and federal service reporting requirements in order to ensure quality and timely patient care and secure funds to pay for services covered in the attached list. 10. The Contractor must return all written results no more than 21 days after receipt of Pap test specimens or the patients mammogram/ultrasound screening. Any biopsy results (if applicable in contract) should be returned to the health department or screening sub-contractor within two (2) weeks (14 working days) of receipt of specimen. 11. The Contractor must contact an RN, APRN, or PA at the local health department or screening sub-contractor by telephone within twenty-four working hours when a mammogram result is a Bi-Rads 4 or 5 according to the reporting categories listed in the Mammography Requirements which is based on the American College of Radiology reporting system. This notification shall also include a three-day turnaround for mailing these results. 12. The Contractor must provide timely telephone consultation by a pathologist (Pap/Pathology services) or radiologist (radiology services) when the health department/screening sub-contractor needs more information about results. *There are some Local Health Departments that contract with local providers for some of their KWCSP screening services (Pap tests, Clinical Breast Examination, bimanual pelvic exams). The term screening sub-contractor will be used to denote these specific providers in the KWCSP Mammography Requirements and KWCSP Pap/Pathology Requirements. KWCSP Pap/Pathology Requirements 1) Facilities performing cytology/histology services shall be certified for Medicaid/Medicare, thus meeting Clinical Laboratories Improvement Act (CLIA) regulations. A copy of Contractor's CLIA-88 Certificate must be included with the signed contract. 2) Hospital laboratories shall be accredited by the Joint Council on the Accreditation of Healthcare Organizations. 3) Cytology results shall be reported to the health department or screening sub-contractor utilizing the reporting categories for Specimen adequacy and Results based on the BETHESDA 2001 System as follows: A. Identification of type of test (conventional or liquid based and noted if the specimen was examined by an automated device) B. Adequacy of the Specimen 1. Satisfactory for interpretation 2. Unsatisfactory (specify reason) C. General Categorization (optional) 1. Negative for Intraepithelial Lesion or Malignancy (NIL) 2. Epithelial Cell Abnormality (specify squamous or glandular) D. Interpretation/Result 1. Negative for Intraepithelial Lesion or Malignancy (NIL) 2. Negative for Intraepithelial Lesion with the Presence of a. Organisms (identify) b. Reactive Cellular Changes c. Atrophy d. Glandular cells status post hysterectomy e. Endometrial cells in a woman greater than 40 years of age 3. Atypical Squamous Cells a. ASCUS (Undetermined Significance) b. ASC-H (Cannot Rule out High Grade) 4. Low Grade Squamous Intraepithelial Lesion a. LGSIL b. Mild Dysplasia c. HPV d. CIN I 5. High Grade Squamous Intraepithelial Lesion a. HGSIL b. Moderate Dysplasia c. Severe Dysplasia d. CIN II e. CIN III f. Carcinoma-in-Situ (CIS) 6. Squamous Cell Carcinoma 7. Adeno-Carcinoma/Adeno-Carcinoma-in-Situ 8. Unsatisfactory 9. Atypical Glandular Cells of Undetermined Significance (AGUS) a. Atypical endocervical cells b. Atypical endometrial cells c. Atypical Glandular of Undetermined Origin 4) The Contractor shall provide collection supplies for either conventional or liquid-based Pap tests. 5) At ongoing, monthly intervals, the Contractor shall provide the health department or screening sub-contractor with a list of health department/screening sub-contractor clients whose Pap tests were read and the results of the interpretations, in a format agreed upon by the health department/screening sub-contractor. All abnormal results shall be clearly indicated by the Contractor to the screening agency. 6) The Contractor will provide the health department/screening sub-contractor with a six-month and twelve-month comprehensive profile of findings of Pap test results of screening agency clients, in a format agreed upon by the screening agency. This profile shall include a breakdown of BETHESDA results in the distinct reporting categories listed in #3 above. 7) The Contractor agrees to provide information required for the health department or screening sub-contractor to meet state and federal service reporting requirements in order to ensure quality and timely patient care and secure funds to pay for services covered in the attached list. 8) The Contractor must return all written results no more than 21 days after receipt of Pap test specimens or the patients mammogram/ultrasound screening. Any biopsy results (if applicable in contract) should be returned to the screening agency within two (2) weeks (14 working days) of receipt of specimen. 9) The Contractor must contact an RN, APRN, or PA at the local health department or screening sub-contractor by telephone within twenty-four working hours when any Pap specimen is determined to be ASC-US cannot rule out High Grade, HGSIL, Squamous Cell Carcinoma, Adeno-Carcinoma/Adeno-Carcinoma In-situ, AGUS according to the reporting categories listed in the Pap/Pathology Requirements which is based on the Bethesda system. This notification shall also include a three-day turnaround for mailing these results. 10) The Contractor must provide timely telephone consultation by a pathologist (Pap/Pathology services) or radiologist (radiology services) when the health department/screening sub-contractor needs more information about results. *There are some Local Health Departments that contract with local providers for some of their KWCSP screening services (Pap tests, Clinical Breast Examination, bimanual pelvic exams). The term screening sub-contractor will be used to denote these specific providers in the KWCSP Mammography Requirements and KWCSP Pap/Pathology Requirements. Your contracts with local providers must include a KWCSP Contract Rate Sheet that includes ONLY the services that will be reimbursed to that specific provider by your LHD and show the negotiated rate. Note: Only codes on the approved cpt codes listing beginning on page 20 of the Cancer Screening Follow-up Section of the PHPR can be reimbursed by the program.     Page  PAGE 27 of  NUMPAGES 42 Kentucky Public Health Practice Reference Section: Cancer Screening Follow-up July 31, 2011 ABNORMAL CBE (Discrete mass or abnormal thickening) NORMAL & BENIGN FINDINGS ON CBE (Includes fibrocystic changes & normal nodularity) 1. BREAST ULTRASOUND (ages 29 and under) DIAGNOSTIC MAMMOGRAM (ages 30 & older) and ultrasound if needed 3. SURGICAL REFERRAL APPOINTMENT WITHIN 3 WEEKS OF DISCOVERY OF ABNORMAL CBE (Regardless of ultrasound and/or mammogram results) 4. FINAL DIAGNOSIS OBTAINED WITHIN 60 DAYS OF DETECTION OF ABNORMALITY (from date screened) 5. RECORDS TO BE RECEIVED WITHIN 60 DAYS OF CONSULT/PROCEDURES 6. FOLLOW RECOMMENDATIONS OF SURGEON AND/OR RADIOLOGIST 1. REPEAT CBE IN ONE YEAR 2. ANNUAL SCREENING MAMMOGRAM IF AGE 40 AND OLDER IF SCREENING MAMMOGRAM IS ABNORMAL, PATIENT TO BE NOTIFIED WITHIN 10 DAYS OF RECEIVING THE RESULT OR WITHIN 30 DAYS OF THE PROCEDURE (whichever comes first) A FINAL DIAGNOSIS OBTAINED WITHIN 60 DAYS OF DETECTION OF THE ABNORMALITY (from date screened) 5. OBTAIN SCREENING MAMMOGRAM WRITTEN REPORT WITHIN 60 DAYS OF THE PROCEDURE Able to contact pt by phone within 10 working days of receipt of abnormal test result or 30 days from procedure. YES NO Schedule counseling appointment. Send letter to pt. w/ regarding abnormal results & need to contact LHD. Pt. shows for counseling appt. Counsel, give letter w/ result & schedule follow-up. Refer to LHD/Dx contracted provider or PCP. Did pt. contact LHD within 10 working days of letter being mailed? YES-Schedule counseling appointment. See left side of diagram NO-Send certified letter to pt. Did patient keep appointment? Assure that results are obtained & documented. Evaluate results for further need of diagnostic services. YES-Schedule appointment. See left side of diagram. NO-Determine if result is life-threatening. Send certified letter within 10 working days of missed appt. & document pt. refused. Is result life-threatening? NO-Document lost to follow-up. YES-Perform home visit. Able to contact pt. by home visit? NO-Document lost to follow-up. Does pt. require further diagnostics per report? NO-Contact pt. & counsel regarding further screening recommendation. YES-Notify pt. & coordinate further dx procedures. Did pt. keep secondary dx follow-up appointments for services? NO YES-Assure that results are obtained & documented. Contact pt. by phone within 10 working days of receipt or 30 days from procedure date to discuss further screening/dx results. NO Send copy of results to LHD contracted provider. Send copy of results to PCP. YES-Schedule counseling appointment. See left side of diagram. Could patient be reached by phone? YES-Assure that pt. understands further screening recommendations. Contact PCP. Send copy of certified letter. YES NO NO Yes-PCP follows pt. Did patient keep appt? NO Response from pt. within 10 working days of certified letter. 4>?LMYZ[% & L M { |   $ % W X ] ` a   = > F G O P Q  hPhxAB*CJphhxAB*CJphhxAhxA5B*\phhxA5B*CJ\phhxAB*phM34?MZ $$Ifa$ $ !$Ifa$Z[MD)) & F Ud$If^`Ugd[ d$Ifkd$$IfTlF~ /)~ 0)6    44 lapT& M |   % X ^ _ ` $d$Ifa$gdQ $d$Ifa$ & F Ud$If^`Ugd[` a  sjOOOOOOO & F Ud$If^`Ugd[ d$Ifkd$$IfTlF~ /)~0)6    44 laT > G P g[LL$d$Ifa$gdQ d$IfgdQkd$$IfTlF~ /)~0)6    44 laT $d$Ifa$P Q sX>>2 $d$Ifa$ & F d$If`gdBn & F 8Ud$If^`UgdBnkd:$$IfTlF~ /)~0)6    44 laT eJ & F 8Ud$If^`UgdBnkd$$IfTlF~ /)~0)6    44 laT $d$Ifa$    < = > a b f g o p x y z /0YZjk=>WXxy*+34<=>ijrs{|}ghxA5B*\phhxA5>*B*CJ\phhxA5B*CJ\phhxAB*CJphhxAhxAB*phI scWW $d$Ifa$d$If^gdQkd$$IfTlF~ /)~0)6    44 laT  = sXLL $d$Ifa$ & F 8Ud$If^`UgdBnkd3$$IfTlF~ /)~0)6    44 laT= > g p y sj^^ $d$Ifa$ d$Ifkd$$IfTlF~ /)~0)6    44 laTy z 0ZksjjOOOOOO & F Ud$If^`Ugd[ d$Ifkd$$IfTlF~ /)~0)6    44 laT >Xy+4= $d$Ifa$ & F 2Ud$If^`Ugd[ & F Ud$If^`Ugd[=>js|sj^^ $d$Ifa$ d$Ifkd($$IfTlF~ /)~0)6    44 laT|}sj^^ $d$Ifa$ d$Ifkd$$IfTlF~ /)~0)6    44 laTgh)sqoojqqqdq !$a$kdv$$IfTlF~ /)~0)6    44 laT gh()<=;<23Iw|}"#z%%'','P(Q(}(ѿާާ蜐xndndnhxAB*CJphhxA>*B*phhX=hxAB*phhxA5B*CJ\phhHqhxA5CJaJhxA5B*\phh48hxAB*aJphhxA6B*]ph#h^hxA5B*CJ \aJ phhxA5>*B*\phhxAB*aJphhxAB*phh^hxAB*CJ aJ ph')<=;<23~$a$gdHqgdI7gdYy !$a$"#q r !!!!""##W$X$}$~$z%{%%% & F **>^*`>gd[ & Fgd[  !d8$a$ & F gdX=;gdX= !h^h & F %#&Q&r&&&''.'_'')(P(Q(}()f)-* & F hU^`Ugd[^ & F ^gd[ & F h^h`gd[ & Fgd[ d8^` & F **>^*`>gd[-**p,-.....h//Q0V0l0l11r2d4 & FgdBn & F h]hgdBn hZ^Z` & F >^`>gd[$a$ & F h]h^gd[ & F ^gd[}(*+;+O+z++--Y0l0~11112%2/2r22222222d4445=56699::::::;;>>@@t@u@Ϳ؝|| hxAaJh2hxA0J5B*aJphhxAjhxAUh2hxAaJh$u`hxAB*phh$u`hxA6B*]phhhhxA6B*]phhhhxAB*phhxA>*B*phhxAB*H*phhxA6B*]phhxAB*ph0d455=5066667C88x9999::== $^a$gd2 \^gd2 & F \|`|gdBn & F L^`gdBn q^`q & FgdBn^ & FgdBn=8?9?AAYCZCCCGDDEmFGGGHHgd, ;-DM gd,; & F-dgdBnm$ \gd, \^gd, q^`q-DM ^gd2 \^gd2u@@@AADAA4BBBYCZCCC]DcDdDDDEFHHHHHIIII8I9IpIqIsIwIIIInJvJ:KHKLLL7MFMŹޜň}}}}yhxAhxA5B*\phhxA>*B*phh_hxA:aJh_hxA>*aJh_hxAaJh_hxA5aJh_hxA5>*aJhxAB*ph hxA5aJh2hxA5aJ hxAaJh2hxAaJjhxAUh2hxA>*aJ/HHII9IrIsItIIIaJwJK-KIKKLL7M2 h^`  !hh`h hT^T hh`h h^` q^`qgd, & F.gdBnFM\M2NQN-OnOO$P%P&P(PJPKPLPMPOPPPRPTPUPVPWPYP]P_PgPhPiPjPkPRRhSpSUUVVVV콰ʁʁ연vvlvvhxAB*CJphhxA6B*]phhxA>*B*CJphhxAB*CJphhxAB*CJphhxA5>*B*CJ\phhxA5B*CJ\phhxA5>*B*\phjhxAUmHnHuhxA>*B*phhxAB*CJphhxAB*phhxA5B*\ph'7M]M#NRNOoOOO$P%P&PKPLPMPNPOPPPQPRPUP P^`P  $ a$ T^Tgd& T^T h hTT^T hTUPVPWPZP[P\P]P`PaPbPcPdPePfPgPhPiPjPkPlPmPoPpPqPPP   !$a$^PQQRRTTUUUVVVVWWWWYYY ! & F !\h^h`gd[ & F !\8`8gd[ & F V^V`gd[$a$VVWWWWWWWW\\]/]^^L_M_P_k_``aaaaaaaaaab b b!b'b(b+b3b4bAbBbTbUblbpbwbyb3c4c5ccff hxAaJh5hxA6aJh5hxA56aJh5hxAaJh5hxA5aJhxA>*B*phhxA;>*B*phhxAB*CJphhxA6B*]phhxAB*CJphhxAB*phhxAB*CJph6YjZ[[\\]]0]P]]]]^N^^^^L_M_k__ h^h h & F`gd[ & F$a$$a$ & F V^V`gd[__)`V````2aab9bzb5cf[g\gg$h%hNh7j & F! &^gdBn gdh ; & F'gdBnm$gdh$a$gdh hh^hgdh hh^hf[g\gg#h$h%h)hMhNhthhhhhinii6j7jj&k'k|k}k~kkkhmym{mmmmnnoxmmmccchxA>*B*phhJN-hxAB*phh6hxAB*mHphsHh6hxAB*aJphh6hxAB*phhhhxAB*phh";hxAB*phhxA;>*B*phhxAB*phhxAB*CJphh hxA6B*phh hxA6B*CJphh hxACJh5hxAaJ$7j|j(k~klNm{mmmBopVqWqtqrr" " h^h  ^`gdX= & F! &b>^`>gdBn & F! &b^gdBn & F! 88^8gdBn & F! &^gdBnoo[qsqrrrrKsLsdsssssss%t&tKtLtStTtttttttuu,u-u8u9uLuMuVu|uuw(w-wwwx$xNyXyz´럴봪봔hhhxAB*phhxA;B*phhxA5B*\phhxA>*B*\phhxA>*B*phhxA5;>*B*\ph hX=hxAhxA:B*phh hxAB*CJphhxA;>*B*phhxAB*phhJhxA7B*ph1rr ss?sKsLsdssssss&t=tLtTttttu ^` 8h^8`hh^h h^h`gdX=$h^h`a$gdX=gdX= hh^h`h$^uu-u9uMuUuVu|uuuvmvvww(wcwwwh^h^ hh^h`h $hh^h`ha$ h^h` !8h^8`h ^` 8h^8`hww9xMyNyXyyz\{G||||S}}~>~p~~~ & F gdBn & FgdBn & F h0`0gdBn & FgdBn & F 0`0gdBn & FgdBn & F \0`0gdBnzz||||>~~,ۃރ03`\]^_ibcڋuhu`jhxAUhlhxAB*aJphhYyhxAB*aJphhlhxAaJh2hxAaJh,r:hxAB*phhxA5B*phhxA6B*]phhJhxAB*aJphhIhxAB*aJphhxAB*mHphsHhxA>*B*phhxAB*CJphhxAB*phhxAB*H*ph$~,P)`\]^_i $^a$gd, \^gd2 & F \|`|gdBngd,r:; & FgdBn & F gdBn & FdgdBn & FgdBn & F gdBncuv78ƌnj%&01ÍbJ 569MdeSٖږ%ܸցrh_hxA0J5B*aJphh,hxA5>*CJaJh_hxA>*aJh_hxAaJh_hxA5aJh_hxA5>*aJhxA>*B*phh2hxA5aJh2hxA>*aJ hxAaJh2hxAaJh2hxA0J5B*aJphjhxAUhxA,ÍK 56|ʓe & F/gdBn$a$gd,gd, ;-DM gd,; & F-dgdBnm$ \gd, \^gd,-DM ^gd2S&-HeǛ,CqBɞ1q & F & F & Fgd$a$gd%&xIRsx $%,-.DEFGH,ݷ}o^!hhhxAB*CJOJQJphhxAB*CJOJQJphhxAB*ph!jh hxA>*B*Uph'j޶Q h hxA>*B*UVphh hxA>*B*ph!jh hxA>*B*UphhxA5CJ aJ h?'hxA5CJ aJ hxA>*B*phh_hxA>*aJh_hxAaJ hxAaJ BuȞɞY_xŴšypcYcJ:h/hxA5B*\aJphh hxAB*CJaJphhxAB*aJphhhxAB*aJphh}hxAaJ'h/hxA5;B*OJQJaJphhxAB*CJphhxAB*CJphhxAB*phhhhxAB*ph!hhhxAB*CJOJQJphhxAB*CJOJQJphhjhxACJOJQJ!hjhxAB*CJOJQJphhxAB*CJOJQJphq(H~d8ӣXY_ & F d^`gdBn d^`$a$gd ) & F  & F)`Χܨ9rȩ*Ϋ{{ & FdgdBnd^`gd| d^gd3 & F d^`gdBn & F&dgdBnd & F d`gdBn & F d`gdBn \\d^\ Χۨܨrȩ(=!*ЫFLSTUVͮήijkmnدٯi䤙}l\ڋQڋhxA5B*\phh/hxA5B*\aJph h hxA7B*CJaJphhX=hxA5B*\phhhhxA5B*\phh}hxAB*ph h}hxAB*aJph h0{DhxA5B*aJphhw;hxAB*aJphhhhxAB*aJphhxAB*aJphhhxAB*aJphh/hxA5B*aJphΫϫˬTUήklmny Vd^V` d^gd d^gdp[[ & F d^`gdBn & F d`gdBnddgdK_H & F( d^gdBn; & F+gdBn d^gd}ٯ(̳78Juv & F &~d`~gdBn & F &d^`gdBnd Vd^V` d^gdK_H & F d^`gdBnistʳ̳68JU\tvǸ֌}mcY}cY}cLcY}chxA6B*CJ]phhxAB*CJphhxAB*CJphh/hxA5B*CJ\phh/hxA5B*CJphhxAB*CJphhxA5B*\phhxAB*aJphhhxAB*aJphh/hxA5B*aJphh hxAB*CJaJphhhhxAB*aJphhhhxA5B*\phhX=hxA5B*\phõ@BCWŸƸռ & F @ !^gdBn !h !hh]^h`$a$ & F &d^`gdBnd & F &d^`gdBn'(=>BCŸƸǸ͹"ռ6||r|e|XF"hIkhxA57:B*CJphh<hxAB*\phhhhxAB*\phhxAB*\phhxAB*\phhxA;B*\phhxA5;B*CJphhxA5;B*phhxA5:B*phhxA5:B*CJphhxA:B*\phhxAB*phhxAB*CJphhxAB*CJphhn8hxA0J5CJhxAjhxAUռ6t*B\q:x^:`gdH $xa$gd  & F !hgdBn !h h  !hh^h & F, @ ^gdBn & F @ !0^gdBn 8,-)056xxm`xxQhxA>*B*OJQJ\phhhhxA>*B*phh/ChxAB*phhhhxAB*phhxAB*OJQJphhxA>*B*phhxAB*phhH!^hxAB*phhxAB*phhxAB*CJ\phhxA5;B*CJphhxA5;B*CJphh+-)hxA7B*\phhxAB*\phhxA5:B*CJph &@b.g>~egdJ"r0x^`0gdH 0^`0 !gdzB\ $,PY$>}~de)*+]^_anoһһxxx`Y`Y hw;hxA/hw;hxA5B*CJOJQJ\^JaJph%hw;hxAB*CJOJQJ^Jph/hw;hxA5B*CJOJQJ\^JaJphhw;hxAB*aJ(ph hxA5\hxAhxA5B*\phhxAB*OJQJphhxAB*phhxA>*B*OJQJphhxA>*B*phhxAB*OJQJ\ph *+^LAkd@$$IfT4\%&&44 aT$$7$8$H$Ifa$gdrAkdE@$$IfT4%&&44 aT $7$8$H$IfgdrgdJ"r$a$gdJ"rgdJ"r^_`ano.ikdA$$IfT4F% d &     44 aT$$7$8$H$If]a$gdr$$7$8$H$Ifa$gdrAkd'A$$IfT4\%&&44 aToxvh $7$8$H$Ifgdr 3$7$8$H$IfgdrikdB$$IfT4F%   d  &     44 aT$$7$8$H$Ifa$gdr)12]ef*23jrs;CDx7?@]efKSTιιιιιιιιιιιιιιιιιιιιι hw;hxA)hw;hxAB*CJOJQJ^JaJph)hw;hxAB*CJOJQJ^JaJph jhw;hxAOJQJ^Jhw;hxAOJQJ^JF)1{j$$7$8$H$Ifa$gdr $7$8$H$Ifgdr 3$7$8$H$IfgdrhkdZC$$IfTF%d&     44 aT128]ex$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdD$$IfTF%d&     44 aTeflx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdD$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdSE$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdE$$IfTF%d&     44 aT*2x$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdF$$IfTF%d&     44 aT239jrx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdLG$$IfTF%d&     44 aTrsyx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdG$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdnH$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdH$$IfTF%d&     44 aT!;Cx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdI$$IfTF%d&     44 aTCDKxx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd!J$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdJ$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdCK$$IfTF%d&     44 aT7?x$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdK$$IfTF%d&     44 aT?@F]ex$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdeL$$IfTF%d&     44 aTeflx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdL$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdM$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdN$$IfTF%d&     44 aT$KSx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdN$$IfTF%d&     44 aTST[x$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd:O$$IfTF%d&     44 aT#$BJKkst<DELM.67ηηΥ{)hxJhxAB*CJOJQJ^JaJph)hhhxAB*CJOJQJ^JaJph#hxAB*CJOJQJ^JaJph,hw;hxAB*CJH*OJQJ^JaJph)hw;hxAB*CJOJQJ^JaJph hw;hxA)hw;hxAB*CJOJQJ^JaJph0x$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdO$$IfTF%d&     44 aT#x$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd\P$$IfTF%d&     44 aT#$+BJx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdP$$IfTF%d&     44 aTJKSksx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd~Q$$IfTF%d&     44 aTst|x$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdR$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdR$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd1S$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdS$$IfTF%d&     44 aT<Dx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdST$$IfTF%d&     44 aTDENx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdT$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkduU$$IfTF%d&     44 aT{j$$7$8$H$Ifa$gdr $7$8$H$IfgdxJ $7$8$H$IfgdrhkdV$$IfTF%d&     44 aT$.6x$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdV$$IfTF%d&     44 aT67?Yax$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd(W$$IfTF%d&     44 aT7YabCOPVW IQRw {X`aS[,hw;hxAB*CJH*OJQJ^JaJph hw;hxA)hw;hxAB*CJOJQJ^JaJph)hw;hxAB*CJOJQJ^JaJphHabhx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdW$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdJX$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdX$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdlY$$IfTF%d&     44 aTCOx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdY$$IfTF%d&     44 aTOPXx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdZ$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd[$$IfTF%d&     44 aT x$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd[$$IfTF%d&     44 aTIQx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdA\$$IfTF%d&     44 aTQRXwx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd\$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkdc]$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd]$$IfTF%d&     44 aT!{x$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd^$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd_$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd_$$IfTF%d&     44 aT#X`x$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd8`$$IfTF%d&     44 aT`aix$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd`$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdZa$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkda$$IfTF%d&     44 aTS[x$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd|b$$IfTF%d&     44 aT[\dx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd c$$IfTF%d&     44 aT[\)* ltu{}!#OWX_a,45<>hpqxz,hw;hxAB*CJH*OJQJ^JaJph)hw;hxAB*CJOJQJ^JaJph)hw;hxAB*CJOJQJ^JaJph hw;hxAHx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkdc$$IfTF%d&     44 aT)x$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd/d$$IfTF%d&     44 aT)*0x$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkdd$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdQe$$IfTF%d&     44 aT ltx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkdf$$IfTF%d&     44 aTtu}x$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkdf$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkdg$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkdh$$IfTF%d&     44 aT#OWx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkdhi$$IfTF%d&     44 aTWXax$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdMj$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd2k$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkdl$$IfTF%d&     44 aT,4x$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkdl$$IfTF%d&     44 aT45>hpx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkdm$$IfTF%d&     44 aTpqzx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkdn$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkdo$$IfTF%d&     44 aT6>?FH~ V^_ef)-.TXY)-.eij+ηηηηηηhw;hxAOJQJ^J,hw;hxAB*CJH*OJQJ^JaJph)hw;hxAB*CJOJQJ^JaJph hw;hxA)hw;hxAB*CJOJQJ^JaJphC6>x$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkdp$$IfTF%d&     44 aT>?H~x$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkduq$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdZr$$IfTF%d&     44 aT x$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd?s$$IfTF%d&     44 aTV^x$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd$t$$IfTF%d&     44 aT^_fx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd u$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkdu$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkdv$$IfTF%d&     44 aT)-x$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkdw$$IfTF%d&     44 aT-.6TXx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkdx$$IfTF%d&     44 aTXY`x$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkdy$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkdgz$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdL{$$IfTF%d&     44 aT)-{j$$7$8$H$Ifa$gdr $7$8$H$Ifgdr 3$7$8$H$Ifgdrhkd1|$$IfTF%d&     44 aT-.6eix$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd}$$IfTF%d&     44 aTijrx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd}$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd~$$IfTF%d&     44 aT+/x$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd$$IfTF%d&     44 aT+/0nrs.67r~ IUVWvwqrstu㴝ΖΖΖΖΖthRhxAB*CJaJphhxA5B*\phhxAB*ph hOpshxA,hw;hxA5B*CJOJQJ^JaJph2 jhw;hxA5B*CJOJQJ^JaJph)hw;hxAB*CJOJQJ^JaJph hw;hxA)hw;hxAB*CJOJQJ^JaJph-/08nrx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd$$IfTF%d&     44 aTrszx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd$$IfTF%d&     44 aTx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkdt$$IfTF%d&     44 aT.6x$$7$8$H$Ifa$gdr $7$8$H$IfgdrhkdK$$IfTF%d&     44 aT67=r~x$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd$$IfTF%d&     44 aT~x$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkdτ$$IfTF%d&     44 aT x$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd`$$IfTF%d&     44 aT IUx$$7$8$H$Ifa$gdr $7$8$H$Ifgdrhkd$$IfTF%d&     44 aTUVvwI?kd$$IfTf%&&44 aT $7$8$H$Ifgdrhkd$$IfT>F%d&     44 aTq1?kdQ$$IfT%&&44 aT?kd$$IfT%&&44 aT $7$8$H$Ifgdr?kd$$IfT%&&44 aTqq?kd!$$IfT%&&44 aT?kd$$IfTC%&&44 aT $7$8$H$IfgdrqrstijnoabMNzgdYy  !gd%9gd%9$a$gd%9gd%9 $0^`0a$?kd$$IfT%&&44 aTmoUj>QRa z|z9:wͤ|obYSY hxAaJhkGhxAaJh48hxAB*aJphh48hxAB*CJphhxA5B*aJphhYyhxA5B*aJphhYyhxAB*aJphh _hxA5B*phh _hxA5B*aJphh _hxAB*aJphhxAB*aJphhw;hxAB*aJphhRhxAB*aJphhRhxA5B*aJphz|zvw%]L./VWgdX= gd%9 & F"gdBnh^hgd%9gd%9gdYywz,-./12VW       4 p q otiywƼƼƼsdUUddUUhw;hxAB*\aJphhw;hxA5B*aJphhwHhxAB*aJphhwHhxA>*B*aJphhwHhxA5>*B*aJphhhhxAhwHB*aJphhhhxAB*aJphhxAB*aJphhw;hxAB*aJphhw;hxA>*B*aJphhw;hxA5>*B*aJphhxA5>*B*aJph!     @   3 4 p q o-kxw23 gd%9gd,r:^gd%9 & F$gdBn & F#gdBnh`hgd%9gd%912&*8H 23u*ȹتؠؓععع؄vgZPhxA5B*phhRhxAB*aJphjhxAB*UaJphjhxAUmHnHujhxAB*UaJphhxA5>*B*aJphhxAB*aJphhw;hxA5B*aJphhw;hxA>*B*aJphhw;hxA5>*B*aJphhw;hxAB*aJphhw;hxAB*\aJphhxAB*\aJph3:JI23  x$a$gd!; LL^Lgd%9 gd%9h^hgd%9gd%9 & F%gdBn&\''''j*p+r+s+,,,,,,--zhYG#ht\hxA5CJOJQJ^JaJhxA5CJ(OJQJ^JaJ(#h7]hxA5CJ(OJQJ^JaJ(hKhxA>*h(hxAH*h(hxAH*hxAB*ph h(hxAh(hxA\hxAB*\phhxA5B*CJ\phhxA5B*ph)jh;ZhxAB*UmHnHphuh!;hxAB*ph)jh;ZhxAB*UmHnHphu!!%"&""$$O%%\'''''''''' hh^h` ; & F)gdBnm$ & F)gdBn^gd($a$* $  a$''''''''(j*+,,,,--.-$a$gd $a$gd  ^` & F* **^*gdBn * hh^h`  hh^h` hh^h`--.-0-H-I-Y-f-g-h-t----------------.. . .ƴԗԗƅyiYRKYRKRKRKR h;ZhxA h7]hxAh;ZhxA5CJOJQJaJh;ZhxA5CJOJQJaJh;ZhxA5OJQJ#h;ZhxA5CJOJQJ^JaJh;ZhxACJaJ#h;ZhxA5CJOJQJ^JaJ#h;ZhxA5CJOJQJ^JaJh;ZhxA5OJQJ^J#h;ZhxA5CJOJQJ^JaJh7]hxA5OJQJ^JhxA5OJQJ^J.-/-0-H-I-Y-f-g-h-m-q-v------=$qq$If]q^qa$gd;Zl =$q$If]q^a$gd;Zl =qq$If]q^qgd;Zl =$$Ifa$gd;Zl --------------------=dX$Ifgd;Zl =d$Ifgd;Zl Ffvb=$Ifgd l =$$Ifa$gd;Zl ---"kdd$$Ifl      ֈ< D%* Gm t0      44 layt;Z=$If^gd;Zl ---------=d$Ifgd;Zl =dX$Ifgd;Zl ---9#=d$Ifgd;Zl kde$$Ifl      ֈ< D%* Gm t0      44 layt;Z-----...=d$Ifgd;Zl =dX$Ifgd;Zl ...9#=dX$Ifgd;Zl kdgf$$Ifl      ֈ< D%* Gm t0      44 layt;Z..... . . .=d$Ifgd;Zl  . . .9#=d$Ifgd;Zl kdOg$$Ifl      ֈ< D%* Gm t0      44 layt;Z ........=d$Ifgd;Zl =dX$Ifgd;Zl  .........2.;.<.F.b.d.}.......㵣xfXFff4f#h;ZhxA5CJOJQJ^JaJ#h;ZhxA5CJOJQJ^JaJh;ZhxA5OJQJ^J#h;ZhxA5CJOJQJ^JaJh7]hxA5OJQJ^JhxA5OJQJ^J#ht\hxA5CJOJQJ^JaJ#h7]hxA5CJ(OJQJ^JaJ(hxA5CJ(OJQJ^JaJ("hxA5B*CJOJQJ^JphhxA5CJOJQJ^JhxA5CJOJQJ^JaJ h7]hxA h;ZhxA......90000=^gd kd7h$$Ifl      ֈ< D%* Gm t0      44 layt;Z......;.<.b.c.d.|.}.....=$qq$If]q^qa$gd;Zl =qq$If]q^qgd;Zl =$$Ifa$gd;Zl $a$gd $a$gd =gd =^gd ...................=$Ifgd l =$$Ifa$gd;Zl =$qq$If]q^qa$gd;Zl =qq$If]q^qgd;Zl ..... />/?/F/G/H/P/Q/Y/Z/b/c/k/l/m//////11R3S34umubUKmKmKhxAB*\phhxA5:>*B*phhxA5:B*phhxAB*phhxA5:B*CJph#h=hxA5CJOJQJ^JaJh;ZhxACJOJQJaJ h;ZhxA h7]hxAh;ZhxA5CJOJQJaJh;ZhxA5OJQJ#h;ZhxA5CJOJQJ^JaJ#h;ZhxA5CJOJQJ^JaJh;ZhxA5OJQJ^J. //+/=/>/?/@/A/B/C/D/E/F/G/=dX$Ifgd;Zl =d$Ifgd;Zl Ffj=$If^gd;Zl =$$Ifa$gd;Zl G/H/I/9#=d$Ifgd;Zl kdl$$Ifl      ֈ!$*** t0      44 layt;ZI/J/K/L/M/N/O/P/=d$Ifgd;Zl =dX$Ifgd;Zl P/Q/R/9#=dX$Ifgd;Zl kdm$$Ifl      ֈ!$*** t0      44 layt;ZR/S/T/U/V/W/X/Y/=d$Ifgd;Zl Y/Z/[/9#=d$Ifgd;Zl kdn$$Ifl      ֈ!$*** t0      44 layt;Z[/\/]/^/_/`/a/b/=d$Ifgd;Zl =dX$Ifgd;Zl b/c/d/9#=d$Ifgd;Zl kdo$$Ifl      ֈ!$*** t0      44 layt;Zd/e/f/g/h/i/j/k/=d$Ifgd;Zl =dX$Ifgd;Zl k/l/m/n//90.)$a$=^gd kdqp$$Ifl      ֈ!$*** t0      44 layt;Z///0011i111225363R3S33444446_7778 & FgdBn & FgdBn & F $a$4488888888::::!;<"<<<==L>M>P>JALAfBjBCCCDEDbE÷yryryryrgyryryr]T]Th_hxAaJh_hxA5aJh_hxAB*ph h_hxAh_hxA5&hJhxA5:B*OJQJ\phh_hxA5B*\phhJhxA\ hJhxA hxA5hJhxA5CJaJhxA5CJaJhxA jYqhh\UhxAUmHnHuhxA5B*CJphhxAB*\phhxAB*ph 88888888:::;;< <<<==M>N>??'@ >`gdJ >$a$gdJ>gdJ>$a$gdJ$a$gd!;h^h'@4@G@@@AIAJAfBgBhBCCCDbEFFiHjHPIQIJJJJ $a$gdJ$a$gdJgdJ>gdJ>`gdJ >`gdJbEeEFFFFiHmHPIQIJJJJJKKALCLMMM2MMMMMMNNNNNDRFRRRHTJTUUVVX X.X2XX=Y ZZZZL\M\]]]]]۽Ҝ h!;hxA!hJhxA5:OJQJ\aJhxA5\aJhxACJOJQJ^JaJ hxA5aJh_hxAaJh_hxA5aJh_hxAB*ph h_hxAh_hxA5;JKALMMMMMMMMNZNNNNN.OGOeOqOOOOPEP7$8$^`gdJ 7$8$`gdJ7$8$gdJEPsP}PPPPPPPQQQ:QVQQQQQRCRDRRHTUV>gdJgdJ7$8$gdJ7$8$^`gdJ 7$8$`gdJVVXX Z ZZZL\M\]]]]]]]]]]]^9^G^H^I^ $ 0*d`a$$d`a$gdJ>gdJ]]]]]]]]]]]]]]]]]]]]]G^I^V^}^~^^^^^__```````UbVb\b]bbbbb󼲨󼲼||hxACJOJQJ^JaJ hc(?hxACJOJQJ^JaJh";hxAB*CJphhxAB*CJphhxAB*CJphhxA5B*CJ\ph hxACJhxA5CJ\hxACJmHnHujhxACJU hxACJhxAjhxAU.I^V^}^~^^^^^^$_=_>_i____!`"`N`g`h` \`\  j^`j \h^h & F \0`0gdBn$ \a$ \$a$h``````````aaaab@bSbTbUbVb\b  ""^"` R & F hR"^"`gdBn R"^"` k^`k\b]bbbbbbbbbbbDcEcdceccc d dKdLdldmddd$a$gdn7gd%9$a$gd#I$a$gd%9 bbbbbbbbbbbbbbccBcCcDcEcdcecccccccc d d/dJdKdLdldmdddddddddde*eǶǶնǶնǶǶննǶննǶնՂyնǶնǶhqhxAaJ hl"hxACJOJQJ^JaJhxACJOJQJ^JaJ)h9hxAB*CJOJQJ^JaJph h9hxACJOJQJ^JaJhxACJOJQJ^JaJhxA hc(?hxACJOJQJ^JaJ)hw;hxAB*CJOJQJ^JaJph/dddd+e,eXeYeeeeeeeeff)f*fIfJf{f|ffffff$a$gd#I$a$gdn7gd%9*e+e,eVeWeXeYeyeeeeeeeeeeeeeeeeeffff)f*fGfHfIfJf{f|ffffffffffffg5g6g7g8g;giUiVi[i\iiiiigdJ$a$gdn7gd%9$a$gd#I iTiUiViXi[i\iiiii h!;hxAh.=hxACJOJQJaJhmLhxACJOJQJaJhqhxACJOJQJaJhxACJOJQJaJhxAhjbhxACJOJQJaJ :P&P1N/ =!"#$% Dp:P&P1N/ =!"#$% Dp:P&P1N/ =!"#8$% Dp:P&P1N/ =!"#8$% Dp:P&P1N/ =!"#$% DpCP&P1F0:p&= /!"#$% Dp:P&P1N/ =!"#$% Dp:P&P1N/ =!"#8$8% Dp:P&P1N/ =!"#$% Dp:P&P1N/ =!"#8$% Dp:P&P1N/ =!h"h#h$% Dp:P&P1N/ =!"#$% Dp@P&P1F:p / =!"#$%h Dp6P&P/ =!"#$% Dp@P&P1h:p>:Z/ =!"#$% Dp$$If!vh55X5Y#v#vX#vY:V l 0)6,55~5pT$$If!vh55X5Y#v#vX#vY:V l0)655~5T$$If!vh55X5Y#v#vX#vY:V l0)6,55~5T$$If!vh55X5Y#v#vX#vY:V l0)6,55~5T$$If!vh55X5Y#v#vX#vY:V l0)6,55~5T$$If!vh55X5Y#v#vX#vY:V l0)6,55~5T$$If!vh55X5Y#v#vX#vY:V l0)6,55~5T$$If!vh55X5Y#v#vX#vY:V l0)6,55~5T$$If!vh55X5Y#v#vX#vY:V l0)6,55~5T$$If!vh55X5Y#v#vX#vY:V l0)6,55~5T$$If!vh55X5Y#v#vX#vY:V l0)6,55~5T$$If!vh55X5Y#v#vX#vY:V l0)6,55~5T(8Dd 04$J  C A@?""7{\X0Iw|1f7a@=^7{\X0Iw|17ꍁZ,7xԝ ]UyLfIdACrfI$H'dH` 8X@F$UXRrWn^iZi*m]Zl""EkTי={Ι|@7~ߵ~9SEgGQ .EZºKGQM4Q(2$pfMJ(#s[-j5Q &PSQ_m2tlV{.N,!#;,88ī+F AhhH | ?m{<Mkalb̶v:=@sSӃoٶz&DLs}Az;m^ڪsN\yZ̀uDQCnlmdL5t6=H+YcRqWٶu}-Z{.Y2 =8o1nXRl␯ 1yq suV,bWsd~븿"|[7'ܯaz6/W)Nic>hl<º9|NTa)4\<=:} }r(J{SX ~};9*G{ ևt >)_>5x_i13w~<͢Rp֎.3a^;tiʱ߹ho*v!$6h53SN.q[o)n)ʻ> rDWEwo~>X Drcc8n1zM-D<aDdzJ]orߓtV}]񎾗r{t= [ >?:Hט@1֧2o W9ۦ%2hTɶvqNʎܒut瑶e9ӏp绩L郷=ڋ-ZU6`LZΞP #S_Apc*3g%ہo/q.@;s@hW[Z:~vkY ?\z0yrvc.vK<^p㪳&_웟B t#sf9gN?gG!2[;ëkR_A#כS,hy=)_A8OǜgB5;7.枏{Kַb?8~:j޷@hm eۢhi{4^;X~mr綋Ύݤ_m}n{{^+(<[?^i.-u=&B~.5v+22)PL!o:ƽMmd:ތ6ȫs+h \<uDُ- iOuWy>>qNGE(L{:Y_]Sa^)Ji Y]T'|=QʼC;l}$ݛuY;!reގSڡ+22)s* 0信e:i ſ!qOnjmmL~ a{S})/J~_9tc㼾SڡO mɧHspfjTʗS{y>(Jދ#r¿y{rWxθbZZ;Rۑx  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~+,Root Entry  FР= Data  WordDocument -ObjectPool ';70|;7_1370939100Lud@Kg2';7@N);7Ole PackageIBCompObjb  !#%&')*+-./ Microsoft Office Word Document MSWordDocx9qOh+'0( <H l x  PK!-[Content_Types].xml (UN0#q!ԴGD޴m߳IA^"En]EA[QH~ɝb v8,0dFV̈́WZxj-bccUWP'L8i)Q?H6Me:'sJZ˳)dXg=H[e,fL.0uPvҞv3isMS)">DP*Nz0BI$мf޺i+z P0"f3\ȾTI SWY ig@X6_]7~ fˉao.b*lIrj),l0%b 6iD_, |uZ^t٢yǯ;!Y,}{C/h>PK!hJ1>word/_rels/document.xml.rels (N0EHC=qRV-'a qk՚[6 qO\jyR̰YvW~%.|6}9K}3$?t#7tE^0<^G0ԇ(٬ EshZ}C9oZp&Jɧ8e;0̕_?`<)u:SyԦ͔A~Nx\i?!hpc-.Y~6?7W=?{2;Df͚HRVS&¤ 9$!ytG S#4 }w!]Lu>ױ.,c|cV7D,S  e==ٍdIX]՝noƦRI3J4 {߯W@ͧ,>SrnhK+~K+J\Xq.GN3p{o^Ϝͼ\ 2Cސdt}Qɮm3h|uvz}'tdB1R$UJdtzF,7?הk>>}{xDw!5/Ye13 ެs;8+'z{é_8/.(=qۻ7;V ŵ(\" c"8fc3j5;u[>kݗjM2z}?=L( гܦWˌN#-s@V%1|^d >(b;r!̺Na|jTn(5!* g3.3Ҭ'?jIY+ZQ)elSPA[翷:Cg{#ޭ6dwz9/_ }YomRje1+XD챪ZTq5BD,x\Ja6 ޼oA$Ƒh& 9YB#-Y bT,YRCaIktGA3p`is 6L g?)Xfr${@/p2i6+JUm8[k#sڮ{Am=Hf,_I*4U%miM-MIBapHonہ,I=y:qMAc|!݂o&v<_R~XųX|/4 nV@ 00+I̅Bn c0V%.L?8g&CI(ZIU@8ؤΑ( LAB02)24ؠh le1prCYJ u 7%cTxHqTنBTܽe$rXR35aDYڀ >/ʳ%G5[&׸&rBbR ]is؊< JvxB%nz$CQYҕ@>|xu!R$a9UG<(\QK7$B8l%l]B ,a!TXpУx# 1$=UP+HP#K.2Sk5%X:)N}:VSs7 eⅹ7L?Ik7b{$G*Y0 NٹҜKHd9 Z $ +kۅ"1y)dH!9!6p֧9l)})Z4PK!Յkword/footnotes.xmlSKo!GXqiF+Vϑʲ1*0Xo3,feҋW{̌W7FW{ېŜJZO kvMm+rܬ] bP1Ք98i1ف7>m[AлqqOLs%-Y:1\&]ǻ[h MbvKPǓC <'RmC1ϡ{XonSɎ:~<'W3ȳOqrEW?Z%!׷5:xCK s<>S'FerC-c(PK!. /.word/header1.xmlUn0?b4IKa!g0" $%5=%[FE9oPQ 3r$M).#?,H%FCFU֥Zʼn:Ʊ5(Ƃ8.V}jeYBp'^dq:!JpgB_0USxF{؁D FZX?Ǣzi2*9)lcBAvg\i=farF<qCH8䜔(& [b;^xlԥxwU&)Ȕb)]/)*O[7۸/2󄌙?c F;B *.Gwi;BAD#T;2m<H$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3ڗP 1Pm \\9Mؓ2aD];Yt\[x]}Wr|]g- eW )6-rCSj id DЇAΜIqbJ#x꺃 6k#ASh&ʌt(Q%p%m&]caSl=X\P1Mh9MVdDAaVB[݈fJíP|8 քAV^f Hn- "d>znNJ ة>b&2vKyϼD:,AGm\nziÙ.uχYC6OMf3or$5NHT[XF64T,ќM0E)`#5XY`פ;%1U٥m;R>QD DcpU'&LE/pm%]8firS4d 7y\`JnίI R3U~7+׸#m qBiDi*L69mY&iHE=(K&N!V.KeLDĕ{D vEꦚdeNƟe(MN9ߜR6&3(a/DUz<{ˊYȳV)9Z[4^n5!J?Q3eBoCM m<.vpIYfZY_p[=al-Y}Nc͙ŋ4vfavl'SA8|*u{-ߟ0%M07%<ҍPK!H&{ word/settings.xmlVn8}_ X7KPH$EkAIM_ߡ$V9!g7o_8Di*E+yDb_&siE$GGۛW9dn 3.c=TR˵gr%PP9SgiG5cL[R;NLa@zKkUNdM9s~g݃TOƘ,V$ZCf9k1NF1:m>i:}{&(+;fbed { kߙ>@LKEKa0[ո9sf;.{=ܶcx NpJ2UYH^+HLXKi4䓲hIpMp޻QBBu2gD56M"*mۆ/0ଵwIC`C($"a|qt{%T5F;%wuzP *݂AwzTGwʱi' N2 =(|]YCV2#/IE |58~QϚ3꼡ɝ9Jֹ>C  ]Zfj ٞ_$rTJ!HiB`Vd^|}Ӂ?k:R!#qJ.p#QR\PFPgM+FQ4͘U"qԁUj<5jqDc'{ ݦ6k'[s;/PR蜫#/w0FYtP͇fƛPK! 9word/webSettings.xmlRN0 #U,eUk'MN`|@k$ezv`)߳ݚ5ݏrۖm{bYL)aAټuEWH1..dMJ<#1XZKXYp|HAlԭO%HBYHmx: RnEx:}f6/ L < Zp|#}8Z-#b< IcibpaΔ]Wp>5wzpƠO0,v@>PK!vwglBword/styles.xml\KsHo{bYr%Uy8]{Ȣ-ίߞ!m'ELyq:?d*/##OAt7uoo._v$/Bɩ$?xpOL%g](Vr-j##xTZ5;Re m2J(HOnP @5Qc{"{sd`iv1L;23Olx-Ix\M ;@վI@aGl$`7 X5]>FENE &@&C~țԝA#o,ɛ[8?["y`.QPJ=7*yPѩ#ondB R&C~țy!oPwn鏼 XlnZ$o,P @ 7*yP)}I%`T²M-dȰ09FC!oP?Mꇼ @ɻ?&`rj @lz@E& yc1r&T%o ;:%B=Q8fzC[W^}q8 RU⮑sDŽ1_6%PTf8.55N=YW"*xkobx -޽-Gw}Nݞh`²w2"πA/~x;Q"IVA\ ;)9Qp ӣ9 O' &ˑn|2$@pK.hCM:H He(]taNҍ!ϞN r)l^"mn~#5A:|{ޔ8<-_gzkoW4ݴxs%uֻf;25+){-g}-V@+b@[Q7PK!E`n&docProps/core.xml (N0E#?D'vP$@ Ffg1!Oz4pny}ab2mX] VS^۰uyƊiy6@bk#F TɥF {F I="#G+ʸAW[@%J>˰Ղ o8t`auU//B?dwV?Y}WQݿ7rqcV X֪AkUz{|R"HkAV9MŻ*BhH*4ˉAN&>C (Y`S%Ex7hWٱ6oq]Z\oF,DL.(f>^=郎Ŷ>m2x+A.@o꿉3`JePK!Wword/fontTable.xmlN0M|{Ga8u^}3VFڒn{Jq2DKBwڏÏ?|* %"sz͔E@2ZdK {__7h8+gqy)BS0VGMQ\<|vq$GR:umM.YU?Ry]4( *-Ԡ j;2Sckćb`QF~Tl$b(叾+aUPBW$~G3$ݴPK!7LwdocProps/app.xml (Sn0 ?7JnmEŐa[mϚLdIؠ׏WvO|4HQ;.yYUֶ]uYDYXGPC,C+ƢꠗqFiKƅ^"24ZS/=Xd3W[C}ᧆqumZ;ŧIH=1aʡ4A,bƀ?P$f A*$ g_7ZI$o7apHsprf%h<9g9_%%OI w&}{% l&g߂LIMWPB/,~ɵuyAK^*1Jޔey/TKya"G 8W7C";hfrp:㏮{ibPg|K[9YcRфndUzN-YL:ȶPjNz_X,gs=:q SPK-!-[Content_Types].xmlPK-!N _rels/.relsPK-!hJ1>word/_rels/document.xml.relsPK-!#Lj word/document.xmlPK-!Յkword/footnotes.xmlPK-!Aeword/endnotes.xmlPK-!. /.word/header1.xmlPK-!Pword/theme/theme1.xmlPK-!H&{ %word/settings.xmlPK-! 9)word/webSettings.xmlPK-!vwglB*word/styles.xmlPK-!]3word/numbering.xmlPK-!E`n&6docProps/core.xmlPK-!W9word/fontTable.xmlPK-!7Lw[;docProps/app.xmlPKu>ObjInfo OlePres000$1TableSummaryInformation(       !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~o[NlMt])$8.Fr.oX ݣOW)7; +]N'2RڱҥǪ˻(%+]HuY;.c˧O̚4\vuigFH;^EW,RƎ'#Yg]>eS&˩W7,q/zSx>ǓW ˑ bU=Uxt22?G?Ҫя̊⩅tT0WyVӥ-u?ov:1逸|hѦ0KWx5ߟߞswjoJ7KC!}};鹝>~+g@.$Sߎ4⧎ǵvŽ~6ˮ~}i860zmN24`jJ+P*$HS2l^H/qm#ԃ>V]-#*#ج,yv}W^/]E?lHɌiF9q.]H!v43m i);އ2xezdc]NiYݚwl z}yS \ygǴMKY @(\!(leM[`!zR/=}Eu{=8TgپƧ^ q)Q>u:0/vBppEGG\=S8g-e^yCQQx0(nEe6.S2]7 6+o!/]I>4˹.֡eolj)u LCW1ֆσ \?y`|A9ƻ{?,ɠxu ~X =^Lzn|M"e>;lw;uBS8Xk><ǚAJcw&'Bl)g%.OʗDg|L|;W|e!M[l;6kx;3e쑧=5dOXZ]FL'zn8{@佥=`tYu{k>[@gJa$ꝜP:_{)m9zs0Hz:m7Mܸq\u4nKYs/@ 8g;O(cɫ eʜ2V2]y򔩭| dy(=~ yϐOݻ%ϋK]ϤR'BdA}@tn<i^ZXJ}oދVwTFcy䝒O(?mД,BGIhcܯ2*#She>\EO24|>Sy @Qkssws sÙ>wd ~+Y{;/% cӁ.lk K>l#/;. {އ>P/4mxbՎ{c؏9V7exv>(YȔ7ZGTa\>gS{S7(7o"WrML6XY@ o @_K#z+\dz0 )6A[ ?~._s;kg߆8C'97+)ҷxXe{軏1USmڟk[ڡFZf<ciʶ te24z/߶ z,8_e|.Oо7=Е|\f8SUy=7evSKH$1.Mhr\JWkݺHZv?eWO tL}"9ed̻T' .O[j9t҇NZni @ž k+%+r;z9C9OU{T{_EOήkkD>!|V79|`񌦽BhΟ0Q}7}ƽh!V9e2C)1WCuov e.-?̎S>-i{;=o}V&5ɳl4T]?h~M^z6}gSu?6wFgfB} ZzxAI1d_urky'rН_Ρ0޷=(>ZFyCQQx(GeeFyj\ݞʜ2)]o"Kk9$9 r?C1OO߈2dHZsRjC3Og 㘇ͮ 3f8K%1ɹ:]M~Y29s{UqkG $yp>|.}>М?>BiC}o];0V!mgxo}d))r` dʲJ)1O!y/?mC_Kez!?u@_9lfOa Kg}vz mŚq=i#ϵSOnP}IqXױӱ/3Ѯ}e~=22VG\*ӆyl]%:ygO_ 4BN4Ju 5?-<GnPb !@t:/øFW2-aᾓWm;Z'`}R16~!(S <~cm+ph@yqc6 u l v%p B멯?s܊_ Iޮ-R_ƖU̼y/BIRRk>/E5yۜxmK|=$oB!N8~4j젡sz&0ּ= >Мv}y$K=1)`92rSv}fN`NK;þ.3<Ǣ8V<3o IYzq:t}2yXlyȕWԟmAdg+5ב̟Sq|({a 7nZ1{7nj/ƲvϺ"S?L~4Οq/:̠C{C+W(7Aq88wΟ91ǚ?/2eMJ͟ƜӲ:l7?ό B`X \)z)9T9ȏ+q9/;n29oO&˔LXmQ嬚BF[A e˫Fge6|E?pSrWy.k6!s_UҞMt@ zlu'\q/[5GX߹bWs"e`loBWn&zwW(ervP}, ?3ܷ?:./~?qXhD1,XbЁ{1-im^{MnE >>]MNL(_ 0NOTK97 `q;~EaZ村IY \w {nnmݭٹ]7nzҺK$Wp,]7sb%p kCח}pwn1xzԍ?[↟-ήBFjگ~1}qa\_ N?Ż7\Bim̮15F__O׳^/'U7*험6yyl&(kEOuQjri]9[}:t]y?zvnl/nzkv]]udi~@Xu_:Ժغ{[W27]W~ufbG5uu|]Pa]mպmuuBi]F^W~Gr2VPPzNt!އyTnZ5=l\WN~u53ۿ^'\<}>oa])s#X8g'99߸pSW6º,C΃]_y_8-8ջ)?ۯ50\mi}Xσ?DWM*ʥ\ ݯ&j~*ء-!+ q-p;s gn_p[ h~[M;!sn[^9N.p跆bSm2ΦG=Ԕ O_?+m.RM x.g|^ \s`( 5 iġ !K :lDpM3ėSgCaBR:3S5*}fjU)uͿα|;t1#T1){)$6jy}.SfBb: ,K(?NNK!G˅̫NI=+ց|{~M-?}fzy5]/摎VaҨs} u /cý@آ5ݾKw,D$7/cS+t}fNGb˺PJSK9KFKAQ:n*WPy iؿ u|a4sw%_%N6Oޖr s2?Æ_ÀM&Ǽ?QNcӣǓ`obV5ӳs,_oNMX@;Ii ;1BNh-кs}<ey!Fr)e1}`i(OLOLKҺwYZAi{6SwMhc/x\eci/o 4eT&xo?foOs_1O򻘉<JP bA >m`hYqnQ~>g߆mWw&r⻩q˗|}^ɇ=>Q4!K!.y)d׏9ox,@މ@?[1pBYnxr  Z6yy{fW/z:ڽہ)_Ϯfr}7)y ҮҼYsegM]DJc[f4oC w9=@[z9|\ӁcAZޒ;)i%X 楥}/u^A# @_WE a^XXgʹS7eƗg1/ya]Z,@5:(P>T6zJϯ- Պp^sM)\qM]y N`^ \z-v`{goƆ@3/X^aЗ&NӁkW.p$^jԗ={M܎uQZ~{zk R!R][VҒbT^ CA8,u!K :lfasZ0NuŤq ~rJ~gS lx76|XyoOln,i:܎qQ[yb=Gn~h7 Г'..Gn¹~ġ}q~K :R;?Pn?6܁ ٜtULuHn\A= vC2'e/ <}5v|u^߿Cz(GKkFq֮opFodYfVqx~*ލwTR~XIz-m۩})_r,F 8`ܜп β5{N`@wl9|yegZ:BbJYK| /߇k~~mHCdhAGu`Q_޹gɡ7Lۍuog75v> 2Ζzo>NW GhhW)[u`q ]+j9 .b<ǽ̸9UixtPc4*Pp[)HJ2w5gѢ:'N" =l}FVH_Nfre#bx2?/Zu:sv 1[rG8=ŧ`ke) C O~u A+仧nUc {s" Fݯ_]Wuu{e۶\̳råcIbW!CKgb9Pc_gxqЧ=)Q d.Pvά`Cά;^l޿㱓ϾQX9@Pߡ̬-u:w(ʿCI}r6߰g,}g֬;.H}C%άÝ̥:!},1HDK|a4?/3?ouq9@yoIی5?)(ٌ,t"KEuYe B М@/:@O4nT^oM5/Wrk$u y? S9.:u/ھ;6?!jJ q}zC&O|> !]b<a}  :"3縁"5XW.p$yH}y┲y"sP*e'N) c >Abbɷv4%Ő<1KB+ ^קqXp%q|B@H片Al<5cB*XT~CJ5A扼{Y4r?ge'81ʅ`.X ȷ\ B:jW)SWkh^ʱ hgC/6v̱М|&L?s2"[/AsesVm֖mgAkng4d͹TI'9-?ͱէ= \ymy=zQ6mXkב:>FZM"wp~kü#}B9[6m= {.WG68r[{m7"BZ)A86֭T)l f/8Z,# /(M(bH4h̢"Lp ?]m Bbw7ws|z}{# n2Y5sx,c}3&] K/ׁ20 J䱌/6v^8V!yj)eAfH?yy2w;l79UqpT.yYUcg68En^*e?7rq@Y:TT5pu rYr}YWiBlykL;9_vnd,Z@{eUkn.w:)@X*O3t)pL.ʧ8 Uʶ7V9Xz37z.Gz! >YH{40y5t'Sv.P ƻbk\PE@S; LPIhI~|d#>W5%.ޭ0=]%<ʈyH _܌YW\C9RnHH5`í'N=k<\GT0 7)r+ϵ3@d+Rf^vmZQ]en[Z=:?O?f>@ ?H6 )zq^yW սpR( Z?:repoVw}VfSu_ݍ~dob pr盾2ԗ<١jM}B_kB/jWc__)v#62vx+/6ôiFi4+6nz|UhoMƧ4|fZ_/?iM_E(DĻJݕXµ.ɮ/gٍWƾwc:mFP{'2r2@?2~ܟXKic9ql [13 [1PmHݴiFq.p@c((~-+}̺_6+{be'977R ز({Kk%ZG,^UZS_mLj2# Nkzl1Qգ֗[if{Al!myHKmsz@6髃է675}M_J,cMKZJ0=l>@;y6sE }Ƀ*[/EqHj  ؁(Mo$$If!vh5&#v&:V 4&,5&/  / 4 To$$If!vh5&#v&:V 4\&,5&/ /  4 To$$If!vh5&#v&:V 4\&,5&/ /  4 T$$If!vh55d5#v#vd#v:V 4& ,55d5/  / / /  /  / / 4 T$$If!vh55d5#v#vd#v:V 4& ,55d5/  /  / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / /  / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / /  / /  / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ /  /  / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / / / / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/  / / /  /  / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ / /  / / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ / /  / 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V & ,55d5/ 4 T$$If!vh55d5#v#vd#v:V >& ,55d5/ 4 Tl$$If!vh5&#v&:V f&,5&/  / 4 Tf$$If!vh5&#v&:V &5&/ /  4 Tf$$If!vh5&#v&:V &5&/ / 4 Tf$$If!vh5&#v&:V &5&/ /  4 Tf$$If!vh5&#v&:V C&5&/ /  4 Tf$$If!vh5&#v&:V &5&/ /  4 Tf$$If!vh5&#v&:V &5&/ /  4 TDd(6J  3 @@#" ? uDd >Qp  s >A?Picture 3""Ft45w 5_b"tˊ@=t45w 5_bH'Xsxڿeϑ -<" 2 Yrp+( 2A+G_rto}3#NWUVw{wblgwe{G' ?۝ys`s`s`sg? CL?O?+_2`_{__IǹM(|_ c(Ǿhȏ\+9l æ +k6Ɨ<Ǖ́ՖE? y6k}V[چF=4#Y>kt*wկ2LyTwݴ v5[h7_?n1G :8k&ȷi[N~ɎIotS׼xГCf6o1#\tA9zc4Fщlsq+‰3^biܛ{s\2uy; <9dz9+Y䲥t:+FO<[Qt%FtevPOC*f\ՙk5'=$gW-?ִfK6j?bc]eG8~4φ?罪G剧|obw^d8ɓ@nAI$.grؽOGm|!kx:<ݑ| dL2bڙ\4ι]oz8?IkZ8c]=E>YKos==cWw/CEmVsڻ3V9j:f=W>%kXM3 wŬӏ{u̗޳ ky_A#Ms4u/Z#'¦iws4dYgmN|xeo!;G]&97q1_3GέG7"5/K~>)OMߒ-};=Dy{{r@8jRW~.MW降7Sêi-KGRoD C4ѻOuFyh6zG=YSF> d[lS6e͆|V=0]V^={x}v|__ ; Ʉ=S&MƗ Շ8[2hր#8>wbi=KƦsu(P^wjwZ{%n:;scsM~%l^xssv766666666666666666666666666666666666666666666666666666666666666666666666666666666666666666666>c'?ygc99929#O9޳k޿́́%޺|l7/ڱ={΁~[olEu~ W޵́́{[ӷ̽΁cα9Yr[,~nMX9pvx~-կ~Q͟?[rCb>JR_"ӟ.}~|Qt-zz3zkk]No7!N}OӇk}Iq?~?ѧʇo+I˭k#:ig*_Ǟ_ٶN;ٙzz3{kme_rL>og={kǠߤV2@W׿i̓L6@d+4lt'y%3#[7S2Fkzه ·65ۂ9?xpdl GlE emg%giWa_1:ܑ |1##}h/ً/ۧ;3gwdq{́3S/zWOv{sW5z s}OޔcMO;kѧs}JGF~7Clٙ_|Vl?+G1#np3k\oÖdE̅Kz9ugC1~x2[b1 rO&Ӗio94w{ǙzzOZ=}[YY~o9pvH?#d/0.dS_}H=Y|ꥎv7!^/:\rN.RK|굀y_W<td)/^wԟ]oқ}@gKwLӝ>>6G;'G,.;8^Ǹ^2 |<OVǺ+{{Szv)oCڛc=Fc ޤ$x=(Կ _]/KiÔg-G[& dN|>99tx3^zA6zv33ϾΦuN6_[Nzumz ~{ 9⃷?zsǏ>8SOy毩_nW~qL>\;o:0'%|>N,No=GBvkynd5T_R_GvΝLyeęwoӏ'`#ۺFѢF|z|zon$Ϝ^ktMxtBFxtdqI:F: gMO G|/cvO=- ӇJ4r!lv!;?ȜgN<.AE>͇KgWg-؈GU۽_>3wwc\zn~M~}xw~| G_f}[1eŜ'޷==ǯg̉~=Gߑg|PKն#[^on]-t'+}›7wߴɡ= $/}g8x>'+ѻ2HuFun򳻽u{b Œəwr;gĿkvL]t13v%lK2-Ltω-ٗε_^jL?=;_o5Ǫg?~>yЋ'iFuQo0p~z䲉 w^ig6Ϟ93߁|tN0Zl.^wph| -9;ݔ#^ɜg.؊5Ͼyx8؉zi g=!z%!/>{~CrerDə2n >>=󌇌hw8S;'d][_禺RwE1gLZg70w?CO[͍3gZc5k(&߸羹\“ { /l{Yå{mb[A6WpbS_^,Cz>1iWN|#3_|v k2ㆾ}G%5а7[{N9.7o|g3.ճS@^vG X{[^W[zO·u y-EVzg 3T =>|߂V[ymT}>RnoN:wr]^Nds||l|'m`o4%tk|QC70=l[￞}t[ X璅3pO>Z7K_#|pb34_LoylN||-[w~歍}u|awk1cpΤUo{kfk~c5i7p⚫5hق{x._H siV۾dU!Vx>jc׊Sm]F_;[~\1'|U+p0cԧ&]u4𩽞dO]Fv׈_Gco,>1Ѳسlz{XdlB'鳆5Ǔn|217ZQwxșɋ?Ncd{4I7l*N2|LN{N2_.?"~[kS;uULn{~r}b#کѓHg7=-t[']Ff}<-ևO!sppwi='I^z%vu^7վlxߪAgϽcD^9L\N=t!g| ȄSC&^w@\#Cϟ ;xb :]Fl=Ot MA.`Lw} d%n΀G U2;Ov~H.]]՘/Ȁs <#+=Ӛ 84G{5wO'wT-x'3^ֹ^yA.q' ;Wϣ7HNx!I.yNwl\0}Fs/.b=XW μf(E6w}w~Ʒg=&oE5}7hܱ#}l@mgZtd}'أ=Gy#ހ=jE:ɢtAVxo4~]|/=bhk 91=3Ȏםm}_Y_z[w:֞h^oAoւp|`G~mΗE^ʟ[2Mu+;wxwF8>o-{='#wy—͙zzx-jSe}n5X}8Y}D{XSMz02.Ny;Fk:5?ꠛ,vǛW\/t&oƅ^ϔAnvآoN>>xS[w6Ϗk=pc9}[?39y~&~>=X=:4@ofMNhbz(o ؑIwIOt\a3G;YzY@^v d9^kA Y{>9ת=޺~/?9K O꫾6W?Ai]62WYz)ɳG>oFc>>1c:ɣW<=Ń4'z82A.>gj;R-N^YԱKnqh^ w&.6hzSpmwSn?=Ӝnni#Z]?>^up3S695ǣ{G^ܕ9pv!VN[d;9tW +Ӗ|`}IM{ٔ=ٟLv9?ÿ֍KW\ Lѱ]x҇vƭ<[w5V=wn~/ɽ9_h}5w7=ҾԚ]y"uKNu\ìyMn񻶿[糿U;ՂK5=ҾZvopwd!Gu6cSH}ѓKs=d '?I5Wsxw|[lF&}$3Oe?OŮ%c>`=ا'tO8yϵc,n{ۿמrV8H9(OOr2eׇطg>{[ug$G =NJ?=eEmd4Gc>u%KOF^hӘ,/z>4鷗?h9pɲ)f).!i7@,'+yΚͯtYܦ/l n{[뿷+=rV/ԫ_#~}ޢ9ګgxcϓzg #^twKў>-뉌~GG>]>{=Hu~>kp'FdO;1Z\Ul4_84l_l^|ozzxMBu_~?rV?:ck=a-ꯎ{еc= >z.XA?BOK~A8z15p^[ tx͑zKLtd[}=8Ho}jvctΞ[کnXͳ_?b>\M~/9c=>~}\&mr4Kǥk8v~8cTksm& -u}oyqN~ߢ3>է j#)oI;jFįfMk걽 |07yG&IwS:h[g\ӆD?[ .ـdeo=9pvv!⤎ھT3Q5BMu TAw#.}G;aC@{{u~ܧΆmtF{q>ksm׭|3gZefgߠ&;䁛5}Ҙ=hx{Od yAVu9:s}c響=yP6ש׾>4]hӥƄgn%ߥaissjʫ==Ϙo]O_K>Suѓo,׳] =>ճ&Ms:&؛>^dgmhr@O=dϽBO <|kǵת1֔́ϕo]O_K=Sg[ozLɪgxktD7pr߅ߕWA ڋκ xɿc\2-nٜ<řک.t;\ xuzs_5S_<嚮36[d_ҩFrsplr'Oqx1z,N[6jNߎgznPo4:rx)Zq䱧Kwgo3“]9}9#۳;=yOsn#>Ld#4Kdwk/iHlc ^WL[wZ[1|MՀj%ԛK^;5sfNISoҼ|8O 󼤎uNo>GnN}l>{k=%YxjڈިIhOT|=x}!Ho%#ZЃiwiُ>zkth_fC{h89GL+Oz!7F)D:Ӈ1oOYg }8&g<еX\,n{ۿrXnjKHw{O7ewY'G?W/ OoSX/L aњ#?QFns'9?6ii86e]>6N9?/~?uO.M.0}dF>AӗxXܪ[뿷+ruc1nNRƙ՟NZ~=TEc }#z;Svb~Sֈ>*|>8=<6#>GgSSX#<8Hyw7<=di/=فڈ>ə|d뎟oӏ;sй}}~Jɡhދ&~w1gjZ&oy>_?f|7wWoSNwIƆ%'y2&ݜgʞ{gٳ;x[xLηvt/s{-NvhWO{j5iM <ͽ}G^]z˷zٓ}Lɟ_l78SQdQ|I7_1d3iEVJ69pvyY^)F dw?h)^3Gcd;s̾b3;ޣKY[4Gys 2tz8SO1ү|o ՂiVLqvd#)j>Dמwv2;`fN&~=^lM&~LOb~~ěS6y.4DotKo}z{5g^ϴʙ~'X{_}hxws|s`s=[og~O/fOV/o5i]l_[7Ҝ{gMBrȋo@[,.9q`G=}pvgw)Y=p:?W_x-{Ɂ=v>z#HvO9zcz'`ΚSsb=bN5l'= cYtm &CxLW|pinɬo'nLl2vsrl,շc4a3;A5}϶m[S5ׇ~[5H.νz)_/W휴m'f7?u#NOŞo#Sz^=ܹc9KrL;Vl9ꮫ){ڛZ=ٷlz9p_X1<^JpR=Lz.}yvGk[/#kG{~cާX}ʁ3ӝܒfGόf@ݜF ti㼓{XOȖc.M;<&7h=g;B qN 7־>߳'i1ڲ99p3noηdserLCk~G1wsoӟVڞg7gc=!>sx5GcC>}{A[rԳG:{輴Nlg?YbANѠoҗtoǗwǏ3gwfu{ȁ3STwKÏC[ ׯEE&;p5#>ׂϙک=[=bsq\v{0_>x=ޔݠq곟|Hz8kW$3^:aD]l_GOwɪם{ }l lhɿK:{^{^g=ӷ*[=U׍|P{W׭+L_sq뱎tz5zoSѶ g^ՏMzm~F=mF?m#ۚ|"/de%v~7676gjgߵcRL:wպ:1ܾZnmc<%ФzVOnΎjϵ8g]1Yg|'5[]{?3q~~5\U;00 5_FoN>/zc|WW=?9Aok|Ox k9|d9G_m/YcyvojQ-8jZb~?Ґ1yM`:dj&_Ht/5Ŷ/ǯ{l=W _Bګr^,:OwRu^8O5ѻ"\%yh%;z0{kM)lg}`s|Dxjc9qssׇկ]z;}g_XowIg< #{Ro$섫.;]Y/{G%I5z \le#ӌҨGJnf>y YY/',NGBG6{%yxL4^;[m>xS=}o-֟󱽷v.ߟʁﮧԟ]&_zN}L )/z2I4|ᴁ=e|ɶ)>v?6pVm描yl]Z♼F+]F ~ϧsy)/.HlK_W'gzܣY:#_%j%=_R/^\CzV{gX>d3mf6.,|8R;=GzΟGů3z{z{jh5:5zD;Gm|]+e^׬֫or\o^2ȝ{w1{a6:]μ{lo%Ȣ?Gj:pVGG=YsE &W{ѠuK &54Xl-=oi ]wFË>qO̷liO;od+<{-^ق}9>x;bv5=[_=H=}l|_!_N쁘 {sgOYw[ܳ6߫/_GjwK|V'stnFgFtҡy~qLMu&Ş̶cAxҽ=zݷMpWg}8k~t{Ꝭg|_zszL9O2dÜ_9[MvD59Q\GUo-r7"3v4ȿϭ3##F를nv ]=dOyϜ?Y3m[FϰsH9j V^gיk\|q^v=opO\y^z9JZBߕ-#~x[3zge93XK/2rw^GD/=>[G/& ~ k9"r$'^M('̻g,wF{ xmu>SwmwxẂ#9عsO~m/tFgugsu⢣޶wLh6ǃ->6kOO<^v5[wEo=;𫟡Gghn:zIGtb7כFm<_r{tJf GgtƇ?˵=z}=\鿙}8m4,3|[owѯfʁGk>ޗk`9COzpKnMWg}V<47>ǮW˼W|v-&zǽ~ מ!\{?=GvYWNW5gϯ^?ZOoy ߢ]=ʁ_%V\Urqr-W Z9kfr9zn+S˧˧+v>gx~f ?߶}ݼYy_l]O-ro~~Xw>8??ogݜZynl]O-skwwsrR{J mw?}ĸʏx5rg/78oKzNAϭK'.ko-]A>K^F/ngR=}U-Uv.9?Yq]q}W\z#=zm/ _vR7{II\n33$lpFzhɏhAZg=S%ԛ\2GN}=G8>" yvbzUfmpʏ*;rkk8R;pIS?皽ۖ^V{G۔e-CLz<4>[{§־za|ųٺǗl # vϵtv僕sH=}-϶bjsD=7nHNjg6dX.O{3ȮoN8鏭^K2ZHN!:}ߔȕo^ Dg?:6b9鬻\U>Yyz^>u3|ĕd#\e Ε]{2kڻ|3}Y=}v->M}Qԭٓ@ЙWxUѪ%~%Kc-=څ{\)ū3\ 咱3Yz-Gr-xvQ[k^}k5Ԃ rEYUT,nʥc<]ʥ7c.~NwjǷo-Y{|wB:  Ƿkk<>h]ʁrZ=}/-zjW5]A_RC׵(Yo{;m3'I3Ws*4k~3y_re{:o'ff< =zӓjl>Ѻ,~ϩ˯˯GrzzG4x]eEw\{W{9^Z[=?E3>L/Yٶ3.۷!̮q/~b$Q1S8d U.'ooEv)~|ǹڹX=bх'Pl\ւ]/ɚyH^-o#[]sN!gdɿG[.۟KL|rs=R36أީ9:sTϻWʴjp6g(IwȘUs-C;[#+.q[1.O/gZ.n{andž[r>f>JŠ/Fyė-G7A?ޞ#[Kzz UVW/zzOlޯ5r{?-~{ݙ#gd?r#Yy4gtZg ž rsŸ??!KǕɁ{{ҳ5^sa=g˯+~^+~^.sޞlW n;=+ %c{V_)Vݾ2:mZz'=[c+UgV%{>yw=;l[^l~K+~+~9I{9#{_{;юҼ]߻d+ežW8[_ߒkߊwρGg|B}_X5==ꕲ^gj|r#z3yJ}ٿ>'3=+e;*;bʁgkr {f$sj?䕟]xu:>۵>/ uq EmV='<{C]0?v ??ךGc^yoPΈt93L;!|y|F=ts &{{ҳ5Vn񒛞W-&WZ2_m_L]^)v+jeuJg;;Y=:G6Ad׃k52۽-=z cW3;K#>ŵ|uk1<w32< {.=ggn_e߻zrM8-=W//xEv&?c><6>"8{akY3Mdk/۷ԫzqU^ h+9o9?gu*l񑖫~Nm*9X]98[oC\Ϡp|;c~9h=:z7\:t/s/zm~ۏ\Okg!(. 'hk`ݽmlwHs_'<~'=hnoIO/{Tf$5VEoQVoK;˯:}K=yOyo9iyu1ZٺT==yַ=yhV{F!.~GOx|OyMQN]Ÿx~hOʏo_?|{^26¥uVwW׽z^=Y}o_Q+^Bܝ`;w&?"Gf/#]f/ܻjԭ+lo|Xs >ʼniL}{_ ʫky|LPpz[uzRr{`Q05vO/yȘ[d9!?|M8>k=;x9ۺ54(wxS_y J嵹=&ɣuϔO'Π;#e7^oohfL'&r̿U '>6{gqgP]5ڋ Z@gϭqdW<>x-}>[K8}\s`O>^.o-=1R+0|o&|1/^Ūu:5mɎbok&[z>jA?OqŻ:13< l.ge ~K[Vۿ*^Oʇ]t3raHtbBGSw-K|`d֞|-FbXnyOncd.}fA1__?Mwķwms quák?ֹst83'=>n,輥gYMʳ7z#.J.Z`/[=6Ӷ|'t|f6$V\1iߩ;Z`ot=S Ϛ15k?߅dO|4L'+yǽX&?=Όʣ2^=gQ:+Ǿd黇GѽGcbt8׭^ᏞmO|?{ƭ\g";-$L}wsMg#綳 L5=칔S_5g g8ӈOMѹ [Kwg+tc .{%>8)߭d\ to#'s6}d-@?x+8r߽ܱ?SonyQ1~tMط]ֶ4#=kg>@S{߹{?<ۯ̥WzR/ڿۿVfeL/ܹs-wmIl:9X&w/ؐ=geeז}%϶<}ILzγ1J%#r4}7^ }G9BuYWUnw+s镲WWzs^7;'\9] Ġw:s#>ew/V̥Wڳ'Ԙ[WF~wg2^z[A8~Ls/X=Pcʎ8eX\tVQ.?]z/Mpⴷ瑸>;![N'Me m{b=o_ͶG>uĮW:Ϣ=+s镲~bNWgسrge8.o\[{v|Z}~~g}omye.RO̫{{ҳ5^zⳲbMy_9{|RWΙ5핹JY?17I=?svÝln-. JY?5]WO_Kדk=#g]{$Yʁ΁uz,~+W9I{k|{Ʈ\?V*wYʁ5V/ܝx5ϧ`ۓ6ξ]c㺞ϕ+ʁ ?m.[k|sы.dL;|4/ؘmrK~? @Wm}-'Ύ˝Cpr]s֞=D7s1Jtd^zzZ=6'o¥#ǽ^ؽw|}^XK 3pdZ}ם+;<,`?lH^yu.7Љӏ{7^X;/oD}Y}/k|ٺ|ks9czjgt{:gf|y>GhzKc<36Im󩃽g+d~si+'5f;t<.zOx~Cn`%ɽ8/|5/=?OY 8Y7Mv +{r=췯g$ztvp*Po?z.G_j$޽Kͽz_g5{Vn}聽&/Y{,~__FZSrDݭHf{᜽5^!p rrLt~Zf{Oyvހ<cݳ7h;mk_K~Ճ3]Of'z)׫%[^H6o7g+ۺ+(&yJfkdvrbkK3,h\ͺ={ɜ~ɷxL>;і&O~1^DKWjF5S]r--F}<{i|ԲzZg=jt ]﹗׹iW:ܢSvmN݌Ѕ@9hlR{W}\v~?ł^t*tg#s_kggǚ;gĵ^3Sgfj{G~Nko}cȳ~fOgzRgMK53wuVgsj~ScqPopj9̭էtpxL:x+%s@?.xg/ɣG8zX 'kk=GRkg}}lf\[lmNb_e٘ۘ?0_3+pY;3 8/,Nmc~v/LD#{^Z&;;l]K;΅bS9ovZWH<{nC=Sg֌Kxg}DOzFGȽVo[jϼs|W}~@6w{D=~n5:F;f UhBkT?L]շKν6o:N>Ӊmt68zI鞟?uz|WjZZ9xDOz&n{rwv]{U_/gb<>Nz;<}5W~~G<=p`;p㪕_%opr`'l<2{r}"_|nny|X.V9n}z3B'\o,}]ұ#^۵[9Њ喽]5#bxXx}l{R]5mϞ{|{d|́m/s SڻY߱f]?[cr껌dZ뚸Wν7W6V|W~/^9P٨nw6nqk6xxOZ|_~_9=r@=>m/=[gحܩ>geM)߷f»ϖGtp-M'ڿl:vZb~,OO+^O: FglݓO᳗^>_mo$|'W:gOݫ[g'gj:y]b8_N=Y0}uoRO꽯u.}~lݓYٷ̃!9MO =Xok]oq}tt@tFб==):7ƛ}oxs|\y#ŢxrOKw6%c/&G☟f\?|}/q//]8r'<ٓ?ʕFx,'1wslvϽ~[ ;AO\79V>ӆ{_5jazޣW_y^Ow!~~lݓ{;=wUu@f"sY?qGg4S_蜍yNG!dt9;6B5{odK'AC9dor|ݭC]dbh|1?խ67t|TYG1(u4W^?X!th_DGGDoNplJѰ]te^9ӯqZr7g<- žsOzS۫Mh6cԝѸIG-1O/8}:Y+Șuig';ћә<{A:ҁMh61n{YgMmqh]+[>o$.9Un˧o^)|^x=(х5ϔN={<7ɪe M<WXO =؞MFӅh"ozсxYwu=dOz -֓AK5x@>0GysSm~^]3gu^yGgw,融:{{Ј|.kQ.͸+?Org-7 .й'\m/ Ѹ>p٘oLw|᳝tM>EO6&p|T/?s /܋' : rxX/֭K#ٓno}oo8ѕS_:YGg}Zf/ZGgógg9LWmL{{ W}?8ϻog>YǷs>< tWȶjW[g dNw^:zo߾H|qD'Ǥ-'={5~*bXLS<~yo+6A=:lF 8lj-lß =/FYj]|W/|OT;,c=jgܳՂ)3sg/B4Es<Z.xaOOxtx'Ziʇ銖A^xg'}ջYzV}KqW{)h.ō}gbl|pdBov}?/߾&?R|\_͒{bykkx[#v_}K!.՗KV|n{j35ZsuF:wM=@ts;;3 h]=>\%l!>ai Q#;::i}4an^56t{to lW.>#q<<C92i5C@^œXڵ\\\WQnzFg|ݏCי#[հb/{ݗ1~{"|ٞ]0c~;:w&ZI|Bw.[9}uf=zGxY|ʁw:Nܓ{s4%K~wӽ=ܿo>qV3sa^{ʁVj9Y9rೞwgk%o|ǰxsV]ugrWo_~k⽟X?g䇥믑++ηT/i{lݓF=g?|Vѥ=|.Ww[?CuG}opf|_.0&g+GZ+qfW쌳~]Wi~'G2y5vO._9>q#ǿozF~GyL&yJ||iTMmhhug {ݶ'9_/f`S,hܚ8m<1(݋\C1k?t X5] ؟n3O?GFxN.5Gu=ſ:I[e䧩\b^7mgG?/{=>9@?Z:jm z=ssYoi9 {ۗ j4 ݧkt{w%/[[Zçz_||k1+hfZ1/Dg6&9ݬQ>ßL>vɅ] cnٍ4 9lߎĩ8=?v,ZDiP_zQ q8Xy4+#]87z Vc=O{@?9犝#ͣm;CZk&u}]}w6󧽙_1Xv/v+tэiw:{4'qZﺎ~ :Zݭ;CX%&/$/~rNI!_a[[+gݘ=Mo5c>XX'djvg/^w8\ҳbY> V.#:y2ưaI'1nmVlY)ȅo_vqk/zW^a~N?⻼b"bdr+XO:SGv&-|原cwm #tLlW#ž`k]GB5 {ҢtnkwƊ̦eN3C6^G}/vHZ>M~f.a.mkgo|--Z*~>׆Fbݯ;fK{؝o>uOgmߋ3ht CtSvTdpe hr/6Ipm^ |]t~1}ajj;_9/g<,vd}>yOGCz G?5L?C"kO{٧0.Z1$oNx[zjpl>x8_׊#Ŏt7}l>\|G}\º6+.®^9sDyl_SCD|GZ)lڋ83_y|w=V>r }z0[>|Q<+7r[4|p6i<ܺ#茬?b~tf*bpF$bGGr^CZowF7i?U}Uyq^#t|6hjW5B/&{6G5Kx7z@×G.ǎlkŭ97dz6ļ_yȥ=ug=|=f(zZE{#-?g3譅WLkZvf =yWX 5n0Tus[k}vVZ[ݙsfekϨDxA„xxn֏~H~G\Y4yӎ*1qV|.ҟtxykYȏ?C:{4FOUwݝw4w~6  ml#џ_:]qta1Z53%{P >؞{6A#N=AczĊ>qWn,>#\Ɂv.Nh3W-;{{讹P;b[־}bકύ+~nI}_gz>z޲{Yۏ`g~&ryvYZbx|Myw$`>#1zf@^5qsEɟIڅG9'D|w>O#~^~b >zO~^Guz~"ĺk@皾~>ײi>u9\srk}kvqi"ڽ;I1wl޿I}|6yCNKkoxol_kd?:v:MzkZ:CZ^83 0“yyxaNc}Ƌ8=֣&tƟ}t4Xѓ/h&b>fo+zq5r;vr '㫖ɩupSN3yQwÃg=kpr],E.s f`L&z4g&\s{C餛y-w!Vu|Xegh^z+VrX}^Jo.h';g#ra>{^pFvK&O{`^wW>~m1WQ+9[q=,''rAF#4|ÂߧgM[xw:[N?5/̑>}\"ڣrc.0[ټܛpSm?ް&oq@nz~Wc|vkZ2߭_)OGO|gkj C徳|Ml~Yp>:80κL|'w?ΆX{dumsʳ٧6tack/W5f\nMM'YK-q&s=Ơ<քWGf3MNWؚ2IkWkO[sstt-4t/Y|d5y:;)Fy=昝{װZ5A{}Kg[^h=6æп{6uly/5iK~—\TgOQhl;un'zWXr챁xh;i E6[ͧ?5Q.?e:~>7Bgc:}p.[S}ŷA- }]׆޻jW=~[cywa+nwuʞnδ_Z~5FN Ϧj+y2Lxjxxg<Ѳt=ΒG-@כ;#s9[y-=dkʯizb.Ȳ0B?g4z[7^uf/'zkOs{0:3.2Üs1W6w2+&7>2ҸM+lD+3FM?u++w䫼=ҋ?+>y }g̎|E|ٙSN_a C߹,u2 |XqF~xK1z՞{Q ;ϨǿϨGy oGa\OI{t yvđ߻5|{LUVV >5ga +v V\m]1=k:Z &<[xA82(-f1a1V3_yӡ?{g˚ի);tyAX;y37?z޽WCWo|Xv'Uuݜx>^m=ζGE/{OiコY+߃9Eazf߫Iɽ7noG6lg]\[i Q;/-Ͻ*z'ujR;s5vKHwm?gu= U+ W/ L wRwr݇I?gs?wH<.\c L,^5녁u^xzag`` gNl>uOuG}w$ٳ}{'Ϧ? }߃mz;81ڳ>/=;&o޿~W ~?gޅ/}ܻ3GH|l3kgaw=>[W8.z׼>n}݃s$+};s+̽ˏD _1x$ޟw!~~s-܅'>jOϪa܇?~jbg{w+ہZ18s'uȻpw]>Y}u⎱ҏ&x3+ݧ}#ǏF~ml_Ufo}^mb+񬱗`}7|C +>WaEc?5N?3}ˇ_S1[+n'ֶ;H,`ϸZ  d˗pv]Ye{ڍj}?GϺ67ƷSq|$NQM/5z` &^w5]:8Gdt[<[ͧ&yo~y>o|񭻰==>;vƞ;9k^suu &\:=M9j/'d ;dw;d}3I>{s|ƛΫO|B=^⼾cFl֦/nLpc Z|Bc',p;mwm|jϨ\gjr#'Ь[Kh<1-a>|ude{>_Sz)8Uv8orkGW3泡Op/w_qglJz{.}F9{s.nag)CVkj(\Zkmzgk'jv5_6~i:X竿Gbu_>NWk;|tY/&&;cs뾸G$3Sve10gM| _^Zqo?xGg|>V>sb-][c^- Nn]ajgk:hl tZ-=]t=ЊS?c ڣOBϚɧѤ -*WM!z!Ɠ7w錦GzM[Ć)K{lX[y]]糾/.W;^؁ZVoogK EbX»lE|Zl3ChlNw:<ŋ3?cع/y߮6|3d⃵𫅯\O5p61AoZa|m8$6^Ϸl~kGkxlxO[>~$70*`kpUf/ưou;taqSf<:|5jdyH#='Y=s3^n{7xv=9Һ LZ ˏg$b6~||={9v``ǷG{c3i?.Bz'l 3w}?9nb3q{%# z'Ncgyόo}awi3|3xY=8'[js^x=$Yq]_?~q{V Kwiķ_y]hg#Groݴ{6~2軾=Nz?,܊7/{u"W׻pLwbߑ񞭱Gv_1v>k^w{|h=OZ#Ow9M=sׯ?<^W4 mkg>ܞz~t|WMjl~L[sw'۹^+ڊ\!lˉ9ư8xgyNS<0C g.&a5̳gbN}gYr{|=4w4؂X:dϞXu3@:[kkaӥD,_1gM:w}H^ݿT :t]b ڮ6bYkh&otYg>Ӎz7qynu;#?5>]_ă.NG>t[ˎ+޻>ֺ}/?_G3A#j0g9iiO3FOzԛ\7=sJ3hgg'}zvh\ )M}g?j+ Gx4ٲoN4WgK8K.v/n3j#?t֗;98| p::9I9\XMƧ7$Ou˷>x>#~+C7l{~3[<{Ʈvz0l{9sX7L[=Þ1,hzqjph=4gF͸s9H?z1l5}Ξu_}m[νخ|r)+}5|aïfٴ6s60f`.s6x'5|nmB?YWs/\1Ŷ{HN}:y JmSkzp1ϋu5shS=>Xc5{ 6>~\aqG$b7ܭE[b*0^M\=]]\k;[.^m-{>f}.fگw~;9]Y .]9~y>iغ7|p㻇{Ep}:J[~:/gpI_|Vqbd(a[~f'&r[G~5%[{~>l^Go\qtW氢W^GchC_`Z~ GX{պ3kΣx.2+wݟgϪ\3έF?OiG:{oٯ'ǫ=~b_0NauSwwM+bw+JZysTqI]|kwsjv/mU1;k׻ wwQb]v{l]wGg%w\0s0pN_9ry1;}t~{&[n} ?]:WN/ <ϸ3^y88gwr?issv.Y+~Gs|l_?Zw$/o£Nzƞ;YG0^d=Cz5bZ\ow|}|d}w^>syU^?{'{ gkl/g͛3ӸYs]7=qwt w<;te>dߙԦ?޺nO?菏/\koͧjh_Gr;[xO/vO\5y/zo|Uz>?|WۋA,z{ZsOrAG1"N+2#|?zvnob[~l-͵X~bezȺOor^(n'pF.[V2 X_5e|OuXԬ\˧8lߋauYm&|pO 6Ҙx_x|gk8u$39}w}܅q>ju\v2ʙ9‡ q86&71;+Oxr2?lQ2p6僶މWw'O^Fg_r|XIĞ>ؒ7K!O/r{>S ּKdڛOFq_kŰ)6ܭ[aNX``]co0#._>z*MOO i: x=1阸1f#=xϣOiZ>\_^|+Wr׹܆k3FK89+^z?̏"·^a9k|͏Uiwl]m\ 6>r^k%7n4boy?F3_+w=xӟ?W?i;?vNX8[6iGtX%+o0vkt_w|wk@{HlFv֦<+i-Qgq=?{zVo6^]d+vFvCѳc}]˟> s`][wR1; >v_o[l;0/X/QkAKV=M kM[蝍)Xc#N+^}"g465lxQ,WCc\\;.=hlˌK3nt=}n;S\K؅-1[cN/{ӗgZ߫?Gg;}??[g,K'X~C^WGgA~ <[+c:ӝNsݘ{NzfkGa??Wzu|h]#ڣWv+}W9V>0a{ ɹMMk&9dܙoM5:ӳd݃l?.]~vdָ]c\0fp&~ةð˾պ>,ګ'~n/?qw>=[cW>l-SU%<{#x-{RfwQ3p >)c~?{uyx]XتW(c#{GyK ~:3_0ha~?`jtkK.ڷYٟ,_~f–ֻkޱT;ٟD#8Ut'ך{*yn:gS9v.,G5XM';d?r>u>,cŌ޻ b#0sbwgޅoٹ?WX]x ܻr݃w~F|&λpcw`t .+>W8_x|a{b;ς}oW.|>j{p}`/~O^yvaZy.no}wc~]~H~Iw$~$.u6. \)jŲN_ߡ)s*=svٳ5yw>kUbq >Gr}Gݿg?,]GdaM߹}go~g)c=}lѿog×bhl~mL?.~xb8Nou_^c1J=gbQŬ=5hV CȱElinF_rݹKO?=|v^>+?~z/yj콸]wp# :=b}]8}}>ݸwֻ[Ow X3^t%Onkܝ/dg8l-=x1^=ÖO[;tϚ:1՘ȷ~=O;9[yo~[F_m/O>lOvW7}al'}-?bοmYwP|vONzng׿so=~pgmtџ޽xka^Gsٻ[m]{?w4;Z3Ǔ?o};/%2Bf`O_Я1`S[N[;~&z5.^8#n6?iVpgn4⥃?,ld'u|O#>ӏn_AIk>߫G{;"|sϫAGW. |/ ܫ}+>Ozǻ7n5==%>dM⫞xءͻ^>_-|^bP<ѧ~1,6 /{ӗgZ V>χcdI:}(s9+bkȘa#*18* `>odUWUWW׫0/<<~靯&];ܷ0TVU>Ӧ__{v\o|~)>sv{FlU;g<>uE9]]xV lUoT'T;VqJL=Fj.f7]o^z&/Gk#ܻYƶkZ~ze_'Kj㞛ky֮y,{#g@:agG5q_mRM5c1Q]C՚qS=t:Ys5u?L_u֤jKZ/|+vQ_{{WS{=sw\g6ݞͳ.i{/=4Z'.{\pTZnp-Np ]pZGo&V1KibuǑwxʻK2Z~f-gK [׶k;.́sXo[9_ͫVZjKֱ]sK}ڻy5[>Oغf-xja8jƲZS{s{.SJߵ~˫=cosVޱm,wLvLv^5i\tyo-<]:f~~W΁w\+oẂ.G-| W>n|g+ٽʝ39r︽50ëYJguu9rέv|&{u?wjk}F?~_uy߷jz1&l<Η;5t}?{+^k.3~㽰}W^ꚳ}^l޷JXf(VrgՑm{MW?_9}"]Zh]fgci|@3/hl~263~^>I;Ŝl/2Ǽ{{ڍ٘~ė9_=:;%G+7֎w'{dŊ ėwcKϩ=슋&NWw-|NҞkqO Мu=7,q<Io{}|w9Wh=E3?3N!v7u!wc{~?dC6"uZ+bdK:V}>aEqjYsҝG_U3Z#^<ɷ'~r ӏI϶}(G߾Ӈs7Gr _9̟Bg=Ǔ_M 91줇oűukiUƯ텽*\sosyx$^>%=sW>/[,5eo 3`;z>ҏ+6V:M/|ngM64Gw9./-{nfKOV965d]Q<9g=s7>%ßx[{:>֙b'k]5F9gxZY>;cg[ފ+~O_ֹϚ\gWG>ek9ڤOwޙHu0nv"cκ7Ǹտ[-e^44l̷ w𛧋]>w9cemt˖k_,[s c|ggOӇG'G˷r93_+9՛؋>7=%gkW_ +}G(o=r^cͽ/GFOZnvfQbc?ӫV<1_~73?OXo'}?H_Cë{mLFL5:>k7&j{hsl~Z>M1җ|89A7]TLŞ=K?>2rgz{k[1V(ZϺ\v6)&7ۊ G2+ϝ_̵ΰg<Ӂ6W_:w53sζ>';me^k]b@>E8Gx266.zf?3k̾X|л?9~e8{x5.];>#j b=;ҿVڣSrD3ߍ_kOIyz80{1OdZ7z&[^9W֥=#C dWwy}#^猟֪ϖnM_7e8[⥉icqbOCwsԞDOtXb#?̯~L]so=cqЯs/EkM77>}c|Ӈdh4O}yl7:;OYh3őטfYz~cw-G}(//靕kx{y~gŚG]Oƹ=9uXVhN-9\?j[q~bj9 wg4>Nl[d87[yz{D`(ȗ%da܉8t']uhj6Ci7bsdKٞku |8:ŀiص?l?Z^r~Lq:'C~xgL_z%G51NϺg#Z|5^{g9;5:/_Woγpf8xC nr)̵ Wb)U'49sS=S{Q?/ڋ#őEv{9c=?\|F_k iO⡯aw/~#wtOϗ .59l^;nx=cV_֤?w?7[bݵ='oٿ-kX ~oޫgρ&U _w>/ѽ^g{>_~;G!6V<|<><|xo-|+Ʈvնja}z{Ʒ~ֽ~m9s#r`cΫȫsիZ]LGɮW"}~e瓧}_u\X#kZ{~/ǚڥS[s=o9sX|ټ;_Z~7]]?[?SoأZ~j^Ƶ_;6V~΁9֤jag{֟]^rsbggk}>~o5{7gtV]z/ΡЎ΁΁Ͻ?99ޚV}]w}nxll|lw~xr5]~η+~9^=~vww<>ުI/-vʮeފ?:zcs`΁Y%=wL-߂wMGĠ.g޲g-^aߟ.ӽQzѩl>fby/ˍ^ SA񓏚5hZk~譇d̯눞/ŌGwgz-u'3u>٨M]5q>̑&֚z^m5Ȟm='?+RNw>ϳYt®#쒓Q?kh߯n|ì0-) f1?IO\w݊~9OjatT&WݥoO{S|L:bTϝd_zEK'_3uNuM{0m$gњRSY-;ӟhփ4})ڔ|(Nn9=ٓz#bH?{ɏʣ},ʹtnw&ãyͣO6u_ֹ~q iǝ){cyT#]jjNb{7Wwz2bj~6T'[m[Z?ݓ {WY'4zS؊3Z5X{_b\:uԣjWc|]}ٲrGtmƏΩ>LM>sO6iGq*fܦT.|}m~ɏʣtϰĀUnӼ:+Ӌ }Ņlsv+~q |>?y{Doo?Bv*i^jIcu+݊Nu̷a]?m&|[c9k9'6'ƳAuO]+O}?lC2t﹂=s-xcm詾e |KO$<ճ d[>?\[lX5~Gqk}INb?޺msYȘ<v:E_+Iw_z:gg~8XYcΏĀGךԻY.\:w{t |yIџ.02-7}4| Y75X/lŏJ<kt8lw}T%/U.afhٲ枌9MO1iv~9ki[u?c\-̧{Ęm|sѵv乳޹#gN +;yy8,;?nGū᧽-Wwyv~,?w0[|vx^(nOvo0}$`w|uu_BSVzrkyZǥr|k-x[|GՙlW[jfȘCK)GܶxT-܄-|kZ}gv|'_7~eމ?2F=xN|`5hCXau:QZvCֻxo}*~ꢣ3NL:Zɦ_^+]ZK-Z}wja>̆^ڹ|ÿUY`>7Vz,Jsnjg[.O68.kɡ/3&Yww >Gq+٭Uo{mwGS1>}s koލݗʕT=j3;[}{M?ukϏύ] v}E;_\I}^;bu}gz98gw>7c[#ޚg·J2>|ߩ.La2k_Lϒzgv^Fߊ_}>?}S{1hωZK> OZOw :Zw)̹xԉZg~!FYs.>{s~l7ԩs[P}tܺf42lM1ǰi8F~&ڌK4G6|Ƙaw|s䑵s㯀3~&S;0PO0Iw]5|#L[s+iZ>6lMG;cj#琝=Q0VA^=|eub3toq 9Z/辞?0F헌1}w%Ys37/|kMדғdɷ-V:fş=w4j hKc|笭x jT]ܙGs޵:) ?Nu^sC׌{^tkf}96'z6ߚ[5m~/iߺ͛ž̹bMOjgG6[kKO13{~~m (m=_m9qȺcX`yǓW|{~}[܊iO V/}3nkM:߻:Zv9\t-,;s8y.O;֥;tTS ԯNFLn{ߺ`q+b9&o>[c>W7]v>ZkNgқk=t̽$)::Vŀ^:lok\] ;0?^?iXƅk3 ѯ{FĨpG'{G8&{/~),VkGo| ~=j_ך;YqO?!kjatjkMUu隱g, W9Y<]ZAFL&~'d 5cvozix}qk6/|ǯme/;Q͵5觞4[/\~ٛ|#lmxt-l 33] g.)7k>9x>?sʇl-b?9cON5|qyT Z -u6}O] >nѯݩu:0Y}}S=Rւʟ㣳>L?{^xa~黶^GSso{JnjaέsyÉebx~s 郇0 -zVwђscZz|IZ>IO]NKx)LM}{l RMobGa)?pjnH>x&v/19x9egˣj/!Ku=? bx3㒘p̻Y؟mFLbicףZgOEjk\skg}u6W͋G¯?#ʋ&\Oզx>f߀Gߒ[rx}/yk%_ύuZT;nn+_mG`G`G`G`G`G`G`G`G\SV Z ҾwVϦ>gZ3wT>z-}v}O[~SO>ϾoKG-oͳ[{>"#n~nV=<ߊ؝j{̵$0QO}1>)ψ|ڵ}JXֹalw.΋t5oS1zF<릿ϳdc?}Y?gUsV;=}\Y+LGP[?{?z:OjzzvϞZ|6c]vAw[?yob$ӮvΠz*W;0"6o=7\7^up1J~Gg7zŚ򡞜%wOsd#~=KZ/sSOö1Z"bJ.O鈇Ps:&5a28{W͊s`:†&v9pc6|hO|4x74e-Hf9|NM.ӓ'vd.r?yox4\p/IW6w> ŊO~Z ͭyt'Ƙ6^pJ 笧V>Н#l[1gbvcgc|heƻ)3;ӹ#LG8*V;>jak쌞|q󷼓#~&>'c~α0<ձ >M}f/Nɘ9Oь Y<L_V<#G9f1HW>97&6Ǧg;֎Fwv9>gv-<3zI}Ljpq̳bİ0dI.ޕxCps0mb>:Ԙ|~6ۺusqc?1|o:[XZwN{3;wͿ ssvaӤpB&'Ck>g3y/L5WXy-?[ۑ??M,N=leŊO~ZX~8p\?׳-`@c `[xQams'WM9xȇ|m'4=;thOdUZkaX.WʗGjna}?Wﵮ5w/ܻٟ~Ou->vov?G_Ͻ8֬K 6~y7KlX˩ ?ֻ |׺(4>Zk~h .7>?Wφ5{vmy,6>ĵ2{px5޿U =wH\S 3f[ޛOZxҎ׊3bspIU Ny>jv-|3c'k] o9zvߎja>ng?yOZX>##ZصjʌG`9{=Ϩ{>v{?,j>{}|l{{:~upv3ψ;nϭyO] gL+:3O6ζ9o8pI.=:o_My]?s̞;x~~{5%]6i~#,>G~5E{ hj4 [aےu^"sǶtFowP滛O頳u4߻hs7Z^4~o<"Ö)?y٠w}lq5jby V|Wg~8tu=_tM̚&Z8fy]6g7K:6sXn}uꚯ^ݏ?ݬz܊e6sp^1 dOT;g>!қܳhͱe+hx=>T/|֞l??Æ/ɦ|t}:/?Z39:j)o_M| V έ3&s]kgLWzd3cs(0czW{+Iӏ=c^5vrUumMcZ0d&:ͅ&|M^lY)֜sy`htO59[L>[tOhO'䍧|{?ҳŭmoÙlrv;5gݹv ΰ>l}3i>h-|qon] _>|{9jkGMzKL޲oLx} {wX^[vnU5:پ~Z ѦՀZs[8kUkI|뚾%F&Y˴ֽ r}غc֥5mzG~D'3ױ=bk,18xξ39is9tzv߼^ L3/0!^8/mj{_3/9kz&[0VOƾ7mmӗkls0^[- 9K;Vl=t#̿%< t=y>= ܳmʙ~v`a gcLk ͇Q.O?e⽵&?Uߖu{:{}&kҾ3B?[fVM~\8km9U\^sπ){ͺku/n];6ura}WkrڴぱxuɆgB*m6] .kotm=oj?7_|^V=KVο}F3λϻϱEWo|lgms{^<#v}?+g0߻8p7߾Ɂg]߯.+yߘxF{|5ӻX֥Y fl9ޣ1\ێkEm_+;jvvvVVբhVWgy.:f-|-s󹼣M#>}.p=toϾ5}jGxX~~,;w^ܞkMݬ\=j(bj.ӎ}v?/>os_{+̵r~{V,g og?X?W;wܞ#kM9Y^ {k>;<(.{5? {t{lw;jl$~t:ɮ߇6z|_Ūg[ox9nǽO*N;4/<|*F^u=įdZc}r}r~_m\gӮS8R 9u~3|3KZtЩ!~埉~4N9=fKqigơ1Fr{{|k-3j>K%l{.:^ayz؆d4@SN/^ͽgZnM=Z:z^vy0Mj#9֪,ٛ|x?zrtY|v2yf}kblq5ߧ../g;^;{:92x2cqkyUmǗ֍>uX9syN-s1F댫;tG S>gz9za#9]8)=Ǩ<װ}5Gդ>X~9b,^؆Zԩc]pZOhz-{մo5|Gz W#ǕՖfgh3:MG:=ʼfݞZ!krzs3И/_Q,]ާq+Ωse}=g{t9_mt8G瓋|8/YKqy#5lsu Ɗ[z/6̣󭽗.#|KG.Zp 'Oy5LR'zf&Sjo9ѻe=b=[Lf ʙ?;պ%xڊ5h 8z;Vw6ҹ/jknXrKZ۽G,a8^ڬ#KN~}fLyvL̯qi-gcξ=W|h>xg}b:6}z~Y>gA qyW {pݭ:z]ﵩvkSO#_)#_s~ɭugkw?__sq֝9?";G齣l˯rإ̌r,=Fϔjk5Grek,7rEcrÍO9}|Fo4yJJrj~b7,G//-v7l)?4z|kő l5c:H>1H~]K4#z_'[ Żbp|I{Pgծs=]8p׿93#?:ќyW^kQ^^/\͕H/pţ';D'O<钏ܻ+%߳cbͯŬ~c9\&s#Y93[~84zleO>am|tK'y|b3&9}a+FtÞ R,5I;;ὰ~5 Rի6=c;9Pu|mrmt׭R~I^Ω(O=A1|m'X~6a9v̇djﺿ}~=>|jk5ʹ~$G9W UNi\i+a3S3'_ҙ\ |^P]xm:Jl'.-=jŵAϷ(^:cc~V,M݋!`W;b/9Y揄դޣOp.\GrH~쪁gpL^{mgmv:rs[4Xrg:,q5_A7 [x@46]ardn>N[ca/ͯ͕s/ޜc=H2<:Mo Mi9OK&ϑ-W)5+l''k0iõc'1ɮ^l4cx_>ᛍ[1 s>V;^Xo?ykPoɱք\:wye#>{[}͉rV7_^x;^hhvI2'u?'_ZÕM[yXpվ׾k ɕs?-^]WQV9\&h5JC.~ts xQsFg{hQ}6W\S.t`Isd6XX嫸L1,k[ϯudz |I热lg\nfĊQtkO8yI{5M7,PM+i5׾ƥc!6gkw?_?+ۛy3گQ.1ǿY}6Z>=<3[01oňkc;& Vugo>ͱ]{]^ӽu{[ɛTrꥣf9xz/s׿s}yU>_1<u^-jSi[sStgWmp[v>>߃akE-;bT\ Cyuv[5Zq^^o$y9vˮ#ԿlL,s|?WwΘ:6r>W=c}֤{6QMz4ǮvScoVo?^oۺXM}v+W>'kM=`|Z5"]:?u;ߥч ׬;{t{FL{VֵϤ}_L>Yw8sIkMz$6U=gGq]>ku}ϔgt|~FL{1~YsC Q Qz^gظxε&}٣9v{Oky9ൢ6_33l.@eo^οV t3W> t5/71&/8Ѵ뽚ull?#ؼVy\97(GV3|2sJ+ZXnr5u6]~O#N6ON?xr^+>O=4Xհ)xE3=#}^4V,ܧMVl# }Z>mwÿ[4{tN[JGl}&=c{ޫ߬Xvݽh s?949@ENA'ONn&82'7kүǯg8r25v}\>xW9#=ǦrK2+'{Zkwھ1흃wz ͋g{kҽGKvE+W\"pEHIjaG^{kW-w}%s+V+9luFL{1zr^{9Lrx\W!lW}{z,矹֤}ߏW 6ggĴ/kaϪѬV7~o y;_;xY>[ ըG=}o#ڻZ15^ߓ?yx^Ѽ{ P hSwߙ{/\j־~mMm/,{vψ靱9C+7[KOΫ*o=m\-S'?Cts;t@s$=%+ythxeKc'7羼Ou]1xvJ3b,o?Vj7z,&ofUя_+_y}[Ur'~[ 7'?S `߼={r}-v5/Vb&Nx #?;+,1ܪI{G?Os[Z+?j[^c&9+9PyMNJOy <%g,'+ᙺґc=9c<θΈi/U|4WN(yiuҌՌ[3͗g<ˮlG/c2zXg6l#]d#ۓ,6;ZpvOguoÅ'_-sZ5?ݭѬuYGb!Ə_Uq[kҵ&>cWn/ ^>%̹ry \-4utM.+a8~z?:q/:VyHg9,@^4c4X>3yT'TNhtN,[e{|\MrtMl}aȶښ<abx+9Zux&ewߟU_gu4Ǯvzx?MZ\~yr[RC7҃Oд^7YZM+isZq/ڼVhoyG~rZyjҍ9 ̣3SӫժѪW _7u˫L3˛x ׳]rx]X(㡣xe{򰊫VIO^Cx>k3D֤jᏚZzh]:_oK>oÖ\bQjO1 {sַ{錘bX#yZ&'_ي\Xklw+n񝕦sXkjax99Z3ޗn*jw]=Z k~9{ ~Ȱ#R)^uyn1t]Mob6}kpz{G`G-&6Z;:b֤]}X]lt}{t}|{sky|~FL{|ϝ+~#~pv^;ZS{%Zu=p|~FL[C{W-|{яw8޿[5i歾HGtj5W"pE+W\"p4k-|{3 zmGmy}vϦڋ}U8}qޫtg>Oh1ʓgɕQ>>]W}7Y>nl1{E5p5yߵTM5{8cɭ{QkKV9v{#[߉7:G~eJ>Iv_߽9|?#}XɳGu+sm]fNnnhgg?yW}Ɯeg΄rkMlkMz4ǮvW?bdlͣjbzt:{)en6s.x+j} >0}%tbOlFz~bXGrsОO~Wӓo3_’p͸}d=-LᢷߑޢM!=Ń1k 1 `k\7so0१yss{~֜8c3G5gϳgo;c}9:ݳy-46;w]t¦9g|光nOF.}ɥkjy:hBFԲ|-:wmyWbhӷ<I̹g7)l.~l`3k{z6J3bʓ/Icg>4s4iogo9ѕuft_:gxmb؝C݇aA'M>['Ӧ1:~}`l%gη6h5u/:ugkң9v=[yYyvoy;][ʝ7s{y.x"=9csFl19aI^.*6~t;|gg=g>q=iN| :4Of]2ac~уŅxVex^do/M52|$z1O==}%1Xڣyߚv+:7^s>ϖ39ÏFghOx MK'#E$YSf>s隸ihGg}ʅ7|@3ys[1Sl♴w_Uگ\GbeT9a9 ǔg0G.В蔇5.=\Z|x~;{|1ƟbgFzbC]akXܓb!=6Oxx{+yΈiwٵ32z{:z>`=uҷtf7۝+~lW񠱃Z`ŝpw ~CgxKԑZE>u}= Z4y*{o6a>zqy'}x5uMU=]6Թ>L=g7ڳ_^\WϺ/7=:ibVzT5c#׺o~&n3fG=_rpN=&1{o#~1X?9ꩭށVjszm>ܒ*̇=g1= {W;KvmYk{~S9h=]yxĶͳ rsWc3Cr6Gyýܺby;U+MLV9u{Z5~υZk ?#KϤ^<e#Zu'Wk>dS-|o^}ό߽+b >??O=֤j{ڳ^ѽh~׾;Ͼkq|~FL{>S }q~uygZx/k7Vzj;?{k|?WwΘψi֫gxoo^]w8TW{_ս^={֣UώV-n{޺ٿ#g\VMz4ǮvàGD{Chx޽s>TF6<>>Gbe~[R+>{ܞ;8[09_ksa}ҜQHm~3e{&&S5~)rty\9~=a.}.>ح}A]xN\txٯLb{k}Ks.xI]t;|(=[XɔW._T5^u?}c|oy/OɕSǴ;3ỵˡ#uAoʥ䋩>}WXu,^Į\y=Uo䚭hݳeu*S홉Z+gB^?ώ9_gbr~'~U˨yͣ0eW]ܠ9sέl9wKS#<+^:҇6- r|f5O1ᓺLvybj~M3,9֘0u~;ݗÝyֱşG4 +>mՂW?~;f~sx-0_smz󝮭|+ܕK_WL=ΕZϡslL_>S+j#^aGmK9{Ş5{r֞XzV%['Ӝhlo-=oʟr+uv=oaV yBxk繼s9}wg\o[}Z0fŸ'LI^ ._W }:gY9[/πgax&=cղ^<\gg<'=^Yk{ٽ!{tGάUDuO(}Supou=?㌳U{Ӈqo䣹rbq^{KǕ?k8zs|E 9h}fGmb]:w/]1y1~+l~|Juh%wfrGm_q{;`'\蟷p+Gs,6jW\"pE+WFٚg_C|}c;q< =r<}]όi)Wϴt}wW媅o{,T]g~+DWφ:ݰ~;]v\~5O{⳽vܳw}/ٞ_w\3 ؐ3<^ʙv4՞=Z/G^o:cg5x.x>}=)ogr./;_y݌n>q|yZמ@_} Z2[}.G/-Cl?i^rk+dtx/s]:*,f[AWx͋F>se;;aGoDq,l3&6{τ|q-V{x>4^tֹ S% Y/q!~,l)qnrsmYhm̱5/N3<g#0m/xBxit7~־)"_>zu:fߚEnY׉zCxX8yN)x +W;7{e֙8á}Ygl%~M~1aoNZqbVcz`c_[}ON?Ï9,a_֚A;}[4OzG>8&_b5}_c][8CO2akO==[ua4KǖM91]Ŭl/oohŰs*S~< ;p+{=>c]]unߞ ?2uǫog{4q:[2Wrz̵f ?' z6]L[s4:Wtj[e򪏝tsiŊ0wpkd&ݘ{g4klWρ8rtkl5_~̵Y%..t:qOw>ҙl2G#[ui8' 7_e1iu꿘kt#a߻o{|t :{`'S>=u=OM-}v5Itv/1x:NxaV좙3}־|tL IONOYI6x_':<5Ο9"o0׊5#~  9vf]|׌mA?ɡo,.E1_@IQn][=[<[64z[_aC[_Nɥطȴ'>Zq$շ?a2-aI~/6hxڇӞhyv&[$[a[qZk+ku^n g{`F~􊛘̸d06G}7n~݊'4¶p̵i 埰ʻ}1]J::6æOwogA㯆X m_vGv붵V{kB }-Z vӹxnƫ-a#}WЧҟ][9zIq8zO+W+(|}q.L3WآMk<׹?h {ߝ|H^{rŷAܒ_їMtr\|7V:x=6^> =Anj}͸}_w%/[6kz{L^r?F|[=P< 9Onv^580X1}ٚt'ךN,GGji+L->h '?5:ym]İn훩XLg6i̼4z&}i]||b>}&qq|~L[;[kG{ ^51}?l&ۜ[&d;kdevņL~dk[C61͹bO6<[k&a&becƄ|c=̛z%=Ōm~™_`}׸=aғ+OꭑkW]lJڌ +kZȉ7YdSɠEk|k]e}-cp3foo_O}FvF.}0;?g\L;_[Ȇښr^Aq+TM~spwg9|,f͹gbfv73i$W,Zcs-K'g]̦<_|G~'#F+?>OfO ֡s/]ZvA7֬꼑_Lo>'Za+ك;b<|nx=oyꖽWoL>[/41M}XjJ3ѕȶO*u{|0s~?38ڻAN=-;Z|>]D|.X/aЎozW{{(-tzJzUg~;=n4 5|nH18zgh|]"%R(`-!vZ\yw o[|G9[x+.O$?}!Upߒs#&^Vgn%^y ݭKG~)~SWl#Oh53S+G^o>,O>RC{r-Uoė|WU^ǣ/_qQ#w߻[Vڝw=X]"V ůJ8lxKGW9U9{/OYù\9k CnkЇSlN>1׎tWG]=kux|z٥9O~Ϛ}CLSwFOvɛ䫁޸s:Lu'{x4Gz{P+罋T5ݸb~W}_]ro8W_䤣Q]dzE{şbқsΆ{rg}qIgUOz4S2wbcb#k}bѽju{svo7_bkt.OO맍׋G3ƀk3ڼ:m.n l l l l l l l W~ȾOO)n;n ooy7.b,_Mx#6}'?g[Ub\?럍b{awU=)ߍ-ukzKO }͆M`~p >?'ߩ~wcod7h{ڈgkzM^-?͸cow-Z66*^5?ꑏ8:О5Ǿ293f?;{Ǟ,5`~Gb-8'wOh"֦_1.݉MG^W`q{#Zt<g{vUgw?xÝ{{=>O}o<_vv9F.@kg4@<,FԛG'6666 7wӻ^6zn^ï{&dy>zMzK[]sc~gNʽ{IsΖ[ďA; Ý߹.3Vc2µ3r@nt _1`>-r.{}7666> {3{O/5p~$Y0l|Kxzg]9ףSN)JO8'ӧG~K:;3ѹ8 +c܍׋Wū>U~#}F>sOٟ.|o8<|8g?'g]2nsbVzo1X͡ ޼޻k l/Wl|?6666666~N l/szzzc`c`c`c`c`c`c1{ G{Kv 7tb3#~?'״wO3ٿ?tȱ~+G.*eN3#]N.^Khv.ַxfK?:p|orps bT0=|^&o^hQ# 뗬g,O=Sh FkKx$#p!pG^rҕS>COv> Mǻ112Yg\w_/4oqnhz;w5}w)f/%=kLj9w|𫚧x_5e˞5>ߵz~Aa.&@ sx;z\T}{WGϰ*2'g x59 v;|O'de~ͳ$dgG<:|kt3cǩ=tlc~>[o5)>mtmn͹5_,'Chs6?}7¯?y#}v$?3jF|{.{/o$I~3es-՗ll:ۇ3![c?!F(oqZ,=wV,U:NiJ~|h~=UU Sf qh{xwМ>7{z!hMs,x#x1ؐx&^tWCĭܷ{4⢚b۾Xh%#y⯽)IQr']b# |yE|}_<&_52s\G66v>Cٗ.F<qvJs>=FtFwpn?] i@\kc{!pM 0ﻍ|uΎs-?tj:j9Ͼ_mVs|ԛ~W>{޼gpS>'sYN{arJ7^pV{zQ!QF5P2C1%O5ZWdćhCS<@owxɄ>}|𙾈o5Gً=BI?m3'>Ml"Σn} uvu>y|| 7>u׬W!.\BkztWErZ,c^g?~6iWEKwggӵ#~=:GxsRGyC+F[dZc_Bvij\x[o2Zkt:y@Z;GW(nQoY~ނ'jBu=Մ-Ƿq [էu^<7wWhy ?kj-z>'TbG]e}/߲/fǁ_f ԋ=nCoz‰y+nW{7xlc\!#\x]#_1b>ͦS zr}Ͼ31OrZqz%R}ǵV Tkdģkp-Gіk|9/ſ3|)vxyO>_g񭚌>_]#g85>Fwԝ{WG`§ptuGr播Ύ>s}IQk/,ffU/<ޒ|8z_Wn5={a$zk -_N>e9Y}Mm|w-z'ï?~%x-Z {6|o_sWsv;V jyߑ:{規; V?K['w嵽όoo l l l l l l |Gc`1wj}S꣱;Xt(@x ZYG:GyW} sl[~FM{{_ l/|?_>s\h̞rKUju9?럍 ;wc޶ݭΛ~&7]}8=whnuӿ'+d;wL΂wG0ٓ:ʜ=3{ [M~b?]C\#^U\qyijSxd=qKG)?Y;۸111sbb^[ m~ToN|x{r뻣?+z)g'ܟC}}셟G{t;y>A@;x~HOҁ?Wɿ$n?oq'bZ/Ï^8{?q+f&Q{ ϣ]7pzzc`czQoM֟yK{8Mz^|@+ճY8ͼpfzxL| :oPU~^COƟNLik' _O@koi_W?grS,X/b|1'4xdKf6bLO7G[̴qϖhyry y4zGԈouuȳU{a~6근Ǵ =O{=2ه/{3z һ>վkpįmQlÄl,xW~aG|ޣ|Ötog1f=l^3jbJp9q^fkH3.5eT];\y'OlNS;]>ã^>~C'/#ypMq3z~eLzW{ݸwNϩ{8+|]WhdN >dM_gt 9O,v9_rO#t&YyLW{d_[K3'7F΍7 ;<:tu .}/Yg1ൟow8p<ܘݫUza9 |{#/\:yVMՄ͎k;*k|srx̱zCFWޯy]==zU٨6NUpuZ8 ~Qß ^ge8@|P]q;銩%Qwo_Mp39AGw/:Wx|~|rzLxGOg{Nxp]t?YGۜC7uKxS)ߊΤ 7ݧ;wY|]{r87'3|P.#|8wrn|+cZH5 of?SWmçG}諱=xg? ]2 ɴe5g7x;K>杝??g9xYSxGzOl<|]{ӟ{{zB>zg8zs=?z{r)/{ꛌN2N@/Gޔ97關i?leF38z xLM“o@{FrN+^} SOve35E|9𰗜6F}w?뾿K\z}WȾUfa}߭⻣ٟh]-xroq W\~Wh&P/;?{\~c/\/wֳ{3ݟ˖|辍^Yn3={lG[:m/|{߷~S OGQ^e]|^Ӗ{>Z?S `(>{\ @樆`⣛`=y; _}#fROdtOG:oƴ z}rM^tڟ=s{b#0 cݼ xXXdY:>TtMJ1__57tܳ_"7[[G|ވlrUgto}.?f9>3' ϭɘ:O`s/[l;'[ww11]{a1Mޚ{N mk+o7G|ceowwқ7. |ks2e?ؖirN?;?I/d}#Z{o6v1馾߷|2/[^:;!:pѷp/6{Gb->w.fx3bFQ<\xd%o1;͖G]ww11z177|#%~#~ "#=p3:;SnNzl};Z;#3;M1!<ͧo.^q8u5<=\vOpʃp/:q֞kyT1k9 P_ y#~'k%8xþ^d,Y,>xϽ%~&'oсki#>_dz^1߲ܚ:w~܇}ku뜾|"qW<߽G7w B/\?z;=M>p46G]G>u}GowxꔼxGzGw;؃/;u}Mo<|F<>vL3^j7G|Agɡ?>G>]>Ǟ9< O|-k}>xCڿv$k=ީ9z\ٝ]S枻~+]x-)ON)o? ,{ZW {B|I՗ٽO>_ TWM,tuV.7܃[QW_<:#>y!Wr{k3Zd\-~_u>=}.k!޺|{>[:$*Fفͭg[tppGs3za='W7Yc$_d#xl/SiP?oNϪQ/5:hۮs@W]w;'N#Ȍr#MM#Gsvw{䯿{3gwC3azWY1~]n l l S. |^rΏJ6|9HxD[hd9]~-﬏69ճ]gupd~V~z`g+tp6b=ywzbW3z?Nr%W)|nQ|^0B/=.r36)g;GZ_O䮚>WlZߊǼ{z@c5tcқWؒN-ǯ>YVGÞ{o]j _q!}£xsF6ƃ~&\CoF|1][=^?fm{|{>w߽oY=hGgݎ8Lw3vY>>՞1|t&hьѠ?@t'B}욺MLWOH&o]k7NWwoӍktstSx<_V_1F*g@`ޛL.Аij| 5~vVmO>ɬ&C99ɴ݄7A6s]ϧmpO$_Mv?tlL&~t*.Ggp٣یd=g :=>S:|^:]}fr(wF{>3W~u;:> oTAxV:Ղ).ä8j|,Ec(M{yI?|>={IsGNtܑ87;~^/ǼCsy B9~?G<=~1 =#n8r4_t )/6M}Ό+߸8=GMƼskweoʘhф??ߎy,|rO߽.'{rYbz^1dE/j]%G?'[ޑst; ~=Omۻ:}WL--T]0`OYټ;yS iD.c͑̏6M<)o& o?fדcL6=ڴ%?N:gWo3l~/oL8yooO~`kgswgϢ׳,~z|^X.r}$gǩ=mVoߣ3z5gF{7US{+Fދ#gz$g='9x}f=sF;# |ared|Y~=fL9Mpis.#?љ[9|_pp_8|5YcSZwO93Ώy:>>_폣 o}(^zky=0[ݾW'}kq UlïGsgKF#{11:10{K=99|s~|]Ѷjrt>YsL8ƃ.7(#dLMOw6~Mt8eѯu7(ЕM[??Dm,oy|YG9ʣc^74x'rNWsy:I|$@N9d7_ ]`==sK54c:d9$NوgϹu d) q@}{ ?t/pA;+>NI~yù)'ߢOO~|v\'܇\l7唵6cbPWϜǹ=1^ݒ:pg'rԾs;rF&ޥyz9|N9$jqv'9e-x/xF`l?w\XdN'!1SGCx<(?u,8?99h zK֬ rϣ]A\y='7^}dãg5y~ldOJiGn͵zN'!\Tz9|D<4Oe{xJ%_L9usէpYgZ.ppQ>8r|r:&W|wU;4grᝊ|Ct2/>8ۊ#hckrrԽwO|?qm{ՙjQ/͘ome2Idx~Z@x:I'v8t&pɫs<.Wg"gʝh'1 KIg{XjyvV'^'>>䶧!O'{c{"w9^~:B\%ϼR[~5L~V9i6U'yzϱ>CFʜ>Md' ~խOS=C3$kAu>ޓ|ǝ;'lpK_<)~%٣Ȳދ커?;#_]돣/t1O_Fts2,#|w?{錷 ҃,Éߎ ןjTS-7r(K6~;/ëI~{l[rph#?0I_Fdg=@|NAӋ.'_Tki'~4ZQι{MΎY^^7-/n[-ҽ/o)VL;7Vַ8~9pO]=}=#6;?/p|o6Ã^̸W̼#JjQc}u{1<xX=흪׼Owޞyo?׷șt;Z"o9&VyhYS ʭt~޹ZYp S8jto}tN셫gk}>]N=w}k{X.s5\zO~<2i^nTPCY N{sQ,=^K-Q^/NZ$H:~οÛ;{N-.oӨ{-$6ۭ|ޫҽFn/>}FU?O4a@GpꍩԾ;w]Q7{Sǝ?o}ڻٻx^xcUbyX5ޘ5fcfc`c`c`c`c`cUb`{Wccyc`c`c`c`c`c^xc֘YW7_%׎十[c`{ፙ[cf7f666666^% 㿟3gyuۜx^xcctxT l/Z[lg6|\0X!cS\};3+[ZkP? iGfWw9s`WρW¯޸ʁ??~ߌ?hhE^=ɅlF2a;]?+%w΁;waߟc;v;v5ooo/??{͏z[u?ow&cv]ǟ?FqZ:k#{}΁su;t=}wvz}o԰I-5q:ѫ_9o]حMh#Hlޝ/;.;w|yw|v|S9֘?d>R 騦mM]^VWkhz>nZx[se\9p=QC{cc]r@XjMw߬s~;~X}MN#u0}U|,wg/G.9^}/w{G1>99Н\]*FkjW՟9"lx޹O}KޘM0eSվɤW?u\ZZ׉YZ峣xů5;]<޿N}}_{s`Aul>sm:BGy%}wjN]>O}#[-7>SiBԢN2xo[ >ӺXVz{>⊯XUNkzg̙i#tVJhxdgSߡ3cuz׫HuO5Y~VST?3y֪G;„5k|AZ*4rvēdg,l>?Z_itƶY#5c~ĬOՔR=/~-zX׃R,04q9m=Ō=3G>:: Z5Y'j_mڕ?G}&l=E_\%[5kTg=3g:u*֚^˙i׼5xʧZ3wcyt=QNi}V]cwVashN>s4mg.9N=KhֺKtv4gG6N28y1/sWlTl/+/^8rsѩ~>}B' xѳ^_~gb=b*kϫ;WΛ6ssj:s3_ηp;gx“v%юz{E,F߻Ƙtv=c~9F7_&rދQ{F}}-K%:u::l::OYH'tڝ:; r| g@1k3aǃex՚n*;z6inNJޡ̻٨ [\-,7%l͇ Vr0lp6$O,v'׾Qo͟ճ?߹=K~_ng{Gȫ9qF<YS3o=sc-^, l3k=uw1wO9Ze;~<̍WazGJ}o~E:UݳxC&/Y|8Ӗk&1[ټk7wGzg٦Fz\׻6tO'cm_٭oOݹ{!ZvЕ^4wM_u7.?zѓ]_=Ua]W$oOՖG|XVT5ќ>F>j84xaO:Y&.֎\_ӋSFvcؿibd\=mϫq']|_io_4i.tzŻ5=!lbXf0uÝc60Ջ߽{_!k]"6Ϋ_5^UxJu5Է/yW׭rͽ {zdl9ZݫfpеjKY/5d6#1.ś=^˿# Q-w ZzSQZlǫ' )[Ç?a9ήWg11v-k{ac9:u+uxzhzj{l zֻ~b^ԕxjd>7f-3?g:I;79—Wڴ#cqժE^gy8?<9j5u6Cd;hd3_:˫|f7zyg s^̯yGɶ3l,wԩYz=s`s`;ޝs>zTM賴qZP=jM=3&=tSm,5sҌmɷwԩcmﳝ;Ɂ] Y'o}zjj9֟=3ެ&0]Qݰ?gߓWG?o;Sߡ;~|^9p>ΗGr@U{Ѭ?.99kGK{~wG#k::k9s9k3͙9gzWԂb8h5= GZ-祳qA>=p2S;w 6\kv|v|v<'v-8|q9s@N};wUr`;\~\GN}w:B͟{9Źߟ}[d#O~#~Yw\|EV] ܵ< ykNo?N}}W{(@A}~N7m vw}}dђgīN%Oθvڬ_lg2pgOxe>f6X8xҍwvr_cr1[+Ӿi]k2Ktl#zpEFz3,2Ùpİ_Æx,||Y9|G3I;ja2[4F xų7]G5&F.AלoϘZus{=sں|/'Iy"fL윣wLڥ|qw6ݴNż3`V<.eg,?Uu:3]'yw3׹yccH-%rɺcsXL6pֺ;{!v‰&#V>ҽIHZ {.{ņtﮱr!_{|uxa+I7357c '[/Gg\90{6}ttO$bLΣ3Zy'wOvhX씣q'$îlNzZ6$O&*vGrŏɛOz+Ϯ)QgD7f>+&}xS,\wd;À.\Ko6KvgoAhhȐϷ=ь_6 e_clݷxg\`a:rbWݩ߸]k M.O{Y;Lg>u>H猭ΐo9~[at>fGs_̊)z7N}_u̯| ?[gγߊ~;ZZ)fLk͙Y^ѻ<GV]ֹϜnv0+dӴɺ:OXa25Α\Ӷ}orޫK1lgp~&$xpwbSSmwmYgKӢr⳾*;.z׶ٵ{I~kG؞ťQN~ΜTMH5虎k$;k+rU,HgKL&mo31Xl^]W{=F\^=Vֻz1G[ch>uow̭;w+Q-|[1_7ڵj=qo>rwant{T'բr{G; O#YMFW@1|WWͽ5ꬃx}ϼ{}΁{sߝ۝?W[Z;wd| ɟ+'~9X7X wur};^=`|uusqڹcs`F5-wzn޹sy΁;;;v\ʁ{k] ZW{m΁ˁ] ^w~90k{Ƿ|Hͽ޳g;>/v-yycs۵}Vys`?svsk_Y ߂}#Fo]Vx]w70;wڻ{u<ckGbowߛ?k-ܿ3~}Tn>* o+b~䷺zd{U9k[ʭsǵg¾{\S N<<ծjDm~~욭9>6nt}EGN/ho/6l=Oe}+vl{Xf~?ޙ|ۺv}Fϵ8ܫZZMwj,~NWkȨ}־:zQ CM ǜo邃ڭ٧'>iWhĝδ%8o>h~d#=ٝ,~tʗlgeoqpl=9ko̷kwρ{kT5F-jo^"WӣR/K֪Y{5W[€|9_!7b YF#`3cN[Lrh^?sL8Ѧ[3olW-,cZ0͋G{i>5f[8wX wG:w|{9Qlhg<7.Ļj{S s>R]MFjY qhōp;j) {SsXCc?٢97.r֌.?zvwP]=t٘n%6v\fMڤb bM#mK^X<_v8j1Xִ^]5y`VxcMN1Z:ZX6r^a  &ѲeF^C /:t٨{ڜ}U8لǸe YW#&zww?=wg~v䳳ӹ71w$;{gy9vf;< tMtve0:u±#2>vƭix̻5`LvlGMO>{-'0g)[pɷV+=0g,NtOGڗ#IǏIcWM=~//nby:A{o=,5xrޫ}hmI3vgt.ֵ9ww6xMWY#>;díw cpo{w׽ؼ:HVs<Ǵoޅhݯqҧl'nuo|};ȸegOnn|%[blʛoώ{omjK|6vg6Mڥq<0y]sq5Cqt~0#};}np|vco{zf^&wQkgZ}Cը[-H>WywuɥzH-?b5[ŭ]?۫iW;|(Η; ;Z'EcO9,vfH Ėݫܻc;^?R~*] {%;Gw-+=Ҧ(Gjaؗkk-,nG[mg'|v[.%K<ڥxk9$d5q?;+ǥM58Z<޹s>z4z9/p^:|^1şK#/΄6|s->k]~-vm1&?sl+W/#_&{g{Z'lflUvWiif&'ϥGj3sH̵=~w;ջz5ޏ`{!f|v0>NR'R'v#d;W˜sk`6)wZkgt_ҫf7TaVMv,KkٰD?{mzx_^>o;徭CWkc{z>WwVW#jxg=ݭYvf<ţUx9Wz-[zGx[~1?Uc =3Ì\S O)QkKk>hp|M~y?>{_6ޗ_3QN=ԫg-uwZ ;h&Q0Z{z4-͞O?G΃պ-٪>xқd+sg'3>۞;WM3yʼHɠy66ui-Y/\c?E+rw2yUrz;Ͻ:J^e̦kVxfu3IU&q6UϚW?dz>zGs_66xֹԵZ7twֻ3 /᥻댱k|]gw-kg۵s|˻N}u@/%G!Z#X QYܚe9TMF]zuǵ▵Lgɭpw εy16fsmMY~?M{3Yј*w~]:+;3|?>}m+k[;;wf^ͻZ Ȇ3lkr&\gҽw}|>7ó] ?7;?wOrk9s`7;?v3>]p}ྸ~'s꾯V?{׿oka-y;urN'P5->|6U}5ϕg[O˙Sh$ь真軟?7__ы}g2jƆO,d"Ɇ_,3QÆ3.>?ĝq?zcc<gw^q ;4g܎群ftsll|#[Wߕ_n>{Ik }kɚ=dƞӖͧٚwֳL:LGoֵɗ?1{Q~VoMgSՏ}NM>M\|3c{kTRޫ˕3Iʤ5 R˥7S.Y3>x+aΒOdg>}E&?&^vkt-pӳ<ɿ/ߦήlx!kmd68s=?3^3yO=mM?}kb'̌Y4t:򯸆/fφtyL>boڊ?u%صg^Ld'YkEzV=yrīGg5<Ѭðl8g>1f|g&O('`mg5'ød5.W:ˉu͜+r1cl3!dWߎ &[5O\'lC/ e=OYvJ^\/:,r|w}+tNdwZv yo)/Ȱ 5|ڋߣuM 䜁x`LiuxkxiJ5p׬O;&_E-3^|km?{')?m0^q/ٓ|05iQNdb,Nl:/pCS3\^CK1Y43sl=gqF\D4~kp4>Zw7+6ۼ> 3ۤ {T9:p>uK?y'?rt }7l`:GkG3~ɥ#4ioQsnu2ʅ˜4dg<~O0+Owܫ9Ώ#X:yu}Wk|+?ۃ;3s~8_4r Kn+J1%/OxK޽~;[ł4egqBOb9ug %:dCW V?!`Kc9_38tws'HϔOX0igĴ;d֘789?pk^ӌxt͞^6=isl].NZr?xe3-ؙZΗr-[X0vvDKx_M[|a=pγ0 .cmfk礱5Eo=nw}ګ6~|obswtu_v3gvvXKagrmL.^Z̦{O]3ɵoχ  4;ycL}]rkw^1Hwgg2z1A#Z[uÅbAtw~gقa3ooڳKO.X&_7v?ȵk?:?3;gru=lw\ʓt<'|}3iۛgaz.w[j]Jsf1Wz[l}fc-:"?/ꗵ!y~g9Wwn|>C-SGD>+_G>Q5vW}F-\L/trp_KyK9^ЯjGC?98◳ڥsϮόIYq}{އڪ{TsyQۻxMG(5ysf喻d7>j󣵰=SzγrT?ҧe{K\ݽ$Kr"@(f``A/,Hp`yͬʮ鞉0ˎ?#+y ts1Nylѹ.>Xsx?NI5>⥿=^dl\aU5HMo>"xQn>{Tγ='';v < [һgbC=ra2|gk~{x4Gy|uҿ}{iw1++r_}~bgυwG{ ^Yp*\n#eX#}ol|{l7oeZ Zgb{̚stG|>+9}7+EW)U>|5T&m:8m\x21+9wU=WG\>[/o{üSw|Z^fɑɪÙ#;K:)=+\occNo>Qa>%Cwa3ޝ>a_<Ѫg5jt9V[="h诐9?|¶UV}xѮoѤ /s֕ t&qjnU.`ϟ餞2e ]Nkf'.=ѾoaTӡJ.P_?;3ks+Kc߬}U۹*=6Χv  1xryTΣ~twyOG47}~D\C]N޽ }J?c䦓6ǣi?>:4}9K> O4O`(tWN}4/인钾+*+z >+SV8SVh?@ABCDEFGHIKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~#= /tϷߢ?KYǘvj}ezzO~ͮ#]CL)gGMyd8)<̩ל+;+hc8UbGWʝwF3+=qM;0KËL4#vl2Д>r 1tgQ[|zUh[, |zc"MIhL/]yKlS阭tW0G~pENh>O|+==xu})GϿ0ǘXϔ &{s)V}es[Wucm9cg΅SWNi{h{q}w1% }b SƗ}tVOXjo~Dg'ݍ+FO|1zU%K;J|V }bEi]G.xe!Z[tǿlŢCrZG:Hcz #b:9WOvmۏW/y^>+ܽ}=5Fˑn;~St>?}3zEʅyxEǯFL"Nѽw3v|)w4Y<#ngHGsTp>GsQ9½뺵^8];K3ִ1x[r_xg=^+G3:}6lw3RvthGK:Dﺇ[V;_O+1'G{ib ]#1<lw+ɹп5vTGQhj\W}o}+}d^-o]p;>s+/Z"Y+a?,٧K1S%WZ"ZzAvb N{yY]缵3:K)6V=Ү48Чb 0|{/Xy[s߅'8t]=W{a:ugN,2Ѱ96}߮b<޹?c\nv\x<ͅordwUѽ=ޑhL'֔O_[4zSnc֗_/rCfpӭYSQ6tY獷>5OW0̣VÄFv4 _>pw>VkMLzqɓР?Х Z~&p'7}f,=E7|hk+~Tgh጑:${n?ó#t̺ΪgpwTogsUG;#ݣt*~4=|^L}#;{8{lϮIK'vϱo~\ـ[;[zV[I';撑N6N/9] xryTΣ :/"UOp |tRĎg+F߈~#C<+٦mBrUž4te3g&Ӄ=Lx%Yd4OOo0uf~yk|~׆7nDQOb>~ńyx5M b{?'^ulḥ~1 Mjҏ0_b0/tOl>7x.Vpwfߑm?>F[\{&~{" 5遏+7m,.  Kg }׷:/զr[5tZi2}n~/{j3}mvy_Z=6vчyvKGi Jg$[%ӌE+P`ys'yx0ƆgϚ w\]c]'}1V-6a׍ab ]g1oS?3/V=s-^5{Aԓ?eKxGM=1gzW}ly27|\|mXe8Oꕞ 4w]u HcƏ!#ݵ]x+EO8_6MxԦ>BtR&_KNuvW t0Y8ͅy{-\؞\stdNx꫘03>HXHc4*sn :6iúh=#oɸy=󾖏= _>Qܝ?Ol|g/cW(BGx.}൶S9?SWͅɶ<{l +arFos6YŒ}"ի Sֹ7G^&FmVړ}wܷtgǤiϹKg^a~sEH3bڸΔk8S'FoMنe+'}D#ݣ&6vCc0O}'=Ys<<0!Zms9Ӎ@{l$K7#Կ11rW xԇ2:&0m^c|y8d&4)> j0[uxX<6闎k0Ci/gumM_uUz(hnm 1\wl~+茗u﮴\&j8~w5~?O4{VN׆tk+/|;sa7onꎮNQ` gu>gB6șcVowB=}̗Gsk_t7yjShakWMUhV暒ݚlBK5PMiG_̧162y>.>oow |ع[q1p {gݬ+C]irbOd^g~~>;?ߺ콲d猁5GQ+rSyqkpͅw*s/t9Yߔ{m̺זM9ge?>Ŏ{_.5.+Q׿lX_J}xf|_uVLt?*QrW|0sg3u8>k_v.{pyg]6]cv5~~7vr9mQiy#̷&pWGWQpƌt6O}\k{w ts!49AcV}B. ӘԕwKǔ;Zyi0Ͼ\WMGdߛgO{fGs-w>:~ԗÔy1ɜ5k元7|4Rßao u[p\wB56sa;D>[|VUs᯽~_%ζ?W[Gj1wb!ZsY.4N#u}rϮkrљkmZEWfclMV[3pw袍Fygv277K<9|8L\Isl>zBFғ +'M6p‡d{cGKqĝ<I|d',żxW|c>pn>sv1p{cq'xf=殺wwúLgc2˯qbqWUo{Nw#rݷի|xѤte7~| #/>M97ԫ3}SmX;Z}Swss׏{ s>h̝Zwg={}ŨvQt7î~4Gϕ37W7~9c縶9z/܊wԶΜ"hO=sWcz-1vf}xqn>{vuzlَbytr\9s.o+{=o=//v pn;8g>~v!ޙݎ76=w/{b2Y3)g9Xsʙ{&L+ح^knb9oOsݼ[t?b=Н}OG}E=ߟkpEΦyܾ8g^mW3ߛfJUɥ#\U'io+ 7ɵfkYE.>cha;}9\k6LzgWVqĎO'hKz5 gsz@.ph*C,}܂l?ӦK<j{Y[*NGsa8މuHX(ϖA{-Z*v\*7Zc}2u]] y\pjyzw'9'=0N?56(+Ȏ)vT3>ٓMxlVq>(aŇ&ێg\ǎQ^e7N?=ٌ/ٶ>m6' 64#֞?ñJzjoH֣bo}wʉ{Ww?}3\ qV_>X?O3*ϣ35n"* 38ti6},p'^aMݎ⒏WΑ|1=T3o78ݓG7Kwcs x:?͓i I[AfN~H~ß^遟h}n]Gz5흳~T *bg,٫sô߳a;Jƣƣ]JsG~9;Y}v:vysμνlMط'3]1^X:>EaOng=_{u5ogZE:ا =3=>Nx|k.,uY9c䫫Fk bC,kbC-f0ы>eNm|㵮_'?1Wc/s/j3gL˾t>=a,ӕ6}4{Qg[?ia8[tc-;o8}5׼u&}:?}Þ#W;vƯ3ggzˍ=OWIqbҷkj{^WY={ϙqFg63E9-Sǣ6Z9:#_ j >lYJr\u<MZ_,Ffk\鬐JvS4LlS3W,6+oEWysma:aݞQ?1zb=Ӧg9jm]5_'ww<N-S,!^y1>XM^g {ə~1LtT8۝9xWYze6'F>4= }-`LZmtN=3ZynLL|0 sÛG31w{3Ϝ*\v;gXm{o=}j|9t}ڹZ;&:?yxmzN0U]ة\tk<_ulu[癹v<'93'>W+Gcl^̧hE-a˘#|?̷%87.Vsz=jG7袩}F=S'xzQ\V>Ϝ(>ābߺc^Y~*)1 Cc~1Ϭ:]R׆aO1Euodקxhau|ꔿ`N[z:_Ģyzy©}vb-0WO{;'1\X|G bKεѣ'; 2;C&vgvdQu۴ݚ+_:_}g3>ewg4ώ[/eU[>1ѝZ/__04aL=~6k56n{dg{d]sa@#W9| ߟ;˿_>YLCŚ9+zƞxCJ6{`U2iZy{N.lΫΪ9<:]g{5 :[ ?;V6E\΍~NIn[\jOd *=\Vt):_i?#wss==ܙ{~jw^-;xO&%;ûΰl~VĒdԟ;⢹WխC^tk_ to|cgѿe˪}2V_>^ >04= wWx[_^m?cBqUξh~=4ޕ}U瞫Z}tv&x1L{s[1\=3?GVw sK[6 sb]]¾ >zo|%_]\͉`*kBRt36;gscg{s[!+=c+3hn&.+A5~979;[;~D <\ʙ+G~+0}a9]ȏrY>qė?2zw"Gq8iw{gt8;w *10sGW\4_n=1c3΅w~8:8*1h~:ͅ}b✵/{1b`;?Cnv~x}m룹$+_[}.1=b`;ξGm;~v\xﵟem;>6}E~;xcT{x_Y'mw9NVv*+;Xϻ~1s _Jw/V9){/,ϟ?w.sٽ{AޤߡCRͣ\tD:;lXd=sܰ{r{?Cޱc~ 9}ak;{^Y:{8>>1 -oU6.՗S1߲9h9ۧGV&vctG_JsὟɦqcb`QW̅a;d}s6Vo_'{cThW{=ܴV\j93*YFX-g7FM7v޹W`81p-r{ ^ |X ;;޷~K*j}OK9g3/Ff:(G};L1A?F-[sٳ\#rs?ǝ}zϹgZ>sw&jrjT^, +g.dQ~&9,kg;; 5zֿޢlsl|;[>}[s~߹wgsv.cbUp'?*]R}{aiȕW|GHU[V΍5'ߛL/rS=%+Cռo} sTk}f_eb|D_XSχ?)?0o ~sg,ѷ0?:W|t=[SS5sa5)}MƧ?]a?ZthShgxt5/oo!|j3xl~>! mt{Gk=aܑ{&Y|߾s)&?5v3>i5QwlWj17&?= lSվOXpCr\Ωpd|E}2ϋA}㰚79ĤRlB.=׽cN4٠ζl.Z1>x`;3<7,.}4غwґhz$#}MWt/6T!#?LHw:6C:^O]٢/%αx7a7O›<͓7eAَ/%i39g'hGk׽t&d閽)[9j90\{g:]{m-`Qb%j?c,.'Cl.wtݪ>|w%5 ^ͯ{UZu՝-Kr}GsI YൗGs4vMV|W}!uT??M t>ٱ[։l]&nsSu,y䋉 t+MS?7F:N}˺a |Hޔ9}:g3N)9:]ѵW,%|4dg%l}+_==|~?;gXy4quFkOYO5ݴW/v>g6nO͚䨋/vdXԞlMx'73m&l4UâKQݚWۺW<ᡓ2A:7Л\GcG6&HpO~>6٧s?ҵ+~g^kiOzTqxӅ<G>A?u3N:̔ilյ8h =¨^Q/o%lh*sO#9k>=j? Ӈ;LOCJgzk_?W㽼R,_eY.Η/ ?U]…Gny)\4_^1Q\kslj><6csbhdw&E VlX9ϬdNLc5 K:Fp&Sgʋ\ѿ_/^WoG5-?]1o.۷شS;җ,6Md?H7԰9>%:!֕/AFܻu FVU֫DD jy:|;ѵ7ӎycFkq&T /=WZ+ߦ<~ё'xhٓ3mlFkeKZ|k|tfӼs65=:Z:Q=dgοtqȶuԣyu_=|WŵK~ۇK4Qo0Mkx{tK4 |3mR_֝nݵGC=YW2z؛p(ՏumS{ͧ*8WNܥ9wEkoA~wWb$~pH6dϼl~,ёW~>b|u/\\3w:X޷x˥|I/|߳}h_}x/e{8xlS5NMf6$7/WH+uKƙܒѺ<Ѿr|G/p\Gbc3#]{Zg(;G^?j૶*_iz9W+cNYk/"5o8ӯz^۲WM}X}{Wm=k5{1ʸ^fڇ^eÑW‘K Zܳ(^odk]^ϟ?[LY;w-<6ݣpUٽmchhs^WS8y籟)yw=q#?gv0~ݒlp)?4۾~=N5p9]m;;;n>9P/A2Lq˽;ޟ~w>9fE{ W|.3`x|>r΁;;O\z^c_ {/{x'v{scr`;;G^\}>0ܭ|X <{}΁_˝;;=?q?^O=T߭'G+9ٙqTȁCND=σ2lKƽٷtku݆yUny6R.=v/:+{}~ˁWE_}DYٗgOH>?=g`s|.Zu̸n SO|]Z?Cl0O>[h[_{_h=J㿿CG~\쬵/|2Yxcnrd;|v7 gސu)kS173ytæI{ԣOGcvY/⟼F2[r(lI+zaGV/Ѽ^璮H\h~]WύWݲW?~Tϙ>(?!gI}5\t@f57yx<7^c['vg /G^qՓZy'۳ɜwL49 3h7fd;rd/1#l9m,w剿=dc1g_C6Lps<OusѬ}^14ZKV5Y I}91~9#Zc r}x:ҝ|+;Y't;G[9zޘ3o&_:c?5Xbkd ſ8>Zuӗ\n=KWvg={:Sszanm xF}R.}Gr:3΂3<30ut7;ٝWxrGuͫq E8'NCz'cEKn#DdJ>q'3u(6#(uW>gns:ʱÏ\*I\|~X#/{끸/| +wlē l:W'ٗv b={]Ȇ|i=<3AK|,FO6Oŝ{ծq'@ēɇѡ&&?\6Mdͧoѯz8:\'v#[Dy2i˞uv>S,糾_C [^㩮zNuM©h,.ǝw=[lX|}=Cc=v#^{tZ;wIu[M:Z[ots oks;#z !V^2tLdm33{g'ZMq}q> >=s|?##7#.Z|d'oehd\0u7$I^]WU?zf/,7n^32h=gܹ~:#;s-]#L=eϟ#0Hk9/_z3_ók4grwkܟɛ#Gkww?2U_ɔϏسy>&=g)~E/W$/L=ccs=՛>R/3xoLX{GwC艓l={\6</y Q9gmtza^00֟zagUg{x͉ϝ_;^ 9o΁9p {q}F;Gw!={`s6xr΁r`;v-9s|ǯX}{o/I֭qr΁rnUL|_|3}SFG#ޅ~G*]k>흈U냽{ŸWW=~U,G9r@IS9a_;үt;ӆ{;:k{ hog\4gd|8mvs`WɁ ˢ]}y=I۵nOWz(ϥ }.8qF !JGk7fϼ%#?w/F5N~ܓ <8kf3:y?c4hZmG?t_0۳-<@;iy:1{Y}] _vKzGēSi-3&{}5c6wpֻg3VdNc{B^2~<{^x_%߷;WB^3e_<^sߺgusz'yGS=~.;%G`o=5}{< 9t}2菶OqCuʉLjo8tݳi hl읱N*?Zʿd4FOf$ d\)nh_7f9HOukZ譯{E7@F&MѲ_Kv颷0>y텽K_!ƿŎ΁OgQ/,z{+XsUNw8tx=dlH7%írbK^zԿϔzG=}#[1F8\lk5≯ofz:_pb3m`>Wrf,S:Oz|wNQO/~lLNggskhd[=~ڵ{>3?snnx,~R/9-W<g3D/m}Gg}7= :rȎ~= [֒SL_ϔȈ&vEDG_1#5y~?[Xͦ⃆v5_cM=@gE L5#0qxxO<'.O]Sטlz(p^|hݛ'GS[G.▾^Xozߟ6^X9_0qsGN=yDko.}ԏm/gv>R/~R/o7r |̮g'D|PA6)'ˑdfs=Ѵ|JHt᣿>?)˷N^uOWA6:rǣknsLr ;X=JYL9_{cِ4pdGrhĤh#o͋1ɳٷOYuW/ʯk;nW ߶[u~^H9况pGctGkw_,^E?5|W~@ϓm-g떜G?Sy$F3z36k2gbV>r:K_[/:K}֖31{^?"٘\}𕟯k^=~ag"+9=n ;@?U~b{`4wy nW'&i6c|F|lXXI~kF^uY䰯}%/xO^@7@tptZ[c?v4&hfl-;'L'޼9ڳ[qh/kߋy4k +p>qex|- pt/J2Л]on55'9z6_ࡏo 7%-_3;s&;XE?nQ<ޅk%ȇ#9dO\yFF1f۔m^k k_yU}M'/=2{m=?ɽ{l(ڣ^XOxM'?.]d8W_β\>4Mݞ{uwmNG4֪zn$𮞝˜Y7e/1[u}.}״O,tbj 7%rI6ќz׵kqG5O|(|Wt8x)h?[t1[S>Q|ΜݍSo>/3X񿘘#h5}s+V)kɛ<8vgbk/݇K}5ߣ8ӯzӨyz3_g5.)3ɳ [`];FzI.yn҇=s!3G$Mz!ĉɚ 1_icNywkF_UFy~]s \޹/Z.9YK_2G7J.bS+rAfq*M{d+:r\.u9m?qioh^~gsQq ~onY;Y9SsLKߩjsuVm=.xzg%9ع5|`T/:р(tɊ&ޞoo}@tlqv/sO5m7g掠vu 㞽G֊ 9nʬ׊-@\Ÿ}]〯8']3VNNc6xȠ a>J-hY\¿a@~rlG;gƙ_fd%M~sdg[6Ó284ίK5(ut{y7}_{x~x׮[ۆ^w?*gzFͺ w~j-[K-g3z3Gg;⻆1DwWC}%ֻpb'q/_8tاh%=ɿ'GrMz>?j;3_{B5G8_䪉fϊ]4/͟ O3p'2LTi8dOZ;?^|L[hlB>W? h'M^l\eS8M;Iyo][oe| ESLcr`v}oA_6d\~EՄ9zɳzԩdsdz]u~ոjYlum_ц7^q:.lVyIG4dxb`Ov5kYY,oG4֎'=wxzjǭ}&C%gza}}dxLx5m_$\xY''OtNy{>O?ؼW + _N9_gU3_1]/vxWNuo[ӁK?g~~]o={ڕ=@gO_}&-ռvg~^}d'LH_6V/)=}ۿqԯkzbnY/?Zoٳ9s怺hk~H^iO׵w5xM8 7x]{ӺUW΁G{ΉL͝}w[K_9]?vxuN}ٙ>]ݑ&4Gkptg/|g>]idڊ^gz{y'BΔz&GV}gRzɸvm}΁ߕ泵VW?Hg}Iߗhw-suwoٷ|9r@ܵsOgr`Q gjG{᝻s83uy8~;.;.;~V{_]{oKS?+~9^w$W]]qF]08 ߭ڻ(n_c{;G{ [eQ/\6{47Ίw`?w^{Z^v|/Wqohw~T텝;mbݥw{u8,;ߞmsԏg xF+d,Ƭ?}ڣ< '6?*V[9i/~Sꃋgg纾+)VGΟC$})Ϯf?^[gYYr}[pـN? <<{GW]䲑eK#ݓ/>bϘ1\vfwv'F ]b9Zɜ7z'CAq:>{g2L·ֆwߝ|#^/aFS֍d.;f ONkh4̎]yGmg׬C:\x M̵쟲ϮMNggzgg %εW˹kdk;=GQ{vD.)\5:]kdߴ#.vK']b|v5G'1o/yi|.$(`4 9Wzz'Ҟg̏t̽=qjD=\{&]?ON<4Dg­zqbw: ].rȶkpIv&O˾brG5V[z̅Ϻn?(z. 3Gƛёg73EL#9dOܻÎw'#t4yq1s?h)_ȲLƪ+;StЂp?6~_r2']zɜf9~g3W1Į5߉GKO驗d1zK,zWKS_6f @z GsIF10N`[ٗ>G5[v>Ɣq4G/[?+zzp7y%3r ~4-t6 ٞ:}5so\MsﲟS&9 nE?ek|tm)yp{|.nž8YF8ؤ7sFf6tkuuO-3dwȥ˙Iv8?|!zxbdUlK6ݝ{oS'z|;;A{rW\ i91g5q`/V۟zt'7ps/N{kƉ<~ao.>5Z2jp%oC'\#d3f;{-Ntk[>x'|ɯО&caa6ewG=xsW_]WntN-}r2ґZݙt4/Yّ r_Zw`^+@Wh흑`-֚&}xf~9wt>K-~~3'Ք[yjں=~yRv.@5ȮLE?9H1?{ZI[iOrpdo2KtU׼7$Ӽ\u#3ዟ?>x.XIZy2|ֳi9|Dsrg\_Mqc_N^qtko${|(FxZ_cb^/zkI- 9pMƤ?=,adw}w]PȇjYk5Wk}h;䠝}*'7W}w.z~e.`}gsCe~m:9t=yd~vO>S-w[@W^E[MqwM|_=O2ώrmgY^trSᑻ?C, ޭ?/{ wvU#kG#tOSUO:gkg%WlK'nŝW^ߛ/.tWW=x:+wќXRN=>-G_ӻ+=+,ZsyH_yk6BGxNv+PW,>1)Pn}2ԛܻ g>EѨ^;wZs`8QG}죽|\?qFccs+z[?/sO6"u}oA64l]9G-{>_;v|P7>oի>}=LO'#+g_Xt_.8YL>I~׃fn^_u˦j#K8͌/5/УKNqH>֜ފn sFT=TmgjsuFGjr΁棵sn{^_'o}M 0$ӺLW_gff^_ng_f/CH9o_eck*tzW݊'5V~k؁m41P/|^gýpixN{gdd.5z6~wWwWկ3~K¯Γg<#'xފϼ_NuyX/swgj`=ߤ[' gf1g s^g יe;;pt‰݌ߴ#zg FѰ}q"5`3.\ 䣷/gtpgV,]Mk·}_tgҿ.Ćڽܻ~f ΧGl36x;i=Gw, Lz^FȮzy֝`K}@{ڇ_=܉WzJgEKs6jo<4<@&]}ƒz}-hoב>ӦI?W1ok/ ~ǜ>Y͓O.8~̵xy.zqr/ռe.ŖI{(홺|nO9'9axs{ !{ȵ8⻄KV/\Ósmhy:o٢:%znu`|~o|s&sf}ɝ[svlq>cskSϴq^>Nƙt^yFO%[&W|'7<= ;qg;ccsȁOm5tۿۏ{ٟzHPJ~lqS_82o1G/Oǚ.|pxA}i = ÈM\æl!oD&֜zI79_>a#Z1(:_F{SUxD[Eq3/&{u^\Gt|Aߞҽk1ؽ8|q9s@w W#=zo]???>;h0?@} ~?{ps$kcBvn'Ce<`O}w[/z2 ^ƈNz9=zM+~㵇%-OKF4e80ujNȷa)Gpb׾Xߺy)œŹX||CO6]uzw/=n~E<ˡnvvv8Q4soLxu=wu~~h]nO{O5|}%yUF= ]Gw]9?c^Mv֣%xݳ vS×gɻ'_W@ >'Ǻ=wozFΣnv1d}gڣMday|vFT=ۏ񟍯z ӛh^>?D/_o0~t.F>G:1+}&:aڜMĊ)>eL9` +G>"^$6}ǣdx?/~=ݒ5v xWwq۰{;>+UgܫgXmL+?+)G[ߦуã^^^eґy/+ oSMhڮ[;&_vqq9WFς'h>?ӽRsh]g'"{_ccs`瀺k΃] ve}Q8YG{U>r螰}s`@9nڹ|΅s`Q`}|>}g$V=d3`꿍~^޳s`殝;/ּ;'vwAρRs$֨olDxv\v\v8ʁ83q_3m߲9~9P٨;ó'3>s\| gw޼_={s}s{a ݫyڵ\{sW?}S_ _|;v|h/vGoN/;%swp/9hIn@Ř ~#6Ns-i{urj/ =Wg\n1>&tό|.L[=Q;z9VߤGg^ɷF6o61x_=j5^̟m{z|4V{ZQyg}{a]_;֯SolN,֎\|d/h2zz3YO']g\fYNܜ{)ul51i7m^XEwYluߣ1ҙoq=;g{z{{򬞏s繺hW ^4nt֫գ OM^G_=S])]1ew]N~Iޑ dn>G>fGO{1[X<[V[>ėxv ?~io6YוjeW~&䦧>{Ƿh.!>k^MY*QL^d;s߾͏;yKҞɳdzo/o>:C2z3~>uF=^@_\z<_ّէf;{l>d|1gFy%;p;)3&nog{TJ͍>7T/{js^>Ad>D7Pu"GsOݮTn>7^xV' O7~iN&YDN<ݜ\bf!+ayZG.~䛱s lw8kkm\{ӟx(ckּJN#Z2ɂ#>?Oұ>n>[;ljOs9/yr3OFg +&떾jH2L;N9Vo}:彳5z<\?Yӌ7w#[j~Oy'~ewRs>+5kgh3Vy|ή5`zLͿjP5NNZ'ZGN<Ø?yc'<^6OxhiN6Ȟb/r:_ƕW,3>ه.gK>|Ɖ_fr5fQs! ޣck)˫4Akd7h֧ٙ=>~53W澭tWFd^G'GʥG~?tW<9?Ggdy~7s%W}}[LtG}RssEW|ĺ}-s^ҟtϻ- cV9s?i}TO&Z}v|aQ]Lhً=|Lnq̞w=9xF-˦)/6 |,-][A:%S3ߦ s2a>MY[gg+WO|H&);N=R7kg8Oթw{=gxǣsuu:W8w\u^m(vC;W\O͖=>^7s̞Q+5Y=Wd.Ak810svp4.Yh dՀzuO9 pթծI`:I~Ox|+ɀK_#?=ޣc3mj̇ߴAq_#ߌwO\~8mOۏrk,u %++~cGűsGk=;Ѱǘ{|^S7yqXͯ?kGuϳY_WuÇ[X}zx?\hhܜyg^yՅޕ_VyJ=Y>zgueNo}X}g\!m-]WiV})oCyuSs{2_>>†QG{1&ۧ__{U9l:ޭx`Y`3ݿz9YWGzW6>^SyOln}G}dDwն+t3W>^>9} [+ޝ5~뼬`s Ʀij{3||߾|h|WWdŀ}dr纇́za9^=ԏ?Y{3>dS3tܒԫgهޞػ5#\}7y|eGֲ׾#NWyG芬IH/W;v+v/W,v^X9p/Qy [{}΁΁ sүξٷk;wn9{-緿;?ټ;v_^d';7~V??{oxؽ>'{Ovo<ۣΟsү>__{oP7w\19ki_hs̭oξ.nod?7Ć)sx?|瘾[NwGϯh߻&9mxNA^Tq-?ym+{+?})?l>X tE7{/&ѓ5g1==?5r<ӣp:󝟣s͎=mqgk> >>Y37@~gڌi9l5/Of18Ե|vcJ||vNg'wI3ͤ6L &s٩LڅgS <.#_-u$_#s?tJ>3y]3Tďy q¯WΠq.ـF87<9,yǫ'g<;ut?mt?pjkyܛWХ{vyHw=#6}p=sȶ+2]?o<ѱ]@GG?=li3&d x?q{,<,g˹sE3BJ8cj[Z}ϵj/\6å+_`W}zg{Yv_zTUoYP5$stf'dǤ7~&C&=[F4 [_''M䄛c(VU+[܀z|j-^4GlBM͋c3(X8{|۽;˻{:g!sI\毬xtg\|v_L?K:NZj_t^ç7_L@3:2M?n={e{)p?l*z"{嵺uBV=rS+6]Q`KrWkR^b]V7wVay35ޯ~%k=ͶϸےN#ljof6WS4ӏ>Wj.gN^YugKM|Ǣe/pYֺ>?c>?GĸQms.(g1X}Jꑼ3Y5Q|N~}n2a.:wŶWWt4o¯O}Nq[o[ rjxu=G܊5wg>yμg^Z{jhgT/6r?v=o}ѝ8<2#|GGw~]vdï셯c;lu;w|߾|h^xGsh9^9{ڏ}>~x^ʿ?ΡΡ?{vW^c;;Q{ wo>;ww9lZlүNGWduo޻<19߽v΁Wqq9=s^x#;;;vˁG~fሖ{w.#{{;v{ܫ{{~}΁^ʺ{^l\uDsO^{]^Wo.Fh?t&;Yd [ 3v\ٱǿɎɎ΁G磸+uw+v9iy73GOKg2gRW;>;v|HZ|>w]v<O]Ͽ7ss5&vx^1;;O<ۣg\}ii>6VhzdY肋Ƀ/򷟧||}N֜;'v=Y=ݽρzbӻ>TY3z/j>~Ú>X;g㮛Xm΁޹΁_->cgzb~Y?0Cg3S~s3v/YnlȍVS6{qw~K2oÖe|G?p>w!'cvfw3uwo\Wc?;ּg`Wጶ{xg|Gguc}8oẃZEl_ï#{Јty<ŪgϞl/̦Igq~G8bG>cI~Gu ~~^UC ?·i?_\;ϑfN3\uzŭ~9/݅zY5yowG+u+{a{2}^}c#9^{dƏ&Z|}/p/w~ h>y9q0L/>~S\xF3Xǚfk&Hf|O w6&hKvggYdZq&-7g)~yOf|1k=j5;뫿_ήwKו|o΁Qa+uY=Wd{7bF߽opd|{=hv%X_r_=d˦|(v3^s2O_q<_֕>ö{7ݚQoI~<>+7Ăx3~wfLsٝm|!ǚ11l^?}G_U^lϟ++uH<79sẃg{TwWϕ+]ztÁ ts;Gݾʈm6|˟Wl'=cб6{N.[sՑcOd5qgs^X&=ޔwkm5GoXĞ#W޳?hzo'?#(g_nc Dn䕏g mŇ3jG>R7 rK~ ;Sg6Gj͙jwjӺ~j-W<ۣso.&vwykȏ^k}&-ߧ:K= \usa/{y|ٓ>t:#KߌZgf㺶G{Tgؚ+_Wؖb_܋[2Z4~<[#є +|`1ӿH |&[1K=]s˯_떎[r}M8j`߽U(?Μw9j>(YRw}t",ԜS{}ڙ{xLg=n_yjHν8G}-ػ#kh-mWcNz{(6kb[NowV}QlL˩3^N~=3K{t^kx9]}|=$ y1';8;+U28wv>L?ծñ?fl>nŌSy!_}[ gzqj~M19/x_lZKąMxX,Gۻ6mz?sΆ;)d}^XݚglkWk/XW[N.8gp_E,^4!~6kڽ~vջ:t++Y]o}O×lztT_3/xkOv1 ܒp]xU/,DޮLv[F>ygzupfgv CrM_g !+4Ǚ+=ߋ\^ 39kJl;:ݽ1.;_|'y9vN]Oa57e'#^e̵?Sgϖn~V35x~rǺ{fWVr8(ן/'ֺjϼLFxdog?Ћ_M~3S:ﳯY{3L9~rV;[g&f?p瑚~fxѵʟ#3G3m(gAs'MKr /v&ؒWlJ+ls^x?;׷%gcO鞞=ónuI+}?/Bl/E爗zݣ޴)w'[U|ʶi7?1%ǚx'<2w<"Qڵs8jg}Q롯g\vC;v9ʺ9{>c<+;@P>aw=sY>0~w-cڂCoc^d>Y}4;rzza{ /Wý8>l__+?ۣg\ںvs`{|[Gz>gɳWzt%zG塟v~|F]߄r>+}1g>~V7 _u}Vϫj={s}s`ݛ}nj9Ͼjv?b=30]gOi |/ui|3߿ĦYz_>+.z Y>ѿ>s}WPGw?Ý#LGݏJ*]FgE>4A_Fw{zK'}r<ϵݒk}p/ߢ{4‡;ѣ}}{z>G5c̟huWϣV?cK2^-j$`˯3=AkޓW+4=M|7H/.S>nG=\L9m_b4z]deˣYѢqC*;}XCΌ'}lL>{>;sw^k__[=rףgݻݯ5h}GxѸEd_<^ 94#54ZO/!cɊ7:iyO#]e=&M3yŖ GVt>zĮyc:_GM}G[oůlg#t[OU{{}GG>فߜ?lm~&~ߥϼse΁pp[;h#$#Gc鏀;{^_;'{9#[I{Qks?@k 9G?S;л9%|㏾Ř%\񤫸do4p<ljpd5#gw6>{=XO/G2gkW蝁#]ɘ;gxq1~8=;&;&;G|EM}=_= 1m=F/кѻ}w|z$=z&7::;=9tx gp]߁>e'9Yzh+<[xgT<HO:G|C .kr!:xk #ٲ{_ l/46WFq[hN^ظK;ys+j+t7;=ܹz@ ?&n!c@Z:phzk֕&F>z}lу'1N7O[sOgKF#Sdct~v'mofx?}<񃾣piqf=D[#[oщiEdZk_{w^[z_gVSsԌ{5c]'E}8\g,YϜW?Сpw%I˪#kyjGu3,Gy ^ =<[L%9%o.P } yNQ`(&Gz6~Ίh;}ΙTղ[E5w֍Wg~uLΟ|}EM}^^]ڦ\@3guQ@g4 ޯSy7^'Չ)+G{x~xG?18BS QN%laӑ~p^QS^HGgn+9<tS}jdos2?_ +M&tV ic#_GvjPvNZzf]/#9Gq>7yٻ]S_vY~x/7:ض[f&_/2ˍ|"G(٢vN\}@OJF6_}Zc/$kO1#=`ӽU5ulȏ`Ef,WۯttJLфK^oyH^&ꃑj{5;k:j^DMwxw^fm0G܇.$ٲN엒M.7f Yjm6ZտUwٞuL_>{vxCaşןMx%w>+99&͜ы~ƟzE}k̑S2)림O<?Gx/[.|0y '/31n dh+]ɧ`o&Zswuum}G't[K XCBz#gzХH~h>4ͭͽ ot?2V#J1(&#e$ mȳrCY$=ٻY{[\75`c$$<|93ufz2ʌdTt͜>=>=Ӆocq =6׾ȳ\A{m;ҝMoSWgXup}}1Xx٩y3T9tծ{yzn"ϵ#yPgqzs/֯kGtњyzek4Hj8kbM[V0FF~F'] Ozv 4i??BrK3V3Nf:='MNM_ǚh[*3i5sSfԿEN]ucչٿ1"z^j!=w[='= 驾Yz+]Ϯkz)]2ىϵ5G5ʃ<̛krOu};e^W1VbtMvm/+K}^k{ g+{f;j])-ro|U}}1Xx>Pc?a3ܽoV{6:Wd7|sڥb򩱎5MD}Iɛy@\}1yk>i|s= >[~ͭ{NG][mGb&,YӮaV=/ WGgK[U:V;;ar:B=Q,:ZcZ6#`r:=gsc`c1s#{ml Sq߶}V76vNZz7g3tubOQsN?thh4g/lΓ9k֧,s͞G͞2}N]nigwSUǻr~ȟ7bsk~_eg`L_k|-|bN&O-eO?~Dxgf,iƟ9^;˗h<#p9 aڹFe.s=~,<3t&wG{L9Y]Nze:ӁnڅyQN>[Uk\vo?zmƯtyݼk6=糛iߡq~=]s/R,\|3r:>Rl}Ό3RqV+YGolܡ[g 7WkzOax>ˏ͝UQgܔKs>sg1֎b푟!lSCOF>}'-<yflt铓ܹf<#9^ߌ%['V]3T8|,щcn+{ɟl̻ld/#tE\΃ḙMy]:sS4.>wN_ɮ@ƚSܳȾuh?1ߥgOχd\Ȋߴ]'^GC9WEvL/:|ӆh=Z =b2FuVKl(録ۧVOdG~.3>Z7cp>pd5?;}2ce<-kʧc|8lϧ}zË)G3 =B[qv콄d3[rLz~&fy&;gOlGvNjtƝ˓Ώk//rIo<}rǚ&2A12wi85NnТ!CC>>Lؘ-x\MaϾsr˖[X{})ޟSs.{p-5fmx4G;3Ήr\Ys5g=鴮l9[>JzW{'>Ɍh*sb.tG6^r~y(ʑ|W܏fb#r4d{69 h| XJf/'hSˎlA/?Пh=ŏ?%]慎j]e{f zOޣg3t|89~3فS\0r6;wyOse\6flx/oYKߜk:40\4_׳tk~. dɞ4=_j=ݧ۟u< <.ё;mtֳ/ʩ1?#h̥=@xg:٢_3&R,AO{߸8<q|FN=CG ow{}k_bg9ye/,N[d?Gr}Cʹ_Ѿ?6iZ,'g{b입OCSOO|TMgUOϳַ~>^] ^ּ-Z1n8H{;#=V[rҚ|sV;\ɾC:heYϓ^zyP4z'f/k!Wka9Yb#;ȗ3%} ;n<'Fyqx8#c}iaac1sxxxc`JǾ66666666#k|[۸;;9mG[?v-kؖ10y[bk0pFl>ydcbkϋ[v7^g׏9u3Ll |L 76>&6vv.aU?O~>FN}Z7?u?9x^ߴKy{s gkڮ6>&?s2G?#>B-Q|?~=#o[k;HG?7_I>Mj>_O&cO1>Cf׳q>Ò]TWW C }ڦswwO?tm_ju?mk:?Q}m<k|q}g1}5:ɸLwjYC2V5 37hՅՆֻ/yS]pDAF=%52蜺:+ɞ{|ӏl>6;N[5Ӝ-}fa|FNO/ڄ?=[o~Wӽ~g:!yGI|!>%rCz~܋O|1hB_≗>8Ob.&]XH:`k͜5הǷg꺯;cs?jjYW._V;I5|ȉ^onևė<= t${}s15`:V3Fjaׯ:1/4ռj~uWss_3fdG)w9^j5ܿoOy5=oߵսcPgՌ՞h OkgygX6ejwkϘWFm^_-_>N&Y[gyvuΧ~5˸J>zo9k)T;kF]蹁L4Zs?kHzgޣI{@_?٘_Z:={}92t~V%GN^dϨK|׵){X{Yklf8r_y{onM WiRT;k4uXѫ3b>ѧ&V&,7VvwbUX6YjZ߭&=iˮ_?kw>>#oos|VPO}Mӯ5=GrՠsstWS};_kגw3r[j`J濵q_c}0wĻa)^X_mv(Aq*lM/6ոڌ]t`-Yxi= =] ߇=wg}e>gFMVѾ [Y,?$ZNZmsR5ZL}esFN}Z:{XFQ{ܞSU]a/ٜ{}}Ͽ폍9kjYVKj TTX=j{|^-Xߣ7хܸWG|۟ٿ{o |. S_NMTݢ^v{W-߬z ~̟Q 0~&&=|3g=O$?m{ͷon[7q)NjCk-n g}}sc♿qظ=#s1qo >ۏ䯽sο[sb|ȩ-O`oy;2Eeg?M>oݷ>-蛍#thL~zɣ˿O6}@\zO|I[䄓6^bO֬3UX0Y'){ʛ-a4hƫ #]tԦɗС_ol|Æi/N52_K==Թϗ%}}10pOޞ#!ͳf5<\.n>{泴f=kg<+Ѥ9_-ީ>ܳ3SF:v{3~~{᩸񢋎xֹd7s=SXn;?U{|Ok %t~C~ʝcm/lFW;췖CO`sqO6im/9ɩӾ{/r~ھپx< ܓ=#.l]똌|/}g޸8k6/{œǗ4e5ްRG~zk{r59l>^Mڔs3,rzM?~u4~ᇉyh[?빹)G~ѭ+MixZ{>^85=y{*lytvzޙo! Glv^Y Fͼ{2{l%-\~M$~|߽zXezQsL/zỎ-zzO}h]ۏ۳([ܳa3׹cj??#ң#wfoأ߹rϦxm_Sѽdܔil/ZtOɩ;YpDs(.VC5]=f:?m4Nf'#oL}g-9Y3DGvgev'1WEuv;y#vןӏ{<7s,lu ,hxO9Osaҹ7lhg,v}kLղ1̧+vVn;9w>jg~%s/`/{%yɞXﹿdc2 ܓSޞy4zXxG?_qJO9gVv ?ק32e<3{fߺsZeN~:N>웾uEtM|k^i=&ӏ{v&,=P¦CtHfmsZr3D~:\Yt'4zo-)6kuoa?.at>#5]ynyv\goާsq}s;#س6ў]}ka6>af-?ʉ1i`٤>'MYkp?k/Z3y/3E{rK\ny)#^so|hh3xI^f,n;̬XGmxZ)0ˏJ(Vɺ[cuOGϘEgR]پ7\W7]]g-lѵ|55~ONGLgΖt99_ZY#GwT_Uz<^غg.vS֛}4V}V l[]6M~Ǟ3O]2.=}:7̵dGӚM?G|qGu'j :_jCs[zI}qc޵kaΙy_ե㗳Ye[Q6q5{z-ڬGagФ;#zs=̩-G{4?O_N2f)?Wc5gUL,n oȩ~}}LZT_3W|ZpjSj櫫zL^5ݬY7ؔntdsMIw4^L:³lVyݓ6?To|6?:>}g%6wg퍙̎e S3Ƣf_ԒT߅G;#Ye^݅X]iL_4QܑUrugGZ0콦;w?lh&6##;~;~ck㱱}11ٰ7N76g] (ecc=`mmc`c Sw-|ς3g 4{[YUPSӪQE|ֻ^ !-[ɛbuFNݵʬ`Z-ڵ16}Z\uflqV޵:3v/_bףOtg>7HgXʅ3rꮅ= Zx.hw-Zػ>_|f\ #޻~_gKyKm|4~{Sím}Frdmws޸/R|cr|NXk_>s9u  _ kV+ɑq_7ytg)_wM6Ōu]ӱ׾g[4+;F;Fckp&Vg-LV;{>Qg}=%n>:}[vDsF>һ?;;9uĠzM^5tڧLޣ[F{uֿ35y{3gsKboj5w{][s<_kmLkxo9u'-gcac1pFq8mnn | Sw-1y{cc`aiic1pFNݵ?k?aɻ?>ק迦-gм4ob7? o[c<ل_<զ==ڷm:x$?4=?j-sB{ʏɦmq~//ɩV~gχ?לw'elg=Jk;Kݫw/O<:2wtOﳿ17oR>Q-G=UoO5W3'}yc`c9 aon l < ȩ] خ·5j#]=۪}]CG{n疍0pF~Άq11(8#v-(ydc`c%8#oĮͳ111pFNݵ>ll7n+uۮ}.76^g] oܾ6nό3g/ g] .L18#om 7ȩ~?gobccqqcc1pȩ-O`}fuc`c0pFNU k`c`c`cu0 ok`c`c`c05l111111111111111111111111111111111111111111111111111111111111111111111111111O͟o/<>?7+hT_!c`n_o~/pXϕ~?&v\w\76> 5?yT^S_st{Vkt- ? pu11510ߍdޗ'?y@iy׿~Uwh_c 's52smAkd:Ȏx[cZ{|d[6=xӛts_l}КO^4SOOi7YlC7]bFvioŕ-zvo?ǯOl1gx'Q37iec em<[^D~6xO~zܷ_ri3o9Yɣ;_4O5?t$lE&%+ʇŃNގste$?gyz=Gt|oҗ7Q%+:sG14Mk-۞+jΘk,9$-Yo8%k'fk)?g=g|\{ cNǼGN/]Wh>ko^!=aWOQ[fo]t<5of=[h];a2HΊeckzkѰM\MF~joh]w{F4]g-~6eZG˯|9t|2&[Z,f5 ݣ&6FF9X{l&|>{=M_9Y`G7?%Ѹ7o͙'dcoѐ~+.S~]O.۳=?3&$gٻN?>bcn ӧo>9=}GfoXn=8kHokS1͞6ڛ9{'ȖK'pYЦIMV'Mv揩,=f^l.yxs1tMfEs$3OmOߒ^챟tЯ{>#mz59!}䯽5mF|X6!,tKviӊU{k&;~=7ǟP[׷vtEE~E|b9}O֦Wi8=h^y8IlW?[|Ӟh3͘e.= ]i_/a 8ggz:Gpx@dwMjNY#kҵ>SڋZ&Ϙ.ΖɆ>e72u/tZ|o}+?id]6~/z2Ko36]hӢ5W>ܣ8LKѐa|z}>afNkS7yϣl̜q6>s(;e2Zk>&&Z?ڴ8GfFެ#[&o}Kk hdOu6Ot39yS:7=)]tC%~62Zˮg%gco7[|%wm]ϯɳ}|텾E<䲅\tV Oߒ_YY>}s]lG&s|ϸ=gI+ ]6|ۧ]hǃ6}M+_:Vggxm>+ũWnU\Y3O1zi棳\'5{`G쒱>}xБ]e}Iȃ;W͞L=oh5`/m|i/ק4)+tKl(.'j[omʛs'|̑a?Xq9}c '6]/>U?fgXvt_i:t/t$/ۧdӯ,94\̙A!( \s-T;jBEȗe}oDʮ6;''N;Ż3?8пb˧X3;mgrJ7rSoz>&p'c997mڝy3iSW,V'#_dW6ٞ5j>f+aw;>ުF`LՈ<9žoqȊg.+v60rEtw5L/x+VuKΏtz Įx0 ٻ|ta [~pCb]k~豇<+bW48|XŞ5!>E\5'"yzX0 gʅz _m7׻ۏ3m?g>nW=3uj"78g ҙznd'/b#s⟾:Ƛ <AYwŶnj-tkǹ7oՁеz:>p?cW;u{8"/p^ש7uVm-ӆN{/YS/N,FJX[t/!7zگkQ+1&J^KW]~uN' =0f_m~7Fk|5.δ:Hiԯ ա}/Go'+p=jxA6}7}ǜxg<˯|c_}=Cgki"V{>jYo1NzFܹ7SQStϵ>'յ^cڬ^3c#;>b|_ OWW뙎޷^ߺw+~]5{?uͻbG{s꾲VcW|~o'>{>kNWi['#k/6ww(g#XJuo׽0;wja.s5=J~\z|֏ܪ UW=syOG֯by5H;]xН{}؝3BG{Gzdvt>.+#;sWu:+&yg\f~6ſ'e|ɧy\+W:|8W?_糹utMLGu_bMs^}9gxuF:u{m>|dN9?pwV]]g.qʹ|OWns%gL~6w>kv]c=================================O쁯o!-s5@~;FˏR?z)wWw }$N_ g{G&?_?";U{텯7k; u/y޳߭l?;}g o_k_c/z<=zo8^eXa7}i_cM1=mͿ8m-?{FhocM0\]3O{h}7|AO)o^Octa)jGϛ/Kut?}~*rSd[,z=elFZ}_~[$+ͮ<9ߘ~W\ 9}{?elbn>9e.|&0҇%>›Nq{s-FvFuԣ>5[:SfVLz0'.F>ٛW?9u'6-钟g<,~xyA~r.l|Ó~O{tzONdti(gu_؟7Syط3=d÷xi>by`+p6[7bo^͸BK>bdGM}V֍ն53o2ղZy\8%ѫt۫{^6Օ~u?s«w:WL1I~o8ʋnug,F5oo%/tx7ſ+ҫ/pLvˏ4oO5XzxUGEaYDƏt'ts\ hzSH<>3~3A'y>/r ?.P~1W_gfa/b>^i·.2ONR{MYdsZ$/4}ux}m}=bŬvc׉ Õ/1coaiAxf]ϜV;_a#j#֓`B@t<Š+wwbO"jO/F>Ķ^xӮ3fo;#|3tb ˴GU_^0M.5ֺKH^0I^mWSs{Ͼ&2Ʌ>3>=,~bQ霱a9>.͍]r ᛽;SaaLd?#RbĻ;Ffr~'_2o+}޻J?}9ev8罋͜}XMOpY7k$c6r#z?u0˞"Xw7r bWw÷,{-lN}7;3xY=^;b[ L/dӝ53>Gw|8b;'1ٗQmwgBgژO|"~èӮ{*S89ثXlu^Mf37l1␱/>w'04Xs)~`˺6iOxb)lKF.n{~Rƒ̹xŠ 韾6~pe/\bԋt O}Pg:K3Sv=jaX‡wUjBtc r3?|`\NjQufYؓ#?,ښxFok?:歫>{xub&~1[3j\D0&H.Qg%W.;SQɼAsP񽏼ԏ꽔~>쓌zda+ֿ?{w yv3ބ|3'\l =ֈމ#y9#b[69!OxNGue]s^gL|GRKo?G/_`nslӝc+?#4nQOqtP13~0',0w_0o):>J}ذTlwyRU.kiPu:};K'0XO?j ?ӟ-:vG zŇ3KWttznhW[#؟޻lzoȽްfOSk:wǿ[>q7;*Ͼ锳}:9o[/_*:sMW4=?HNgj~=O?xW#ۙߕD=篷s{2ޏ^]`#w :{Q.+d?={+gg}1^wZϏžUכ ={{o_;b*w*guiOEz+^qEt'WĖGsV'4+𭏟E_g{{`{`{`{`{ط׿ǟbk=====}{`m{m^{zo{؜wK}:nI#&?Q>Jd$34pF|7NW;c~f9I}fSwncU32qn3i;>aQ)s7W4uۓWYo>r9ZLaA\X5g3-mi7ua:4ug/Mcf=9/߉3\SZdԢ߹b5K9kQ];1U9DY)&wqʑ܃>YՌ6#~Yg{ |?}`^tfWzݣ{w=;|^WU'Rȫߎo=Y댻7[yYwO~ۼMwerptu~5|c׻GN]<ͷHWϳWu[k–ɛsr/aU `n/gm^yW#~`ze/X_|T-{FqJ~OlN}w[ x͹o49qgOۋZ]I1gʟB>lոz rnq`ɪ)y||W}J^łcW*F1ѬUSr>_6H]/v>CگuwxUb?) wvuv7V3z}^7խ9Ω]}Dyw'\-~=}wOO1Cň5V: Cz&}$7"r;}W|c5a \o˻XوY+rcON_US|: Y3A`LqƦndc활nG6s?K8l%|ЌU\ Mry?UGgp/*>Y; g}ںֹIx)~e:O?囟;yXf1>܃bٷ/Ŧ7k]g#F9KɪC{Ĝty]ms}m|ZO٨Ìofm]tL>|ݳɻKŏyg^k1|5g0gSNxa>D /<Ӿ7X+Gw/^8U|g[A8#+/^W#k~֖OtHnSzl}wru_Qlg}z[ƫ:?8ŘlO;FNj1mgU|Uw6/|0 Nt_7\kQ@W~{ZzQ|Tٯ9M1}z틵Z\3>z*w[]*Vķ}m|{tO8s}/\uGtS#>:3F컏m^ͧ?Xݿ{Cv?իYφ٫S:1Y#&n>Pu5ʏ~:)9lHLo5j/&,dYl(Əu}>:Ur[1&60O]śy2j?bWqsnz|ɌQ7g7MW>Gz_>3W^7&a7f ?zNasWbeL}~t69Ȟ^f}4)7'?節[z{ĺs8G.7⡫s}63g?s_}޻z'G^#]Z<rqK>Ţ;'KXNuSRL?嫸x㣉KWxEՊbw}MW.3y-3G8c^~Ӧݬ_|6(韾՘-*bØ>bLzD|&:Ɍr@3~{4.\wt$^F`^ԛ5+zּZOlw)F{pyL/]ϳ]#E~fԫ7N :ԫ}-ގNg]>j|Gտy8йvsMqܡq+Kfw+b[>i_iD{n<7)#Y7|>9}Ty?Nzֺ;_ňo'>s.A[qnƢ;SǦy9=Rb:`.;Ǯeg*tйxpsg {=q93f&;>R?vjWl]j6q+\AuQ׫8M1fmԯSgfS_TrjNf>|moϙYLu^+ L7^pgL||w; NbѴKwf=&sd?zt~/r\гx37F1ݔw<#n{atGjM++lgW6^,>I.7ѬEzc|<`~DgLş/?$`G\M;{Ĝ<ߝCf50&$Sn] ݻٸuNh=QyҬ Gz}? )TaDd =Op  s >A?Picture 4""`=Wgh#2*l`@=d`=Wgh#2*J&2`x읽$I`p $h,$0w`?sm=eUOUdFRufFXU]/?}~9?\yu|\\r_X˟"og<? Yz/.?h}9>o_~u_.|~K^A0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @006>}t/)/ ` ᄏC[O?]޿A0 @0޽{{*1}G罗 ~`tk]XæcVN 믿zfW{>]cqcs{&:q`:hN/øCƘmxN` ` r1aDw*ü>ǐ&dV58G.q0hc~qK{olpU]\^^96n&9IN` ``.^o?632nm?呬?YkVpGPPz}xn셁v/)K^q97sqG9 @0 s0{ 8bOMyCGvԑ=U%@jGcϢWʑAZ/+CΟ5y ` ^ =^ulݸO c̽ W[1~rJdC5:~V٥/-OsN#GGsm^]qyݒ,` Z -፜.kWp\/8sl2!'{Wƿh μ`T g'.^̷΀Ö3:y@0 @0pp0^ml<-rA瑑{:79~xWw (U~x+痫Vι{s_˗۬Ws(9 ` ` @~[Z#{gV~|KswMs8wrwm~W{=}*~$0 <Ykgrw]l_@0 @0l i~` `1P 3#4~{w};'{k?S4/$s~[?#Ǩߣ&8z:v7^ O]'SqVkyp.` ` a689!yt;^\;u,veX?bpďW{\kcl18sl0!F}Yl&9w|)` *drPᦕ/ԁ1Wk<ÞQº"_ȽS^ƈj=WۜÛ1xO ̱O-6݋#=Cmܹ{6` e|!?eN^f^Yge^q/<!G="/or oOc5ŭՇ6rL ч23Wc"F^F<@/t|@0  ){C_q(r9l;{ɐ7:Q4&Xbw֎GYZ`wk㪼=''渍}ør{3` 0 o"܎9=r d=GNJ ǫ}tV^)sV;3>ٳkc!fN[5Fƽx>:o?q]r @0 l> ȿb\&1rrv^ˣܭs9<Q帷ld#yj @0 KgԽ_S돊#vJS` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` ` .rt~sj-5sf~K1?G޿㐵S3p]m-2p-oZzޚ:@0 wൿۅ`~uI` ` a/>-e ~85感?a9[=t<lNz_}cʴrsn;OP7ILƨB^o` ؂O>ўj&qΑŠWg?٫PlK?lV2DO?VejX9j</i=U!gVʠ[s5Y尣-jR}2bnqXg+ GIjsru ;v}牃x:b{v9o|sG掋&9:j"ڇ*COsa~o'6s9ob'z2TɘU#z6k}\؛7kgo0P exO⬬ѧ7R˼=sڧ=8ex:= %{̛kT6Ǽ``+jkyчO5z^ƼOz1Gګr\c`O='?Dsy[coQy^~Π`no=9lS~fχL`Az^gw+a_ u[/yoQ_T 87>q\VQ1P#TNyS{)]Ч#Yc_Uګعq+?d>^{C'ss|Ϲq,:ڑχ1q`l/N? Y氁mݙ~ǀOzsFe_u<}jm~&G{DOWp9LxWe=eإbS7>ƅ]Ƞ-pnuOTF~<~&q]=7EծkƊ/֌kf/䎁s6Gq ޵[;,s9qhMj,L?63>2y{>cŰuh#Ǽg`?+3Ct {kzC}cVGt^o:#ޜ]>-ɜ\u9"kN3nQbCb^^m[C5]櫏'kg*7qZlU'3ImΆ8=NQ%”4: |H?yg\X-iy⒜G+ǝ YU-~o=aF2'."xGڻ[k8.5opڶNbh~χ` rjֹ=9#9>FCr?X6fF9X{&z5qpHr`srJ y >|xK9@^E9Z՘We5q! kǟkcTݿq9؆[{=ϙ85'p$gLj{HJƬۈ="1k@^ԗ' .Ws15ܷr\/[>zUs^Gy:ju89Ck{*kWxw\591Cۘu;>q?G@^ԗ܍{mI9)东焗C;#\R{]c 8*1W[ߎkW=|zk6s88=y=^FGr?(un=={_48)\^ Gw.M> WC= +YGW;Q _q_Ix>ŹkY^,{mm̺opl ek|c 9<)\c,9Ty%AuM.92d _fkM=11AXo b#.ֱ.qӳq>y/ ۘu c5끁g\sU]d?W> g+rGݫ$s,unWs.z~=Ms)jGQl爸;sޒ1?R1V{9O /W7>1g^U?U1?gS1=ag/hyN<>e{fY+8&zcmwa!/[kۘuRg@^k=Aݺ=o~Rm̺mytS3bg/댵ʞn]~o_6fݶ<1гuZeOzPp.o[r_/un[j9lԿMU\+g( KM}F<ˣz\se':Ʀog js{J|ncmKͣ={_}\ԿYp_y,sܿK{-tΌ Yo[ʱ9嵐6XG6sOK/5>y5XsY5Nj}f ek|U[glyc9IE*r\" 7]嫜k>%}00yUp\@^ԗQNuy[ bqo5p\-onGAmrOodZ6f62+ag/[K+ Q}Uݢ9*`$unsU0гP^m=m9n'[=wܺGv9*~R1vT<%i/ ek|qϔwTµ}^3xŘ>5KmS1ym̺I'G@^W>6.)=aF=X܇mgcu}mۘu;?G{cg/kq~HY-5nj~F e=}VӺܭ#-KƬۖG75?#z2|e$@2 $@2 $=2Ћ_=|x;<zٽpm}8IƬJVO e=}M=og^߾o80wM9MߚGnc` 9`3x6:L7|6|kC c #^<Ǒwȅwρxt^#隯*={ߙcKLƬۙ{IL@^ƗyN>&c5<"9T;p?t|/-&w5rdz81?R1v[1гk9{_˲0>>/ #*9=*ț37eo8kܷ6ǑHR,Oۘu{ޒs0г-d"k1j8|9l9Q9׽.hc2ǐI7wE݇=K~'/KA =q*Glq%c~ncl# bg/[ >'{չ5+վ[GYqۘ5GvMMu!^'3*un={_.'oݧ\s:z5}`Oq\9o4=g|g܏Y3-\l/.ǹ{ܗc'5jZռnנ#G0={R_r:1ޣx&ǽ=o^B++-oʧSBk;_7X-'ۘyZWm_9~XH|6fݶ<1гuZeOzPp.o[r_/un[j $@2 $@2 @/^zҏhޑ:;]ums-Fwg~b9w"G:un@lg@^WaSk>C $.=N{p~7s2unGz'`zS[C{Sywٻpw7kw&c~Υnc= 1K{bg/[h{5C9-m^+W^Gs8xW][ӟ6jYF\؀CیV.ƛ}uYBZ3G9r]q.=:L_NxLƬ[o_prt ek|=\JJn^rK9 9. ^\ul39vpJb/92csb{V q0ƈkW c&.bj[b&N=|)qcWĈ:w#9b\Sr?g`6f^d ek|U[1(t996Ya#Os' pFb;Q>OɘUU=Xk1C+f;ث91圽%W#(un_zv/÷X2WNq\xQΆsX6E@הP3G[l#kyhrﭘ8.ŹɛyrHǥ;Rǒ܏YEl/`Vrr?xr0"ΉMy<'L^=<ؒ3o\@]ֽ6}!۬3ʺ&PrLk1#[d yG^=gߑyX1?R1J%{ F`g/[K>&ڏ, ¹'d對=C)f!s]tcyYS#-dqyk>XC9|=j2slc66xkʛ#l&yX^-~ϡm̺Z~{y^Us\_r W /{Wz..:[6UdwGX1?R16rH30гd}r}{kr\rӓ#9q̍et9r3F?s+un= ={Z_p6' Qo{G|8|9t|G搑'b{ʯƈ_d볾6>80Fl">x~3xS#rb=n da7y<2|}<{zxr?/OGS6fݎ퍁l/x|Jϒ2Uu^rDl˷5Yo/sݪ=j%F &̹+Ɛ܏YW1sz ={YO_zOw;/[\6fݶ<1гuZeOzPp.o[r_/un[j $@2 $@2 @/^z:X1}g߫&COIrtncJ|Uo e=}#`<{[ߑuQ#HKr?gZ6fz# ={YO_sj@<nYgs>}~m̺gd#1г- πofnQ~gEn]: 21 } j֖XYUW]։c=|/' f1f~/~O][$9OQϵg̏{c𝺍YG?vR`g/[ ŀ?s[5}>,V8< >'oDy86<<NƐ v}ϫOg*N:?r΋XG=ǿxdOct>_l Ol8r쁼̭6a/j;gۘu;vCs$ ek|\5wp-9r#P%oBp<)^@õ@9Vā y$>=Wk+#kmbg ?,u?zdO[mDGr.os,m̺= tD<9eĆ]扻k8G5ea<1ؓbZ`ElGvbcy=9;R1v$`H< ĀɣFŐk|sb1z˻wagSF[?pe~8Gr\╗2|5/lg9#\^35'Geax!?ӿy&yrsnUF7:ur-{/un{%~bg/[ Ðk)W{vLG8!\S2W9n]o+D^׮pkG_>z}ۘu_$:2ǥ8Qas %^.=_>"?ݛ/ۘu;:_p={R_:|?r֗K9u__Mq6fݶ<1гuZeOzPp.o[r_/un[jz:cu=([G-/[ꗺY-5nj~F eHd Hd Hzdwg/|яۚ.T,s<}.Z[#:Qr?潡m̺^`z:b}&’Gۍ;#(unGRb @^Ɨɝ=W?nŀWЕ?:zԶsmؔaS/km ZU9X#>arJ%Ely挏< L@.g_5'2'uzx?9SmZ}Z1г%B!pD`=8 U9]sbur/oL< Br^cE'YÞkS61+c0-9Gq\fX !>2G6czOIۘu;vCs$ ek|ɻ܏71 z_SgSF=[[r;ފ5(ws9 fpȰGu#Ρ#em|_' q s7Nb#/k樼{fpvm3gޞq$g؍<#(unGRb @^Ɨ.(^W/ϟ~rW}G}''pJxc|m֏\KnO~:/GK6fݎ\@^W-q 5;{{]@k9>rN~-gx٢}9_=qY=11г-%EޜjNp]gך{~o{kgg~Zg豧g؍==#(unGRb @^מ9c-}(un[jz:cu=([G-/[ꗺY-5nj~F eHd Hd Hzdwg/|*}=Vr<ϰ{.x~U6fwR`[ e=}Ygfe`[L-{l9\~V6f־Oz={YO_֋{-mIl|` 1SۘuKI݂o1гUpU?U 6|-i:s.^[ݮ?r~5|1 ]kFn|:bQbq/|gm̺G`g/[rxw.GZf2PJ@ g=~oNu4"+,Y6"ýwtuVrGx|q8)t1ǽ\ڟ6r,sЎ=4xky,t֟፳qē^};׬ ֭ƼÒ?͞c^xm;t4?g̘&GmT/o{u;gM7Gʳ_?\8 dFrY8\qmG<&KǓ#<׮ ?9-]3r y~7&9/#6d2M̜\Y8a6n?svn#a`Yv/Mɡ_frr?922r\8 WQ/bѲ Yk`gfLaY}(Om׌R9eĖy& Kq=1cy\>j}yo97n꿸9VeM;x n! _hp(m| |qNc5aLC1z2&}6ڇzSVZ3Z8=k>M-ӆ?ZY7:4cZY9+m?;wܟ׺nv~t=Xy $7b\'G|tu4lI"qb}AA_{9osO޷qxvκ][ʵ_+ϲ{|eN,ӊ{x 2=U~os|ŸҘSk|јǶ6rk,vQXgMAs&c}>uΕo+ϲ{|Y rWG+ir\Ka=2\˙4n`8Gu96|g}5u;guuZwʳ_5SJ/w9.E2).ѻ㎱sP3~m ~[sY]0,5ןUi gw|{y<8iODӎ ؃Kg97i|? ߭9N.Xy {8' 5|X ߵy2p[:إiY`,gllYw;?Q [9hݫߺVef3s7Σgګ:ZsHj,0,[m ~uh#Ovκ=RgJ_X3/o[s__vκ=RgښfhfhXY*_ʟr}텻F7먹9_͎U,퉁gJ_=e] _w^K ~}v4|npx1,[+ގIrq?C]g@̏gYkٸ[˯g٭x:k|O߃KN.w{ʘ覭g#?CG\{̜CXg#Zd}ccz|n.km_l[K[(GR~˳lws.OGSvκ G8+ϲ{|ɓ<ߋ+υY4z&z amEƼk>rPx}8k汫o{_^g\5Г[sͻiO'sƵE暷ro7vbp]GS|rzڽ\r~u;*WVef~]8M=-zځ!Gc [rEƹ>k|Xc}{ pR$\3ڌy&q&7vzd<6#ܿC^ev/׭u;gݎU<텁g=tc~{(y2p,[i5cL;\IwLYc:ջlC}"6NRF^uk鑹fd̗=}3*gX+۹zs <%+ۢ;Vq8pbib;ej?/cbVy2682{28kl7i2㚷r]0&F3\3暹F|~moׯ͑qӺnGTc+ʳ_17Džcqp1\siC<<ͦm},yv!G{b#?ą921F2Oc†1!8i֚gsLɘ1r/%69p]׫l<棹1_GoYq?Gʳ_3m_Yg[澹?2Ve+}9mPܭw{eLw!&Dž7V䳹wrϴ)M|rYdfx}g+xkc=7Gʳl#缱=N|̽Q&y?0\?g#G^9vfWі6 +ϲZjsQ퇅[S;9O dKEKm~q9`U=~x[b=0W|F2#DžGhr[9/'9nx=r9e˟WHL{\x~)5yxFw}s_ |ʳlַ{\ ܊;={o3!r*{E8q_Ѕqż [qzi[r|ƈ>1¡|hذYlcZMjkf<r% ;ا8G1̌&#RkxFgة@1'Ve+}>֞w#Țs$9r`S~ ǟ=MN<˘ ~%_B{4zE5r;zb55[2K#zzl0fgV9/u eA8NO\bĸj=\4: Jy緙oΔ;_r;m+wޏWo9kdʔ[ֽmm +ϲޭN]g=!w+ᾼS^5Xg}i[]r[8?qqǠ9Ap^8ĢHW:3䴑~X|oM^'un;nxnb`Yף;3{ڔG|1NYKc\rїvygHlcYCڟEk9ظ^9l5'[}y=.|я:1s?*6\1yM[/qly>M<Ww9q 43]qݔ5?2ȣ9&8`^3d<9/}YGןoB.6ͽ8Ibqd5פ]baMb!'3K)ʑ×f͗2uGYb9bY#Y_أda?hcf5N.1֋_׃YrOVź3$f̞< r遻iSkv-K?b.fQ޻gfډϚ欱rCƐ yv2FvO1Ǐ1iHآklaۘYmO{2׀> =csmwQ<5e?Ǖ5?K5cʲ>̯2f9.! 3;3μԺ0?8ړU5No͞gL`ƞЋARν>kzȽcR,3we q;~=+kȅ(o<kY1d~Ƚcrop^ble>4s1b5m^s^1qNLʃ8-ոoǵ˘r7N/pmo߱ScrzO<|g-4kGrؓUq5}SQ֗\O,%G$.0EK^Ů/kgܯ܏ſŇOƮ,##b#)b=Gks)w)cL3]lO[}vGݞK<ߨ yM|X3d1FϞbACߺ+O,cGk;T~^sO N̩2Ӌss=kO.skse1b2-z8F^_ʩk2ZQLG&uE+zR>VzƚGHߜ=g }υG_M}yV``v~]C?ucW泸gkY=F}߷##F}~fOnɸkbf~|LsϾ g{Ukٵ~5ǰ#7B9>gS}tU~fkѿظg2g:fN?bb,kkh;m|'纑==}|rܼ]׏y!'fmƞv8Fo͸ضjW>.c 4jq9]cPKkj_KԽ)7;}{eO)뵾cp،qb|wCO,u޷yh{$=rr5{R9¾!o]峽 oᑺ|G>q4¹y5ߞuZQX|ņk.أ9'bƢn}tr.]7XQ9ǜyPgT189?:Cg5؛/eO#č:%k5Pss3_]':cb+z>VzƚF!];/v7&;`g2k[|W<1~]Dv|}69ƶGh>O={ŵw=^I=X>ۻ:c33e]Եf֐q4kgc0#4Fzb7~ta6vs=b5m^c9osY>ᓺy}ik~'93W뾢C,9`ƐzScӧx}s9F]bi5h]ǵk?sϺWſ34T,ŭGb{Scy/c^a{@zbզ{}=@ri#mx_G6shqL)u~6ǣ6nշ&96;5X#tf{#C!ߚ-=+ObԓZ֚Ig/Yh )2_3guwk=vi)m^i'u1-9Sfg6euIe/2ui#sM^iy0n`ެWt16kvc2.e3b0qY ?X5Ykrqߤq6Ry\[,6dž--eLb|kLŵ2\+c1wqfzpO[mcl0gLyyKl1?FYktĖMr'[[?Ēƒ{W?f1^+VYyF=F̨ ]9{7ͳ_ƍ<8`yy{ij6@>7r:#Ae/ɱ)5}dѳFQFٚ5wZ4gbxb|+z>VZy>/zvN_;4 <3qYu<=z#Gf3V9ƈM>Vg٪u{u[⺹.^gJ_0sܾw3+ 9M9UDž\W:fq(u>Nmϭ|w1 ,f݌ǟE;'ḟ功S? :msM 7F;7`gS9Cj]rfci?>yDG췇Xyu4)sy >rKFuc`YWkVոh#nYGj^1,W[3 4@3 4@3";kY~wb(b(.;n[b(b(b(b(b(b(b(b(ǀjYv7wO[ ;~?2~7@=9~ ?,k{m`=4z)L~kE?Cs1y˦?b5aMG?婍7!zxMOG;Yeͼl.c`>sEh̡6qL<ȳv}ֺ뽴OKYo{:O;f\0ޏ#ne}M沞\9= &\7=SϹKϵqᖳS=K׏?x_ ,L&F> }`gm9=9ǟ2>|&e>+>Cvp9y8~rϳQkuz>%<Ʈ%gʘ3Ӭso^2b7}wcYk|=ő9ҟ1eKÎ!μW)9\ ?[Lu>878M˺q<:ƨ>=5Q=lF8o/GĊ6.Wm{]+c{}iݬ~̝{^?9~13qska3,s(Y ek;y.R9k"gZ繠Q{U2\CærKgsc3ʽk)C|k9E=uk]\טg}gNg#\e)oGYc\;9ocΙ~Evaqs;7ziqesQ.1ܸO24}eݮgu>qs3Yq[olƢ֤z:WQGkA90k@:bLykq ec+>==4g7gL>٫ċϝy2\_> Q{bb>#qsfq뺶Iƞ)2g42L}ʘ(h5}X;u2&q[ێ>X͜9XQrs _cjf,u3b.3fD9ף>6sX*uȉG61͌QGbF\ )ϽuSGu^[Z Z[Y r*AO>.eqb?f:b͘ƺNc_ſR^|ƼyܸЏFrc̉YGg̯{XxiGdX{y/Ko6gY1~3t{j當Fplz#7rO|fsr$-{ȳ噪ׇvx`W]zh戞GK<>eX5=5 &nBƢ ZCdy,2<1Ќǜ5v7cλ cK|.ol1'̏q'k<8p=Ρg1sؙ>{b1Vk]se'&9s%Ƃn[8 1ьq <-uy̛0}_ڿ5mMb3ֳE9_=١~^{)31FbFsiCW_`z;dž$\k|'g0vko>2d<~hvڤ9aN9z8wY<~X3Mymeٺ:n}0kh֗kǩ/ucX cii5{mKtC\39ﵫ+c:;o c!^ ՀfƏ~뚶yGla|Xy9Y/FӜ#?'O>?y&>\1frL1Q{bawVWh-h>{i>ԧw|y̳ =j6o!o^~>4{<'sWX|hc#}2=2#s;c>iޏ\Cb}>cƤ}¾P}#:k7pm}GM$iGԃFѥ3cY/MPGknam@922\h"G~cMbƀ]y>1"OsP yygٱe<#l豃]>G>&?ٗF{|ib$&q1[럭/r/w934sqpͼbFX|õzѧ~M1pO>\gƞQ.{|uѱg֜njfݭ3}wf9?Smqݛݛ@1P @1P oI nA|@1P a_q?Cn_U{cs'і`9|37Xs;Ry1ğ9=(֕9:orcZ[<挗:p?įq!h8}iy5 yu'5vM;'(boã\íwf8Q;] ܔ{l~Vylc !g ek=grzrO䒏3Gc+$֖qԡ7\3Ljd:9j'[PYL.֝kub(b}1 k Ir.FrG!=bN1Gx6>hBr(sX'mk1tiLf=2U~>p.ڧnBy01p=f.cG=Zֶ(b`s?$EGyzƆn_x )]uF4ʸ-*wuoc#45es\+mc1xy"w)5'c.hĦ]i;b m:qm پa1P @1?H Vrp"e98|Y7?{8r&d/l2܆k;o3\γN8fi ǚKk^c2s pOi\5Bw ѐɚl_n϶ַ-bkc@ =|A1U4YyÏmƿI \y،7e?p1VsBk@Aٚ ~irQ9r*O+6cY/汇.5k%Ouu{i}b(nvޭp8-z[unTYs.fa/'2OlĔq!9uL_×k/0F Y׬ol=닁b(1 \ k];[0áw h'y_Ҙ{7<ߵ圜ԑ9li+}1g,%?uVckKn'ε$%s>c\S8&5cyxP&}\jbӮ~I)Ocic2׭ƭq1P _rXy>8|s8iq,uG̡/Ock|+GPrZ+N9O\3:s\3˵_{k5~\gOXĞf{jG)kf\ѨȈIg1_{ֵ}1P _ r;B8pp 1Cw_>}y}x/BsD#Fr^<;[2nsźq^|&2r nCO1Mb汇 NNÎib5ksw] 5ոa,}8DžWI Yhp"tߍn33J]举NY^(b1#u-!' dA; dZ^[.g߯q"d5b/aE$ TVU|V(g4^Qun|Ɠ u-,〿wqW~"qs}1P @1P @1P @1P @1P @1P @1P V?͟7ϵŗnb7g/x}Vxߕѵw5֧;kt:G_Oߵ>zF8}~;{qc1n b(bx7 j^7w|1P }♚ڃH9ޡN+ZG~g=̩uM]Gʕ9dGsN?؈C3v}/Hc=K3D>0N~tٌIN}4d kIksC9Z^ِqb(>'3z:'eDM{V u\SѬ;\d^8eekck?Kme l]?>K}\1~4#|:mVOiy##eFt"OȇCW~ꂖv{V;qso1P @1z>u 񷎢F]?Ypm-&/5|)c!+k\|5Siz?>}IU2r ɗcl4cx+iگ~ִR _/5i1P ŀYOG|>ɺCޏָ!4ΚzE=ٳ&ifCQ㷦:q5 @flw~9%9]ml}.bENʛE7M^cWN;۾(bx} PqYkaN:k8kQjgzk 뭻h:x'}ZcvOG]h؏!s/>X@{lnD>Vgle}.]Kw6Ƹ(bzšcjxhJ^ӳfcKoC֒cmOҳO9Ig<5V.Ԇk{^cg]PҰDA^eM"|>vɧ|xɇ> &W;xʆKo,b(^ >?RoP'$hLݱN~9C&m5aE{%Yh*^}\Kz|h>"nԍQ^_K]A D]kJdV6@eָJgӲvi>7ڗ5.s(ȷ+1%+}<85N@1P 'jQs|ϨimMy>Rӥg٠k#ו_-?Z)y(b(b(b(b(b(b(@gyՎ~\<<^=&&=_YǵeڮWW>ww_Z -~b(b(e<Ҏ*b(65y}yw[Am.䣇ϟgwKQ7od,c~p72xi:.xa#Rؓ{fL5\3%}uz1mLb(5;4_BFԱ9e~OM5zC&љsTI1gֱkNC?GhF!3} KkKkE:jK0yz9uch4}`O|h̋5 n2- meCq^1P @1aƛZz)粦&?ӮE9ꢞYIL@Y 7y3QָTڪG.M;*~q|p<x/!f&u|7@1P b`驱fa<][lls5u\YO_Zfh=~y{98ԋԍL6W:#)W}Ez﫤/{mY?7ܷ:7@1P Y;d1QCs?2R>cjd3qz%is^˕V7yƅ昘q6mgyssVclNVfFk}h\Gkٕ usYc@1P $vu$^jtr'?<4ZYΝ& 5 -jc|/s_vAg^3F|~;?*Wch͛60ֱөVx1<'ċ3sN{w6}(bx] qWasU[9goSֿܪƵ}SWO);aOڭȵFyݼ6@1P >>R\[SM\QYdK-E;WsMyp=k\m󮍇5.kynz^%&]w,sSc@1P |3[>*먱VVZ7lԹu ;C_kkst9(b(b(b(b(b(b(c`ߏy\v ُ{?|#0G]ݟ+v+w|t-]dv\ݫv4>~ֿsO_ n1px}u?|1P @1{ Zc1VNc@1P @1;%|lx*5.D!6Ac.~m퓺s /:|JЃ -y=soiOl`اޕ= cۧ_Y>3n`q`N{J'r ~Ā3f 6井 }`1P @1^VvȸC:kjjBEDMB]Zxq#k4Шոv =ؕڏLxX^إe|}ϽAC2٣;7ߏ[&`L4|_;И^thCs4b 7?y)g^ِw^nbxo Xs$n}Z#Y!5ֲ6kIs%Rc>96Cr˽)cJ]h~G:|)#ʐi[8ڵĄQog-򡣏6ϔ mi޹obx/ PWXW{j٨k*#ʡƥ9qY'ڂ|jEg-^|fSGzO{]c|_j~?E4O3~Cv1eC>2m-:54)X}]Ns/Wkb({h։'{YZwyQh%$)Ȳ1(b( {ֳָ+,dG܊~ܟr.:OywG|EmKCm` Zh3GS5v=rg8@1N^*qQRK٨èޞƥv=&VۘbY㲖W~].s@@1P "Sveg'n~F?o>1EO;`3E?f=n {.a݈٨s/q-~wjVb(b(b(b(b(b(b(b(b(b(b(b(b(b(b(bjYx{}OFc=ݛ2}b"i9ybh|'۴~\W5Wù#O6A?)\χ:9~Ηʣ?{VqDvGއ2A?m{rو{(45́aƳ^ș~Aԙ265USǼwbku91nglKǮlP>ss)_=wb(v,ͳE^8[i7=^rγok]I</癬ʙ.{=/k&?Q'h51Зv$-2E}Ll@46i9i?2Hڌ8?>n9-٨oٚ8y{"h%qUQ16^A<:xYk}Гq@&-iB2%Q>ICN^=R_@1P |3-ϽOK<ݝS[cX xO̵ẠVzcO<{՛g4rG[s;ݏu@>w<15)o^5{OٗR/+cHiY3\KNOK+rgU?FN>qI\ՙeqT@.V_b|'=5rhi?:٧k࣡#B>OeSs(b pѲ&HxN⹝|s %38YxwF'9yֲ+v^߬5{?Crv~7/KK5.Oy}{LJڋ7ҭe#˫#6eZ|$ z8Wu2=3ǹ3-xڏ|qhБӸN^ @101` v: ^{sG C?zDۘޠ6޳5I9y袭OmOi[~sؘɛ<Ƅ:~Ӭ׬aV{Nh|:kj v2/?9F@_u<[+CLq׷Y]g-NЍU۵aWu&];{j+Ogpk6\7#>c~)=ۊb(&ine,tOs+>h}_W@{c[8ے~DO~Y:kC}:ye]|U)uw͑dҨ\g^o'Fdg֝kS:5cw%~_ܩ>mK%>Ğ6+7mG{g ^g\WuͪW{0)w%y֥scnڏNm嚴y9oCOxG1P `stŗ9yu>5̶\{-yٯ\vQGLƆ[MSM;ط~>Q$k5ks韔{Ηiϑ_k#1^FnmM}u5'ԕk vٴ]\ΕLe'~A'v+'c -uO2Q{>1L{@1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1P @1>?/~w?/߾};Y(̠k6BܣK=i'\}ƺ.b(ΥNe_il/:z#|va`״y=¶V{)KR @1P qcP/,7k\j546 m˕nze"9lO;R'2F?4{PkOYƼ퟿nik0`tCg:l"V/Mx|ت[4t~퀎w~}gƒk h9a h4rg|cx2w:Wډ lxc3̍a^s|M:?u#9lG6 Z?WLN{jR90kSf3+{Вiy/9>Mkѐc-5s{eNme4Z{r{~9̋ʧܷ^bFc.+TsqǶڪ>c' {׬a /_y4n '|o ?CF.r|/Zuf9ۓ|^2%?>3c˃A:zͣIg{Z\t+yv=z{1X2>sY)7g5~H^Bk潴=ܣާɷۛ<ha-?gO FvG|1'1N9oА ߴ;mYv>uzy2{S /v6.*^pkc̽=`74x7qz'SWD==)K^kε'8Gq&>!0ȠAs=d+CW2}>طsSr\e2'ꃩ[ԁ-CC~=eCV_lc m?{ 1:/؉\'>]m 1{ZmG9õRu%A.Mi55.k%)}c>V6Hc6ȓ)h| sYL^9w5{ߛs'X|%~yM\gQ CN;+3|Cjr'[S<ÚָϏYyt~3\yK_YV֎{/voD@engC,bm֊\Wh+C k~>mkr=:u9m8#GͱZL9f]|S-y~p6ἱWM<[yi1r;‰54\[ 82\#ޣOv7F9!獻2Sw OK葟ܒufq ?!6W++O&?y +~HZ½ '%}Ęy㙥Gs<:ћӝϼ0q*Ϲ> /PX%+k>,5qF5mUWqO2706ૉ.X{1Il'qԆUlǘ~|s8O G1@ڞ\G9֑Up^:\ىI3/w#=S2ی731jlwb=!d>e_er e?JoykNLyJ47pL7,&ng z湁N sc~'^1Ȁvil.`9c5c;^동r9+rn1| e;I7@fn /I#7q 槬%fl1&{3w?{<=7g!ҸOLظ*X?SɃܕ!Z3yހwՁ\Xc,ѕy :kww!6 ƬKblm,d2*s{6bCcCs )i]wk3:k^;t9B㌡ uMm{/CskF,1b1\'&&|Il ^֢x{b*Y#ގ?5~1Gq^y+^]^ۻ<`t1mмF>׬W=smN!ki&Ag5;XO;ɇ_/}D߻x.h'B{:|oh{q1gs=йmvwaZ[bnelbO&Ϲ1raS{J2y\>q9UܯyryEk^tC}|Ҳg99s~|$=9^Yq"4~_>ol5<7h~9)k/]3| =0艛SdsSL]{^z^E.uursO< i0n{{aw8a9ýbNybg9I=z&so1ޮ-~E"G{d._cCĉfߗ^yٰq>ʳ5~y?9f 31?w-ϋik2GG<[_Wڹzz<01s ~|}3L}U[-fgkf>g5`'oCю[xZoo7T-b(b(b(b(b(b(b(b(b(b(b(b(b(bG ^(+ANq|olcݿCe=}i~4wOv|'H`s;JGQ @1P [}5׾XGڃm仱i=۟s}wƺ(bc:zRhPWϡg`@Nݭqxu}U @1P 5.u|˻۩%Y,5R7s\|sϬWs\D ~4"s)b(b(TgQsYYRZ3Qìq Gڙ?>ly9xcs[u5o@1P c6kUjY$rmhޯ:6G{ە6Գa+s~/Υsb(b(b(b(b(b(b(b(b(b(b(b(b(b(b( w$sz|wLv{wE0~Ֆ|YQ[]i;]KW]溞g1P @1P @1P @1P @1P VRg鯿zJ$ϴy=?ӗz~f|X +OY<3ۤ#=^n>߾};ɟs×OJS9N{Yo|O̧,Sv`?{w\FٌG~8ckY{L_=>۳W{nwg{m3G=h><sBҼ]Z6៴ϳcW\e}N ܳu5ys/c_Ƭ'gM;:khu?\3f#mڑkR.c|f s`9]4yFM;#5;c4ϻcu>[ن=M;+؄F >9pUgMCϜ:Z~|֚0@f ̫ {p-6:;V|{85F#k|/|=y8k%͕9of:skӼf mGg<7a=Gږ99\h)1sʖϳق |X\i#i9fo̱?hzڞ}>~6[q~6j\y\kMHΡ_ޏN3s9==?oHugƇ" t]9OX?WV"7јcrh{D|J'2shqL.̖r̳ёI<2[#mkW);lqr';i,٫6k|H#;x=\z|fָpq/0h}=_539}=\^gHXucK6?=ȧܴ6Ƹ1[Y+)7+trr譙uk|z7b:zc>>1m6179e\au"kc}Y3 |X:;GfM_CLzz,ճgv}}5.Xp}J.:s*wr9a_Ƀμ|4ms4?ztSAc<sC| FWƳY{>~ v>^q_Ѹ{}9kܿ?{%F밇14kش/́hsd}W߽#ȱY+jj͊f]I>)¼>.x:tMU&;_Scgɵ8xke$6s$.=}5-G\9C'j|)jmi~^V6YO{{D'gc ޣ}?We(ڽpS* F$A+ WkWݺ ^r==|]q\tjawq_}6o5vxZyu]rSZ;yּ3[mˡwN9N=h~H͹vk>3_=#}~}d?v6[_p֜ݻ:]jsxyټ,b`1X ,b`1X ,b`1X ,b`1X ,b`1X ,b`1X ,b`1X ,b`1X ,@όsY>3j//{gz_[?5V^K͟ʻ9}?9ϨQW*_1=g1[X ,ba[b`1X < }? j7)v_S9msjظd\_B|]|P䀾ߜǗ+NQd_m\=SImS}_wV=Qm1jtYGϖj!I&Ƀ.>U hxW;Y=b'tEVgj͗:?I~sǘhfLS~=:X ,5C5Y{Ъ7Tۨ%QiShjw]ZNgno1k٭vm~O:b'4/uN[>N]Ʒ Ŭֹ9~!_tNzc>ZC>L]s_0.νWKTκbmd=]e[-zu~ohoht-S9])/lk>|L3A~)\f.59~g x-[9bg]ww@ugM_]WS5ƃ_z/٩ߘ|6TcyZG=głtxtt÷_O{dY3o|B#}xOי{>/y|)K>ךv/'j>|z:1k>1GKKܾ6b`1~r[T6FլUQ4y-zuJeޥFՒɲ፮ɗyti:XSqҗgZ|?t[c#.czŚGVǦx*V \vU?_cu-~?ޫoϳ.ŀ{A= 6YW$oz.M&1x-b`1ճ[uWj|[L|wbqa?b`1( jښϏoeZnwG:yȆ>4o2~6Gb`1X ,b`1X ,b`1X ,@ig˧> O=ߝ}k9%2ݖsryݼ.bsc@}ݷϽo/=,Om-gĀLܷo[ ,00; v]9ۜ7{=?szFϫW-{!7iGf5p˗+bϵoͯE6㛲bڔZ2_9f~:޹Os._^>mY/?7\9?3Dzޔ-S\G}BɳQFh<8e#ӧv܋i|~iNnS^fvX<3'mb`103}vt֢Ww9[5=Z_g3fxZ;ˍ;⭧'᥾'?c=t6N~;#^'{xKo.'^g8{KM>z[|g/)lh/@xaEBeSH.C[q3gf 6}7>v;i}~yG>gn[b2#3x.k>dʇE\o{^/΁dz@wtn[wy[gRck(^^ٶ6eZy5oܺ3?Zsg3l%˶6+?򃾹6^Nfkez{Ob-_씷K3>srM:W5c|d%yOL=N.zYc<ņVzdK_97BV/h|+zo)3WrYLS\#_ʗ)?9uKg~?n.6wY+9WM`޹ipn8?ZsrRwLlڬ-cǯ69s?Y~s{< 7fC=8YЅdRcojykM\lW~̽wIto-nXLJbCˮl՜9UW>'Cg&VȜ-Zz닧9_FW>czWrWLS\;=9d_rl4baZ< w禹=@gĺz&zg ^cngng]u^ey2Y=9o}z+MVLѝr2C ~v%Ui@/٩XߒAY'%SIlޜ;?> kn2x9|G>g'z~&š4)ϧ\ыO{27|$SnqX\l.s<;?-hslqkte9Dlxَ>0VCA?۔qҩGgoy1LWUW3]|-Yxyk\}kL~/Z~Yްu餫Z$][\х?սlk9V/_A>WyD[>=3Mh>Z2:9#%zv/~ۙKsO̥8_9![m\,=36gRgɤ1΢>?w6:&<36qҡn>k9|ϘȤI,^ ,G0L&k޻ƭヘ8ۗ45k1{ǷWx~Ig|ĭK=9u|Ϲb`1€d63g6rhWLt'}3ͽu{' ϿZ^`H w'^ǵ{D3߫E#槼$˳gb`1X ,b`1X ,b`1X ,b1 /sSuo|]wsz콵y<-b`1]0]8X ,b`1Ow_/b`110?slxʛgx7:5f-YlY3ow|f]֦֓t뽴kY?X9`oƔVM)㽎-b`17ԅ̍zJ휟,hSaZ?t-ףWVj_O"W}^|Y3^I'xŵ9ٜ,b`1]Zsom<^5ZLn\m֫hdmAA{HgO=U7V/3˚rd\= gO堜C9{|bu|Njb`1X ,1P63k,s6kJCkQ9l^iMK5^ɪ_՟z7Nѥ4οrRx@{tU5PӛqzSK5.dtmA֋X ,b~9sJq}6fR㺯5G= 8D5{,jV7wȿ}NqxsX ,k0.=FW7ghTj}+9k{6W%^>ɧ֞1;b`1X ,b`1X ,b`1X ,b`1X |v +šM;36? -uߊz][-~~- jvό={Ou^SWΞ=O7^6b`190:Y{Nx/[ϊz{[Wc/~7{^Oc/6w>7E ( 43:>|u&N}c{*Vi1t~dGt5#:)+;ɰ9cc}kW8\Yϯۉ v&qGɓ.'vg ي|5t Lr~MklONOMMV+7Cν)W1OdL?Şq3/z8j~\Kk[t[1̘lݿݿakǮ'n<~Ԧ;#S޻9n:س~|9/hȧMkT{7J>Z==a^lrk:H.]z3-t{_v:sɟ|ۜh}ƕ6mL[7e se=93nɿW6u #gizZ ?SߴF<fo>6k0q wv9\{;@Ƽtu̳,[δh%| ϏnGl4uƢixYTl_ًN׳oMW5Dg3ܕ38t_ݩ ޓ;g阯zh -rzlԟQN?ӥqS>j*.S[o9^{l]+l :Å5'¡o|-˭˘,023?5JGS5aX ,^Ϋ+yF8kaչ\î;<}s ݸ|kt[?Cџq:~C(։o/ӯ_1h+ٻ39/<\t={*[X ,ކltN84yuutmw>Xs.tw3[~_;KSg# iKk瞢G~ v OzM6{ |}*7tw)xi@;CNؚ{cl)^2+WrH%wX[ϷֳQn7FOuIAkrN+z9X ,oǀ뭦wuZNjOk}w?7gKk 0v&̵xg9)w1H&?&:N_[CˮޜZ9Ho|{wlg#Ě.sM^tuW>ܲm>Jk53a=m7ktU:_t&OW=L;Cw{>E>׬W+tMߋoꟹ.k6^1 6^>Гm~'g5|AF^%Ϸn11е5t6w.9+^{sSlo\}?g4yq{V;#RoVN;{{ߛ|\q~x u:7=g9*-wݗ#>Cӏݿ]>GkGt]WK{|/=Xx?=ps9Y ,b% {o߹/ͮl7ߋb`1>^3}>| zgF3矘w7BcУ\XxﹲX ,@̹zDMMQ]R}h}mLV SqOS7YV]G:xR?6t[of̣P'q9HovMS>.Z)/|@|+_lXʑfM.ٚ#t|k'?Sܳ[9g/S<ԕ|'{xeb`1X ,3jj tz-j/4k[35uZ˶)zŲ뫋em~M_NW2[ڴov'jc6kz~rS~W>1dH7Og<[?b[/U'S]-SW6ȟZ\/@äY-.qcsy ZsrvPwLWzH_Yǩ7^OvUwͺd59uϵˌ\rl[}NgM|z>7'~Uݞiv]  ~suzEE?b[{_Oz|qg&s{^ ,s1PpͳFR8텱zY=Vkwjx32 Vs?䧺zuE7g>{⊿\_E!]~PN4g'I_5So5=GC7oe-?<N7k"oeL6֊} =˧S]Vw78 ] oϽm~7b`1t'ڜ;]P;^6O?`|vʜssoZk`IVMdsީ?g.ȫ_E㧃~1q;13^\Roqu2<şp+xEW =Ny5\|bmڡ/b^ɱe_b1X ,Ӗb\s{2R?~tRP]7^}{[ծ۷b`1X |n Ɲ>yǩj?iܷ3_ѽ.n[٣.1=:5l|@S;<۟WjݺoVZ~KK'aOgʟS\aas^ ,b`1X ,b`1X ,b`1X <>X ?Tӵos3b`1X ,>z٭~=sV?[>ן==\ ,1o5kZVJ1dsX ,c|BuPo Nn.u5<{h6i+_Oa.1)kNqX˷c&1|ј.rRtV39wb`1X ,5ouXu:K-VkVwH%u:kUZ͸:UǽM>Ϛ ^եt_9=9lUƫǟ.kR/N7^6b`1X |} TUCf]6_ϰYWUS_'Ns|tO[դOVO[9GŘ}tO/[.MZy2\;çjYߋ5[s/Ц[~n{b`1X ,ƓYs Բ=sƛ5ZQYU7U|}lO}haTfxÇV̓EWrN3hNR1!ֶ{cs9Y ,YC?.uU5WVU#LJN.v֗h|itT[SMθhlz_ct%O|ʼnF7;'ؽL/U\,b{`@ݣNZU]YS콚OCW;&K|^ɢ 41gK5'Zz9I˗Hq[7Z>7}cMl.VϏx.ڽXӧq)y;b`1|q/T}Yr޼}<5nv#{ٽkb`1X ,>/ոG}'Gcwƭmזb`1X , |=[ ߢ#e=}{kb`1X ,b`1X ,b`1X ,b`1 :y߼/b`1V xﭾU~{b`1X , }g\ ,} }/BMWS}jOAG̚ wVu/ݵ)l;qm:#_[3;[WvŖ3lh|g/^F|[v'zUcve'^l~b`1PiHYIcw_RKW59:YG#ncJ?W-/6|/bq T;M1:QקqkGzZ/fW{k|IٓN?ampu>k:e<=x>9(^mk]ϭL{pg1\,b0PT}&5ڭz-Zӽn?cu#Y ՙ٪նZyf1ӗл,od^3޳s+M..4f~#S?/b7k;KzgָTj(uҬxRۑI{'5?Ԛ!ģ {ͳCz> 0nVG|S5SnZߪq'RlY*ֶ>\l.b`10PQ˨44kjcqR#_=VVȪ3yu\q6dO#{skɏjf>Ό o9'Gުqɕ{4&o^ޒ~X ,?Ph/0Y IUK,6Fo5ꔉVw瞫g{-] ,b3bEKן_bTW5nuɫwcib`1X |V WfzMYs:}]}7xԻ{m[ ,b`1X ,b`1^ڳ>ݸڲX ,b`1X ,b`1X ,b`1X ,|GYS_֞oj)OX\l7b`1X |e O{ϫ;Ťޝ5og0m>x \S'lGۿW~/b`1X |^ iխHXٳԭYSjWc5z=wwΣ'|ϋݛݛb`1X , KUjq'~Wyb`1X | GkW~m=}V}zлkl]K/zGWOb`1X , J3&)sV]:ծlߩ%>uֳ|~3b`1X ,:t?5}wָb`1X ,Ā{uOֽԭqs^|-b`1l go]*<;տb`1X ,b`1X ,b`1X ,b`1X > ?zV 3k c3Q,'7|Xb`1X ,&=;o]]_`s}o|b`1X $ xޓ[#XYOzn] ,ٯ=cA 1ۜA7?fv>k{5Ks<;tMکj㿵guYj=E-cyv[m1?k=z{N56ʿ"f\ᓣ :^?=ٟljKL|39-ڕ_dռٸƲ/_ ]S]+]{]dM:8Ϻ6Nkf3֦ZӾ`޼'4=@dIx5in<'?4>A55YZ`=ocYQU.5G6&91Lm.҉7=xO8k4O~cwݳԟ; 7/s61L'tSX?߶ey[ |> Nv:h:O\][v־%|t.tͿ,N΅[9xi{?U'̼CsÝ#[3>[ٶ>eZwֱ1U~e3~5ug/|f _^F1o/:U~׷'w Oć^YΧߊZ9#;EL|*so u/vc\gmwv9L:ZzŒStN,θg1 }_b`3۵ϵU/NK9z}umy[6&xyؙ4=cmA0{&>[ skg=MKF~ 'zCOS8 _Z=-_c^GCW~L]6 oXW~lЏ}zGǟ,춦·WSƏ䦯⿅a~s=W9,[~񯼦wƈf739ۜ->\\ϻfc/os7st2WήǝÝCZ6s3֞Om_͊1i,ڜsz4YpžjZ>gF&y4Xy1kx]7O/]toyb;r|dӕ\EVQƯ7kt.҅^^O_ZQdxѢszg@<5|5.gmoQ~^QW|~^?o:X ,b`1X ,b`1X ,b`1X ,b`1X  ݯ__$?^ҭxnoQ߯,[bXf~>{ؚk1X ,b`1X ,€{TϿs~ x<3>tE?O=o=_t㝍oVFg;ɴu/{~%>ؗg~[q3틘:Gxo\ٺ~>ܫ3&'Ǝur6?_g[r+:g^زk [CN d2@}WWm]~<翵jW#_gDL&ɩ#9O~uμ"[boxuSKl|/ַu1'Gwv2c4>WclZyONT>5pv^ͻ'woPOdӵ3kZ/=׷[k36M݇z%׵ߚޚ65$&S9T-'F^<MZ3y/wժ{Y^,'{jaCյ8Ϝ~Lqi6Yj|\k &,vWt^5Iw'VwMy]87ʞ홋C\ǜLG6S>7oYj'ϫX/?3.9u$Cߜsx;sS6]\VXo/GӫNWA8Zj9;uk%{S}u?ha%<W:w͊gw{|s!Ok*N{oQ|VR}y3o从;wud6yf=w/=-y`R_nw̡7&0s^ֺ]\'ƭO>{ ogbxgl/s3ldsn{eHsSz>ku yK`omu^l֫ gͧy٘[Wqܝ\f>33|?k=eG;7w,Va4gK}4q+?$w^CCszilb:[rv՗֒~}:xzin3_{qg{Ҿ~\쪃y{SqP2ϝ_:ebg9Lӥ^ Kp3^+8 {-e~OL~{gܵIޜ>={g|?ی]2֊QᆪutZ'_6{n9˴^팲gƟY){u^w6f٫8Ȟ͹fgPo{<e=}3z8X;s1L?Uly\GS=뮱yYYilz.t:1Vf\sWܛcQF~Qyin,=YiБk9øs:=+s.ju/=>{&yƐZ&_n)0xWّ<=;{rβzVtz9ir?]..;k}Tk}Z҉pOxu==VjtݳjVf:|eB_q֒5}H 9r6ͳw]wѪ3)/^O:Ŗ|Ooh\N^LF6^uGub׸y1S,YSs*`q5#kjspM\מv$ߵutLzOxIl\ٟ>\=z5|trzu"=ܼ$~Ig\+qj3bN|̏Qr OGG=8 ݳ;w}XrZ-My^?&ġuͽ$19w{g_Vκgsܮ⮦B#g9lyYX~igR3c<${ÐgUs5vf8xSM ALjwϫcv\O=awgy*)_M/{~/s˚UfwZ_LO3g7;sK.L^^wOGK*Gz{xf }Ǐµws?||b`1X ,b`1X ,b`1X ,b`1X ,b`1X ,b`1X ,b`1X ,b`1X ,b`1X ,b`1X ,b`1X ,b`1X ,b`1X ,b`1X ,b`1X ,b`1X ,b`1X ,?q<ʙl_abڔ/irڬ ^[b`1X |l )ku==b`1X ^ __S@|}r˿ۿ}{X ,_Àߧ?wVWޟ p/ɒe/z=3z5\Qȗuv*y~rh9ƴΌavo~>59dK/ͳ`./*guwŹ]o[b`1X ,xU/2nq${aþM32ZϾ}gO<-NL^\Ɇ9.rsP-z)n|˽[<[ٛg>縵Z,bc`w<չ'ōBtJy8wN~1n^=;լOb=[sױC.ey{{j yj|u?bL]d4y\szssZ ,}sŗp8ng"CMqq+L ~MhM2s]Y?yތoꓝ79ggϸ}qͽʗ^2A_ cX ,@<9 ߉Dq*^`Vvtlg;^}ھf=znNZZq!W俞\9͸g~|Em8lS\dO]k;s_g.v5(gbisǏ-bo1iW| 4_ddģjjAgC'-_9NMr8ߩG&]=#=/Z~Mlxٙ%i?yVi^k壞5c~io{l=b`1Nhq_w>ww_c?-qZssZ ,_13am{;3NMQNscu,Ǖ3/rf='jxq5~ήZZl-b`1XܪsjW8.ݗƅiG shWg+c2߃u6boǺ&<<b`1X ,b`1X ,b`1X ,߉~}>X|g]^}k7g-fM|Ư|59m-~bb狉b`1.%sO3g^ǜغ:pɟSvuo1zs1X ,>+p8ة|ZL^3tۻ=,^Rbe1X |< 9> L;bCd }OVz^}\ޔKM^'Y/VkL;圼8['[-f{ٞjͼ,o>+?Ӷj6㣯+O)|;?;,:++ ?kWw9_a[Sw_ϭd1X ,^vq 0Nj7ىU2`̡N׬Q ڋ^dO~dg\Oe|3jjZ^^r䜣&jzU3:dpuyj֊!]]Sj9c"/Y>/V yF36jٟ~=qgn:+\"/[yXv7=O>&b`16𜎟;Yc5|/#LNi: 5qGfsrPk#+dKw?k_O.3Ӹ=WS/u[gZ:'qYu2Ռ}6ˆv&_,psngf\ CK gJ(+Ӟilt3f2=c1X ,^^~,23E%M:9> N&1'#>]'N2I/c튟]%;pgZ^/}yk#[njlκGW5G/yO.sη5ږ畟Ί\͜+gzuGzik FZcns|w/ba?sP׬E5#~?}_9oG}c}٭z1X ~ rܷ9 UwHsjڼzGãs{8lguf8s^Cos =b`1 z.wfCMgKԸg,_ImYGN؜6Q8ggX , ĉ ޯ}cpϵw珯wI;{{b`1x }\-W8?5?3ޫ oq99,bm1=M+(Tmw1X ,:X'u1\o{ywϗq}o.Ͼ6Gnj|3.Lq᫿sԞ~m{lӑGOO+Fv2ԙ?/b`101_x܋xiloŏ)HvǣӵV#LqruF)O=rǛ'?uvb`1X ,"p0\+n9Ȝ|7^xjR=/N'Φqb-Nv#_~E+8n4뒍E5vWik\\b`1p-5Wu 犧&C>_ WȲٺycN5\>_ddrfCጝM~q=}4~kb`1X |u #6"U3k52x{8[Kg#kX jbL_1&Kƾ]{{a~vͫFߚ]ܬwo?cVn^Ǒ[W[ob`1X ,:p2|H# 7ƅ569ʗ\GUv>Wvtw1X ,@*7}^\޳3O{᷽/=evb`1X ,"Z =9zߣI<"W!Ϊkg9g">9mn{^ ,b`1X ,b`1X ,b`1X ,o~v6ֳ{Gq~gF>Qr8枰uݺ.bkcgzTl?QsظuX ,8qgw-V+[b`1X ,>'^{r.}GԟZO=b6|}7_)gZ6;bs^{{b`1+8POR#}3|J&F ذn^s2lSxZ/9vkyѝr>̆x߾owϖ|X/)o\#3V=Zl-b`1910=F󞼌v~.J.;8Zkzd5O4uמgmlMlᐸe\?(z{s/GF]&b7.Ww1Z_nWLuoMb`150SB~8O_%vnk\o]<_c2/?'Ǎr|6q]hh}3gt9So_ss^ ,ό|[< ?ŇӬSzed:ۤk_#Ϯf1y0]Pl ^~>tOIX\o͞FLeӕGV/db`1X ,q\\.*8Hi8X-f=;p9</N&o9~q֗ʿSe2o=r1X ,G@W^q{=g ~T{?z ._{b`1X ,Ve~G"⟟xKr omY voin1X ,b`1X ,b`1X ,b`1X |, [G;I}HX?jkk1X ,mpG:W||~/)΍c_ {~{~b`1<WNN?jF,,bQ0;*xs~!{Zk|.~!ݺ6m[e}ئ*=>jwxO8+[tf;k-N|f՘1ٳ:O}gWLO~:Nb)r 7o>OC>|!T=HWs&g3 o?ʾj2b`1/gzLy\DdX8Ql4oMo=~F;U\֒ȳY<'?^q;[OojOo;M܍U'UYo>;_te+{%F;?>{lco{W K-ȘklIϘ\ur.lƾb`1x, x~k¹ڳF+ox=/ˏsx=d9=׌7Ո-{tzlO9ŜḼx5yX̚e_X7uw!NX}q̣X1xK ՀbpVm{{bkcg(8~cdϼ3gWl+f^=V>@/kl4>a]~lղo̾9_1i,4&;swo33Y ,_={!9o,C+.E' y׳e:8ĩu39[ǁA|Qa__lbz䫱Nuc}7P✍YxW=$Ϋ5x 鉃Ls19-uǬAyV՚j1cNrLo}/_ ,]w%VkiQ{[Ń Ʃqq|wwb{3?=rcc1X |L L7gzeq+\游xƫoV:\xU6}ڵc޳γb`1X |'[);~wb{3Nẽ_gg\]ۉ'{~݋b`1X ,b`1X ,b`1X ,[c߮G[?وvX ,b`1ob~1X ,b-0uEksb`1X , U86 cN=5 }:M߽?m=/s|6mW1]^|k3{|frsgMb9uM=KVM,3dg,kx7e},/ծ0cb`1x O[[p˜<a~U86qbߚ:~h[bZdZ>!sfolytʏ3s;qXr˞"c[y`s buOŰb`1x+ _N7‰ģAZ~r\A@vu6ز͸ɒkl/3U#NNk˕msXwuزb[ݫȇ-n~7Cu[_uxqb`1X &$Ml/EqLgwq١i2^k~qϸY+N6]ϥO&7W\|Qdo*fv="TɳzS߃\5X ,kc$8^j•$ Oġ$pMk=q,܎?S+Z[ϗqÆF<[Y{gSˆuљu\392}-?͋y<}Ix      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~K|Z)}ܗĴ2{Y ,b`1X ,b`1X ,b`1X ,0o=>kn^jbo{^'g}Ϟuggx_ xϢg7W8|L>_=ﺛ<}ϩsqx, xvϝWz/77Ͷ޼=r{{?l<ȟQ'r5;OqG̞#{S޾Z5l̽H?kZ>]-ӭg5Ԝ^rӗ<_6AyvN6Ϧ>Y>-)_|s-g ?3NjqSs$_|e,̖38;tI|bIngfk\pծwg>>={nyʾ2ef2z>{l95=^Ŗ5q˙Lwflɳ11þ\4ј،gL9똯狟cK ײx9ݙ%.~ϯUW5}1͉bfլ3ыIɅ'Uv:t3Yq%\175.kϸ'{^%w]}e*}6/1`F#O1sE0:Cdƕ|eMmc]6⚽e}[ba`>^z}ig{[g=zٜ2=po<K=SӸxY5}?md<؟x։u>*9.G3ָf&3ߜaU=f_jƿZvNlk\/_Ѭ僬x5ޞV蜛SIˎtf\^]WvgW6W6ftԲu1?uFzwU8~sW#[ozMri{.1pwo~fY߽o7a=fg{ٜeߚ;tvϘW_ݛ۽=վfls3׽[>d{6E<+=_{ԓobv=CH׌lZ/&ݚ7^䒡oZ&|ectgsl3t~e~1k5wNαZa<3b,:sL Ɲ<3#3qVtdzVlY|l7.|ks|wތ[l[wfWvwe.^6ؾ:'>;5-pںxV-g7o^r(I1KgR:{v;'wOݝgb13T#qOct[YgݽlOOc)^v͎1ٙqyɷ^#[Nl5b{?Yo?AdkZg\@%y'#ʷgߜXԚMYsڿ:3v4g=зl\;qٿO.1L4dQt&}k]klXq\uƐovi ]`Sc\ï&rfJjX;S^\r˧37'7_d) vkWy<{ߞc}_}=z\=ڙUly9q%ka϶?坍[w.Oͩ#s^=1˱[w5/o<=e-jS|Wu8Yɵ=uGss==GÀ{`m>O+OKxgks\^x8ߢnoÓ3}yM{kg\m#ڛ{D\- 30}o.Y ,~Tpݧb=%{<_~D)|=5m>Sr=o?^kL0VگZ{կɥ8%|{Ÿ~,OޣrՍiqX ,b`bgzb`1X ,`^z>:_wqr>O^?b`1X ,'HMl{-.b`1X xwrZ;,>b`1X ,l.2~,Ĝ~d]OLeLߗ}}s/._Ŗl=t4j7 ]>csŶ^ˋbkc`>z~x^gY?~.]%֧~W|/{+_xY׀unwx1w} 㘍8|?=n+>f5gscDa%B!^ug>rgl.ˁrr$~gKa{912vu'i)͞\>&?{kr{Ḟ:{lJ@fM>:sֆʰMǵ9oԛ\'m˞g9qx9 }ba]41m1!_6~høg~.ʁr>9;w<}w502{<ͻ(؎];fN!bWp=veց9{n%?7"Kx]r읳O,]om{}/^?oWj~ºuH]󞛍]W悼ϟ%׮ӽg߲e?WSt 5.?Rfyl5fkyY~9R@9P<ZϗqٌsNfĴcvv}j籹kʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr8pGmgΌ*Og.rC>G|ߎ}Hlu,sSf2p絸Z@9P@9P@9P@9pj>u~6c]Z|{=_.{䥿@=Ge`5[`޹U3=3AL|qsl12ƙ3A`4F NLXg<ʺA͖zb 2:#"^3Unyes>Sw ~D~aWn#s3 c䱁M{3LJm1FVl)wGb&|8oBz53r s&Y'~LJLb3Yc0FFCVB&}E}?|켲"p0:9A1J?19? |ي:B'ḵ|kaرA'wCƯ[}+X&]as3ωc7yZm;x M:g\2'sYlȦK<}!c2*x|/I0uO`Ҟ6u;lfYm!}S_cQ?2'#2\[&Nwc]z39yO+8[S{8.>tCz#*xfY'<<67+LoK] ?42?bӖ#~,~1;|Ul3&̛/l|c+5l`[lrC`;qvoco A=*:6ə PzrMxε?8W{Oynsgl6{xMe'N#mooæk/|㘳X}I0ҐvOu㇦}Яw >i&2`6g3~4v1"}aT<6蓮O!^ְ] s9eqBNsu x&s;;wcx9v93=T޹U=.,zy;mq?а6yO9O cU޻ [436W`M]rGy?q,~d^>4;=uᇶą=ƴ9?1='?R9ܲ>e6[8>\rpY֟cNº͖yrݽe?ĢlDݥ}:wK=yn /X޿ Qpis1O:E!sߕK]lwQƳiǹana6q2vMg"Cԧg 6:?ʼn}Z9?c1?c0(3wċ Wq~Y+91Zk2dzyT|eޓ/)Mcʭ>5b|?+}[)&yo9̵ǎ9}^?b#o:%޼5|waW<yZX;l`RV55XkcoOFrrę5Zym!k)x&fz3:=V-č~b׼N|=[vČ5q㋼_?n6?cĩ mo+虃[:/u;@h̅wu{.|޽n|S߯@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9Ppoyi9(o݋E9P@9~郍ri-'4־;ʁs/5'<|w^y.з~GGW_}]2ںjN>{w~=5nk{{c9{ZMlg?K/K泶ޑG|8kpu?cQGCeW=ߧ̆~ϻ1ѷvշv_<+ا\΁'~.f { Ɗlș_킇|`[;S;>W:=_7x]p[3?ִ:\3oۃ~V~~iՈ cR^κ7}v^N~yn޴^ ct$Vb|O Ɓ!ǜ׾2uՈOX3Vsuakml^EOrN0XgO=F1l!Gsl9o~k|Fg7c25oǰ#g3VKso{/^cm%>;ϦOy:e~Vs~D?U)`a,7%w+[ $r<>v{π {~Ċ=r>e _o.ֹ|]Nr8pRSY:G΅sdγó:z8?}xV88ϧty0NAmbҷ/̃Wܳ]cZw?v NN813kU^D}/9Gs쑃Q8{3c9lym~k-6uM_ȧ/u|3}D70rZ[W}MMl1oL0;G͋vԛ|O Ucϸ:99?S|˜xW^Sk[Ys1i˽BؘOyrok˴.#9g~Mo'5| roac~gl.a8r߱{Ky1!~~mgc%c҇ڷ'~ 7}1jK{:29u׼ler <݁Ls~=rvIاq]Nƣ^7Z4ר<"u>Fg>6e{41vָ֝#-KSnIayƆ1h|М9y/?XWꂁ-ApsiKY Y gA2MdN}'&XySɳM0r}C3Ow-y`Ώkb>d_b\>`2ʋqϽėcάp~EO[ܩ\m=c?vb2M# [#״:W =c5t\q7BYyʽ"tYw/ż#/l1m]w+Vb6Sc_ObeM9)G5Ϗv6]57s=E>K\&W?.gF8_r3I8 _ey ]X<+]|c>bayl~#E_]ic43&Q=nFK,k{5+~g˜>smjPZָȫ jY2vM_j>Im.A?ے|ܢgѡ;Gyk<6@5 |Ȫo.=fzژԭ4ѝ: vj\Sc;]75&Ϯ)˜Yq`5 [=z{Wy>;8%:m9>⓺؟8.7}}g8='U.{]>/ﷰ pa5B+ 4oc9 E^9hpZɥm^s=h. v=<='#~;gsk\sRcs{ci6\1aUcئV䙖j09mi9zaݾ%W ]f<`;g_|>+_kɇ;|%<8Wo%o-k1-3{}!~ONs}zxi)#›?ݳ<.D_]z%rOss[Ü^2G>}/j^֏ýpq^,ʁr(ʁty=R8{/@9Pp^8{/@9P@9P@9P@9P@9P@9Pk@^76Z9>2_wI]l-F ?>_KL߁"Gcͽ=<ܓ+D1Gڃ{ijjϞ}66'̯8챏\#26.z[Zr|-o0%m zN1r]CCsAnr87V.SF]6srVww|z{^WV9q3';ʀҗsi]k?ͅwpb'1(Ox3&bdyw9=cy;f>BgK!=:?̓#0G=yBֳ=uŘq {ػ=}g.%s`#}2oK.y[bb|oum d/L_979Ky?ʙǜCo&63NIO.iAO\; L z[r9t'VæaWr=VL3.G0;̛2M?iKn~<p{¹UguԶ S;[A<0&[zXű#~s"?R*b0N䕳g{+?s3[3ǩtLu'oʛ+w;{l^/x g#|dž ޓ'ϖVƶ'&CĒ9v?([im!zNymgqacy]_!mq/p[g9{l*3lĠ)yYyx6?_:uǘ7?>meX9x|̙^y|B%x2Yb>u쵇3̪X_ţ~ƒ5W=wP'X#1^xGm\tg VƬ!fn2Yol'rU\iigq"~odztgLm:{s{< M916ؓka_^b8&Ę;w>8lsRgd)ZƢ,s[wO /lh>ek~d'.yNĴǦ\x1{r)gr| c3kEk'>=|aRge<7s=+lr8ޛ lbYx,c覭Am3,}Bƶ: %΍+[!c=[bؽ#,c+GOƹw6m]m>X7^8Aĺ>;fNy_b?Mo g+}NJWc|}Z }?㢟q1^c<6msݣ_QO/ghA//+Y*D޽.#2ԧ߻##Hi;gk[݃V6M frp/q.ux6y=y-eI#0OL.{>qg\1kbc[Ʊ<k968\)̽7%לkD{`>f%R>_yloG0_m||r̭<f'6p%OҼ3.@mȉ i+הi9 Ϸym/gI'*e/3^w-y?p}**lyw=:] \[f%ؽRb,;9dt 8O|ř|>Q|c1}抜!<g!Oc>#k=Q~*''/3CW9)әmd^?y=:*{yMiشe.[s\ϜN?JlbJJ}}ќ^Ngmb.ٟwy=_9ys9egСsZa0h99;m9ǟm<{ֵ~GbN3b17$7kl{06爃iSW č:n͓9m=1qy%Fdo6Cç'Ɠ1`Hyzsm{0&MyՕ+\Ș-W_N<><1̯&xWj8G|/369q!C#gW;Ė{p_2gǺ~0oKCZbY yV˽roݓ=3i7ry65׼]UȜs'.Ú?m{߬RgeiX8wͻ&pb>@X~r|`'ê?w?1<'.vt;RglҲy9GOXg_D챕k>l''ST2mٳrBi܌]?v1[p!]]xj c?'ğ?٬\)=y9M}ғyFxӏKD79i3<9'c :RYb]6ȽkΖʴ߾C(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁW_}OsPʁn}龔S9{6_K@%r`zS<^ߞvOˁr@/Br877r8;|'7=9|H>|(^n~߽_%έKw7|Ny[[9wb s^{]g<z_>rz~\yW,@׻/R=K^/,{y{s=+ʁ{|:1>>2:kK@>e|ri>;ߙ<_9?12w~oG7?c,]l}.GH|_9iNʁr9zz:Z8Yq)k\ V4֬YgyYjF>Ԓ)Q̞Mc_nMsFg#[>x__s5rxxOb1c(j+XLݎȵys[WֶO sq1u#gs ^wk\֙Gk0-sa}ڬa 6vA=K1iSJ6_{*ʁrq`OH֬p %Yexs='ָPcfm~Z7o\ոMly82ܹ<5?(^28֩|<}߻fNisָ?7תq7g.!?a^.ϳהӽkLp`M Ky^΍14=4$uڟ>ANcr[͙{jTۻĐO9{5}sڜ9;6jU+7oUnO@㏇O??ѧM<8yFm^؃?|0?L/8yK\yV}ފ\g&`@xNoQANv95G4[#j:}k9k>ԁѓkRmj?=jE#ϴ ~ڔaL֊`WޜY㱎mcy$NdmM[9o՘'ci`Ǯ?S)ǚx>OE;Vgjuv|f-tn3b7cK]k1fb}ecօMyqeoIug3v|??݃rz;7J7S7{j۪^aZ96ϭq8mTu1ukY ʛh : b5.'7Aٌ;F(z۩w*/]>N6}9p9ok wp4j55uڬ;յ6VK;cѦ\/wKz^oϚ(r^YY[o0q2j0z(!k(j\I[z~J}ɳug.fYŲ!v?eBL s~יY/{Xas3;lXť6]Cn!({zOSڼŁ{㩕h)6)j\ZfPڷO֊zۨŭ۬i]g>kKmgvM[{go^ϺPl֐@\{nո2{m֍ 2:~;^r87NoࢵjͿJ]k5z2g~y6āC\`̹m hk{;c9u!بm>SiƁ˟Eger4%GaS'S1tz86p;?ǬDY:9{g#YD~2</3`#!\5|gbO6ꙩ{Rɼ'NFTSYZicw֚sYsmlQ#bD}st6i3{81qyY>.={瞍z׿53eYWky>?oZ+?ųx́ێOOS949lb[`헃޻^{@sǸ<.mr6Ҹsp9z|}ߵE_~og=1<~sW^֘}|F+3b5==g*ˁ8v]ßYRB5]^ ?}[5. n?5;oʃ{xW_k>wN>U.c(v~.f`Z֗~ʼ*0xM[g{~{èz17Bs!OO{}hLW^\w]Vs;u% u)uu!u{enfe5nU=ћ+39;:O}7׎j+O͓ƿ/^&VsuV պE._s\kRlָԷ[˲ω {ίָ食Ios/[㶚ʕr(ʁǁokgԏ,>eg7jeֲY+Oy@(_HGʱr(n9:ZڐR/RRR Rk2Śc!O-cXtenrԦf~Y".h9vm[O}MN7.*Vߪʕ{@9PVs5.yԐ֋s)jOjV?{E&kܭ=5Żj{~~J9POjq>gZ|&h59 v8K\Po}K=鋟+8)G:>/VŖZrXsOˣr(^_Fzr9Ŵ(np~o\s@sú.mqxsr9|zN>UW8W$x㟆WUʁ@IJ,ʁɁrbrU8W_=g~E*@9pU\1̭wʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(ʁr(>lÜ{S{4{ꫯec>x?5_?m駟e[&{fS̞53:O駟f" 좇n5qKO9Foy?svt"┲IfE]|uy=?j:{Oa=eÏ-><M?+eO_=/k+Xx`{b#/b3>U`'|纘e #1޽J{Fϼ ߳`oq?__crgGr}Gy7 tͳnaT<9މB &Xˁsx̍%$#sxyV$uct[An0?_|^=:G͝g=S9t31uxoᆬ8^~'r̚gًAƆ} uF[yn1B>7ue&nmzbK6NA󌿩DjrόѺ6}M?F"91&=hi'ϰ~}cBߊ_ٸ|`3gCgMLYw?x>_[<[-[٭{zlO s%졁y֍vfKr6鷰a^d}țS31eD3>?1' OȃkѸ2#mpOC\ck8wry^裥ϰ0Ge/o9C$ʵ;gE/Myaž:qwF9J RSU޺$#svhӘ߸h} sfZr5q0O.y[l[s/[:ōC_zx:w3YL=b^l43vCCG qQl3is 7u{&1?8vGK;~>3%g~yf=7y/9Ǽ7駘3Ζ-ϙ}ً#~|=gb{9|a?;>[ yOy՟60,nm lY'i $6b[CrOuMq).r<˟kw9tRbWʳ=wڞycN$'SW 9ryT'[[~ui'zP7Fu\~.{V'M{^ Ils??Цv:8/gmziS/~V^-pÎ6r/{%/%^g~zx6Ϡ鼲G5m(~fY=y5Eмtmؠ^̛3XLR='m!4|yd}&NoyqrhdW] 4cIOrWb-sO%߯óc%nؑG3{i#`>?5r{ib}O^}Y3뿼GFrk97g}WbygWeg=pdm-5xיӮs>X[9ySW}A| =#>8=cy][[:a9{XbrVvs/cya c09όw}MXݓN99i {h3S⪽ʁmx󮑣f!/W\}Ȝ=VV̴nأr#r3ֆp8\dm%?u0v]B6_˙3sa{&ih}7m{h칍299M;4eϰH1F'w6ܑ_;3黜S93Mumg>y~G^ǹ/dХ_1pݲs_K?OE m$VO'Cw7?d9sy)g2N)Oy{u߮mKq.eyX~-ysYNo _rEnDGΣ{˿iܟ"֟ zZ5)kGkzP={y<zk.WqхgD'cpϸ Gi`9[x?:鱑r Ok,Uum5t{ =g+e책g,orߊ랯O% /Ox.^ iǸ9澼wb~:g?YK]N{9?}g=gsy(@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P|?g{_$$If!vh5U555v55X#vU#v#v#vv#v#vX:V l4n  t<0      )v)v,5 5G5555mf4p<yt;Zkd`$$Ifl4      nֈ< D%* G m  t<0      44 laf4p<yt;Z$$If!vh5U555v55X#vU#v#v#vv#v#vX:V l t0      5 5G5555myt;Z$$If!vh5U555v55X#vU#v#v#vv#v#vX:V l t0      5 5G5555myt;Z$$If!vh5U555v55X#vU#v#v#vv#v#vX:V l t0      5 5G5555myt;Z$$If!vh5U555v55X#vU#v#v#vv#v#vX:V l t0      5 5G5555myt;Z$$If!vh5U555v55X#vU#v#v#vv#v#vX:V l t0      5 5G5555myt;Z$$If!vh555*55*5#v#v#v*#v#v*#v:V l4n  t<0      )v)v,555*55*5f4p<yt;Zkdi$$Ifl4      nֈ!$*  * *  t<0      44 laf4p<yt;Z$$If!vh555*55*5#v#v#v*#v#v*#v:V l t0      555*55*5yt;Z$$If!vh555*55*5#v#v#v*#v#v*#v:V l t0      555*55*5yt;Z$$If!vh555*55*5#v#v#v*#v#v*#v:V l t0      555*55*5yt;Z$$If!vh555*55*5#v#v#v*#v#v*#v:V l t0      555*55*5yt;Z$$If!vh555*55*5#v#v#v*#v#v*#v:V l t0      555*55*5yt;ZnDd V?hQp  s >A?Picture 5""mowh.$FdSmq@=mowh.$FdSx5(mx읽rI^Ѻz1H=9)h(BOCn?C~2~۔݆7SS9ypVFdUrWuw?pw?]kw_m6|/oXӷ?Ow_5ӷ?O]j@q ā8@q ā8@q ā8@q ā8@q ā8@q ā8@q ā8@q ā8@q ā8@q ā8@q ā8@q ā8@q ā8@q ā8@q ā8@q ā8@q ā8@q ā8@q ā8@q ā8@q ā8@q ā8@q ā8@q ā8@q ā8@q ā8@q ā8@~O5q ā8px P98ycu|ϝW~q ā8rÇw/_,;_~~~?~w߿{ǧZ]:g31ā8@xIZ% mO??~<9ztu|q*<=@q <>}oxɘmѤ15^=ұk_~oLlynk|\o߱>cEu~SRqm|1<#^s`1׭5w_]郞?YUWq \jԆd6k/j{ЫESnuHec1~@\3x8Wb/k5\X]&rsΝ98Z^Wף۫iclZ8@P'Ԏeۆ|jѩ՘b ;PɣfTW)Չ,z9G?cn'ae읗ZE=h~pK+yX`bܹw׌5μGWgZVq ā8倚S[aq6}H껧75sb*X81/|32sßFLq=ڜĝsxqzU_r[CD9a9^]o[{ǁ8@NN6rnCSrM][qՐ362u=+50wzX롾bX]:_糱uk@q@wh0y l\M5s;ҏV'F03nΧ{Z1?^|>~{q^_41Q]Q]@q 6Ԡߣ_:NӼ7?~φ?3g[]o[{6Ɓ8@qmq`u=:u?gq ā8ztu|zv=@q āŁzq ā8myXq ā8Vף~x[CzƁ8@[GWǷgcq ā8@x[X]mg@q l9]߶wŁ8@qmq`u=:u?gq ā8ztu|zv=@q āŁjU T*P@V@tMztu|״a}[붞gq āp`u=:xzV@q \]j3#ā8@ztu|<<9ā8@VףԺgFq ā8ÁyxZsq ā8p)GWwu+oό8@q :W8@qRX]RVޞq ā8@8Vף㋧iuq ā88]ߥ֭=3@q ā8pGWO\@q āKq`u=:K[y{fā8@q<X]/չ:ǁ8@ztu|Z̈q ā8y8]_<=Osuq ā8.Ł.n@q āp`u=:xzV@q \]j3#ā8@ztu|<<9ā8@VףԺgFq ā8ÁyxZsq ā8p)GWwu+oό8@q :W8@qRX]RVޞq ā8@8Vף㋧iuq ā88]ߥ֭=3@q ā8pGW'OjU T*P@V@tMztu|״a={ywKË\˜ݧO9>6ד믿޻ҟӚ$'N͝iouNq Vף{5):: Rk΢^*KA3{n9\Oz|s2_nBkZāztu|{>ޢ?{̹ƈ1}qߟ{:6N;2|yN{F̌S)ޣ|?~p٘1췱;ONkO?~s|fm1|;'bكߵ6b9Qs2M=x*==mc6GG2O͇qX!/_c4=>hJΝ=kg 5P7bK|֋ql=s0D7's"T|&O4pϸo\̸\\3hZz{?X|ݮ\'>i9G|4Zжk5>8f-wp]jQ-@x-GWǷ.y\coƞM=M~{GT/^4=ߣfۣyi%cVc7q쵳'Mf]lN pg>{ƙ=1 =svӞy0>9Cɱ\wG:=fYgo}8gmOŧ ?y"zXxϼ[hSq q==}~npI58&X|hcALzǰc{퍃yw󘹫i͸ιa[mfɅni;ukAmٜ11\CuƱ19&.}qp͵u툡u|{;5s8bӈ5kƟ\8%>1LSM5cjkd?Rw>3c[_@ռǁ8]=ǾA3-=w^So;uqqbN}8z}GGE h>` Ϝ3fNl̡^O͉k+18Gcm|c^|8,<1XwkH9+]'zs;tT+㒟X?3 XXS⃍q}Gglb>j l&&71וZ 6~q{yqu9]?kGi۽_O_o!δq|b`loch[A;Lߣq0't߸sؼk vlf/9Fq}1/v\{愍3`?5&&mXoz ?`nPOq>b>\O,u~b#Fssh` 9ǵYm>úszr#k1=|9ou[}ms`u=:=}}m{+MT\GGO{=U|\riLozs5=:o[Cp`u=:==ʉ{on?륮KŻDeޓ^K<}kzdqp`u=:=hܜ٣S3f{eWO/m}[q8]ߵwx{FŁ8@qiX]/=oիzŁ8@Ɓm3*ā8@Oztu|i|^+ā8@6GWwmޞQq ā8@xVףoO[^q ā8q`u=:k[q ā88]_|{ߪWq ā8]zgTq ā8ƁVWq ā8pmX];=@q ā84GWߞƷU@q ākztu|׶@q āq`u=:4U@q \Vף㻶oϨ8@q <ŷzU8@q8]ߵwx{FŁ8@qiX]/=oVO>?]no6_ϲ^>|=|rm?g[8]5q_YO?k_~%-痩kqݻ{Z9⢝}t>q q`u=:8}>~78Sm|ga7ħ,8&;}wnw673>q1nb'Ƶ}sO+Q.v5ǎz8rƞqNlד11C;lv^v36˹1W=cl}Aq9]ߵpPʾ fu {8.{uط֡C'98#<^Wxbs;gjmzW|ؿgC㯮63nL5cC-F178s=6G{ykG?㓏j/ƭ7؉qmF;5ZkGk5sw\{rcc :y31< 1ō/kfŭ?f3c9gw/fYx}GWw-U1z^tM0|o1M!> Z9 qt.؁sM8s]}B1:hO~za 8\`.ԓQG#fm\ӱ!f}a\yCW.y:/rl1͋8s.\sWS/I:WjS9]S}){5ܿj ǰAb}?lw>ڃ { @SL]U;X3sN!Z<˸?emgU;r` &n[/jO5q <] ;i\jlNSG>4`ww%k'7j/z?(CjmM|q5M/?9S9]S}=j->)ux }zJlW@q`u=:8@q mGWַq ā8Vף;*P@U T~Zu|u=:Uue\3{8ݬ~f[9Yqq`u=:9+ On->kU]kP]q2X]/>֯hst^nbGMi _}_q Ɂx=kב_{\}s+k:qq ǁ8NS[筙usXsLo_q <ŹsΚ[iuU0U8uq`u=:|3ż˦rEnP;o?S;o#)>ā89][Ĺ:~=8W-ϑS}2''<rǁ8%8]%-<~=xKk\ڣ@qV9]߭y̌q ā8n Og8@qV9]߭y̌q ā8n Og8@qV9]߭y̌q ā8n Og8@qV9]߭y̌q ā8n Og8@qV9]߭y̌q ā8n Og8@qV9]߭y̌q ā8n Og8@qV9]߭y̌q ā8n Og8@qV9]߭y̌q ā8n Og8@qV9]߭y̌q ā8n OĻ~ǻ~=\f}>|5קuztu|2]>|鍫@zgװKq`u=:Sm~?{鯿zƲq=:; h`?ݻw4]mco_~ݏ4Ǝb2سr?c36$ơ̭ԭx|z\~楷˹E|:1bطy猉 ǎ|1qsJ],Ocғ[Q9? ?A@6săNspƟ8cs} 4k?c_| p664k5yg-#ve}#W\5N:y9v>r|ǗXࡁ{hGu۳G{\ՙ18sԁcFMY3b9m#di 'W X۫vO[L{TjρN{jٳ_q=O;zl2ss;=!{k~=XboƟ8\3nj*9gg  lqji~\{룟X\S?cLYKΝǴqޏ˼i9΅83n| Fuvb~nao&G\ۼ|;|ܬdzt+؜#1x/>Ʊ~1ӓh]:!ZV8]ߩ>흋u^${2=װc36u;m\u;Ō-3l\wq+9/.֔G޼ٛ﬛G?-59K>hݰCG纘9!?cA%Sm{f~G֑k3y\clV188Vztu|{iw'Wm\gb߳p`q}b"ymb{%c[iMCgȍ\SK̺X3v0/=>aNb,6cOgΛcs^sc9n^iA]6cr⻍o^bn\Ӭ<غi6q} ~=2ssu3 u֟GOOp8?s7k`@^u}O>scn?xS-EVף;'س_Os}C|\;´Ě6s*h[7);y)mOԜs}W8>Vף;⻟SOSSлמ{k<%C6G~I|P5z⿽~lSG>jJAԞw=瑭vnԣĺV{Kb|ߋMC{O_?|g/Z\M~ ?vzko1[8p]X]/_[+ā8@x*Vף{jq ā8uq`u=:~]|oZ8@qX]ξ{4ā8@Łuj@q ār`u=:;8@q \Vף֫q ā8ʁZG@q ā8p]X]/_[+ā8@x*Vף{jqR <-sOӧO2_w}U⟫VuX]{vƁS2ֻu|_c>|xدuo^^h5;Vr{<w_|w_[)nb\#.7yQm~?^\1-c=o?Opn3S-fji3=:~'ut5#-1~4zW|j>5sB+ϘN[bќ#ΛkOΗqdglO/ɬ>{A.jvOOWW:7Vף;zgDx=в&:קPhAl zM;K׵G-v Q.L 5mhAbmbW܈91[{1NLo<⿍`q`/vjøX#FlM>csF=i87gնھ$Vף{ɵ(Vv,3C]Dε#'FC-K4z/6ꯎ>`y6/1:SI.50?MV_OL1ы<[+zj:muaO×f\{k >1`ǜ8k?Z'#hZh'ZX mjo_LojKL,SbSGbǹ mlN=2ͼqŀ6r {b;38j`)slM<:kJL0s[#9'Ƽ=}AGWׯUkThucj3t6^><S;[}x/12׺3>b/zyZc=@x=TۮuŁ }}h zsyk ݪ|<{˶4K9O4e즟wfٹ8]߹֩<=@ǁ/__eGWwi=;@q ā[ztu|o#9s-G8@q1GW7CǏ_B/Ϻ{uu80[`Nãx,/v*4NMm&]S]sV8=*xat|t?wͳԌa _~W {5]}lF,1o!.|;l0S쉇=q#`⠮sގO5x(Ro|f [7ùɸ؊k1'5X=pZ}ڸW`dM7N1T7=}'` pe|?49G.jagg ?Elluƈ .ã`ax6_'m鱷a˘uvZiXȇ=9\O8g2ذcl։z_%[UVsƽ'y2s1~\9qS{b9ssgƦ~Ӄ84k,63vyM[c8^ϓ=zĥU<9Jl6ݏԂ{s8:z5l;saxP{m{|+f[>[,#'NcՅZ؈>sׄuu{eu^ x&ps}$4js#j o}vxg?b\"ƌ9Mt_u(؂{m#99X^7v,'Ŏkcnƴfypb9fiSϔ}=zģUginĕ^tc<_t: $ug^&Ξ{|\c 9Ǟ޶F\Ӗc|ZjiW#[UVӆ(=Hy&xVl6E6}g?1n~{H!z8?{b['=bO#&%ߌi]f{o_9q>F 5׼g-qi# r胿 i#f1lJ=\u`4w덽gsגTwY{9xG>jsjNɻz-OC6=ZXEb|S a6el<Ï|Y/;?zޯ;9Ʒz5Nʱ3p_Gz1Fm|8}>K^^?_"| /k?Zg=l~s8<F؜3'sGɵ^Ss򪗟>gKuuGau|G@q ā}:䀿}|N ךk\ȵ!=oq`u=:8}oZKs |k^D^o]㚇gUxg`=V>nj^߅Z35Ɖesz숷ͩ ;Fl>-|G >>s2`m4`4w,pL[?c1Ιqf,׉sm:~ըŁq`u=:4Uu-z}wV]Gso`35(猛?4ګ''vhWhvlԦXS9X#~peǜ=c@x GWkR8poMؚL-DxTKjF$6/ԉd{1Xq6T/cŪ c[73֌=flƍEcs_枩V8]߭yLАUмѠjNzZ_>~4x9S#G#{]5զ^J/>jzLC3cģo6u~qܨqOqϲ8ÁS|W@ӡkGk>~\SэĦ9CΜhhxhFl8+x^G׏k&VlpN?5驩3ypWMksX]?=s͆N?z-4Cs>K.w^{Vj^euZiGm<TɃvܻRc+ek^YR.N\GW=Ϸ{7ā8^^.a>q`u=:8@q mGWַq ā8VףqRg|q8_;g@X񭴖anVڹFv[\k[[ztu|Ο3-q9w{+5N?9Jp0Fcf#/œG؎Ol18?C_Ȟ[ztu|o ͥg[R4&}L/),qx%>FC]X=bҰSrժ^y%{W~A~|ĵ0stEǁq5kNzSvMkcѥ6uzԱ~csOG|si'ܽ%O[ztu|oͧg\.=ZVR3t3jj.QbeΟ]f G3&81yQ3%ā2;{Գ)[ޫnuأE'OesXu>hR>c?w6q5Kv d,2pjPG{`A *"MDu+Mb:=?cok-?ؚ=8tҾ{B9P<VGWw9\|y4~\TMqF级kfx+6Xn8F]J=rl?[YwR* 0:ɽwEa{cqM{dlQ=rO/>]E`;9JU/Й>ў67G9/3^ΛcCxFgyԱY/˯sx<5OX*80:2YZ?>U/[CRb{M)'. TZY1FŌ{iR3{V8 kekst(~磮Y叺>{G9Plq`zt c&xXKR':oTL Hu+vШ~E1v߁N56ڳz[bkXσ7q G]tu@9P@9X݋i|f{O{ئzYrM<԰cU/[Kヘr9B9P{s`zt/ࣞx\SU}Nz?zMޖ6eRz11l˩l"Kï`ߜu~9S8'mY8ss3kpCrxkRŽ >α=̵zZykfhl= r<Ʒ{?Ӌ?y*2#ƈN3}}Է?2;n|<3>7vXWq/ʁ*^&xl=[??%ֹGekp@ F^O1|=Y1w|&PYI]2U?Va;S{zg5G;O~n~O [ uΏʁUѽslXqo{ݧSH,ztkeXnj={sr=Ԉpκ׵u޺k[t᳕s3'IʼGelcL'Oܻз6O ~k۵-s`ztoMVw98|ً-Ưo>?WyssU3ou/s֡ճX!:ֶY/)k]2?>~?;ipSӆ]׮8΁Uѽ5[`s\Ɓ53d6kOƱAɿks t=S's~}|&ߪ?zirG>_oȏDjkRcjR/SZޚkp͜e OgďIbz=;˷ .ޢS@99z=:̝޽8ROxz-FlOO[xwyz#v+=(ף{T^4yf}rx5uʁ58z=:x w@9P@9p/^^R}ˁr(ʁrXף+qס:Y{_rxt^~/Fױ9mNˁÁY8Jc;Ŭ;c|&7ȠDwQQA׿;jݮs׹VGWWnޏms^5?WALG^9zaѡS_1F]m-PMݟ3uP܏ף+7涹}/zy5/.+,l|ƖC>5ҜN]axr(ρ{^sܭʁ[ej^tP7.˗/1gl2Ih}r(^ף+_cn[ej_wsqWKKrr/3;X,}ˁrQ8z=:GAV|i u5#s-ʁrX]_y_~6{p˼[=ep=P}ʁrƁGKʁr(ʁrxl^c?]߮o9P@9P^Pr(ny-o5Q~'gj{[3pG}^c VJf'oy&Vxwt{3?EĔ[]][^hG|71=0#fg[ל4y֓/ĈXssۿ 6sDlVߎuGO܉q1Z9>ڴ6gؘ<^NacM| l|yl: r5`g++N6pcH.9:O)z6앟77_ 4uS,׫ԣ{Z2{\ >36>,skyOi8~hp9#>u?4xֹ,)uӴ:A=X ؠK1qOW'*>93vیQ9:c}b!od1KwΓsrh?uək6bƩ/t'Μ̧8,WkkhøMG#F;} 9ujL*^V=_nq?u%Oc?4laS=6S3y:O|w?6O7EqW9Ͻ=f>LJ=cY:^Ӵc,9ǵ xGO{{=9=}Uq-ׂ=8[1|4@{ʉ9qj+'f`ydUdiĦ|1Gƈ_ы9˷_SkӸֿ6s'Sîϓʵ(2ڡOgΥSTG\KN'v\ECL!c*;{g| s^'ݳݯRm|Fd>٤vr9;L8~h]kGdOԀ]kYlx3>ǔo>뜁>Ysz7c)[vCs>[8{g.8/?!K2 GinÏv._d>ƍᙱ6gE.%w/wu!Gk[ưùAcN[ȹ17{8'Q]&¼d׽I^bgM." qϵsaׯF'}^_˥gVrMx#GS9~^\'sw_u/9Lѣܯcm(o'yQY_;ؐYy?zO|>7Aو^{k>m⋏Žlk9{ ʕ-L;{ڠ-iYЧ\bI;\_pk'sD4[s1sUѽ2ru3gSk>O dfƟq;l؜'vǦcG7b9rF`ٹv>dW#-G*J=UY dWkGs@MGbc]qz/ņ~:H;2aS{E݉8c6~} |`=q>~_Dmӣ1 ;IN')o.i9v-Wb6?c7c623sƖ?@V|&=\~<ワnq53Fdiāi{S9k'rOuZZPoݺ[iS_cLKBAo='Ā>6hy4tĄkI61=R6]Sƨ834ưtʕ3?TFN3c>c5:k|Yaq[˙7W_YYjX "V6YO ̷6CGK^?87x,l0>{e13f/zy0B4ǐ34gδڽkjkc=}F}زʚ9k|;8kO>nWآV6Odib9ŀY{9|/ 8Ĥsml׹ԛ:Rysc[[7s^S=bp ɇqqӛˢ) S7޳ngfޝ3Gg ~1kr2!o~VGWW/9`Yo bvMC-:eVf:yYX#Yc0 c4Y8FmX0Ƅ iC[ :4YvMZ_z#u']_l^@Zlǧ12-&{cuܜ^lQF{ʺ۬&ݻƁm{T9p,M/kuzzzהs}6%nkqzٜd]m}{Kl joQUsoߔ9z=:r8ך(ʁr(ȁq͋{U9P@9P9z=:r8ך(ʁr(ȁq͋{U9P@9P9z=:r8ך(ʁr(ȁq͋{U9P@9P9z=:r8ךx]̿ 񜿯ܿz7wu_wm4ZX]_]_ _ >j/٩?jwr9z=:>LK9ywd~\hP1~kԅ;>q9I+vϜ6??} F4>4lL1dqOž:c#c0ƌDzח6+p?re\ Ycqطcc,}1eN[^gjX)~?y;u??0=[bWzԵFޡڂq kj>4k6A>^цy@gGWlޜG}|O"be͎k{m;=h΋_|ŵ!~r.rM3/>bplmW_?hkz=z+>Uws-o]<æ>_ruobrcr-\bfXӶubud#820t^O#صK<+GN ~Ӿq8 qkӏ]M9]ڛ>b&Ǹ;K$&sูa>1zא$e>UG>9pٙH [FmscicGWn`C;kc{`Sŀ.x~RkW?4BG_;zqlU~{q?c|F{{-,r4Ho7[ѷ|݋;sdxNs_ͽ7)Ccôg>ƾX:{]i3l3ŋ.s71j_:iߞ7v͘3w\8[rZ̙f,Gs9b?yIn(+rfknw)u>9|mq`ٙHe9?+}\~ꀙi yyRN,wq}{rkt2v8s9`3'^샙 %y=}y9~+>s%?mf97{x]+9N~hm~?Oŭ[sV|lp} }?湋^ދog־ƞ99M0bWb@X~9kmrދ؍9mh sgvw1eN\Ή5ȹ̑9ݭ37>7ӧ\rrgf=hr22g~X!$rt.mhx kH !|oٿE?bW{;9UN9E+lXy*nzsL?ciqgNƩ\w}99fx̋p͌\j#5r37纙#p^{ާ/^ǭzsw+>ϳϽޓ X=ض{8=_s_7N|)od޽Z?hC9O9?y#z<Ieވ< b!&ýs"Wy:8n<0aLJe/\rV?c2yci5租:}(7Z>ΑSm^G5#֣o͋[q`AON봑8&FϜ=cY]p}n̝5sn g{K1}r}W~sym>#`3G_sFgz[V|!H`u_xz3:5k2NT 1qy%6er=du!că󜳶56zcصOdY;bǟ:"\Ŏ:Sbuy1;qVCn/fmL$0Qο*=]gǞEK|Ms?}==}l:>GLIc6y|c||OR;4{g֞g>xݗp%E̥5FܪɃy־{3нf[qݭY䊼+ۭ[sV|43?ԥ_ޫ/-߁_I9﹇{J¡ԼկKs6;XO{r@9<9gs}<8+y8g:uZ['R<+x$Fm2| `qyq1sOye3Nց`X3Nug l>s`.Ā\u]ԓ4aGrsa&^گwtM&@9P\c'l,欥ea~.3V}z0| 'uk]f8uC#>Dzߚ\,[7֧Zbi\ 29[>*gͥo^>s|u̼d✶]:s|-uLĐy-rk>Osg>S8'ris+W)ʁr`Mx>fZs1^k\Yxr^;cӆXrpe5qubƲf@_[~ߪoŶ7o\Yeܡ?u8c&5c5&8q=q-Q9L̥>`^rLlYc|h5e/buu3^d :;%{F {#k.^k9u麔@9pBk[7Y(KUxz9ʵuv<'•u ,bM[~٬Mr{vCy1l9+5 s3i5%V|[Of-kt4Gf\"g,uf{b>mL5=ģ Ə9yKB,%76u\7b׾3؛ѮkN%l5j}?n~r(dg5Sqvr3vϵXgWeA>rƃړy|ozuX~r,ygMΖ|8O̳>16OMik6xW NXWeyѮy޵|Oq53vŸ63X-YsNN*^qWKP_ee;V_,|<̕*g>\r/ɼyp퍇|1ǼK1 y6}o\zK}lsb7O0\tr>BrOSzLulyεV^Y؜z&m\[/QC@9P@9P5V0r(ʁr(ʁ{qL5虰kj{A9P@9Poˁ3ՠgZ-(ʁr(Ł3ՠgz@9Pʁ? |?S z&+m1t)ʁr8#O{KpL5虰q*枫@9P<.˫[zי~85+zSƐiw꧿_"Fc~‡1矟~ᇋ11Vh!d3"ømrܧ#{zm_~?? >;mj3a-w9.ʁr8516cr|>fSޚ1jʩI˗_{p {> YKj{/7^~~g>|߽W/ce&b 9yIuWNT ֫vhrx$X]_Q?Z5&5l2S߹[Z'g݈Ϙ139쨏.޲6?zSeÇ&Dz^fښF|-fݭ߫T k{6q9P9`=Iχz<:̬15=:~2Y,h`]Ii֩cKjae;_^-ߨ帶fn_0F퉞?rֺ#Mښ4]m0?uuy7X!W/3, ֤B䱛 ]k1l> 9i}3ՠgZޗo[mzz:l=%sso\OQc:){o&52u/=[6d;~۳|=Eu9.ʁe05{ʬwy-yKԛXsr >ObyZ<ޙj3a}44@9P1=3L5虰xu״kZ@9PT k9zm.r(ʁrxO}K+{gs7v#GsoK,O9x-?ܿnz߳5G[c`[e z5ϵx^k^7oͫV);^=bGr=#yuzn>[נ/YX{F` ߾&w]p.^^ƿHMcw{/Q1S×52kqR6'`q1od5fM\ |pbNŨ1INhw+Wȡc؞C[YX#f8!y< r<3NLğm>w`bn/K׸ Vޚ̘:bچclx3Ayh۶\7sƌM{Ms8ZQs̽}q>ʾ~sn~^_٣cOӆ3CF3=<\sg|:|gL]L` pΉω{h{j[s* 4'b;͵qޘZo&v.>t5" LG=Xe1|qLYŇ:H>c1o&֠+(V8Ip^LY~r[yrO/۔{ hA9}d1rȍ9 7Cf ;\_m؃C9'XYgy8Ħ|fm .zbZʙ3zbtkƸSe.GfAriޣsĆ>x\yf^5sycGhܐ;S(>Yags[7ķwN{Fbxψ\5\cKS<|ٜ][3w4fg7Gt:Vbg٨ k~gC:LMޫc.8˰CCO2qM:s24Gq=ekl٭%8zbM97{quݚX\r}-^0"75)C&9i܋ɹ >+4d8E?qiK_-3'ylٴ2>e޹ħ/ǐO\ӌ%>gl#)-<, l, `Ϛ=[o>%NVG-Un_dčț5`lU\cub@^nsЁmpMsq3twk?ޙqL\鳺Z7G,ʁ9r|nf95>iOs}b3 flڜ:xSFgyp h3Fi:j0h[Yѫobs3ov>wӮ2s];mZё~+S!sVur-Gɿ[sBV3g#::?zf\>m+F0G12sx3gL Lrra[b, ʹZ[p!睡-s6A1zlC7s rꢝk'kѣoއQx]Ort)GÜYO};s=93q 'G][D~dz}D ~ p^&X8IAG:곸[7',ʁ9r6g{bnZ~~]1togGo7azibztiUwƭx~-ٰ>ߋG;&%_}V6f^/Yg&G=&G6!;iK?N=k-ۧa}]ۻ}oɗ%ݔGWgѸou?S/\9=iìg-6S\{=jol[]t-gsb>CXr/V~0FO!SsAa+ć)G1d(s8‹ES3ocg\v S.ER\}bQ1 mD^qq0y>:\f_?A{R3 v.Ҟ:uG0}: 3RC_[C\sy`bߘlj>k-김ͭO\~XBK#mO]3}xbJcGsGؾUQW=sF,%&xΤޔMN0z:ы [kF D}GG\rƧ~%7գ9|ưO{SdV'K-}>`]=VK!feggO6ƁZ_ƕAq' mlJ|i#mN]uObĕ}l٥𓹭sޫOk0௱(A.??s=mu{bdL~8d#ԕ}񃂜3kK\G?p:'&9>G_1:46sЧ_[';R2 RoC<#㷜=q.Ȉ=M{??٪ͭgmc|Gur#c)|ƙcc`ѻq5Ϙ`v}{ʑkK}M{.nqQwe=9/~ѵ?3n59ߢ(VK˱+2J|.wY\{glV_ m>Bc=C/E)9e߱>ku9?Sg5|O[E?|g>cwu>5~g?>f31^x9 㴝6els>ykpK'vU1ϧ28i]ìjGUqNFbqrbLV^>f_;l[qO󴑸3~W=Υo0ylN9-.;M|t6}g|k1Z&9G|}]|1b|U-dZ>99{`yQGW= krDyqyg(|bǞ?xO^e=mnkY}:w6=˘0;c`J8>m粞kA_ÖmdWf-GgI b kCaVG=c#1:\vļ\Ƨ~d(:ԛ1ԹGy^3>M5!{1Nr:㸇s^~繒q=r1ܟƔOۺb5md?ͣSXڗ`z",2O[{57C0ح͵Sv?=Tֳ=u>ύvXZwOo9+&F|W}4}/<{vbeohs6{ } s[<_) kmkBy>p3`+Srύ-E /K@ι[|Ss1OZcҙXr mL'Vo5,F)cQ{sol%h?Ϙk}F1]b&W˛K2YiSs (anaLԓ>1=lDu;4&cU3OQ}m6z;:g[,b6goq.8]q;#>QgrA1u2N1oK=]c\-Ћy-VژE>v*>Yԋi*s|b Δ~lTnuÉ6h{nOVP;,u/Ǝ"j 1%61٪;*9=z}1\_|n2ov 5{l,Li ;ã>>0GQ|6j>ktĄx5og,sǘ}u:7ԥk|cԕkCvR'|Cvle93gK_^7sꤝ6gL9A E]OA΂DpFqB[@=iͺ=o5H2E'\'6G1OC.A|aXb֞5c-vbĘڽ~{68-aϏxZel؋*&~]cj v(Ol^W=mSdWrkjg z*qGN{SQ~=Ӟ:-{j\Xy}2`|qF8d1~$}{t~ck+?}nYΜ;_5&#`ugݫ3_::%zb(G#w/{lr:r rt7&3`xϤH 9۹c7flqL|oy'1?}6w|$W >ޓ|t컡|{{|3h@9Pρ+Wڳg{=.ʁr6~om7^וr+a-_Ƶq-ʁr98 oG?wocoq^ 3r>9V90w)mV s;dt9<:ww̐gNzr,A\?naWEĢt:: c Qyl 7m~3yJXo8@9p/7ACμΜ3'y/zKQ';сNO֘zN&sY^SC=[>#wכ/ 2`QGRz%G=qc\/g8y_ċB897gEyl^ W9/>%s`[/{lRR® iw<:V>3n^:d)Sf<;aWA\~.7y9P 72sBgnF.Hg>:93>~ټ;ss3}k3Wz;m *0b +F]`w'=zo+W{T]wƺ(w|2/|I?'͟? Rz%Gb_bssߡov{r9p(V_L>`amFp1XMl)ǻ**#wOf?}&'ٷ=/g0"iYƘ}z_ɸEL\W'cIM#~&$[:c Y%_|ܗn{?Fֽą|9J&M[Qz}ū]7̻vfn;s[}@n ԉ%noMhg\RX,j)sg +yd;g>% q35MKQA _eX3iym:}a{ul;C+sM[Q0EL[N>sGyF^i>"y1{9~!qmͿ'˙˗3FJj1vcEcQ\`n}q{w ca+ƪЁ.տzuԬKf?eP{ў~Lb Y})r :?}sOgiqoxMI9t1cmYx48pK{{ V >+>UxO2PXUqMG;q#p :VuMf?0~2}M:J1m1d3s5't8־YaEr5 5<^lb1s-[X&;)Uas'ƴngi@U<bƩslo>Sֽyx}ܠ*ˁ[rЏ-X70;ds })ޙ||RW1{Q|Ðv7~f6Y31(kc66 {V3q'|Աä>䉱>O, bx8 Ǩglsv2)kᵾ2avMc[+<)[|w{*?gvFgT7r܅F?w9]N޺C~%&Vڌ.L,⏅yc'zq%洛OLĔ5`tL_E?{r&1CuSi_bvO68œsћ2> x:^18qȚ~u>i ~$϶}{K&0#o}\}*9pKѱ+t>+!Gy=ƽC)^#p݋uo|jǯؚÇfKg߃;ogb{:޳9(*_owKmOSnA?:G YVwg˗ֽΓveޫn'|mΖ/v^_{e#gobO-/{2ո VX?[|tȣ,{kˏ}s/+3;⽗/yYo|r8V9{ɕGyc3?Uߋ_sk̻[JM|x\;#_O(gmf\?W8>w 3ε(ʁr(s/|J}i8̗ȫrAf3~梬cMf̭2ԑqa{%ce3Ϣ?ȩ=8F=&}'Ot:v@9P@9 01ҧ{e)j'sM= 5SFY̗/?}9ۚ-AM#w ke? YqR}"vºrruP@90_9q07{1Sɫ6'Vr3;+̗\CNʼטo| q6unbc蛱ۛiK{{1n>Kˁr(ʁr0יyw+97C8򱽜bY\16u|\9vk{ޕ-elR;ƃY?gVU2_g.IGc+zZk}|_pL?tu@9P@9,0י99uI֕9Y^__yonNx-a΂N9F[f1tæW"gFueSz7uX#ޤO)dn5Xٺr(ʁr}e8^ϫu&g&Od9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P@9P\?Ơ(ʁr(ʁr9p<\kqi9P@9P+W?lqk[}>}T{o3 oG/+]g>#\\)U;1r([rmqm+G_/_"7˗e,v5?zh|N,_xo~/MO|mlˁrx'W;~{"}wzvo7Hzʹ-g3JJ~2-k?͗ѓy/gͱ3;Q,-o;G_Wݝ$//s?3ދ=C ؏b%g]\.}}z~9u5˹q0Iٶ(ʁrx܁̗Ww= g bQ<䫞Ùfrj}˗ż{)vxMvZP@9Le>S,s9n.x/_Y͇ѓyρ}xsc([{܇2s:?3vK|+Dn٣xf)泾 7 ﷙g&Guݙ].1F?Gr(ʁGqG2ﵼSO3~--96j-XM99Ϋ9KS#94sH|FUlπr(ʁq;wK|y C\[rЏ̭XwxVW9/LTg(ʁr(ʁsrJ9蕰{R@9PrJ9蕰޺-ʁr(ʁrRz%9}龔@9PRz%C{vˁr(ʁr8'^ k~Nw_/@9P@9p+^ Pr(ʁr(Ɂ+WZݗK9P@9Pʁ+Wz>Tg(ʁr(ʁsrJ9ٱ_޲o)UݧWCkl gk06W[p9hx%s~Wt_ʁr(ʁr{E~K}s?{358_g~x?Tu^9Pg֝8/*w3cĐ>=w8#|ŷ-l}Xg< m\.mϥm|ss3)WZ @9Y9wj`ީ~%믿^dھ{}Y]L8w|WA[=u˜,-2[~+g(ʁrY8]띚>e~xsѦg|_~]5Fĥhz}85e#g|駟^dzMsZ}2WEʷ~,wƷ(ʁq ̃睚}JR{Uuyq>^\}Og(̗9Oy./[߲|~O̖@9P|&ÚR{8W#yɓ)gy}}3hz8|s&FlˮA?gg|ͽk.ʁr|5_f;7]as\V=>Nܣ|h3z :Wm M|AQy|v4=b|sz?T[޽˶?slu Gs3Q޸=)ʁrȗů<;ggؿ+a=Cg})ʁȁyJX̉b3(ʁr(ʁ9pJX˱9X4@9P@9pe\)+sL;3SMXs%iM9}}Rz+:Gq^Mr::ڹ^):j9|`ng_Yű笑똛cu3s\=)kyN9xꤝ9?طF1ڟbԩelS5YkϹ\G?qֹZ;Σcuwzvb܏kv,07;G^ǴoY+㎥]Oʫcڴ?wcZ]SkC:OUO^Fme6u{M>eՕ77KJߴZׇąL?A9p;gQ F *տs2'6~;.jc:ywRuطe9m;k9ֻfw0| z(sgς~j:ű?}7~n\Sd~ʨxf_ [{ě:-cpĸwuQ{Vj-v`/ch}W`xscZpeg1@^8.<2bLhV\Wma?1w|iϽg؋ז-y|Su7F|! m>gcĉ|ܖش=c.6'䃶 x6 No11;#G/#o!#̻gY<5q3m[V=kI'Fրy ?̋y Pmǽ;Ӵ͸23m>7O &e¸8vL+߉1ر/_dV?qξ:{ԋqI0ƞ8kqGWذ3 xv)8K/f9D"p~+iaأIJ\qL_%FuїX#e kЧ!}gic/W?>؞rj,;  ꤭B}cDY ksF_}έYo{j⩌Kkǖ`\Ba\T;vmϛu9{k>l8.+>oWOe*tPȹ(\M5Efڡ9- HOG7k o'ri8P' cџ&n%6jf~%\^lzf~^ 潱/11>杌NlGn k#jiI.02]0jȹvKٹ{E3>Mݩ5U3u91ߋOe'8vPO_֥Ɍ5Xй:+[/@Gg|mC;izA??&Mm2os?YmljǹyM⑾30岿%u㌦qz͸$8Ǯx~gC9|P^`}Cl: k@xw>|ð7^qays8b rյ21e^զƋ dǥ22k8\{#|z쮧u^jn;^b͗y$wc,̻GLr}ոs:kT=y F0ێE/ ؃|ל/bõD| ȱFD4up`kk#r-VϺps x^p8S|s*y -'_Շ~9<+}q/rZ?7~bW_|_䑥;ħ?mT_ƌ>2n\v_Α'ѭ6v| SEDڸs`A;隈|8c=pM!{s +bv7Q_l~Nqb7>h&Mj[z#Z5:F|pYc߱;NL' kly_[ }ss_a&={L|/ `/o zG;N+1pV9#OæsS0duľbSK]~q_r`m Zu^ókug\3C2_ur8-0b}|XȗywN^5:ȒC1szi^<ùؑŶy̫cqpjOuxȣgc|j @a*W\o$dx?Fo}I9} gOޝ=2B>.Ula껏Э|v<{޽W$f^G|S7xG^pV(p_cNq+W T3W=}=_Ͼ NvgI?[Xx=#x~:rw Lz|2,~]q8.+1wkUV5|ig}c !㳽Zr{ksq}{9t*ϝ;c.8rrQ۝p8d^7}gkc-¹SjάW퉯pxȽr+V)|X'w#=?C{ѳŶ>U}V9mq.>iZO|׼7s鞚Gj826a }TNNIg|Vg^/co7؞ʡz{t|N{)e>L`ٗg{su52I:Y6x5QroQV;< ?}&~yu9=np~psϓ^:|k0p܏#5?Cj 계y_e#}F25X9?8K4ƻG.c cΟ~U8SǕնȪy{S}3N~Ě״?s|>iy-g޽8foac#ןUa9<j:{,|k3?+9ל*pyYsg c|Avo؜>a:|\;G-L#ڈcֵ?s܇pbq^kmsZ ngI}NZ:7gvų0 {G~ޔlnoƳgc֏uv5'sk}b&jwCS csϜl&Wƫܵg{֜g@8ȁרkGC0g>:n=7/?p p p p p p p p p p p p p p p p x7'@2 $@2 $[f MߋWm?Vr@8#pvr^,{+_;r{ OȬI򚼆@8<+]`y|'g +?kU8@8 Cxow|Rp׺n}V87 p9ÇS9r?4{ͽ5/?=oh Ȅ@8sp`w={ݲb+[8@8\{ZڼDo=I%]?pY9@]ruk;jr߭ p{Ш <p 9`mroMr@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8@8pwK%@2 $@2 $7dחS`kp=U򞼇@8 {@8@8ÁjБ9yOÁp p`kTuup p H5O.n/_O8͛7/4mf箏Z,?ïBZ[k~["ęk+G_#֠s9;*VjuVXA򳅝5X݋YֳKzq3yügj5Tu~T;`y1.^tc~PߊQ槾q"CSl1h!Wg6s_˼:csvX e+r{^FKdk,9SOP7K99|TkB\3?jkNbWXG̞'Q"^{=қ/ Ŏs]Wֽ辪8?o>`q358eLoϭs1'c^[=ٟO6䴏_<3b/UΫ ^S&Ԡk=^.gjg9>zUmkh/=yQuuX.\A\Wb7j| 0zfjsƠOztkLڪ3c\6sŋnkbW{]9y3^w]aα99Vp?cKd*vm墳`^979kl]:U}k,|9Ы`~.׳T|3v)tfnu[1}4cb2LL}}i^kLڢnwWkڜK r3t]X \Odks1=j& ʉXĺu%s26ܳS{\3MR5׳RQ޵~?6zb3< #ףk?<8Fԙ/X;Tzg |p]R/F٣_[\cks%6,  9ss[ΩCoFڨ:Y _>ۜ6I+7~mx^2'FQ;]*ng `g?sՆ'+zv̌\dž~dȢCÎkž5ؖ+##! >œksm᤼6|Zť\\2%9yf\1=Oɣ5OL\:1oϭs3'c^`yCӯɁ5kbXkkퟓlp"匏{}fs1Qp]LdN;bǟC,5'ȁC;|;>Ǹa93l9;D=8׮=qKq5#ׂu\ Kse>1kZ193m|6s~"Vsmsvy{R[̑[>kqyۈXj{tzUoÒ9R|zu 9r95E^?5A l9[K||^RKֽܻغU׳8Xlu?LwuԜU([{wpp~x-vp-vŃgԹ u{%%_Sk|ə2\Zj[1r-ukc]ʩK <39ԯ"5Ϝs/_iXgksZXk]OwmV:ggHk4Λ@9 S^~m~$KDv5Ze#ՠ#a}F.%朡@8@8 #r%1 p gH5HXK9gh8@8<"FAG\IL9Áp p90R :gRb@8ȁj)o:Hd Hd 4K5T HXQp p H5HXmy|&@8@8FAGºzoΒp p H5HXmy|&@8@8FAGºzoΒp p H5HXmy|&@8@8FAGºzoΒp p H5HXmy|&@8@8FAGºzoΒp p H5HXmy|&@8@8FAGºzoΒp p H5HXmy|&@8@8FArAZ^ek}֩S?ݻwtԥk~駓M4ĵ |>z?O};4ưx79d9DÇty7=_>+S|p pq8g z)Jok=Me>r^&ebbzZZ{ڬcsRҬ{m[!6kYiiƋ<ܢ]po[}i.ތ?٘Z@8ȁ=kP1Jg{-Rzu?u^+O1/pkWޟ ?iÚ[9zgԽ~e\sNvp {֠lOdkvs~;lX![AA>Q1a1\/[د|k\?w˹5Yu8́=kK'KSc%](uUR<Ԇ[>>A,7~m,M`96wƫ ȫ6c\\+s2 p9g z)J=oCb [xթsY?Zҋ}OZn[}|^Yz⪿':>1aqq/kAi.nVWȉi*֌=Y@8سW{bVZW:oY¤24BǬl9KK9;֭d3gU6k@8A/yO}K9l9攳6w9V1.٫6/M3n _"@8{֠cO֝K-Y_gܒ:Kdz9;+r>@8ܛ{֠ƺ'V꾵Ҹ_kӹk?-s9CÁp p`kY^HX/-@8@8#ՠ#a ߏK%ؗ[h-=֌ޚwo)-{ȿZv[썦 =?Zwt$G]ڷVHguq<{O{}z&j: SgQb #q -9@}ɻΓ{H}#<|WVyUy|A#>b =6lnsz!''qks͕@#n:j5 Jkw 4q+Z3Uu/\Fs4sǽc!Cy~*8[YOH5HXnrcqu5c*!vA}9j0GSz:HĶ413.*g eХҶi,^rA^9װZ"7+m^Ƈ5~k?=5/vk=:ՔdsO^-Qc>zsvǮs_T'2?:1r0R : gN8@ bGkM:Xy8emaI 413fWzk,uֱfMgZ=e荙/sAz×8d̺R{ :"o~+[cuݰ-.]^hlc]{է2>`t$55 uyu?6nkt:ЎxjoC.5Pױ^?}㸯w;N~{^b'Įqs{|>q\׈r_ rkOX;vٓ/_ȃq}3=qS Ʀo?_^;#ՠ#a}uﭬQ(-' uuʵyfEZUo^v#NtAfU`>7>k-͎ŵwCXk8ZNFAGzuŬQ8@;Uj|o&˗謱 ͺuo<^FO M }X/k)={η2=0{ڭq`KkZ/>[Y1R :y>'{8plPP3nQOacf(9!̭?%ϣ1R :Q?8'E8@8Lq`t$SfIY56[|_y&~㞉{p xD,ՠGy +?Fx:Z}^/yc>yV{>2b^:1Ѱ}{^O5y*pw,bMیsos5&q=묥zX38::uS;u:Omл;4jk}#ٸͥ2unjՓcϹ~ni?K,D{csk}D.uC8H|)Vμ5&:KmsyYou*eyF񩺓yamj tPu5̔:b'WZ{qc.&qz5^Y[՜Y9[C;sR1gQ uM>'FזUk{rLsm]{T=ǰQ3WmsrobuYc%Hc 9󌝮$9 G%5ޱ/avz}³>ۯo]<DZ>|yngUmþԺǚ>}k9>z|휘Ŧc¾sS"nYu&s7g/շs`WOmX3bqMDǧX<:1v]0χ50iz9nʩ::V{}|M<zZ3?#_!FosﵾUE?k]'WcKsM̳yQ?}jp99T]'[q _$ѭgܔ-Q8M#θkS?yNšljнUKX]-s]ky:^l^lrq{9ZQ>ņcȁ_sQ8G=>bQk(n|[#|ϟ~ѿ?+'}1f3=3D} sг)qxTV~}U~\M^gv=u+v7MNwdnkݓר9ku\uMͩ׏gZ[xGg]|w|Zw-wˬg3=KSim!c+ND.̋D#r=摰F]s+-4D٣^8nޫ^wHsg@8>ϔ_/ӟ.jБ. x%ykܧߟk#_8۷o_޼ysGFǏ'=qffJ7WgGAg*-g/_N.ӧϟ/֝zѶZ穵1ar|=L2k>J KGjGO]Xakfc.^zkưdzޣoc>޺L<4ƭWGњ Yg+5͹:u:6E?vzQlѐ?sU\alc|e¶8}b1nc^3yx{nȋ:w5Wgc3Ĝ\ˁ/ԉ_?Px2Ȣs#o{̼k9f;B`+uQg^~BOV͇5Nܹkkqk,j7l{k2zom r-lW|`kkR9qMxӟ0cGFN11/c;){u^YOQ7~[^/w9kOlaֻ\ջ^1<͹{~#^r%ǯݲ[cޕNO}:Kzn}?=wdjsq^V8&U^^XyR::Y(gjl^C5֕`:!M`f<)1a_ذv @FIlY=Ulj5u>֟\Z;VǍAU^*^bs{xl#c4k-0ZO5KZ:x-CkRu^]0׿ξO>;bW zM.jf{\xֱ.:e*}aZvigqe&./uTkX`cml/?%]mr=}K^Z/+|P?w5c//wؼ_'؛G{ՠĽVjnl jk+kX=f=[oQ/'k'kZC_zY䉚q1_ugCO}przZ?|ML#%{ՠKJGߑY>u֑3wx|w7;߳g5V߳e=n_09<w}׾^&v|$[jep^[/_{ՠkuv@8>~/w-26 ~Xoz>h/dt$Zep lʗn_[eo}1.ʎqx4Fw4b<"`ܯ/p'q>e\\.gfk,^?w^eKϽ3aЙtݻE?_>55xea>k+xygl^F(}zt Τk=ֺ7==H3Rn%:ΫKW?ϯ~<,Qx`ѳ:? /gw>l7ݣ߹y}*yJ;nƥoX!3ƿc8_c~Osx- <Q}!9ob~y(kcaLk +۔ϸbr0W엎>uZk3wmܱL~ hѡh?V5S\K,wDXУkos6@CaΖMAruZ V \`Fgo=Nk5 /^W}wygxa!z{0YYgUlyg]Zb8sg14q>ruYylLm!mV7lth4aQoC@9}̉c7m[)_YY'Zbg_-?9<-k5rt-gPsűؖWӗc ?>M}k#OKXzh b1x.4$h5 M֩ek]ʿ_bhԻ#πq{>#2|_~׿uQ J5]9w8nϳ1 gmԇ6b.ly^l:tu<юzsuC"cB?}O|i+c%';&?} y_!?K^/Zܵq2>Eikq9?Y^miG)qܵяyfZ:>@u1N\_y?{^M`(O+Ӛ5Vb`| ?mi|z0GpGN2ߓ3'u{5 3htxn{fLYʗ h,cE_ԉv)_g|}O^5(jtʊxǬ&\gyyk+<|ף[YKt_ic,c\Cy?qh@<>^oş6T=O˧9t@ڑ K~.$(ϾV--ʊ:2n/f)2.d. }OQkCՅ*w8@<2|wB~gчTF^{0h/g*9O/VXQqF[!X3Z9o)c0sع?bQǘgy':_ /_8Q׷oB_ԋqmv5?1.q2k}N縮~,^f~Ƴ菾-Gt0+O}}7>1X%v=AtK6{ŘDG-Rcz<6#_ ]3u9򺚮WW:#(b 9F,A{no%ΏQQk}e;tԮ+˛#P:zx(oV.cߑwF<%?6ƪ$8W`۫x[v#g:ʼ/gy;ͽ4U^]9}3/s[n=[xyܽǚ#zK<[M=[4k>b߸}㼞h+8fkkl {|p/^^qK>SZ n~fŠQWg>8VAw|RXoKF/^ytr#]/^;/|X~+X[3]\3<\tDؿ<[~~Qףm0`3_og 3zy9XZwdN8Yʬ3xg;~м/#wQ=̈́AgUV}O<ᣬ5gG<[FLc O>qM?svW3_~Q7ÇM-3_Lӏl")v=xYߢ/757؏{^3NςG+H`@?I[sGI׫}Qχ-\#dgʻXߗ`-I#^xY%1i#ϣ_kܚ.Et):b~拗嫮oK:yBe9mbhO]%~jm}^'Ѯ6408k|yɎ=Ww^gN?΄AgҵE~^-оJ;5gq\q>+spԖ?iAqX >$| ) f䙨::ҧ krh|yB۲/ Gr;qWёi{w k҈|ZX>X|Ċ`vƔ c!ot2WL-}0ȏm(Z0b>+ζ0\Q3_:k/mƵFZ}Y2 C&hWMnOƶ|Eg|$U.9wYsrGWeΘ=gIgdg9%2gϾd'אKKhkHػXg{٢F<9/v\ߣWMK% R_Kt7O>gP&#g^Gts88'b6:=[=YΟ ΤzYK٫/gkZs!-={-"^G3'ʩ(I#^2`Nyf3cKz٥s[E>[xxk| /ѨZC3es~ijeg{ϚxA'p9u=Ex9?b=g 3ZU^ _`edOc{w\OU܋8V6=go[1@Y=gMi^7>y$^gLt&]s,99 LI.Ŕ+ܻs ڽZ-rRﳒ>dY9#.y^>O[& :/gWڅe0r>sAb+||X>1/ed3#gMkw-=9F=Ogf w5wRl~f.y{Ͻً9o/.?CGw5sKKQϕK;5Yt35?Ge쮍#T;+߃ -ϿG>iW ^gKQoF1O_LQ;:?vigv0~_vb,xMM_2sk|p^w}=Qk77?=qgG֬䣳 lGu7>s=im)F?xݪ9g`#x_uot5|~IߑJƲD(#3.fi[~d/h5B?}>} x0//C^iG>{EhWo\p%!(f>z`GW|/fϻr& :%y$bތeikȃSt!}ؠ;FΌ7mΆ#h_;3>wo㮁׭9s/37'~fo4񕘗*>&?l΍ r4Q2b;b^xrx3/鹦?ځ~2'u噧k#9b?tF22 t/ yԳО7Gd>Qz^G=r^Fmf& zw] 5yLӼ6Agq4!$`y~|(ث=\;׾ڼE,sE.o1b$_F9)x>CgqkqTc_3}An42>:>0Dl?3NsERuƖy'#MlSYbhzڹymO3^Y9iLm&ȷMzdů=r/W<g𸳮r'1a2{\'Fs3͕מ69Z9WOvzq}cD#~HC#yǦHRd'ǘ>hk_/_KcNBC!X#1E <9*#ʣϼ<_ )#.-qbYh+ڡ,S&G)|LCz Ab3^~^ Zg6.G~#< o' kKg>߭Ӟs}!XY{j=zfx]wg]rLļ\+#7qcϨͷDn7W'ߜNmv3tإ7/\u}=9,rvE^KwY+F?cXOG29gW2lG^#/m?ڑ\umFLK7>uaXh3~2$s^3bbSdm[y|8s=::0#xw?~<]sNF9a3z%[|9%ct{yz~9oQe3UtK5Ka:NWo>*ooo-B|cQm?'f=1u!FIc,wzڸXN>zmn9w^:2Y'W[)++ӓ^ Zzv0?Oxd_uoqK_`V ѳgp䙹gt>2w&]Ws#®尵u,c;^}8NYR0i[zK3/eWd0.^7)V^7Dۑl[يv%We/$kUޓ3!whoo~ߗ ~ϛKg6]_~[<3s=>m/~~rQ{v;|g]f&ỽ:T?UFk ׭(,ے=*ݪ__ɝ+֎gqKGr"Xg3BaNb4p0K͵ws緿W6Y AgSU>,ެn=={-[}3aЙt{;z0>\#7^`GƉ7j{ݿ~S3чjwP,Yyo3 GC`ǝ?-!ws^g 3kC-{ϛ[xɼw~%>o(=Gk-/#|ۓ7 /{{1o][KK|9v^*{yj/}XY3sFH=I#kQsu  ?ᚚ؎LJy_=f/Yr ~Ӧ}-YYs釗EGδGgx\1.+ou|Ug0LnU óvwz>G^DW'|'^f=كG ? U{߾_`-xYŇk_'m'`EdE&O OiI,9up>PĻg*Oj\cUwϼ,75/ȉ.:8}{)δg Τz63'{Oo! >X:pO{혽L?I#Wf Yl[Z1xo|cUgXQ&lI]xX?cY7ᙟk+O!ʊmh <[9K{Qj]aoKx3#}8g& :>`Tf`e(K>̄3e~_#V-L[@|uv[ϗ +?+ m阧GĪʡwKܪ ^39Z|sBm084b~}^F&U<8;xsxGpFᾁ5l3aЙt6yqi.k= we4M]611?d>|g[[tcFlPv1|  Τbt}vY^%[=3w9˖dU>s;n4e.e/x3s#6؞rD%g*Krc:<ӗQ~O<fŽ8\֣Go# /ٷW#22f 3ׯ`Xϑ}f3g2q)3X/Q-ggW:eZc9C|N x_]&3aЙtjINs 'a/,=ߕ rXGZXOSWU|lWg+蠯uѧ43qOLt&]c,Tڽ=)x*GYk{{|sxz&ϊS@G x:}%_#鈼>D;棻 1}D~}צ~ EWT虵zQ.ֳu:Gsxy+^] 17#hģ[s\wɧp |L9|}|h+|[|e.eˏZI3 ڀ|iUnpmN^_]GN RurP"Oh8Zoљ6E_ߪ~N`kk'졬azD=s{}ٻAN\ۏ9o.:Зu/?l ?eZKs9H4Eo<ЋX~cY[]~ʅIvJ/|Q|,;-Y߮8k>)^aO_ +΁ru/WbS皹|C?[r0E}Ev%g 9yoyЎ7~g넮HQr yQCȋc\z_"9 tKv{/w=ojc+mq/{k"6cc_kOsc?#ϵ6r>O hoVcu16F|Q>|é[md]3/||%:EF=|lЯϝǸz38)C;X ؟eGZrjc#* [1;7ggG(A>62?1J~x0k>q9Z:dK^Kk,[_N=W5vReP&A&:kZS'ВNQGYq]~W?W_sy@ck_ҷA{պy5`l`RcYDd#V-CF,d3GEbs(SGԃvV%JWkNsU0m9oOݤ7>ҡcKr5{5eolɔ&(s>6PglsS8=@q{zŃ{k>2c/: gIVGzO|"Ci"=с#}Fq.>AטG~7둯_.D~ȀƹKXʓ~}\Үc]#5z5l_+ud+!',e.<*srzj)x|5Qy>6 <5aQ噷@|QZ:ku@‹B;aۜM?)O{˶CcL1kmG}}Kۏ^-(5밴W?a'q%Gcer1ރ}q|h/qMbcAtcoS:کd#ڈ7Ks,ɫ>\+eS陓s:#sdR̛}\WjKԅkW\Xz%/}~?؇=`/R:Ůss}C16BC[{jz!<,*d38 5B OO7a.OmWDNY>D~V_kc5;Pi5>0Ό-}{!Sˋ:7}6Wh۝l"&Ǯ{8?ݛGh;{(=1|yڥ6ߍ=5*a-bë0_+ |l0 }p_HGާ {6}KHƏbt^{&38&3?u2O:W|xЅky@|VѧFgٯ^\Ӹ@>'mYkbv_?(?;Ǿ[Ϋ15E}ތIKs?c0[ч?ݖ^qo^odȜ4gA5c|g;cSo+9Ys_\UȚJWq:fe"^fsLkCO?Z6B2z/bJqIJȷvWy{sUoWx)n6X׭vMkV=˞w/oS ̤jN冊Lt&]+&&Gb`& :G֢]Şߧ/C{^1[10I׏;w^F5>TAv^w*ۊoa=1`nf+=9,mci& +6׈"n/sZ̨s}X[|ρ' -ᅯMXH z!1ʐb=P;_s>t,U/MY.ydl*;FN_d]m,ECt-'cO 莾[Gl?2ܫY7O_k2昳eY~NuҦw]]c1HW?8Ǩ ೥+E wSpq&-Qmdtڏmߊ7:ˋc-q5mh?s71K>-ܟ<ϵ:|,Xs9_}h(YI>кk*Sݮy&i\Suv=!o 58G샆<%:d]Qqj7~\eRxD&s2HO[]>ЧlC՗XʚG>K+Xr=K;}5y}z 7{uuݍ1WY9XxӦ/'f-899C^<墣<􃖽Woڭ=(?1s81;&ֵgz ClZ0'yU=3]-6e,/{-]ڮ8n +-X3/^/~JK P'Ǟ:B^kƈs߲IsG?1yD5زK0>eq̵~vq|x/z+eܺ褧κ:'͉QOW裬omXC8WZku{PeY;:Ƴ>Ǫu3vYs5wt<ѯbWken)(qH 3嗟0:Qw>4s Z̭`LNk׶Q.Ƹ4Ac1oqMEн`BHdbbu1R؂\`&|eAo#]=\wW="]𡭏X[m7{#_ٴ)Ÿ@|Dd0՟^葯Ԏ1:ƹ9Rx'8W[ᜨ7VWҴz1[%=b<9>Ʃ=.ڣ+>?c|ckb6%Dw~HgBlTѧ11.=8/>#ST{-XkZ9ߢ޲ }ʔoFupvg)Zv{-Q^k>b&Ƴ菾ʵsu1=Jc\!}KtK6WE̓r[:e;u[K2\cskhs\g탆am< YW\gFl.=U=Q(EWe9O9ȇ'C 6>eU=3<ڱ6ux07騍7 j?mJ\E]wX}Olh=|ҺUzc=~%/}Qy[Iו>a죽+;k {Rc.?|dwnk>F\:^qf1/Equ{ b5Ygn^GsƼ9  w=t%|iǏ#smt<{M;Ԛ^kc,GW?9/zm(.+ϩ}Kg`gՏlْ]1EOIq}kj^z1l;YW{xlg֊gO?5q34Z- t=cUs#wwu 7C+GfKkϗ=Cױ[u#Lt&]?rL9<[^J;pmkqj=?Ϗ0LV,??󊁊+b`& :WUP1P1P1P1P1P1P1 Τkc|^>"f 3zZϏ0LV,??󊁏[i?&/΄AgҵsL|ˏK1,$+6+>N ̄AgҵCֵcc@?_]: mq謡mS˳t욖?˟Lt&]gҿr[@bl}1j^vWxU\r#f 3Z=GcccˬU-&vx~3e/`^>/9f 3z5/*'U T 9`\J˼!g_SF=>~<ĹծR1P10I[***88?_;* 31 3xgY֬b10Iwrc@U1{d)ڊ犁 ΤklyO.}RARPXWr>5+7| \sĊU/MbK ̄AgҵbK/ό5L=JV}Lt&]G|/%G} 'B hmZZˊw0L1V"vwS^jhc /wʝ1V]P1P1P1P10[ ̄AgqZZ٢8 XiӧKYyY'2+듩)gE($]}ܘs6~߇]qZl}Nv t t t t t T3qЙ|MV}er*ӘLt&\9]+'›?+'=?COrdEkk klyQ< +^8F'yϦ8LXG1$}Q8| pejy!6ŧL5C=qӃ͆?'/tBx;s-:ȣ12vV~o^>΄l笠>goWٷgl&j3g &q,p1>Ƀ88Lsz'Bg'wAvɖɉ'cơ,XWޜ L)3'3-^7k䒎٫;6o?$kG:w]ċ. k:!_`gTw_8LXnϴ|uٶ{Rp-XYȯ/<1z8ͳw,IsL[,=x̡/S6rS&{ y171gO _ҞN._vG̱9(Cx;.أY'=:΃..$_sAgh[ryX͘2~'-">8Ç1q_}#ʑɇϏش{-_-kY[tZi-3qЙϽ/z}z}_p-y"'Y|̽\Xz_L:3aj,i3qЙv]W_̺oy55=k Agº_Zo7v7ꏿUտr35ۋ><'[1>vNU3qг`N޳&/mKSu ks/Q|>u}9>Ժ츻Wg[j,Xʿm;]|~;w6u{^ ٱUwMϤ .ˎ3sbb tm`WYaKnqZE΁l0SWX)>b}}2h5vLs`O:NnbXC.qie¶8}b1nc^ج3yxknOlE;q =y;t^j t [?+(,w9-|.])Irמt'q9 .'O9;ZgC#W)]aƎ >\uanwLljܒmkϞuMg0nU L뼬hzQ㼀7 o#y$xR>rMqr|W6yRba}\3QΚrKh<ϝaU]1N<ӋEPsLk A(ܥ`ll8ً㾮3L ^teǴO<ꛗ3c A(5`Ɛ"s4*{Ļwؗhp=ۭ/9ܘ;^L<+g 7rt}޸^:Ϸ:ݒ3/wZrçz,Mu/1;нg+Ÿqh9cqe_toc~)ȍ=g޹m/+Gq=urVΈ{&y ,5YH|? G{9NI]FwV{fq1or׬=s_N {$SK Ƙg\k+呉SUǞk ɳ[ lWW68Ž<2닞w}t=Թ=.Gq=k~V 3>[{^qEe Gr% ]cK=~;[x=8 F9P/c#S䬦Y_]䋉ΉN{A>MƄ]?a\i`,Ma8+fy,~\rS73a_̽zz@kRN 5{iXr?n*= ^8s~ zzw~Lt&7]yZ^9/)ZL7očˏ5΄k15-8cry<>[lobVΘ=6o7{i>Gޭf3a}:9C<9}Őy=zkXr~-:cy9ם͚nYr[l̹jףca̚#i;lw6^@_b&o-*#}jAW[l`F\͡6oToƌڿ;DFzjalIlxk{iýʜ ,՚.񙵶u/t\kZl5WŮ9k`i]װ&suk;8eW:G=-th> ɵy6&0$&}h9ǕϸG7cj=f#q_1'M^"oA/og^׳zn]jy՛~lX:r5̛sdf \{k;F?6ϻXZ3Ρk͋z68 k1iY'"4[{zݺޫ8{ Vyw#{?cĞq9qbOnF|SWԘk~9ĆcKF#%ߚRCyk}FuL9㷮˵OsԑAm?lfa6I:.:i^18{Z[8V[ϖۊUw=ؼKh܅^x+OlxO,z W?!>r{>Nyƍ 6& [l$0.l[>=S׏>md.xvbs_-U;5&m=UN6̫ړSg?"{m92pGpe^αѳro]!km]#ss >RF;FŤ8W lgX[ʹ`;wx*' o9rbBܫ=OY'[Uy]q:6[lŇOlC ~ꜾKnl'ǰ\k_=Oz)W%`8:|yk\>gӗk83x5|@o4^ǔ3ެ[/Nz, ]|iZ/K1=lXphm0*g]'b~|L~3>{&DKO] VS~=\Ņ$->eI._~#nM9 7kؑs BO>, ۵;~×xكquArΥzcOyǔþ͵>gb?xU{]9ʙ+gw;;抚P11bb[1twr}}9kVz:a#vn9\w9=["[󡜜P,:5yW9gi{+s#GESlyFȗzhyy@@5Z|_~_Ƚ=N+?Nnvߒ?k_ wK-ފ+1ߝc͗?ǻޡ8b XuVK_~gJ {ūw t 쩁8LXE|nm{3`xVlm3wss{Lt&_sv t t t t |^ Ag{Ryy@@@@{Lt&_sv t t t t |^ Ag{Ryy@@@@{Lt&_sv t t t t |^ Ag{Ryy@@@@{Lt&_sv t t t t |^ Ag{Ryy@@@@{Lt&_sv t t t t |^ Ag{Ryy@@@@{Lt&_sv t t t t |^ Ag{Ryy@@gO?]/OXf? и?uuW__?\8_]Lt&]gY|\?^.bu ϊ]Yo]tl6Oc_{/?>C[ CCun6"+'A_a6+78@||w ~Î1c_[+xb`@^ 0!+FceM|1_`v ]SqW [^lbuZs1G]72<=#&F?C}׌9rmu.G!Ȉ_ڞ΄uoWc*Wtmp6yC->uG6ߗ ys8G\C_|Oރ}BnƗϜyΣ|Ϳ~U1]sK}x3k\cةw:~ѵnY;k4t5>dLZ+u~dϵ%GĂ-ɻ>.- m*g&:Yֿq~rl{g:68bccss9oyFyw74tŤd9/2(3ɏc#`5obus;u/w{ǻ_a?}`3xVV]ĀgM?=sKV? EIj{5e̵kٲIw| i~2\3rr S8^yt+j_z@o~ŘzuڭghUv=C;~-?nG'z?Lt&g]z~\sTFUY8&v޵s|W{y<$Ԧ=z>_3~*D{'Fdl vAx[QLW:W/6*&c7^k,h)~/uͲN?3‡כ5)}`Z3̱69?2(g/6sگ䏚tM8LZ5Lbuye>Lq /3'27ZXF9bs~~Gdv>`qȾ_誟Yˏ4Ɓ?1[֫33qЙΰy%UγsF}1 {r+c }F=r:\ީӞI$f} ~s͑^=,u1?c!0l䅜0oS73&6ћ۬]ܐSv9Vl;m0F'&sMF rMu}sb|黮H6Un>Ոsy`ذ'oFo-.ܹlZ<䙥|$kJ;5gą1΄k؎3k}qy1Y8w+=8b.]U6}%F?Y<F>=17.|9q;di@;ybJ{`eMhG`L9*qgq>4_vW"\wpZ'&l8kXiS}yZ~QlQ#8G8#wh#9;"TW9ļ51vlbwWg<߃;|msƼ{-k܏I=쀃xlHabٵNz~5lX>6ѩs0W%~'ފ9l[ƭr XQ;k3_3?ɯ_3.Ŭ=z\2ԀXg~]O֝Fh#y>'$יcrsMs.cG]І0:m3qЙu|b:(Yٔg>;[e&Xqwv37޹z^_sgOn>;>N#䳶'iۺs_;͋8FzHf-1?2k^k+F뻾c9s^u^Qmq{Գ>GQ>3 k>3HE9'l1Xu^k%c<٪ڮ]yi딵V뺭S3z'o[/Ds[G<@ f\ߡə.FXd7&\EG'Zڠv%Lyڨ@GĽd8p.9Lt&g_wڒr[lmoUfr~s8sr_kϘލ<#_n3xg{V{g3aݻwλV-lUn*Vjw t <f3a}Z8z[+|+&䞅 [}550 kO]]]]]W3qЙW[=qwOlGg1}kk55pT Agzz׿7|ٸ5'w|)ѮgLt 4@i׿Q%/qmW >WxYgݬ&kKb!odp$&R]rX޼97=6a MU>̟|͚IA;0ͳPc]55555k`)g[)'~ ߀`KMyy?Vɧ>WGLƗ1Uą}&/>+&s;|/V|-9n/.gbUn))y0ʹħ9g]sL꺆wYCMdHicG@@VzيU!?{Jl%g;pʛh,xay(t9Tܼ/t2;~hb "C 6~MZ$^q)]uwG\y2M9gAV]|<5b m>ʑkk555m lgVr 9Ƚ%l"Pr`΅ rDxJ6Zd+m\Ur*Od^."y/"凘#'K;<'X2f]FyΙׂ8;:Ȥ5N}֗=xNT9sd7ne/fmwA_Ǻ||t> Br//3ɡ*Q'}';R6;ag5NcKX }"#b.2q䜘̷91_!N R,J/~yyƀ/eEl|x?Xybɗaдq79fs@rO+U;̧]yk .cЦ555550 ۊUNAx|g9 |S#RB\彾3ʈG$^ޝÎz8wdÖVyz98g 9(ob3~I._~ڦOyމfskρ{F;b-fzD~tn>ZZ83r̄X[ρ=5d͞iOg^#:#>skρ{F;b-fzD~tn>ZZ83r̄X[ρ=5d͞iOg^#:#>skρ{F;b-fzD~tn>ZZ83r̄X[ρ=5d͞iOg^#:#>skρ{F;b-fzD~tn>ZZ83r̄X[ρ=5d͞iOg^#:#>skρ{F;b-b߾%_2RQ_ˇ?chQ .m<^Cc,e|q# oZpYmoOyUŬ,=oe9i#c^κ'&#\sb~_7O8csbGlbg1srΉ5{t37Ȏj 7>i<45\[{m>0۬ys\+yWb5yS] $8V%h=kZ`Q.W'p/c7G]lk3y9f+Xӛl E|3CϘyÿcrW[Wi?yr =#[zU}]O <Ӓόi;ݪ>n%\[k\ra|"y$/INe g] e-93OrڋB`Ҷ -8FvGsg(5>ZCը{a.K}ut] s55p%+޽z+޷bxϊmtg뽋Nϼsݭ s{cXw/3]eu#?ɣi[V^C8C1'CWW s5ict~b/Ӷ[/}~9]u+*F/q8Ws\ͷmM5|7o//G݋5HkįW[WjO͛gE33V|3xkL3=#X+G^3.ٷܙ4[\,+{ vo#.iuoy39y$/Ing"1./gp'_dhGe9ixO0ܚp.Ys3ʟa7W/?2R56ťZ+X/Y`g;ƭlt/X(xU|Wq]F5눵[g=֨q4䲶xƞX2<_Z3D^]'+&nq1^䘳\ߍ3r܊=ľH9Y{{)X?j:sS{Gsz#ǎx꾯{}epOY&cƖ36Wz0Nr^wÿ3r܊}xkjy6eRƽѧ{9>+k}m?~ݏ']g H=rKN9ea>5Gyhó :cG-'\yN{qبƌqY;iO#29u9qLyzhFres9smO}x}1|W\~a-okQ;[ki;̉zK|vա|^7j1m_,-={FI[>qOYtAV={&>n=]WOycC G1pO7a;j{sRYjCaN;ܫwDae\k#p33LwOG{\1=76}؋5{1t|3ؔX'๞TzZ+ b|Xs<%ç#ȋ-g |'9~WGϼs{dĚ˜ƖȤUjP]]gl2Zw 2觬9NŃZO5^!y13r iy>s |9)gp˫^pMQ<79{F;"3a="?sR!+x;p K 0|$mLK=zt.U9Ymp9qyrՏ5V6sbLJ#bGF.όil!yǏql@|'V}+Olȗĭ|8z-s .#sC1]j16] !Z1g3cO{LXOl~55<;3Gs)5dzٵ{`Wg&}t t 쩁>'nMt|J =#י]@@]\WTY,Ճv;pp 03fΔq7vsIRIڹVȌqƍGz@ fgc->RƼ}rU9_03~}>R;xq7GG^?Ry1ss3w=h|m~/9ߋߝ>9~Ϟ-Hs w ;lq;u]zq`c!&(Ş89Ҷ>;<գG;)Oc~l-efg5ˉ>\yjCt+ZWP-ZԢ֫k5}AA3׿eGƻqe͉O x|sCןzh#iq/0ssjS+%Ԇ0f;Zd6}َ-SeE'W[}Z^:_rtX͸*?=3~G=Әn=[G9YMwexAv[zԶ- Զ>}&U[gKO6یw;ws^yq*?=3~G=Әn=[G9YM&ʼnom?}Eg;S/y ti-vׯ~_统}F>=HG~׭ikRzN~nf˴oy?vDT>W)L6|V/SOУw>xUȃ90b|}ǹ}F>=HG~ܯUkV l=U٢}zYM'Lu_mlz:4kJ˹m4f9Ӈc4Ӈkr[9@'oO># kA @ <{<Վ?7նOUR>ew)϶{׷2|xYg?<ۚ1z ϖ˯wl{gd ('be]o^~X2g&ţq'=#߳3jefn}^^Z,'>#=#3rݜ:^@{_+=#~7w.0k$G}݈l(mġ=߫x,oϚ%YOv+ :tyz\%^K w|?Nt6JiW J Mw=W{0{=W/G?SaX^rϬ_e\| |Z/߭{EWR?J/o6f~gҺLݯ?k^v-*?5}5m/x\e@ȧ@Hшn<щC7(LL}_21]s2k~~پ|j_u}}{#>G 23iLШ~^>4+v@4w\=c%qח^g"eDZ$u|:]9@{$NI Ā 􌼯{{z=c|j}\(j3+ޖo @ q#>+=#cݼb;@{sW*=#ޚw1'1q2uL\E @ mмF111111111111111111111111111111111111111111111111111111111111111111111r?~~׿7~T.G8/礜o~o_~߾9?͜^^ __ca^11Q=?EӟoyH{pm|oy+Ǵ\Z[ه86;w᜺=;wU~WI;x]#nb\q{+>=[<2+[.3 =I\/;&w}ɛ1>U@ @ 1{jfJ[W__ղ%r1F,W#;zFhW5Wqݸ(vuzX8;96f:O_<;1߶QoǺ5cd cUƇodb b=Zm %WO#<~Zbj|Xo7ʇ[κ6:J~ܛ8+盇momՌ޺Z9sѭPb1]1rls:c˫82mgu @ @ j%]uWs?  u}vt9\ֻ\Ͻ?'syes( V^7ncü?mƍLqp~o7b^mܗP+PTZVؾͰ>6xGLnW:xreǘ9S=gcזݜo]gu>Wis沺g)*wεټiCצ111> Գ.j50ǫdžcr5E{'-ζ6Fb{iԾZ'8i(=y>,ͳkkdlؘs9,c9ƺuc66ohcsV3[y9?p=^'}彼@ e@D W:gK~u5N O>ӡ6cG vj+f۹\PQq8WCRÕq7󴏟e~<񍿽v<ʫv̑>8ij'v5"7'}uZJz3g,S[ČO?׆y87̯1ei4]j/3o,9sI9 ~d>#{{:E?:n 65vU?rQnܶmI_-}Jz`.&>ڜ[64~kZ Cq뎭ma\A~7uɵco>Է/GS.skCҞkmԙ+X898+c]slcIl_π:wfz=fuSqW G*W^́|X>8V/nC|WWfr1_S/on5{^=sg{3qָ7Մ?B/7M,ǟInn~v:zCkޚ@ ?P/nhB']\͋we^ ^J~ux @ |~vT:kX}}z[j{ڮk9Ҿ=]ק1ܹ3־b\icM9 ?uhv}Qjcܓ o ow>\ʵs V]fi7fc~soaWk.%ߛt5 ?ǻ^kk٦oqovOr?,_(;kuA]}~h&>Cmvw9y0vWƿj*f\֮ߕڱ7^]i.6'ڍ{-sy{m9ΖA^<ǟ2qqvY0櫵slJ?>Uޛs#&yYb~sFw A @ |vDσaȵ,ݗ޾'WWmW׹~~=ڞyٜ\T,ǻ15lLז}mVKYOJ`m-j36'Ys1ϱVǾ7^}j ʑlԚej<|my8w+{/ӎ 's{}yNsε8m}<f:c`+8}6v?>m]ה=jڿV|_un^ZbS=`-6۾&[9Zn^6n7O9ec>VǾwiޑ=s8[ <<ϭ5߸q&Ƽ|;x(x;+u1mƵkp5G_om[ 쾹2^ܧT~oymwfcc7-#G=0n6?7cZ;gisЧ}҂LIlYs.تC#_zT169:7okq5-vnql|djw\v4pʵ}w~Yyx}p{`c|l,m:vָ5j}&#'9}O϶?o[o !VoxWvv9Y[:˫Das n׮6KUݮ=<;Wx_Y{YYs}96-{i_yM_P?Y.ڷ?1;Ovgxu߹+|M:7˝U,['b~ߜϽ6rZ[o<+ڷ1}r{; lV#`=l`[v<s8u~u!۟>{'lrmNټ;aL}oͱBlw-st¯Ĵ3QO^wl|pML{0 .6s|Y|޲^rsl/xv,|σqus|gsszsذÿ9bloc&?jeD۳4[O^[αk항w_78K3~+Vvz1ڃyX(wE{Vq_t5Ո=}ur}X[s4?WmUn a|qm/믽 |.vT/uXݣ¿>C/:Z0 Block Text2 T]^T B*phR@2R 4>:Z0 Balloon Text3B*CJOJ QJ ^J aJphL/AL 30Balloon Text CharB*CJ^Jph:U@Q: >:Z0 Hyperlink>*B*^JphJVaJ >:Z0FollowedHyperlink>*B* ^JphNqNL>:Z0 EmailStyle55B*CJOJQJ^JaJph@j@ 9o0Comment Subject85\@/@ 8o0Comment Subject CharJ Jo0Revision:B*CJ_HmH phsH tH @@@ 0{D List Paragraph ;^r r  Table Grid7:V<0<OJ QJ P`P   No Spacing= CJOJ QJ _HaJmH sH tH 4O4 JDefault>7$8$aJPK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!Ptheme/theme/theme1.xmlYOo6w toc'vuر-MniP@I}úama[إ4:lЯGRX^6؊>$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2^?  666666666vvvvvvvvv666666 666666666666666666666666666 6666666666 666666666666 6666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~_HmH nH sH tH F`F >:ZNormalB*CJ_HmH phsH tH D@D >:Z0 Heading 1$$@&a$ 5CJ\J@J >:Z0 Heading 2$`@&^``5\@@@ >:Z0 Heading 3$$@&a$5\LL >:Z0 Heading 4$$V@&^Va$ 5CJ\>> >:Z0 Heading 5$@& 5CJ\:@: >:Z0 Heading 6$@&5\:@: >:Z0 Heading 7$@&5\TT >:Z0 Heading 8$$0@&^`0a$ 5CJ\> @> >:Z0 Heading 9 $@& 5CJ\DA`D Default Paragraph FontRi@R 0 Table Normal4 l4a (k ( 0No List \/\ Heading 1 Char'5B*CJ KH OJQJ\^JaJ ph^/^ Heading 2 Char)56B*CJOJQJ\]^JaJphX/X Heading 3 Char#5B*CJOJQJ\^JaJphX/!X Heading 4 Char#5B*CJOJ QJ \^JaJph^/1^ Heading 5 Char)56B*CJOJ QJ \]^JaJphP/AP Heading 6 Char5B*OJ QJ \^JphR/QR Heading 7 CharB*CJOJ QJ ^JaJphX/aX Heading 8 Char#6B*CJOJ QJ ]^JaJphJ/qJ  Heading 9 CharB*OJQJ^Jph6>@6 >:Z0Title$a$ 5CJ\T/T  Title Char'5B*CJ KHOJQJ\^JaJ ph<J< >:Z0Subtitle$a$ 5CJ\P/P  Subtitle CharB*CJOJQJ^JaJph4@4 >:Z0Header  !D/D 0 Header CharB*CJ^JaJph4 @4 >:Z0Footer  !D/D 0 Footer CharB*CJ^JaJphLCL !>:Z0Body Text Indent `^``X/X  0Body Text Indent CharB*CJ^JaJphPR@"P #>:Z0Body Text Indent 2"V^V`\/1\ "0Body Text Indent 2 CharB*CJ^JaJphHS@BH %>:Z0Body Text Indent 3 $V^V\/Q\ $0Body Text Indent 3 CharB*CJ^JaJph2Bb2 '>:Z0 Body Text&CJJ/qJ &0Body Text CharB*CJ^JaJph8P8 )>:Z0 Body Text 2(5\N/N (0Body Text 2 CharB*CJ^JaJphBQ@B +>:Z0 Body Text 3*$a$ 5CJ\N/N *0Body Text 3 CharB*CJ^JaJphRYR ->:Z0 Document Map,-D M OJ QJ ^J L/L ,0Document Map CharB*CJ^JphF"F >:Z0Caption.x5B*CJOJ QJ phF'F >:Z0Comment Reference CJ^JaJ88 1>:Z0 Com#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3ڗP 1Pm \\9Mؓ2aD];Yt\[x]}Wr|]g- eW )6-rCSj id DЇAΜIqbJ#x꺃 6k#ASh&ʌt(Q%p%m&]caSl=X\P1Mh9MVdDAaVB[݈fJíP|8 քAV^f Hn- "d>znNJ ة>b&2vKyϼD:,AGm\nziÙ.uχYC6OMf3or$5NHT[XF64T,ќM0E)`#5XY`פ;%1U٥m;R>QD DcpU'&LE/pm%]8firS4d 7y\`JnίI R3U~7+׸#m qBiDi*L69mY&iHE=(K&N!V.KeLDĕ{D vEꦚdeNƟe(MN9ߜR6&3(a/DUz<{ˊYȳV)9Z[4^n5!J?Q3eBoCM m<.vpIYfZY_p[=al-Y}Nc͙ŋ4vfavl'SA8|*u{-ߟ0%M07%<ҍPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ptheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] 5^~$Df3y < `  R a   #%&(*,.0246789:;>ACEFHIQV[^`5^~$Df3y < `  R U   !"#$%&'()*+&qHSHYCe$n'0a*<*x***,+q+++%,a,,,-S-  g}(u@FMVfozc%i7[+w- ..4bE]b*eg^-X-i/r6~ Uqz3'.------.. . .....G/I/P/R/Y/[/b/d/k//8'@JEPVI^h`\bdf%ii     !"#$%&'()*+,-/0123456789:;<=>@ABCDEFGHIJKLMNOPQSTUVWXYZ[\]^`bdfgijklmnopqrtuvxyz{|}~2228t88bƄ%0َ-DF'=aXXXXX:X_ +.!8a`a@Z%``$(  ! B *,  #  "<?h   S X?"B *,h   3  "0 (  PB    " PB   "' ' h  3 "  h  3 "% |) PB   "  h  3 " J PB   "''h  3  "!|)  PB   "  h  3  " v   PB   " } h  3  " } M   PB   "%%h  3  "t"|)   h  3  " b%  PB   "' ' h  3 "% * PB   "  Ph  3 " P h   3  " & PB !  "''PB "  "''h # 3 #"&* PB $  "6$7$h % 3 %"H!%" h & 3 &"&zZ  PB '  "6$"7$h ( 3 ("(Y PB )  "&Z&*h * 3 *"6$)( PB +B  "H!ZI!+h , 3 ,") # PB -  "H!I!h . 3 ."P( PB /  "$'%' h 0 3 0"d% (# PB 1  "h 2 3 2" Z PB 3  "\ Z] h 4 3 4"8) PB 5  "dZeh 6 3 6"  ) h 7 3 7" ad  h 8 3 8"a  h 9 3 9" !% h : 3 :"   h ; 3  ;"   PB <  " L PB =  "L  h > 3 !>"8 R !BB ? "PB @  "H!I! h A 3 "A" B$# "PB B  "# # h C 3 #C"7&&( #PB D  "(:)h E 3 $E" :)v:, $h F 3 %F"  %PB GB  " SH!Sh H 3 &H"   &h I 3 'I" 'PB J  "%7&PB K  " !PB L  "dPB M  "\ ,] aPB N  "&BB O "dS@TPB P  "(:)h Q 3 (Q"d:)@w* (PB R  "\ \ PB S  "@ A:)BB T "@PB U  "h V 3 )V"&P )PB W  "&PB X  "PPB Y  "PB Z  "v h [ 3 *["vP *PB \  "88PB ]  "  h ^ 3 +^" d +BB _ "S Sh ` 3 ,`"!* ,b  3 #" ? b  3 #" ? b   3  #" ? b  3 #" ? JB   #" ?JB   #" ?JB @  #" ?JB   #" ?B S  ?&H'HRHSHWHXH]H^Ha8Ht8tZb%t$tttJ&t jUt (6tRR\R$RdRRRRRRTRR R>R>R?ReReR4fRtfRTgRR +X(@1?'UUa     .[  +E4B*UUa  >*urn:schemas-microsoft-com:office:smarttags PersonName= *urn:schemas-microsoft-com:office:smarttags PlaceName=*urn:schemas-microsoft-com:office:smarttags PlaceType?*urn:schemas-microsoft-com:office:smarttags stockticker9*urn:schemas-microsoft-com:office:smarttagsplace9*urn:schemas-microsoft-com:office:smarttagsState   /cqwx@ f hNN?@ABCDEFGHIJKLMNO^`^J.PLP^P`L^J.p^`pB*OJQJo(ph^`^J. pp^p`OJ QJ o( @ @ ^@ `OJQJo( ^`OJ QJ o(o ^`OJ QJ o( ^`OJQJo( ^`OJ QJ o(o PP^P`OJ QJ o(^`^Jo(.^`^J.pLp^p`L^J.@ @ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PLP^P`L^J.^`^Jo(.^`^J.pLp^p`L^J.@ @ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PLP^P`L^J.LL^L`^Jo(. ^`>*^Jo(.  ^ `^Jo(.$ $ ^$ `^J.^`^J.L^`L^J.^`^J.dd^d`^J.4L4^4`L^J.^`^J.^`^J.pLp^p`L^J.@ @ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PLP^P`L^J.88^8`^J.^`^J.pLp^p`L^J.@ @ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PLP^P`L^J.^`^Jo(.^`^J.pLp^p`L^J.@ @ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PLP^P`L^J.^`^Jo(.^`^J.pLp^p`L^J.@ @ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PLP^P`L^J. 88^8`OJQJo( ^`OJ QJ o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo( ^`OJ QJ o(o ^`OJ QJ o( ^`OJQJo( ^`OJ QJ o(o PP^P`OJ QJ o(^`^J.^`^J.pLp^p`L^J.@ @ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PLP^P`L^J. ^`5^Jo(.^`^J.pLp^p`L^J.@ @ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PLP^P`L^J.@ @ ^@ `^Jo(.^`^J.pL^p`L^J.@ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PL^P`L^J.^`B*OJQJo(ph ^`OJ QJ o(o   ^ `OJ QJ o( ] ] ^] `OJQJo( --^-`OJ QJ o(o ^`OJ QJ o( ^`OJQJo( ^`OJ QJ o(o mm^m`OJ QJ o(hh^h`^Jo(.^`^Jo(.$ $ ^$ `^Jo(.@ @ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PLP^P`L^J.&^`B*OJQJo(ph ^`OJ QJ o(o   ^ `OJ QJ o(   ^ `OJQJo( xx^x`OJ QJ o(o HH^H`OJ QJ o( ^`OJQJo( ^`OJ QJ o(o ^`OJ QJ o(p^`pB*OJQJo(ph ^`OJ QJ o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo( ^`OJ QJ o(o ^`OJ QJ o( ^`OJQJo( ^`OJ QJ o(o PP^P`OJ QJ o(^`B*OJQJo(ph ^`OJ QJ o(o   ^ `OJ QJ o(   ^ `OJQJo( ZZ^Z`OJ QJ o(o **^*`OJ QJ o( ^`OJQJo( ^`OJ QJ o(o ^`OJ QJ o(^`^Jo(.^`^J.pLp^p`L^J.@ @ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PLP^P`L^J.^`^Jo(.^`^J.pLp^p`L^J.@ @ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PLP^P`L^J.&&^&`^J.^`^J.&&^&`^Jo()&&^&`^Jo()ff^f`^J.6L6^6`L^J.^`^J.^`^J.L^`L^J.^`^J.^`^J.pLp^p`L^J.@ @ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PLP^P`L^J.^`^Jo(.^`^J.pLp^p`L^J.@ @ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PLP^P`L^J.^`^J.^`^J.pLp^p`L^J.@ @ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PLP^P`L^J.p^`pB*OJQJo(ph ^`OJ QJ o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo( ^`OJ QJ o(o ^`OJ QJ o( ^`OJQJo( ^`OJ QJ o(o PP^P`OJ QJ o(hh^h`^Jo(.88^8`^J.L^`L^J.  ^ `^J.  ^ `^J.xLx^x`L^J.HH^H`^J.^`^J.L^`L^J.^`^Jo(.^`^J.pLp^p`L^J.@ @ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PLP^P`L^J.p^`pB*OJQJo(ph ^`OJ QJ o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo( ^`OJ QJ o(o ^`OJ QJ o( ^`OJQJo( ^`OJ QJ o(o PP^P`OJ QJ o(^`B*OJQJo(ph ^`OJQJo(   ^ `OJ QJ o( ] ] ^] `OJQJo( --^-`OJ QJ o(o ^`OJ QJ o( ^`OJQJo( ^`OJ QJ o(o mm^m`OJ QJ o( ^`OJQJo( ^`OJ QJ o(o p^p`OJ QJ o( @ ^@ `OJQJo( ^`OJ QJ o(o ^`OJ QJ o( ^`OJQJo( ^`OJ QJ o(o P^P`OJ QJ o(^`B*OJQJo(ph ^`OJ QJ o(o   ^ `OJ QJ o(   ^ `OJQJo( ZZ^Z`OJ QJ o(o **^*`OJ QJ o( ^`OJQJo( ^`OJ QJ o(o ^`OJ QJ o(/5h  |`xYv|b_T 5/O' %5 ;z6l6(Oi<?Oh$id~ _c1Pc"gzin}#vXw78Av)I0CJmSiytz)JwxsD7{'/'BwxG q~' 0d\U Q8~[h5}eS6 Hdr6 Ue06 3V ;NN//R        cN                 ,}rh                       $                                                              $        $                 t        P                "lB        ̠5ӎj                        J4'        "lB        &                 T9        (R        R        Hn1      R        P        R        "lB                  .~}ng               B                 P        k[                P        R                 R        -kK7]S5+ Hiqx}Mm+5A(5j3&,Rs"yW l"5A%W%n%) )+-).*~+c-,?,JN-@03G5iC6I748?8o8a9u9,r:t:!;";r<X=c(?!AlC0{DquE) FkGTvGHK_H#IxJKmL:CN[PEQ6BSSjTU/UDUHUh\UX RY@5Z>:Zp[[zB\t\7F]H!^,^ _(_/H_dd_i_$u`jbheEfm,gtMi"jlBWm`m$pHqJ"rWrOpswvWxpxu|}C}IkCm*u@h^ahVQS _=}a1n7E} [QK5/i*r6H_ bHyVnFa^&}  <qw;|LJqjBnI4I?2?a^yC6^C*3=P QM@IQ96"_<_7|To2;ZwHYyN!%9n8.=?'#`J <*_vn| !15aW}8O=hJ"xA%wUmVyyRc^>om207AIR0O'rh1/CppaiLRj,UU@a8@UnknownG* Times New Roman5Symbol3. * ArialeTimes New (W1)Times New Roman?Wingdings 2;.Agency FB3* Times;. * Helvetica7K@Cambria7.{ @Calibri5.*aTahoma?= * Courier New;WingdingsA BCambria Math"hStF\FsF!$WOMENS CANCER SCREENING PROGRAMMary MullinsNormal_Wordconv.dotm erica.jones6Microsoft Office Outlook@L@$߾@_ԛ@035՜.+,D՜.+,` hp  CabiDocumentSummaryInformation8 <CompObj"yMsoDataStore/=Р=K1GXNS5WOS3==2/=/=net Health Services !WOMENS CANCER SCREENING PROGRAM Title 8@ _PID_HLINKSA$Qhttp://www.asccp.org/E9 1http://en.wikipedia.org/wiki/Cervical_conizationa# Shttp://chfs.ky.gov/NR/rdonlyres/BEB8C3CD-9F59-40D0-9332-7F3C934FB514/0/MAP813D.pdfBhttp://chfs.ky.gov/dms/bcctpa#Shttp://chfs.ky.gov/NR/rdonlyres/BEB8C3CD-9F59-40D0-9332-7F3C934FB514/0/MAP813D.pdfBhttp://chfs.ky.gov/dms/bcctp  F'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.89qDocumentLibraryFormDocumentLibraryFormDocumentLibraryFormx+02@P?UJ"r/! xx WOMEN S CANCER SCREENING PROGRAM Mary Mullins erica.jones/                           ! " # $ % & ' ( ) * + , - . Item $Properties(0NSUQDHG10FW3Q==2/=Р=Item 5Q4Properties, This value indicates the number of saves or revisions. The application is responsible for updating this value after each revision.